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Abstract
Wiskott Aldrich Syndrome (WAS) is an X-linked immunodeficiency characterised 
by  low  numbers  of  low  volume  platelets,  eczema,  severe  immunodeficiency 
and  increased  susceptibility  to  malignant  and  autoimmune  diseases.  Wiskott 
Aldrich Syndrome protein (WASp), the product of the gene mutated in WAS is 
a multidomain cytosolic protein which acts by integrating downstream signals 
from cell surface receptor signalling cascades and transduces these signals into 
remodelling of the actin cytoskeleton. WASp is involved in cellular processes as 
diverse as cell polarisation, migration, phagocytosis and T cell synapse formation. 
Dendritic cell function and migration is known to be impaired in WAS. Specifically, 
dendritic cells lacking WASp in both mice and humans show an impaired ability to 
form transient actin rich adhesive structures called podosomes.
In this thesis, I am presenting the characterisation of a panel of domain deletion 
WASp proteins and a series of point mutations which, in children give rise to a 
range of disease phenotypes. I have expressed these constructs as GST tagged 
proteins and developed a bead based in vitro assay to asses the protein activity. 
I have compared the ability of these mutants to bind key regulators of WASp 
function, WIP and Cdc42, using a variety of immunoprecipitation techniques. 
Finally I have expressed EGFP tagged WASp proteins in myeloid cell lines to 
assess expression and stability of these constructs and in WASp null murine 
dendritic cells to assess their ability reconstitute podosomes.
Point mutations which cause WAS have slightly increased actin polymerisation 
activity compared to wild type WASp (WT) and have a normal affinity for Cdc42. 
Although they have a reduced affinity for WIP compared to WT, there is still 
significant association of WIP to mutant WASp in cells. These mutants have 
reduced  stability  and  different  patterns  of  phosphorylation  compared  to  WT, 
when expressed in myeloid cells lines. The EVH1, Polyproline and VCA domains 
of WASp are all essential for optimal actin polymerisation activity, whereas the 
Basic domain and the point mutation H246D (which inhibits Cdc42 binding) could 
be deleted with no loss of molecular activity. The EVH1 domain is essential for 
WIP binding and the Basic domain is essential for Cdc42 binding. Deletion of 
the EVH1 domain resulted in protein which had greater stability than WT WASp, 
suggesting that residues within the EVH1 domain are essential for the physiological 
degradation of WASp.
This work demonstrates that mutant WASp which causes WAS in patients has 
normal  molecular  activity,  but  the  regulation  of  mutant  WASp  degradation  is 
impaired in myeloid cells. Results from this project also suggest that Cdc42 is 
not essential for normal WASp functioning, but does appear to be essential for 
the phosphorylation of the Y291 residue, which is known to be critical for the 
regulation of WASp activity. Further work will aim to elucidate the functional (in 
vivo) significance of these findings.3
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Abi  Abl interactor 
ACK  Activated Cdc-42 associated 
Kinase 
ADF  Actin Depolymerising Factor 
ADP  Adenosine Diphosphate 
ALLM  Alanine-Leucine-Leucine-
Methionine polypeptide 
AmpR  Ampicillin resistance 
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Arp 2/3  Actin Related Protein 2/3 
complex 
Arp 3  Actin Related Protein 3 
ARPC  Actin Related Protein Complex 
ATP  Adenosine Triphosphate 
B  Basic domain deleted WASp 
construct 
Bacterial 
LB  Bacterial lysis buffer 
BCA  Bicinchoninic Acid (assay) 
BGH polyA Bovine growth hormone 
polyadenylation signal sequence
BlastR  Blastomycin Resistance Gene 
BSA  Bovine Serum Albumin 
Btk  Bruton's Tyrosine Kinase 
C  Central (cofilin homology) 
domain 
CCL19  Chemokine (C-C motif) Ligand 
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CD  Cluster of Differentiation 
CD2AP  CD2 Adaptor Protein 
Cdc-42  Cell Division Cycle protein 42 
Cdc-42 12V Constitutively active Cdc-42 
Cdc-42 
17N  Constitutively null Cdc-42 
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CIP4  Cdc42 interacting protein 4 
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cPPT  Central Polyproline Tract 
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domain  
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C-
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CTL  Cytotoxic T Lymphocyte (cell) 
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construct 
DCs  Dendritic Cells 
dEVH1  EVH1 domain deleted WASp 
construct 
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DMEM  Dulbecco's Modified Eagle's 
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DMSO  Dimethyl Sulphoxide  
DNA  Deoxyribonucleic Acid 
dNTP  Deoxynucleotide Triphosphate 
dPolyP  Polyproline domain deleted 
WASp construct 
DTT  Dithiothreitol 
dVCA  VCA domain deleted WASp 
construct 
dVCA bind VCA binding site deleted WASp 
construct 
ECCC  European Collection of Cell 
Cultures  
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EDTA  Ethylenediaminetetraacetic Acid 
EGF  Epidermal Growth Factor 
EGFP  Enhanced Green Flourescent 
Protein 
EGFR  Epidermal Growth Factor 
Receptor  
EM7P  EM7 prokayotic promoter 
ENA  Enabled (protein) 
ERK  Extracellular signal Related 
Kinase 
ERM  Ezrin, Radixin, Moesin family of Abbreviations
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EVH1  Ena Vasp Homology Domain 1 
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HSCP300  Haematopoietic stem cell protein 
300 
HSV TK 
polyA 
Human Simplex Virus Thymidine 
Kinase polyadenylation signal 
sequence 
ICAM-1  Intracellular Adhesion Molecule 
1 
Ig  Immunoglobulin 
IL  Interleukin 
IPTG  Isopropyl β-D-1-
Thiogalactopyranoside  
ITAM  Immunoreceptor Tyrosine-ased 
Activation Motif 
KanoR / 
NeoR 
Kanomycin / Neomycin 
resistance gene 
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KLH  Keyhole Limpet Haemocyanin 
KS  Kolologorov-Smirnov (test or 
statistic) 
LAT  Linker for Activation of T cells 
LB  Cellular Lysis Buffer 
LB broth  Luria-Bertani (broth) 
Ln  Natural logarithm 
LNT  Lentiviral (vector) 
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LPS  Lipopolysaccharide 
LTR  Long Terminal Repeat 
MAP 
kinase  Mitogen Activated Protein kinase
MCP1  Monocyte Chemoattaractant 
Protein-1 
MCS  Multiple Cloning Site 
MFI  Mean Flourescence Intensity 
MHC  Major Histocompatibility 
Complex 
MIP1α  Macrophage Inflammatory 
Protein 1α 
MMLV  Moloney Murine Leukemia Virus 
(reverse trasnscriptase) 
MOI  Multiplicity Of Infection 
MOPS  3-(n-Morpholino) 
Propanesulphonic Acid 
mRNA  Messanger Ribonucleic Acid 
mWASp  Murine WASp Abbreviations
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NA  Not Applicable 
Nap1  Nck-associated protein 1 
Nck1  Non-Catalytic region of tyrosine 
Kinase adaptor protein 1 
NF-AT  Nuclear Factor of Activated T 
cells 
NF-κB 
Nuclear Factor Kappa-light-
chain-enhancer of activated B 
cells 
NK  Natural Killer (cell) 
NMR  Nuclear Magnetic Resonance 
NOE  Nuclear Overhauser Effect  
NWASp  Neural Wiskott Aldrich Syndrome 
Protein 
OptiMEM 
Reduced serum modification of 
Eagle's Minimal Essential 
Medium 
PAGE  Polyacrylamide Gel 
Electrophoresis 
PAK  p21 Activated Kinase 
PAR6  Partitioning defective protein 6 
PBS  Phosphate Buffered Solution 
PBS-T  Phosphate Buffered Saline with 
Tween (0.1%) 
PC  Polyclonal 
PCH  Pombe Cdc-15 Homology 
(family) 
PCR  Polymerase Chain Reaction 
PE  Phycoerythrin  
PEI  Polyethylenimine 
PGK  Phosphoglycerate Kinase  
PH  Plekstrin Homology (domain) 
PHA  Phytohaemaglutanin 
PI(3)P  Phosphatidylinositol 3-
monophosphate 
PI(3,4)P2  Phosphatidylinositol 3,4-
bisphosphate 
PI(3,5)P2  Phosphatidylinositol 3,5-
bisphosphate 
PI(4)P  Phosphatidylinositol 4-
monophosphate 
PI3K  Phosphatidylinositol 3-Kinase 
PIP2   
[PI(4,5)P2] 
Phosphatidylinositol 4,5-
bisphosphate 
PIP3  Phosphatidylinositol 3,4,5-
Triphosphate 
PIP5K1  Phosphatidylinositol-4-
Phosphate 5-Kinase 1 
PIR121  p53 inducible messenger RNA 
PMA  Phorbol Myristate Acetate 
PMSF  Phenylmethylsulphonyl Fluoride 
PolyP  Polyproline region (proline rich 
region) 
PPP 
assays 
Purified Protein Actin 
Polymerisation assays 
PS  Penicillin and Streptomycin 
PSTPIP1 
Proline-Serine-Threonine 
Phosphatase Interacting Protein 
1 
PTP-PEST
Protein Tyrosine Phosphatase - 
proline, glutamic acid, serine and 
threonine-rich family protein 
tyrosine 
pUC ori  pUC origin of replication 
PVDF  Polyvinylidene Fluoride 
qPCR  Quantative Polymerase Chain 
Reaction 
RNA  Ribonucleic Acid 
RPMI  Roswell Park Memorial Institute 
(media) 
rpm  Revolutions Per Minute 
RRE  REV Responsive Element 
RT  Room Temperature 
RT PCR  Real Time Polymerase Chain 
Reaction 
SB  Sample Buffer 
SCAR  Suppressor of G-protein coupled 
Cyclic AMP Receptor 
SDF1  Stromal Cell Derived Factor 1 
SDS  Sodium Dodecyl Sulphate 
SEB  Special Electroporation Buffer 
SEW  SFFV- EGFP-WPRE (vector) 
SEWW  SFFV- EGFP-WASp-WPRE 
(vector) 
SFFV  Splenic Focus Forming Virus 
(promotor) 
SH2  Src Homology (domain) 2 
SH3  Src Homology (domain) 3 
SHD  SCAR Homology Domain 
Sig  Significance 
SIN  Self Inactivating (virus) 
SLAP  SLP76 Associated Protein Abbreviations
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SLP76  SH2-containing Leucocyte 
Protein of 76 kDa 
SNX9  Sorting Nexin 9 
SOS  Son Of Sevenless (a GAP) 
SP6P  SP6 promoter 
SSM  Corrected total model of squares
SSR  Error (residual) sum of squares 
SST  Corrected total sum of squares 
SV40 ori & 
earlyP 
Simian Vacuolating virus 40 
origin of replication and early 
promoter 
T7p  T7 promoter 
TAE  Tris-Actetate EDTA buffer 
TBS-T  TRIS Buffered Saline with 
Tween (0.1%) 
TCR  T Cell Receptor 
TE  TRIS EDTA (buffer) 
TEV site  Tobacco Etch Virus protease 
cleavage site 
TIRF  Total Internal Reflection 
Microscopy 
TOCA-1  Transducer of Cdc42 dependant 
actin assembly 1 
TRIS  Tris(hydroxymethyl) 
aminomethane 
TRITC  Tetraethylrhodamine-
Isothiocyanate 
UDG  Uracil DNA Glycosylase 
UT  Untransfected / Untransduced 
V  Verprolin homology domain 
v/v  Volume per volume 
VASP  Vasodilator-Stimulated 
Phosphoprotein 
VCA 
Combined casette of Verprolin 
homology, Central domain and 
Acidic region 
VZV  Varicella Zoster Virus 
WAS  Wiskott Aldrich Syndrome 
WASp  Wiskott Aldrich Syndrome 
Protein 
WAVE  WASp family verprolin-
homologous protein 
WdW  WIP with WASp binding domain 
deleted 
WICH  WIP and CR16 Homologous 
protein  
WIP  WASp Interacting Protein 
WIRE  WIP Related protein 
WPRE 
Woodchuck Hepatitis Post-
Transcriptional Regulatory 
Element  
WT  Wild Type 
XB  Purified protein pulldown buffer 
XLN  X-Linked Neutropenia 
XLT  X-linked Thrombocytopenia 
YFP  Yellow Flourescent Protein 
ZAP70  Zeta-chain (TCR) Associated 
protein Kinase of 70kDa 
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Introduction 1 
Wiskott Aldrich Syndrome (WAS) is a rare X-linked recessive immunodeficiency 
syndrome characterised by microcytic thrombocytopenia, eczema, susceptibility 
to infections and an increased risk of developing both autoimmune diseases 
and  malignancies.  It  was  first  described  in  two  brothers  with  chronic  bloody 
diarrhoea and infected eczema in 1937 (Wiskott, 1937), and the X-linked pattern 
of inheritance and platelet abnormalities were characterised in 1954 (Aldrich et 
al., 1954). The gene responsible for the disease was not cloned and sequenced 
until 1994 (Derry et al., 1994). The product of this gene was named the Wiskott 
Aldrich Syndrome protein or WASp, and is a regulator of actin polymerisation, 
playing a critical role in the remodelling of the actin cytoskeleton.
X-linked  thrombocytopenia  (XLT)  is  a  less  severe  condition,  associated  with 
microcytic thrombocytopenia resulting in susceptibility to bruising and bleeding. 
In  occasional  patients  thrombocytopenia  is  intermittent  (Notarangelo  et  al., 
2002),  and  some  patients  develop  transient  eczema,  and  but  severe  clinical 
manifestations are not associated with XLT. Mutations in the WASp gene were 
subsequently also found to be responsible for XLT (Derry et al., 1995; Zhu et al., 
1995; Villa et al., 1995). More recently 3 patients with a markedly different clinical 
phenotype, X-linked neutropenia (XLN), have been described. Each have point 
mutations localised to a discrete area, adjacent to a structurally distinct region 
(GTPase binding domain) within exon 9 of the WASp gene (Ancliff et al., 2006; 
Devriendt et al., 2001).
Clinical syndromes 1.1 
Wiskott Aldrich Syndrome 1.1.1 
The incidence of WAS is estimated at between 1 in 105 and 1 in 106 cases per 
live birth (Stray-Pedersen et al., 2000; Ryser et al., 1988; Perry, III et al., 1980). 
In 2007, 220 new cases of WAS were registered on the European Society for 
Immunodeficiency disease registry, and WAS was responsible for approximately 
3%  of  all  congenital  immunodeficiencies  registered  (including  antibody 
deficiencies) (ESID 2008).
The most consistent finding at presentation is small volume thrombocytopenia, but 
the classical triad of small volume platelets, eczema and susceptibility to infection 
is only found in 30% of patients (Sullivan et al., 1994). Common presentations 
include one or more of significant bruising and petichiae, eczema (often infected), 
bloody  diarrhoea,  sino-pulmonary  infections  and  otitis  media.  Presentation  is Chapter 1     
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usually within the first six months of life. Immunodeficiency in WAS is highly 
varied, even among members of the same family, and patients with the same 
genetic mutation. B and T cell function are both usually affected, and additionally 
there are defects in the innate immune system. A clinical scoring system has 
been adopted to categorise the severity of WAS and XLT (Notarangelo et al., 
2002) (figure 1.1).
Actin cytoskeleton in a normal immune response 1.1.1.1 
The dynamic regulation of the actin cytoskeleton is central to the ability of all 
leukocytes  to  function  normally.  When  not  challenged  by  infection  or  tissue 
damage, each different type of leukocyte shows its own pattern of trafficking 
between  tissues,  lymphoid  organs  and  the  circulation.  This  steady  state  re-
circulation is essential for immuno-surveillance of infection and malignancy, but 
also plays a vital role maintaining peripheral tolerance to self antigens and the 
viability of immune cells.
To re-circulate, leucocytes must be able leave the peripheral circulation. They 
do this via a complex, but stereotyped sequence of tethering, rolling and finally 
adhering to the vessel wall, before squeezing through the junctions between 
endothelial cells (diapedesis) (Springer, 1994). Once within tissues, cells migrate 
in response to interaction with both cells and the extracellular matrix, and to 
secreted paracrine mediators. All these functions require coordinated restructuring 
of the cytoskeleton to facilitate shape change, and to assemble and disassemble 
actin based structures adjacent to the cell membrane.
Once a cell has received a signal to migrate, it polarises and develops a leading 
edge at the “front” of the cell. The leading edge is characterized by dynamic, 
actin rich membrane protrusions, which are morphologically divided into broad 
ruffles (lamellipodia), spikes (filopodia) and podosomes. All three are thought to 
be critical in initiating cell locomotion. They are generated by actin polymerisation 
and are stabilized by cell membrane adhesion to the extra cellular matrix or to 
other cells (Ridley et al., 2003; Verkhovsky et al., 2003). Podosomes consist of 
an actin rich core surrounded by a ring of integrins and other structural proteins 
(Linder and Kopp, 2005; Marchisio et al., 1988; Marchisio et al., 1987; Tarone et al., 
1985). Podosomes localise to the leading edge of polarised cells, and it has been 
postulated that they play a role in adhesion and in sensing the microenvironment 
at the earliest stage of cell movement. 
Directional migration to soluble inflammatory mediators is called chemotaxis, and 
requires cells to detect differences in chemokine concentration around the cell Chapter 1     
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Score
Low
platelets
Small
Platelets
Eczema Infections Malignancy/
Autoimmunity
0.5 Intermittent Yes No No No
1 Yes Yes No No No
2 Yes Yes Mild and/or Mild No
2.5 Yes Yes Mod or Mod No
3 Yes Yes Mod and Mod No
4 Yes Yes Severe and/or Severe No
5 Yes Yes  Mild to
severe
Mild to
severe Yes
Eczema
Mild      Localised and responsive to treatment
Mod      Persistent but responsive to therapy
Severe     Requiring continuous treatments +/- systemic treaments
Infections
Mild      Recurrent uncomplicated respiratory infections
Mod      Recurrent infections severe enough to use prophylactic antibiotics or immunuglobulin
Severe     Life treatening infections
Intermittent X linked thrombocytopenia
X linked thrombocytopenia
Wiskott Aldrich Syndrome
Fig 1.1 Clinical scoring system for Wiskott Aldrich Syndrome - X linked thrombocytopenia
From (Jin et al., 2004; Ochs et al., 2007; Zhu et al., 1995)
surface, and respond to these differences by polarisation (Manes et al., 2005). Once 
at the site of insult, innate effector cells (such as macrophages and neutrophils) 
become specialised in phagocytosing microbes, damaged cells, tissue debris and 
apoptotic cells. This also requires rapid, complex and coordinated cytoskeletal 
rearrangement (Vicente-Manzanares and Sanchez-Madrid, 2004).
Dendritic cells (DCs) are professional antigen presenting cells, which both circulate 
and reside in peripheral tissues. They specialise in capturing both soluble and 
particulate antigen after which they migrate, via lymphatics, to T cell areas of 
lymphoid organs where they present this antigen to T cells (Randolph et al., 2005; 
Banchereau and Steinman, 1998). Both the long migration to lymphoid organs, and 
homing within lymphoid organs are highly specialised actin dependent functions. 
DCs play a crucial role in determining the outcome of this antigen presentation, 
Fig 1.1Chapter 1     
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as the soluble and cell surface “second signals” they give to lymphocytes are 
determined by the inflammatory environment in which they took up the antigen, 
and the degree of DC activation (Banchereau and Steinman, 1998). In response 
to inflammation, dendritic cells increase their rate of lymph node recirculation and 
thereby initiate the acquired arm of the immune response.
The  binding  between  peptide  loaded  MHC  class  II  and  antigen  specific  T 
cell  receptors  during  the  interaction  between  antigen  presenting  cells  (DCs, 
macrophages  or  B  cells)  and  CD4+ve  T  cells,  results  in  the  formation  of  a 
highly specialised structure called the T cell synapse (Vicente-Manzanares and 
Sanchez-Madrid,  2004). The  generation,  development  and  signalling  through 
a  T  cell  synapse  is  dependent  on  temporally  and  spatially  regulated  actin 
polymerisation. Similar interactions form between cytotoxic cell (CTLs, NK cells) 
and their targets.
The diversity and variability of the immunodeficiency and immune dysregulation 
seen in patients with WAS reflects the widespread involvement of coordinated 
actin polymerisation at every level of the immune response.
T cell defects 1.1.1.2 
In WAS the absolute numbers of lymphocytes may be normal or low at birth, 
but they appear to progressively decrease throughout childhood (Park et al., 
2004; Rawlings et al., 1999; Ochs et al., 1980). In humans, CD8+ve T cells are 
more frequently lower than CD4+ve T cells (Sullivan et al., 1994). T proliferative 
responses are impaired in many (but not all) patients across a wide range of T 
cell stimulants, including mitogens (Sullivan et al., 1994; Cooper et al., 1968), 
allogeneic cells (Sullivan et al., 1994; Ochs et al., 1980) and immobilised CD3 
monoclonal  antibody  (Molina  et  al.,  1993).  The  variability  of  T  proliferative 
responses is illustrated by Sullivan et al who found that 26% of patients had 
absent T cell responses to three different mitogens, but 46% of patients had 
normal responses to all three. By contrast delayed type hypersensitivity skin tests 
were more reliably impaired (90%) in WAS patients (Sullivan et al., 1994).
The functional significance of these impaired T cell functions tests is demonstrated 
by an increased susceptibility to the opportunistic fungal pathogen Pneumocystis 
jiriveci  (formally  P.carinii)  pneumonia,  other  disseminated  fungal  infections 
(candida, aspergillosis), disseminated herpes virus infections (varicella zoster, 
EBV and CMV) and severe complication from paramyxovirus infections (mumps, 
measles). Children with undetectable WASp levels have an approximately 25% 
risk per year of developing a severe fungal or viral infection (Imai et al., 2004).Chapter 1     
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At a cellular level, WAS T cells show abnormal morphology with reduced numbers 
of surface microvilli and a less structured submembranous actin cytoskeleton 
(Molina et al., 1992). They demonstrate reduced actin polymerisation at the site 
of antigen presenting cell engagement, impaired CD3 capping and impaired (but 
not absent) T cell synapse formation (Badour et al., 2003; Snapper et al., 1998; 
Gallego et al., 1997; Molina et al., 1993; Molina et al., 1992). Signalling through 
this synapse is also aberrant, resulting in reduced IL-2 secretion from T cells, 
which probably accounts for the abnormal T cell proliferative responses (Cannon 
and Burkhardt, 2004).
Defects in chemotaxis to the T cell lymphokines SDF1 and CCL19 have been 
described in WASp null cells for humans and mice (Gallego et al., 2006; Snapper 
et al., 2005; Haddad et al., 2001). Abrogated homing to T cell areas of lymph 
nodes has been seen in murine adoptive transfer experiments (Gallego et al., 
2006). In WAS patients, lymph node histology shows a relative depletion of small 
lymphoytes in T cell areas (Snover et al., 1981).
Recently several reports have described defects in the suppressor function of 
T regulatory cells in humans and in mice, despite normal numbers of thymic 
emigrants (Marangoni et al., 2007; Humblet-Baron et al., 2007; Maillard et al., 
2007; Adriani et al., 2007). It is likely that this contributes to the autoimmunity 
seen in WAS.
B cell defects 1.1.1.3 
B cell numbers and absolute levels of serum immunoglobulins (Ig) are usually 
normal  in WAS (Park et al., 2005), and although there is often a skewing of the 
normal Ig distribution. IgG levels are usually normal, whereas IgM is frequently 
reduced, and IgA and IgE levels are usually raised. WAS patients make poor 
specific responses to polysaccharide antibodies and other T dependent antigens. 
Isohaemaglutinin titres are characteristically low (Imai et al., 2004; Dupuis-Girod 
et al., 2003; Sullivan et al., 1994), and immunisation with the bacteriophage 
neoantigen phi X174 (a T dependent antigen) results in class switch but poor 
immunological memory (Ochs et al., 1980). By contrast responses to live viral 
vaccines are normal (Sullivan et al., 1994; Ochs et al., 1980).
The most common infectious complications of WAS bear the hallmarks of antibody 
deficiency (otitis media, pneumonia, sinusitis and sepis), illustrating the functional 
significance of the above laboratory observations. These clinical findings, however 
may just represent a lack of T cell help for the humoral response, and evidence 
from the WAS mouse model suggested that B cell activation is normal in the Chapter 1     
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absence of WASp (Snapper et al., 1998) (see section 1.1.1.10). 
More recent evidence from humans and from the WAS mouse model suggest 
that intrinsic B cell defects are also present in WAS. B cells show impaired actin 
polymerisation and abnormalities of morphology and polarisation (Westerberg et 
al., 2005; Westerberg et al., 2001; Facchetti et al., 1998). Although B cell receptor 
signalling is normal, B cell receptor capping is impaired (Westerberg et al., 2003; 
Westerberg et al., 2001; Zhang et al., 1999). Abnormal architecture of B cell 
areas of lymphoid tissue has been demonstrated in both WAS patients and in 
WASp null mice. The presence of atypical plasma cells and a progressive loss of 
volume and definition of the marginal B cell zones, have suggested impairment 
of B cell - T cell interaction, which may be responsible for the poor T dependant 
antibody responses seen in WAS (Westerberg et al., 2008; Westerberg et al., 
2005; Andreansky et al., 2005; Vermi et al., 1999; Snover et al., 1981).
Innate Immunity defects 1.1.1.4 
WAS macrophages and their blood-borne precursors, monocytes, show defects 
in their ability to polarise, migrate and phagocytose. They are severely impaired 
in  their  ability  to  form  podosomes  (Linder  et  al.,  2000a)  and  have  abnormal 
morphology (Calle et al., 2004). WAS macrophages and monocytes show impaired 
chemotaxis in vitro, in response to colony-stimulating factor-1 (CSF1), N-formyl-
methionyl-leucyl-phenylalanine  (fMLP),  monocyte  chemoattaractant  protein-1 
(MCP1) and macrophage inflammatory protein-1 (MIP1α) (Badolato et al., 1998; 
Zicha et al., 1998). They are able to bind these chemokines at the cell surface 
normally, and induce an appropriate respiratory burst following binding, suggesting 
some signalling through the chemokine receptors remains normal. Similarly WAS 
macrophages are able to move at normal speeds, but their directional movement 
is  impaired.  WASp  gene  replacement  in  WAS  macrophages  restores  normal 
chemotaxis (Jones et al., 2002).
WASp null macrophages show impaired FcγR mediated phagocytosis (Lorenzi 
et al., 2000), and impaired phagocytosis of apoptotic cells (Leverrier et al., 2001). 
Although binding apoptotic cells was not impaired, macrophages lacking WASp 
are incapable of forming the actin rich “phagocytic cup” necessary for phagocytosis 
(Tsuboi and Meerloo, 2007; Leverrier et al., 2001; Lorenzi et al., 2000). Pinocytosis 
and endocytosis, which do not require phagocytic cup formation, are normal in 
WASp null murine macrophages (Westerberg et al., 2003; Snapper et al., 1998).
Neutrophil function in WAS has not been studied as extensively as other myeloid 
cell lines. Defective phagocytosis has been demonstrated in murine WASp null Chapter 1     
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neutrophils (Zhang et al., 1999). Data concerning chemotaxis is contradictory. In 
vitro studies demonstrated no defect in chemotaxis towards fMLP or IL-8 (Zicha 
et al., 1998), but more recently abnormalities in transendothelial migration were 
detected using an in vitro system where neutrophils under physiological shear 
flow  interacted  with  activated  monolayers  of  endothelial  cells  overexpressing 
E-selectin  and  ICAM-1.  This  study  also  demonstrated  abnormal  β2-intergrin 
clustering, integrin mediated superoxide production, neutrophil adhesion, (all in 
WAS patient and murine WASp null neutrophils) and reduced perionteal neutrophil 
recruitment in response to intra-peritoneal thioglycolate (Zhang et al., 2006).
WAS patients have increased numbers of Natural Killer (NK) cells, but these 
cells have an impaired ability to kill target cells (Gismondi et al., 2004; Orange 
et al., 2002). In normal cells, WASp is recruited to the immune synapse formed 
between NK cells and target cells. Cytolytic granules are then released from 
the NK cell into the synaptic space, resulting in pore formation in the target cell 
plasma membrane. In WASp deficient cells there is reduced actin polymerisation 
at the immune synapse and resultant impaired cytotoxicity.
Dendritic cell defects 1.1.1.5 
WAS dendritic cells show many of the same abnormalities seen in macrophages. 
They have abnormal cell morphology, impaired ability to polarise, impaired ability 
to form podosomes, abnormal chemotaxis, abnormal migration and trafficking, 
and impaired phagocytosis (Snapper et al., 2005; de et al., 2005; Linder and Kopp, 
2005; Calle et al., 2004; Burns et al., 2001; Binks et al., 1998). Immature WAS 
DC characteristically form a long spindle shape on interaction with substratum, 
developing  two  or  more  poles,  without  a  clear  leading  edge.  In  response  to 
chemokine gradients these protrusions elongate and retract without coordinated, 
directional movement (Burns et al., 2001; Binks et al., 1998). Specifically WAS 
immature DCs show reduced chemotaxis toward CCL19 and CCL21 gradients, 
two chemokines crucial in homing to T cell areas within lymph nodes (von Andrian 
and Mempel, 2003). The functional importance of this is demonstrated by impaired 
in vivo DC migration to lymph nodes and failure of appropriate homing to T cell 
areas within lymph nodes in mouse models (Bouma et al., 2007; Snapper et al., 
2005; de et al., 2005).
Migration defects have not been described in mature DCs (Burns et al., 2004). The 
functional specificity of DCs changes with their state of activation and maturity. 
Immature DC are specialized for antigen uptake, DC activated following uptake 
of antigen become specialised in migration and antigen processing, and mature 
DC optimally present antigen to T cells. WAS DC have an impaired ability to form Chapter 1     
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functional antigen presenting contacts with T cells (Pulecio et al., 2008), and 
therefore the mechanism by which WASp deficiency hinders immune function 
changes throughout the immune response.
Wiskott Aldrich syndrome is one of few genetic immunodeficiency with a primary 
dendritic cell abnormality. Although WAS demonstrates abnormalities in every 
arm of the immune system, it is very likely that abnormal dendritic cell function 
plays a major role in the immunodeficiency and immune dysregulation seen in 
Wiskott Aldrich syndrome.
Platelets 1.1.1.6 
Low platelet count and low platelet volume is a consistent finding in WAS, and 
platelet volume is usually less than half the normal value for healthy controls 
(Ochs et al., 1980). The cause of these abnormalities remains unknown, however 
it is likely to be due to a combination of increased destruction of platelets and 
ineffective  thrombocytopoesis.  Following  splenectomy  WAS  patient’s  platelet 
counts  and  volumes  rise,  but  they  remain  significantly  reduced  compared  to 
healthy controls.
Bleeding is major cause of morbidity and mortality for patients with 30% suffering 
a  life  threatening  bleed  prior  to  diagnosis  (Sullivan  et  al.,  1994).  Intracranial 
haemorrhage has been observed in 2% of patients.
Eczema 1.1.1.7 
Eczema is present in 80% of patients with WAS (Sullivan et al., 1994), although 
the severity of symptoms is highly variable. It has been postulated that eczema 
in  WAS  is  caused  by  the  defective  migration  of  DCs  and  Langerhans  cells, 
resulting in a breakdown in the normal peripheral tolerance mechanisms to self 
skin antigens (Thrasher et al., 1998), but in fact few studies of pathogenesis have 
been reported.
The  relationship  between  WAS  and  atopy  is  less  clear.  Wiskott  patients 
characteristically have an eosinophilia and a raised IgE level, and food specific 
IgE has been detected in symptomatic patients (Root and Speicher, 1963; Huntley 
and Dees, 1957). The lack of specificity of these tests and the multiple alternative 
gastrointestinal pathologies associated with WAS, make it difficult to characterise 
the association with atopy.
Autoimmunity 1.1.1.8 
Autoimmunity, inflammatory conditions and vasculitis are common complication Chapter 1     
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of WAS and an incidence of 40% was described in the largest published cohort 
of patients (Sullivan et al., 1994). Autoimmune haemolytic anaemia is the most 
frequently  observed  complication,  but  autoimmune  neutropenia,  cerebral  and 
other vasculitis, inflammatory bowel disease, renal disease and Henoch-Schonlein 
purpura are all reported. A high serum IgM level is predictive of morbidity from 
autoimmunity (Dupuis-Girod et al., 2003).
Interestingly, a large cohort of WAS / XLT patients from Japan reported a high 
incidence of IgA nephropathy in patients without other WAS associated clinical 
complications (Imai et al., 2004). This is further discussed in sections 1.1.2 and 
1.2.1.
Malignancy 1.1.1.9 
As with other immunodeficiencies, WAS predisposes to malignancy. The most 
frequent malignancy described is B cell lymphoma, often associated with Epstein 
Barr Virus positivity, which may partly relate to defective immune surveillance. 
The incidence of all malignancies in WAS is 13% with a median age of onset of 
9.5 years (Sullivan et al., 1994), and historically these patients have had a poor 
prognosis.
 Mouse model of Wiskott Aldrich Syndrome 1.1.1.10 
Although  some  research  elucidating  the  functional  role  of  WASp  has  been 
performed on patient cells and tissues, a WAS mouse model (WASp knockout 
generated by gene targeted mutation) has been extensively used to address 
the systemic and cellular effects of WASp. The WAS murine model has many 
similarities, but also significant differences to the human clinical condition.
Like humans, WAS mice have peripheral lymphopenia and thrombocytopenia, 
although platelet size does not differ significantly from WT mice. Basic T and B 
cell subsets also appeared in normal proportions, and there was no specific loss 
of CD8 +ve T cells as seen in humans (Zhang et al., 1999; Snapper et al., 1998). 
T cell receptor signalling following CD3 stimulation and resultant T cell capping 
was abnormal, but stimulation using a combination of PMA and ionomycin was 
normal (Snapper et al., 1998). T cell signalling following CD28 mediated co-
stimulation is also impaired (Zhang et al., 1999). In contrast with human studies, 
signalling through the B cell antigen receptor was normal, and WAS mice showed 
normal levels of immunoglobulins, and had the capacity to generate antibodies 
to T dependant and independent antigens (Snapper et al., 1998). WAS mice 
show no eczematous skin changes but a prominent clinical feature is the strain 
dependant development of a severe colitis in the majority mice by the age of four Chapter 1     
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months (Snapper et al., 1998).
The lymphopenia seen in the WAS mouse model may at least partly be explained 
by defects in T cell development. Transgenic dVCA WASp mice show a block 
in early T cell development, resulting in impaired production of surface αβTCR 
and a failure to progress to single positive T cells. Zhang et al argue that the fact 
this defect is not seen in WAS mice is due to redundancy between NWASp and 
WASp and that a functional defect is only detected when the dominant negative 
dVCA WASp protein is expressed (Zhang et al., 2002).
X-linked Thrombocytopenia 1.1.2 
The true incidence of XLT is difficult to assess as many patients only have mild 
symptoms, mainly related to thrombocytopenia. It is likely that many cases of 
XLP will be diagnosed late or incidentally, and many other children with XLT have 
been  misdiagnosed  with  idiopathic  thrombocytopenia  purpura  (Canales  and 
Mauer, 1967). Like WAS, XLT has a high correlation with low platelet volume.
Although by definition patients with XLT cannot have serious clinical manifestations, 
it is becoming increasingly apparent many patients do develop WAS like clinical 
disease, in an abrogated form. The continuum of disease spectrum between the 
mildest asymptomatic form of XLT and the most severe manifestation of WAS 
has been long recognised (De Saint-Basile et al., 1991; Donner et al., 1988).
Platelet numbers, size and morphology are indistinguishable between WAS and 
XLT. Both groups have a life long risk of bleeding diathesis. Immune function tests 
in XLT, are often not completely normal, but they are much closer to normal than 
those seen in WAS. T cell proliferative responses to mitogens are slightly reduced 
compared to WT, but are not abnormal enough to have any clinical significance. 
XLT patients make class switched antibody responses with memory to phi X174, 
but the response is not as large or as long lived as control patient responses 
(Ochs and Rosen, 2007).
Eczema in XLT is either absent, mild or intermittent (Notarangelo et al., 2002), but 
is rarely severe. Levels of atopy, asthma and food allergy are indistinguishable 
between WAS and XLT.
Classically, WAS was thought to have a much higher incidence of autoimmune 
diseases than XLT. This has recently been questioned by a Japanese cohort of 
50 WAS and XLT patients, in which similar levels of autoimmunity were found 
(Imai et al., 2004). Patients with XLT seemed to be specifically susceptible to Chapter 1     
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developing an aggressive form of IgA nephropathy, which progressed to chronic 
renal failure in 2 out 5 patients by the age of 25. The authors postulated this 
discrepancy may arise from the impaired ability of WAS patients to generate the 
pathogenic class switched antigen.
The evidence for malignancy is clearer, with no published case series showing 
an increased incidence of malignancy with XLT. Despite this, a recent presented 
abstract of a multicentre long term follow up of 182 patients with XLT, suggested 
that XLT does predispose to malignancy, but there is much greater time lag before 
disease  appearance. They  demonstrated  that  5%  of  XLT  patients  developed 
malignancy, producing a cumulative incidence of approximately 30% by 40 years 
(Albert et al., 2008). A similar pattern was seen with autoimmunity (prevalence 
12%, cumulative incidence 40%). These figures are very similar to those for 
classical WAS (Sullivan et al., 1994).
X-linked Neutropenia 1.1.3 
4  families  have  now  been  described  with  X-linked  neutropenia  secondary  to 
missense mutation in or adjacent to the WASp GTPase binding domain (GBD) 
(Ochs, 2008; Ancliff et al., 2006; Devriendt et al., 2001). Each family has a unique 
mutation, resulting in a different amino acid substitution (L270P, S272P, I276S 
and I294T).
These  children  have  a  completely  different  clinical  syndrome  to  WAS  /  XLT. 
They  have  all  presented  with  severe  congenital  neutropenia  (<0.3x109/L)  or 
myelodysplasia. Additional findings have included a peripheral monocytopenia, 
normal  platelet  counts  with  slightly  increased  platelet  volume.  Where  tested 
neutrophil phagocytosis and oxidative burst were impaired compared to normal 
controls. Two out of three patients have demonstrated intermittently low absolute 
lymphocyte  counts  with  impaired  proliferative  responses  to  CD3  (but  normal 
to PHA). NK cells were low and CD4:CD8 ratios were reversed in all patients. 
Analysis of bone marrow has revealed haematopoetic arrest at the promyelocyte 
/ myelocyte stage, and one patient demonstrated trilineage dysplasia (myeloid, 
lymphoid and platelet). Cultured macrophages have, from one patient (I294T), 
demonstrated higher levels of cytoplasmic f-actin, impairment in cell polarisation 
and, although they do form structurally normal podosomes, they appear to be 
larger and cluster in ring formations (Ancliff et al., 2006).
Clinically  all  patients  so  far  have  remained  relatively  well  on  minimal  and 
conservative treatment. One patient has made a good response to G-CSF. The 
definitive  mechanism  of  neutropenia  is  as  yet  unconfirmed,  but  evidence  of Chapter 1     
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impaired diakinesis following cell division, resulting in apoptosis of cells containing 
WASp I294T, has been demonstrated (Moulding et al., 2007).
Genetics of WAS 1.2 
Positional cloning mapped the WASp gene to the Xp11.22-Xp11.3 locus (Kwan 
et al., 1991). The gene consists of 12 exons which give rise to a 502 amino acid 
protein, with a molecular mass of approximately 65 kDa (figure 1.2). The WASp 
protein consists of 5 functional domains and the positions of these relative to the 
exonic structure of WASp is demonstrated in figure1.2.
WASp gene mutations 1.2.1 
Over 150 different mutations have now been described to cause either WAS or XLT. 
These are made up of approximately 35% missense mutations, 25% splice site 
mutations, 15% nonsense mutations and 25% frameshift mutations (insertions, 
deletions and complex mutations) (Lutskiy et al., 2005; Jin et al., 2004; Imai et 
al., 2004). The majority of the missense mutations are found in exons 1-4 (within 
the EVH1 domain of the protein), whereas the splice site mutations are usually 
found towards the carboxyl terminus (exons 6 - 10). Other mutations are evenly 
distributed throughout the gene.
6 mutational hotspots have been described, where common mutations account 
for disease in at least 7 unrelated families (Ochs and Thrasher, 2006; Jin et al., 
2004). 168C>T (producing Tre45Met), 290C>N/291G>N (producing Arg86Cys/
His/Gly) and IVS6+5g>a (disruption of a variant splice site, resulting in a protein 
truncation at 190aa and normal full length protein) invariably result in some WASp 
protein production within cells. 664C>T (producing a truncation with a stop at 
aa211), IVS8+1g>n (exon 8 deletion) and IVS8+1 to +6 del gtga (exon 8 deletion) 
all result in a WASp null phenotype. Between them these hotspots account for 
25% of all WAS / XLT mutations. The mutation hot spots are illustrated in figure 
1.2.
Genotype – Phenotype correlations 1.2.2 
In view of the extensive clinical variability and large number of different causative 
mutations, for many years there was doubt as to whether a true genotype – 
phenotype link existed for WAS / XLT (Greer et al., 1996; Schindelhauer et al., 
1996; Sullivan et al., 1994). Several large studies have now clearly demonstrated 
a correlation between disease severity and cellular levels of WASp protein (Lutskiy 
et al., 2005; Jin et al., 2004; Imai et al., 2004; Lemahieu et al., 1999; Zhu et al., 
1997; Remold-O’Donnell et al., 1997). In light of this, a diagnostic assessment Chapter 1     
34
39 145 225
235
257 288 312 417 430
446
469 487 502
NH2 COOH
1 2 3 4 5 6 7 8 9 10 11 12
a
b
c
(a) DNA structure of WASp gene
Numbering starting at the begining of the hu-
man Xp11.4-p11.21 locus.
(b) mRNA / cDNA structure of the WASp gene
(c) WASp domain structure of protein
     Mutation hotspot (missense)
Θ  Mutation hotspot (splice site)
Purple hotspots are WASp positive
Blue hotspots are WASp null
*
Fig 1.2 Structure of WASp gene and protein
of patients with WAS / XLT should include both sequencing the WASp gene 
for mutations in genomic or cDNA, and an assessment of lymphocyte WASp 
expression (using either a Western blot of lymphocyte lysate or flow cytometry of 
permeablized lymphocytes immunostained for WASp (Yamada et al., 1999)).
75% of patients with WASp mutations who express full length WASp protein have 
missense mutations, with the majority of the remainder having variant splice site 
mutations (usually IVS6+5g>a). Of these patients, 75% have reduced cellular 
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levels of WASp (usually under 20% normal levels (Lutskiy et al., 2005)), whereas 
in 25% the levels are normal (Jin et al., 2004; Imai et al., 2004). For patients with 
variant splice site mutations the protein expressed is normal full length WASp, 
but  this  only  represents  a  fraction  (usually  about  30%)  of  the  WASp  gene’s 
transcriptional  output.  Lutskiy  et  al  described  a  patient  with  an  IVS6(+5)g>a 
mutation in whom there was normal WASp expressed in T cells, but not B cells, 
suggesting that splicing patterns are cell specific (Lutskiy et al., 2005). Patients 
with missense mutations produce only mutant WASp protein.
The majority of patients with detectable cellular WASp levels have XLT. In one 
study 78% of WASp positive patients had no serious or recurrent infections and 
only mild, transient, or no eczema (clinical score 1 or 2). 22% of patients developed 
WAS (clinical score 3-5), but the majority of these attained a clinical score of 5 
on the basis of developing autoimmunity (Imai et al., 2004). Interestingly patients 
with missense mutations in exon 4, seem to be more likely to have undetectable 
WASp levels and have a more severe clinical phenotype (Lutskiy et al., 2005; Zhu 
et al., 1997).
85%  of  patients  with  absent  WASp  expression  (or  expression  of  truncated 
WASp only) had frameshift mutation, nonsense mutation, or invariant splice site 
mutations. Approximately 90% of WASp null patients developed full blown WAS 
(clinical score 3-5). This figure may be falsely low as children may have undergone 
bone marrow transplant on the basis of lack of WASp expression, or a sibling’s 
clinical phenotype, and prior to developing WAS qualifying symptoms. In some 
patients fully symptomatic WAS takes 2-3 years to develop (Jin et al., 2004).
The  level  of  WASp  mRNA  in  cells  from  patients  with  missense  mutations  is 
normal, suggesting that transcription of mutant WASp genes is not impaired and 
that low WASp levels are due to proteolysis (Lutskiy et al., 2005; Zhu et al., 1997). 
For nonsense and frameshift mutations, the WASp products are very likely to be 
incorrectly folded, as well as functionally inactive, and will therefore be efficiently 
ubiquitinised, explaining the undetectable protein levels seen in patients. This is 
less likely to explain the reduced levels of protein seen with patients with single 
amino acid changes.
With a better understanding of how the genotype and proteotype relate to clinical 
phenotype, Imai et al reanalysed the clinical consequence of thrombocytopenia 
in 50 patients based on their WASp expression. They found that there was a 
difference  in  the  presenting  symptom  between  the  two  groups,  with  WASp 
null patients most commonly presenting with petichiae, but WASp+ve patients Chapter 1     
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presenting with active bleeding. Both groups had similar rates of intracranial 
haemorrhage, but the outcome following this was much more favourable for the 
WASp+ve group. Similarly the WASp null group of patients were much more 
likely to develop serious bleeding of the gastrointestinal tract (Imai et al., 2004). 
Whether these patterns are borne out in larger case series, remains to be seen.
Although the relationship between clinical phenotype and WASp expression is 
clear, it is not absolute. Patients with the same mutation, and even within the same 
family, can have markedly different clinical courses, and express different levels 
of WASp protein. This suggests that the clinical phenotype of WASp mutations is 
highly influenced by other (genetic and environmental) factors, which also account 
for the heterogeneity and diversity of defects seen within the disease.
WASp family proteins 1.3 
WASp was the first member described of a new family of proteins, which now 
contains five mammalian members. WASp is only expressed in haematopoeitic 
cell lineages (Derry et al., 1994), however neural WASp (N-WASp), identified in 
1996 (Miki et al., 1996), is ubiquitously expressed. Since then 3 further mammalian 
proteins in the same family have been discovered and these are known by one 
of 2 acronyms - WAVE (WASp family verprolin-homologous protein) or SCAR 
(suppressor of G-protein coupled cyclic AMP receptor) (Suetsugu et al., 1999; 
Machesky  and  Insall,  1998;  Miki  et  al.,  1998b).The  comparative  structure  of 
WASp family members is shown in figure 1.3.
The family is defined by a common module at the carboxyl terminal, which is 
made up of a verprolin (V) homology domain (also called WASp homology 2, WH2 
domain), followed by a central (C) domain and a final an acidic (A) sequence. 
Together this will be referred to as the VCA domain and individual components 
will be referred to by their single letter abbreviation. The VCA domain is the 
“output” domain of WASp family proteins, and once bound to the Arp2/3 complex 
it mediates actin polymerisation. Other proteins containing verprolin homology 
domains include WIP and β thymosin (see sections 1.7 and 1.6.2). Additionally all 
proteins have a polyproline domain (P) of approximately 100 amino acids length 
adjacent to the VCA, and a short basic domain (B) towards the amino terminus.
WASp  and  N-WASp  also  have  an  amino  terminal  domain  called  the  WASp 
homology domain 1 or the Ena/VASp homology domain 1 (EVH1), and a central 
GTPase binding domain (GBD). The WAVE proteins have a unique domain, called 
the SCAR homology domain (SHD) at their amino terminus.Chapter 1     
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Evolution of WASp family proteins 1.3.1 
WAVE proteins appear to have evolved more recently than WASp / NWASp 
and seem to have become critical once cells start to become motile. WAVE 
homologues are found in Drosophila, C. elegans and Dictyostelium, but not in 
yeasts.  The  WASp  family  protein  in  Saccromyces.  cerevisiae  (Las17/Bee1p) 
has features of both WASp and WAVE proteins, containing an EVH1 domain, 
but no GBD. In more primitive organisms WASp proteins primarily function for 
intracellular trafficking.
Work using knockout models in mice and Drosophila suggest that WASp / NWASp 
and  WAVE  proteins  have  discrete  functions  and  that  redundancy  of  function 
between them is at best partial.
NWASp 1.3.2 
NWASp shows approximately 50% sequence homology to WASp (Fukuoka et 
al., 1997). Structurally it is unique in that it contains a second verprolin homology 
domain adjacent to the carboxyl terminal VCA, although the functional significance 
of this remains unknown. Otherwise its domain structure is very similar to WASp 
(figure 1.3).
Although NWASp expression is ubiquitous among mammalian cells, expression is 
greatest in brain tissue. NWASp mutations have never been detected in humans, 
and  NWASp knockout  mice  are  emybryonically lethal  at day  11 (Snapper  et 
al., 2001; Lommel et al., 2001). Early studies of NWASp function in cells had 
suggested that it acted by translating Cdc42 signals into actin polymerisation, 
resulting  in  filopodia  formation.  Cells  from  the  embryonically  lethal  knockout 
mouse referenced above did not bear this out, and both studies were able to 
demonstrate Cdc42 induced filopodia formation in the absence of both NWASp 
and WASp. Motility of the intracellular pathogens Shigella, vaccinia virus and 
enteropathogenic Escherichia coli, (all of which are known to hijack the cellular 
Arp2/3  actin  polymerisation  machinery  within  cells  to  move),  was  however 
impaired in NWASp knockout cells. These results and others (Yamaguchi et al., 
2005; Weaver et al,. 2002; Benesch et al., 2002), suggest a non-redundant role 
for NWASp in invadipodia and podosome formation, and in vesicular traficking 
within cell.
WAVE / SCAR proteins 1.3.3 
WAVE proteins do not contain the autoinhibitory loop found in WASp and NWASp 
(see section 1.4.6) and as a result they exist in a relatively constitutively active Chapter 1     
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state, both in vitro and if overexpressed in cells (Machesky et al., 1999). WASp 
and NWASp are directly actived by the Rho type GTPase Cdc42, whereas WAVE 
proteins are actived downstream by Rac (another Rho type GTPase), despite 
lacking a GTPase binding domain (GBD). Within cells, WAVE1 and WAVE2 form 
a stable pentamic complex with PIR121 (p53 inducible messenger RNA), Nap1 
(Nck-associated protein), Abi (Abl interactor), and HSPC300 (haematopoietic stem 
cell protein 300), with only Abi and HSPC300 interacting directly with WAVE (via 
the SCAR homology domain). The Arp 2/3 complex also contitutively associates 
with WAVE within this complex, but is not activated under resting conditions. 
WAVE activation of Arp2/3 occours following Rac or Nck binding to PIR121, which 
provides the mechanism of Rac regulation of WAVE function.
The exact mechanism of this signal transduction remains controversion, and 
it is likely that prolyproline domain binding proteins will also contribute to the 
regulation of WAVE  activity. Like WASp, phosphorylation, degradation and spatial 
localisation of WAVE regulatory proteins provide further levels of complexity to 
the control of WAVE activity.
All three WAVE proteins show different tissue distributions, with WAVE 2 being 
most widely distributed and WAVE 1 showing highest expression in brain tissue. 
Functionally  WAVE  proteins  are  involved  actin  cytoskeletal  rearrangements, 
and have been specifically implicated as downstream effectors of Rac induced 
lamelipodia formation (Miki et al., 1998b).
Molecular structure of WASp 1.4 
WASp has no intrinsic catalytic or transcriptional activity of its own, it merely acts 
as a control hub, integrating downstream mediators of cell surfacing signalling 
cascades,  and  translating  these  signals  into  expansion  of  the  dendritic  actin 
cytoskeleton, via the protein complex Arp2/3. The activation of WASp imparts 
two signals - temporal and spatial actin remodelling.
WASp’s structure reflects this complex function. Its highly modular domain structure 
facilitates the binding of several different proteins or phospholipids simultaneously 
to different protein regions (figure 1.4). Its flexible structure (lacking disulphide 
bonds) allows conformational changes in response to these interactions. A discrete 
Arp2/3 binding effector domain (VCA) remains hidden until WASp is activated by 
appropriate conformational changes, induced by the interaction of mediators with 
other domains. This provides the biological mechanism of signal integration.Chapter 1     
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EVH1 B PolyP V C A GBD
Fig 1.4 WASp binding partners
In vivo binding partners of WASp are shown in black, interactions only estabilished in vitro are 
shown in blue, and interactions only demonstrated with NWASp are shown in red
EVH1 domain 1.4.1 
Proteins with homologous domains 1.4.1.1 
The Ena-VASP homology domain 1 (EVH1) is a proline rich protein module of 
approximately 115 amino acids. It is found in actin scaffold proteins (Mena, VASP, 
Evl) and has been functionally implicated in the assembly and spatial localisation 
of multi-protein complexes involved in actin cytoskeletal remodelling. It binds the 
proline rich amino acid target sequence of L/FPPPP/E via a series of conserved 
aromatic amino acids. The structure of the Mena EVH1 domain bound to its 
polyproline target demonstrated a similarity in tertiary structure to the Plekstrin 
Homology (PH) domain, a PIP2 binding domain involved in membrane localisation 
(Prehoda et al., 1999). As a results of these findings, and other experimental 
data, it has been postulated that the WASp EVH1 domain may be responsible for 
targeting WASp to the cell membrane, where it directly interact with membrane 
bound signalling complexes (Volkman et al., 2002).
Fig 1.4
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Interaction with WIP and crystal structure 1.4.1.2 
The best characterised binding partners of the WASp / NWASp EVH1 domains 
are the verprolin family proteins. Verprolin is a yeast protein involved in cell 
polarity, endocytosis and cytoskeletal organisation (Donnelly et al., 1993). Three 
mammalian verprolin family proteins have been identified and each are known to 
interact with the WASp EVH1 domain; WASp interacting Protein (WIP) (Ramesh 
et al., 1997), CR16 (Ho et al., 2001) and WIP and CR16 Homologous protein 
(WICH, also called WIRE – WIP related) (Kato et al., 2002; Aspenstrom, 2002). 
WIP is the mammalian homologue of verprolin, and WIP expression in verprolin 
deficient yeast reverses the defects of Verprolin deficiency (Vaduva et al., 1999). 
WIP is ubiquitously expressed, whereas CR16 expression is largely restricted 
to neural tissue. WICH has greatest expression in the brain but is significantly 
expressed in the lung and in the gastrointestinal tract. WICH only binds weakly to 
WASp, but binds strongly to NWASp. As neither WICH nor CR16 are expressed 
haematopoietic cells, WIP is the only physiological Verprolin binding partner of 
WASp.
The  crystal  structure  of  the  NWASp  EVH1  domain  bound  to  the  target  WIP 
sequence was solved by Volkman et al in 2002 (Volkman et al., 2002). Firstly the 
authors demonstrated the minimal sequences of NWASp and WIP required for 
interaction. The entire NWASp EVH1 domain and a 25 amino acid sequence from 
the carboxyl terminus of WIP were required for binding. This suggested a much 
longer interaction sequence than expected, and the WIP binding sequence was 
over double the length of the minimal required sequence in other EVH1 domain 
target  proteins.  Like  other  EVH1  targets,  this  sequence  contained  a  similar 
polyproline motif (DLPPPEP).
NMR spectroscopy was performed on a recombinant protein comprising of the 
NWASp EVH1 domain bound to the 25 amino acid WIP sequence via a short linker 
sequence. This demonstrated the WIP sequence wrapping circumferentially around 
the entire EVH1 domain, and therefore interacting with residues throughout the 
EVH1 domain (Volkman et al., 2002). Subsequent investigations have suggested 
the optimal interaction between NWASp and WIP is even longer, involving 34 
WIP amino acids, and three distinct WIP motifs which anchor NWASp binding via 
hydrophobic contacts (Peterson et al., 2007; Zettl and Way, 2002). This offers a 
possible explanation for the distribution throughout the entire EVH1 domain of 
missense mutation causing WAS / XLT, and yet not throughout the rest of the 
protein (see section 1.7.4). The functional importance of WASp – WIP interaction 
is discussed more fully in section 1.7.Chapter 1     
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PIP 1.4.1.3  2 binding
The  binding  of  PIP2  to  the  amino  terminal  WASp  (or  N-WASp)  has  been   
demonstrated in vitro (Imai et al., 1999; Miki et al., 1996). The physiological 
importance of this finding has been questioned by the Rohatgi et al and others, 
who demonstrated that NWASp with the EVH1 domain deleted still responded 
to activation by PIP2, and demonstrated that the basic domain was essential for 
PIP2 responsivity (Volkman et al., 2002; Rohatgi et al., 2000; Prehoda et al., 
2000). Higgs and Pollard found the opposite effect for EVH1 and basic domains of 
WASp in a series of similar in vitro experiments. They found that WASp fragments 
containing the basic domain were unable to bind or respond to PIP2 containing 
vesicles (Higgs and Pollard, 2000). Whether or not PIP2 binds to the WASp EVH1 
domain in vivo remains controversial and unclear. These experiments and others 
raise the possibility of differences in the site of PIP2 binding between WASp 
and NWASp, and also the possibility of multiple PIP2 binding sites (Yarar et al., 
2002).
Src family kinase binding 1.4.1.4 
Src  family  protein  kinases  are  membrane  associated  proteins  which  act  in 
signal transduction pathways downstream from surface receptor ligation. Each 
kinase  has  three  domains;  a  catalytic  domain,  an  SH2  domain  which  binds 
phosphorylated tyrosine residues, and an SH3 domain which binds structural 
motifs in polyproline domains inducing activation of the catalytic domain. There 
are 8 Src family kinases, several of which have been implicated in binding to the 
WASp polyproline domain via their SH3 domains (see section 1.5.5).
Schulte et al demonstrated Src kinase Lck binding to a 10 amino acid sequence in 
the middle of the EVH1 domain of WASp (83-93 amino acids) (Schulte and Sefton, 
2003). The WASp sequence bound to the catalytic domain of Lck and inhibited 
its kinase activity to other substrates, both in vitro and in vivo (using a protein 
overexpression system in Cos7 cells). This is a unique regulatory mechanism of 
Src kinase activity.
Arp 2/3 binding and EVH1 contribution to WASp activation 1.4.1.5 
Suetsugu et al demonstrated weak Arp 2/3 binding to the EVH1 domain, and a 
cooperative contribution of the EVH1 domain to the interaction of Arp 2/3 to the 
VCA Central region. They also demonstrated that the EVH1 provides an intrinsic 
contribution to WASp activity, which they proposed was due to aligning the Arp 
2/3 complex optimally for VCA binding and Arp 2/3 activation. This contribution 
is overridden in the presence of Cdc42 and PIP2. Other results suggested a Chapter 1     
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contribution to WASp activity from EVH1 binding partners in addition to its intrinsic 
activity (Suetsugu et al., 2001a).
Deletion of the EVH1 domain 1.4.1.6 
The biochemical and functional effects of deletion of the EVH1 domain have been 
assessed in several studies. These contradictory findings are summarised in figure 
1.5. Generally they show that deletion of the EVH1 domain results in impaired 
actin polymerisation and actin based motility, although the impairment of in vitro 
activity can be overcome by Cdc42 and PIP2. These results support an intrinsic 
role for the EVH1 domain in WASp activation. One study demonstrated impaired 
recruitment  to  Vaccinia  induced  actin  tails  with  a  dEVH1  NWASp  construct 
(Moreau et al., 2000), whereas other studies have shown normal recruitment 
to T cell – APC contact sites (Cannon et al., 2001) and PIP2 coated vesicles 
(Benesch et al., 2002). Whether the EVH1 domain is absolute required for WASp 
localisation to certain sites of active actin polymerisation, or whether this finding 
is a peculiarity of the Vaccinia system, remains to be determined.
Basic domain 1.4.2 
The Basic domain consists of a sequence of 10 amino acids, 6 of which are lysine 
residues. A similar basic domain is found in all WASp group proteins, although 
the specific sequence is poorly conserved. The region was originally thought to 
play an important role in the binding of the VCA domain acidic region as part 
of WASp’s autoinhibitory conformation (Miki et al., 1998a). It has subsequently 
been established that the basic domain is not essential for the formation of the 
autoinhibitory fold in either WASp or NWASp (Kim et al., 2000; Rohatgi et al., 
2000). There is, however, evidence of a role for the basic domain stabilizing the 
autoinhibitory fold once it has formed (Leung and Rosen, 2005; Suetsugu et al., 
2001b), through the (non-activating) binding of Arp2/3 (Suetsugu et al., 2001a; 
Prehoda et al., 2000) (see section 1.4.6 for further discussion).
Phospholipid binding 1.4.2.1 
The Basic domain of NWASp has been shown to bind the acidic phopholipids 
PI(4,5)P2, PIP3, PI(3,4)P2 and phosphatidic acid, all of which contribute to NWASp 
activation in vitro (Papayannopoulos et al., 2005; Otsuki et al., 2003; Rohatgi et 
al., 2000; Prehoda et al., 2000). Of these, PI(4,5)P2 (PIP2), both has the highest 
affinity  for  NWASp  and  greatest  abundance  in  cell  membranes. The  binding 
of PIP2 to the Basic domain can be eliminated by mutating four of the lysine 
residues within the domain to neutral amino acids, illustrating the importance 
of ionic attraction in this binding (Rohatgi et al., 2000). In contradiction to these Chapter 1     
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findings, Higgs and Pollard were unable to detect binding of a WASp fragment 
containing both Basic domain and GBD to PIP2 containing vesicles (Higgs and 
Pollard, 2000).
The basic domain also plays an important role in attracting Cdc42 to WASp for 
binding to the GBD, and this is discussed more fully in section 1.5.1.3 (Hemsath 
et al., 2005).
Deletion of the Basic domain 1.4.2.2 
Suetsugu et al compared the activity of NWASp constructs with the Basic domain 
deleted to a range of other NWASp constructs in a series of in vitro assays. They 
found that Basic domain deletion severely impaired Arp2/3 mediated motility of 
NWASp coated beads and bovine brain lysate actin polymerisation (assessed 
using  a  pyrene  based  assay).  By  contrast,  the  same  Basic  domain  deleted 
construct appeared constitutively active in a purified protein pyrene assay, having 
greater activity in the absence of Cdc42 than WT NWASp had in the presence 
of Cdc42 (Suetsugu et al., 2001b). Although the authors conclude that these 
results can be explained by dysregulated activity of the dBasic domain construct, 
if this were true similar results would be expected from both pyrene based actin 
polymerisation assays. An alternative explanation is that the bovine brain lysate 
contains an inhibitory factor whose interaction with WASp is stabilised by the 
deletion of the basic domain, and this binding negates the constitutive activity of 
the purified NWASp protein.
Similar results (constitutive activity in a purified protein system, but impaired 
activity in a Xenopus egg lysate system) were demonstrated by Rohatgi et al 
(Rohatgi et al., 2000). They additionally showed a relative (but not absolute) 
insensitivity to PIP2 induced NWASp mediated actin polymerisation. Impaired 
actin polymerisation with a Basic domain deleted NWASp construct has also 
been demonstrated in another in vitro lysate system, and in cellular actin comet 
formation assays (Papayannopoulos et al., 2005). Other studies with Basic domain 
deleted constructs have demonstrated no difference to WT in localisation to and 
motility induction of PIP2 coated vesicles (Benesch et al., 2002) or induction of 
actin clustering in Cos7 cells (Kato et al., 1999).
GBD and CRIB 1.4.3 
Cdc42 was the first identified binding partner of WASp (Symons et al., 1996; 
Kolluri et al., 1996; Aspenstrom et al., 1996). The GTPase binding domain (GBD) 
(235-288) in WASp is defined as the minimum sequence required to maintain 
high affinity binding to Cdc42 (Abdul-Manan et al., 1999; Rudolph et al., 1998). Chapter 1     
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Contained within this is the Cdc42/Rac interactive binding domain (CRIB), a 
sequence of 14 amino acids (238-251) which is highly conserved between all 
Rho type GTPase binding proteins (Kolluri et al., 1996; Burbelo et al., 1995; 
Manser et al., 1994; Manser et al., 1993). Interaction between WASp and Rho 
type GTPases other than Cdc42 has been demonstrated (Rac1, TC10), but the 
affinity with Cdc42 is always higher (see section 1.5.1.3).
Deletion of the GBD 1.4.3.1 
Investigation of WASp / NWASp constructs with the GBD deleted has been less 
extensive than similar experiments for other domains. Such a deletion will effect 
both WASp autoinhibitory conformation and Cdc42 binding, making dissection 
of function difficult in these experiments. It is therefore surprising that, where 
tested, these constructs have demonstrated a relatively unimpaired phenotype. 
A GBD deleted WASp “knock-in” mouse model revealed that deletion of the GBD 
had no effect on T cell proliferative responses to anti-CD3 stimulation, or the 
actin polymerisation within T cells following activation (Badour et al., 2004). GBD 
deleted WASp overexpressed in Jurkat cells showed normal recruitment to the T 
cell synapse (Cannon et al., 2001), and CRIB deleted WASp proteins were still 
localised to and able to induce movement of PIP2 coated vesicles in a cell lysate 
system (Benesch et al., 2002).
Polyproline domain 1.4.4 
The polyproline domain is the largest functional domain in WASp, and is the 
binding  site  of  the  largest  number  of  WASp  regulatory  proteins.  It  contains 
multiple SH3 domain binding motifs (PXXP), but it does not exclusively interact 
with SH3 containing proteins. Binding partners include kinases, proteins involved 
in cytoskeletal reorganisation and proteins implicated in targeting proteins to sites 
of cytoskeleton rearrangement. Polyproline domain binding proteins have been 
demonstrated to recruit proteins to the T cell synapse, podosomes, endosomes 
and the microtubule network. The functional significance of the best understood 
polyproline domain ligands, and their interaction with WASp and NWASp are 
summarised figure 1.6.
Deletion of the Polyproline domain 1.4.4.1 
Deletion of the polyproline domain has generally been found to have a profound 
effect on WASp induced actin polymerisation and localisation. Impairment in actin 
polymerisation has been demonstrated in in vitro and in vivo systems (Yarar et 
al., 2002; Benesch et al., 2002; Castellano et al., 2001; Suetsugu et al., 2001b), 
and only one study has suggested normal actin polymerisation induced by a Chapter 1     
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Binding
Partner
Protein
Family
Effect on WASp Reference
Grb2
SH3-
SH2 
adapter 
protein
Synergistically  activates  NWASp  with 
Cdc42.  Recruits  WASp  to  activated 
EGFR
She 1997  Carlier 2000
Kempiak 2003
NcK
Synergistically  activates  NWASp  with 
PIP2. Targets WASp to T cell synapse
Rivero-Lezcano 1995
Rohatgi 2001 
Kempiak 2003
p85α In vitro binding demonstrated Banin 1996 Finan 1996
CrkL Forms a complex with Syk in platelets Oda 2001
Fyn
Src (a)
Essential for WASp tyrosine phosphoryla-
tion following TCR ligation
Banin 1996, 1999
Zhu 1997 Badour 2004   
Suetsugu 2002
cSrc, 
cFgr
In vitro binding demonstrated Banin 1996 Finan 1996
Bunnell 1996
Lck
Src (b)
Binds and tyrosine phosphorylates WASp 
in vitro
Zhu 1997  Torres 2006
Lyn
Increases  tyrosine  phosphorylation.  Co-
operative with Cdc42
Guinmard 1998
Hck Increases  tyrosine  phosphorylation.  Mi-
crospike formation. Cdc42 independent.
Cory 2002  Scott 2002
Btk
Tec
Binds  and  increases  WASp  tyrosine 
phosphorylation. Cooperative with Cdc42
Cory 1996  Baba 1999
Guinmard 1998
Itk, Tec In vitro binding demonstrated Cory 1996
Bunnell 1996
PSTPIP
PCH
Recruits phosphatase to WASp resulting in 
dephosphorylation, stabilising autoinhibbi-
tion. Recruits WASp to T cell synapse
Cote 2002
Bardour 2003, 2004
CIP4
Localises WASp to microtubules. Required 
for Microtubule organising centre polarity
Tian 2000  Linder 2000
Banerjee 2007
Intersetin
2
Localises WASp to endosomes. Induces 
WASp  mediated  TCR  endocytosis  after 
TCR engagement
McGavin 2001
Phospho-
lipase γC
In vitro binding demonstrated Cory 1996  Zhu 1997
Finnan 1996
VASP
ENA/
VASP 
family
Induces (and required for) actin polymeri-
sation at leading edge and WASp coated 
bead motility. Co-localises with WASp to 
phagocytic cup
Castellano 2001
Yarrar 2002
Profilin
Activates  WASp  and  Arp2/3.  Required 
for WASp induced  actin polymerisation. 
Stimulates  NWASp  induced  microspike 
formation
Miki 1998
Suetsugu 1998
Yarrar 2002
SNX9
Sorting 
nexin
family
Recruits WASp to complex which medi-
ates clatherin pit induced endocytosis of 
Cd28 following TCR activation
Bardour 2007
Cortactin
Activates WASp and co-localises with it to 
the immune synapse
Martinez-Quiles 2004
Fig 1.6 Mediators known to bind to the WASp Polyproline domain
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WASp construct with the polyproline domain deleted (Kato et al., 1999). Deletion 
of the WASp polyproline domain abolishes WASp recruitment to the immune 
synapse in T cells (Zeng et al., 2003; Badour et al., 2003; Cannon et al., 2001). 
By contrast, a dPolyP NWASp construct was normally recruited to PIP2 coated 
vesicles (Benesch et al., 2002), and recruitment to Vaccinia induced actin tails 
appears to be independent of the polyproline domain (Moreau et al., 2000)
These results illustrate the combined function of the polyproline domain in WASp; 
contributing to efficient activation and participating in WASp localisation in certain 
circumstances.
VCA domain 1.4.5 
The carboxyl terminal VCA module, defines the identity of WASp family proteins, 
and it provides the output through which these proteins signal. The verprolin 
homology domain is shared with several other actin regulatory proteins, and it 
acts as the monomeric actin (g-actin) binding site of WASp (Marchand et al., 
2001; Hufner et al., 2001; Miki and Takenawa, 1998).
The central domain was originally thought to be a cofilin homology domain, but 
subsequently structural differences have suggested that any sequence similarity 
is  coincidental  (Marchand  et  al.,  2001).  The  majority  of  this  region  contains 
predominantly basic residues, but the final three amino acids are acidic (over 
lapping with the terminal acidic domain). The C and A domains together are the 
minimal sequences required for autoinhibition, and for binding to both the GBD 
and  Arp 2/3 following activation. These interactions are described in detail in 
sections 1.4.6.1 and 1.6.4.
The VCA domain is the minimal sequence required for actin polymerisation in 
vitro (Blanchoin et al., 2000a; Yarar et al., 1999; Rohatgi et al., 1999; Machesky 
et al., 1999), but due to its unregulated activity (both in term of activation and 
localisation), over-expression in cells leads to disruption of actin based structures 
and processes (Moreau et al., 2000; Machesky and Insall, 1998). Deletion of the 
WASp VCA domain inhibits induction of actin polymerisation (Yarar et al., 2002; 
Benesch et al., 2002; Suetsugu et al., 2001b), and leads to the dysregulation 
of many actin based structures (Kato et al., 1999; Machesky and Insall, 1998; 
Symons et al., 1996) and functions including phagocytosis (Tsuboi and Meerloo, 
2007) and T cell development (Zhang et al., 2002). WASp localisation is unaffected 
by deletion of the VCA domain (Benesch et al., 2002; Cannon et al., 2001; Moreau 
et al., 2000).Chapter 1     
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Autoinhibition and Crystal structure 1.4.6 
In the unbound state, WASp and NWASp adopt an autoinhibited conformation, 
where the VCA domain binds to the GBD, inhibiting any intrinsic activity of WASp 
(Kim et al., 2000). Evidence for this autoinhibition initially came from experiments 
demonstrating that the isolated VCA domain of WASp / NWASp could bind protein 
constructs containing the GBD, and this interaction inhibited the intrinsic actin 
polymerisation activity of the VCA fragment (Kim et al., 2000; Rohatgi et al., 1999; 
Miki et al., 1998b). If the EVH1, Basic and Polyproline domains are included 
in the GBD fragment, then the affinity for the VCA fragment is increased, and 
the minimal sequence required to suppress VCA induced actin polymerisation is 
the Basic domain and GBD sequence (Prehoda et al., 2000). Full length WASp 
or constructs containing the VCA domain did not bind isolated VCA fragments 
(Rohatgi et al., 2000; Prehoda et al., 2000).
VCA – GBD autoinhibitory pseudo-domain 1.4.6.1 
Interaction  between  the  VCA  domain  and  the  GBD  involves  two  essential 
sequences within WASp. The first, (amino acids 482-492), spans part of the C 
and A domains within the VCA cassette, and the second (amino acids 242-310) 
spans the carboxyl end of the GBD and the adjacent sequence between the GBD 
and polyproline domains. The NMR structure of the WASp GBD bound to VCA 
was solved using a recombinant WASp polypeptide consisting of residues 242-
310 linked to 461-492 by a short flexible linker sequence (Kim et al., 2000). In 
isolation the GBD exists in an unfolded state, forming no tertiary structural motifs, 
however in the presence of the VCA the sequence becomes highly structured and 
forms a hydrophobic core. The Central region of the VCA forms an amphipathic 
helix (α5) which packs down into the hydrophobic GBD surface formed by four 
other α helices (α1 – α4) and two β pleated sheets (Kim et al., 2000). The α1 helix 
is formed by residues which bind Cdc42, whereas residues within the α2, α3 and 
α4 helices do not directly interact with Cdc42 (Kim et al., 2000; Abdul-Manan et 
al., 1999).
The  result  of  this  binding  and  structural  rearrangement  is  the  cooperative 
formation of a pseudo-domain between the CA region and the GBD. The Arp2/3 
binding site in the C domain is hidden in the middle of this hydrophobic core, 
and additionally it adopts a conformation unfavourable to Arp 2/3 binding. These 
mechanisms ensure that WASp is unable to bind and activate Arp 2/3 in its resting 
(autoinhibited) conformation (Panchal et al., 2003).
The hydrophobic fold within the GBD which forms upon binding of the Central Chapter 1     
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region, is sterically incompatible with the conformation seen when bound to Cdc42 
(Kim et al., 2000; Abdul-Manan et al., 1999). The minimal sequence required 
for high affinity Cdc42 binding is residues 230-280 (Abdul-Manan et al., 1999; 
Rudolph et al., 1998), and therefore overlaps, but is not entirely included within 
the critical VCA interaction site.
Other autoinhibitory interaction 1.4.6.2 
Although  not  required  for  the  structural  formation  of  the  autoinhibitory 
pseudodomain, other WASp domains play a role in stabilising the autoinhibitory 
conformation. The basic domain binds Arp 2/3, and simultaneously maintains Arp 
2/3 in an inactive conformation and stabilises NWASp’s autoinhibited conformation 
(Leung and Rosen, 2005; Prehoda et al., 2000). This interaction alone is not 
sufficient to auto inhibit NWASp, but is additive to the effect of the autoinhibitory 
fold. In one study deletion of the terminal eight acidic residues in NWASp (484-
502) resulted in constitutive activity in vitro (discussed further in section 1.4.1.5)
suggesting a role for these residues in stabilising NWASp autoinhibition (Suetsugu 
et al., 2001a).  This data, however, is difficult to rationalise with the essential 
role of the tryptophan 500 residue in Arp2/3 activation (Marchand et al., 2001). 
Together these results suggest that full WASp / NWASp autoinhibition requires 
the interaction of Arp 2/3, with both the basic region and the carboxyl terminus, in 
addition to the GBD - VCA binding (Prehoda et al., 2000).
Interestingly the interaction between GBD and VCA is specific for each WASp 
family member, and therefore the VCA domain from a WAVE protein does not 
bind to the WASp GBD.
Autoinhibitory conformation in vivo 1.4.6.3 
The existence of WASp / NWASp in an autoinhibited conformation in vivo has 
been investigated using fluorescence resonance energy transfer (FRET) (Lorenz 
et al., 2004) and using a split yellow fluorescent protein (YFP) fluorescent probe 
(Lim et al., 2007). Both these techniques used fluorescent tags at the amino 
and  carboxyl  terminals  of  WASp  /  NWASp  which  emit  a  specific  fluorescent 
signal only when the two probes are spatially adjacent to each other (i.e. in the 
autoinhibited conformation). These results have demonstrated the existence of 
WASp and NWASp in an autoinhibitory conformation in cells. NWASp showed 
loss  of  autoinhibition  at  the  leading  edge  of  carcinoma  cells  in  response  to 
EGF stimulation and at the base of invadopodia (Lorenz et al., 2004), whereas 
stabilisation of WASp autoinhibition was demonstrated by the co-expression of 
WIP and WIRE, and disrupted by TOCA1 and Nck1 (Lim et al., 2007).Chapter 1     
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XLN point mutations and WASp phosphorylation in GBD 1.4.6.4 
XLN is caused by missense mutations within the WASp GBD. Each of these 
mutations occurs in residues which form part of the α1 or α3 helices of the 
autoinhibitory pseudo-domain (Ancliff et al., 2006; Devriendt et al., 2001). GBD 
sequences containing one of these mutations (L270P), showed much less structural 
stability than WT GBD when bound with VCA (Devriendt et al., 2001), and all XLN 
mutations are predicted to disrupt the autoinhibitory conformation (Ancliff et al., 
2006; Leung and Rosen, 2005; Kim et al., 2000). The Tyr291 residue, which 
plays an important role in the regulation of WASp activity by phosphorylation 
(see section 1.5.5), is also found in α3 helix of the autoinhibitory fold, and the 
phosphorylation  of  this  residue,  and  resultant  introduction  of  a  strongly  ionic 
residue in the centre of the amphipathhic domain is predicted to destabilise the 
autoinhibitory  conformation  (Torres  and  Rosen,  2006;  Kim  et  al.,  2000). The 
conformational change induced in the GBD following Cdc42 binding (see section 
1.5.3.3) normally exposes the Y291 residue, facilitating phosphorylation (Buck et 
al., 2001; Kim et al., 2000).
These  findings  provide  a  structural  mechanism  for  both  the  constitutive 
activity of XLN point mutations and the regulation of WASp activity by Y291 
phosphorylation.
WASp activation 1.5 
Cdc42 1.5.1 
Originally described as a protein essential for Saccharomyces cerevisae cell 
division, Cdc42 was the first protein identified to bind WASp both in vitro and in vivo 
(Symons et al., 1996; Kolluri et al., 1996; Aspenstrom et al., 1996). This interaction 
results  in  WASp  activation  and  actin  polymerisation  via  the Arp2/3  complex 
(Higgs and Pollard, 2000; Rohatgi et al., 1999; Ma et al., 1998b). Subsequent 
research has elucidated the complexity of the regulation of WASP activity and 
the involvement of many proteins and signalling cascades, nonetheless it is likely 
that Cdc42 remains a critical WASP activating protein in vivo.
Rho Family GTPases 1.5.1.1 
Cdc42 is a monomeric GTPase, and a member of the Rho superfamily. These 
proteins are involved in translating cell surface signals to the cytoskeleton, and 
regulate a wide range of cellular processes including cell division, adhesion, 
cell morphogenesis, migration, vesicular transport, microtubule dynamics and 
gene expression (Heasman and Ridley, 2008; Jaffe and Hall, 2005; Nobes and 
Hall, 1995). An indication of the importance of monomeric G proteins and the Chapter 1     
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regulation of their activity is provided by the fact that 2% of genes predicted by the 
sequencing of the human genome encode for these proteins or their regulators 
(Bernards, 2006). The Rho family has been divided into 8 subfamilies, of which 
the Rac, Rho and Cdc42 like subfamilies have been best studied (Fig 1.7). Cdc42, 
RhoA and Rac1 show the greatest sequence conservation between species of 
the Rho type GTPases. The other two GTPases in the Cdc42 subfamily are TC10 
(RhoQ) and TCL (RhoJ).
Rho  family  GTPases,  like  other  monomeric  GTPases,  function  as  molecular 
switches with a common basic mechanism (Nobes and Hall, 1994). In a GTP 
bound conformation they are active, but hydrolysis of the GTP to GDP results in 
a subtle conformational change at the nucleotide binding site. This causes the 
movement of one or more (conserved) “switch” α helices within the GTPase, 
which in turn induces conformational changes or positional realignment of the 
effector binding domains. Hydrolysis of the GTP nucleotide results in deactivation 
of the GTPase. Most monomeric GTPases are prenylated at their C terminus 
allowing lipid anchoring and resultant localisation to the intracellular surface of 
the cell membrane.
GEFs, GAPs and GDIs 1.5.1.2 
The activity of monomeric G proteins is regulated by three groups of proteins 
(Fig 1.8). Guanine nucleotide exchange factors (GEFs) act by deforming the 
nucleotide binding site on the GTPase, inducing the release of GDP and stabilising 
the nucleotide free form of the GTPase. This allows the binding of GTP, (as the 
GTP concentration in the cell cytoplasm is much higher than that of GDP) and 
activation of the GTPase (Vetter and Wittinghofer, 2001).
GTPase activating proteins (GAPs) enhance the intrinsic GTPase activity of the 
protein and catalyse the transition of the GTPase to an inactive, GDP bound, 
state. Although  some  GTPase  effector  targets  act  as  GAPs,  not  all  do,  and 
WASp appears to have no GAP activity on Cdc42 (Aspenstrom et al., 1996). 
GAPs and GEFs are themselves activated by a variety of mechanisms, including 
phosphorylation, binding of phospholipids and interaction with other secondary 
messengers such as cAMP and Ca2+ (Bos et al., 2007). Activation of GAPs and 
GEFs is important in localising GTPases to the cell surface and is frequently 
associated with activated receptor signalling complexes. Deactivation of GEF 
and GAP proteins is largely by ubiquitination and subsequent degradation.
The third group of regulatory proteins are the guanine nucleotide dissociation 
inhibitors (GDIs). These sequester GTPases in the cytoplasm in their GDP bound Chapter 1     
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form, by binding their prenylated carboxyl termini. This isolates them from potential 
effectors or activating proteins (Dransart et al., 2005).
A common theme of the regulation and signalling of Rho type GTPases is the 
crosstalk between signalling pathways and the promiscuity of interactions. Most 
Rho family GEFs and GAPs have activity on several different proteins (Bos et al., 
2007), and many effectors are activated by several different GTPases. To further 
complicate these signalling networks, some monomeric G proteins activate other 
G proteins. For example, in Swiss 3TC fibroblast cells, Cdc42 activates Rac, 
which in turn activates Rho in the sequential formation of filopodia and lamelipodia 
(Nobes and Hall, 1995; Ridley and Hall, 1992). This complexity makes identifying 
the specific role of individual proteins extremely difficult. The biological relevance 
of in vitro interactions must always be questioned, and results interpreted in the 
context of in vivo animal knockout models.
Specificity of the Cdc42 – WASp interaction 1.5.1.3 
Cdc42 is known to act on a range of target proteins including PAKs (Manser et al., 
1994), ACKs (Manser et al., 1993), IQGAP (Erickson et al., 1997), PAR6 (Joberty 
et al., 2000; Qiu et al., 2000), and CIP4 (Aspenstrom, 1997), in addition to WASp. 
Furthermore, TC10, Rac1, TCL, and RhoT have all been described to interact with 
NWASp (Abe et al., 2003; Vignal et al., 2000; Neudauer et al., 1998; Aspenstrom 
et al., 1996). Interestingly, the kinetics of interaction demonstrate a much faster 
association rate for Cdc42 binding to WASp / NWASp than for any of the other 
GTPases. This results in an equilbrium dissociation constant for Cdc42 - WASp/
NWASp complexes at least 1000x lower than those for complexes formed with 
other Cdc42 binding proteins (Hemsath et al., 2005). This degree of specificity is 
unusual among small GTPases (ACK, and MRC kinase which also preferentially 
bind Cdc42 do not show this kinetic), and mechanistically appears to be related to 
the ionic attraction between the basic domain upstream of the Cdc42 binding site 
and two glutamic acid residues (Glu49 and Glu178) which are specific for Cdc42. 
The interacting interfaces between WASp and GTPase are very similar for Cdc42 
and TC10. This “electrostatic steering mechanism” allows a very rapid turnover of 
signaling between Cdc42 and WASp.
In summary, WASp probably is capable of being activated in vivo by a range of 
specific Rho type GTPases, but its affinity and kinetics of interaction with Cdc42 
are higher and faster. Cdc42 activates a wide range of different effector proteins 
involved in diverse cellular functions, and Cdc42 induced WASp activation itself 
is responsible for a range of different cellular functions.Chapter 1     
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PIP 1.5.2  2
Phosphatidylinositides in membrane dynamics 1.5.2.1 
Phosphatidylinositol derivatives play a central and ubiquitous role in the cell biology 
of all organisms. There are seven functional phosphorylated derivatives (called 
phosphoinositides) and the generation of each is controlled by phosphoinositide 
kinases  and  phosphatases.  Each  phosphoinositide  has  a  unique  distribution 
among subcellular compartments and this is determined and maintained by the 
tight localised control of these generating enzymes.
PI(4,5)P2 is the predominant phosphoinositide throughout the cell, but shows 
particular concentration in the plasma membrane. PI(4)P is concentrated in the 
golgi, PI(3)P in early endosomes and PI(3,5)P2 in late endosomes. In the plasma 
membrane  the  interaction  and  balance  between  PI(4,5)P2  and  PI(3,4,5)P3  is 
critical in the regulation of actin polymerisation. In resting cells, PI(3,4,5)P3 exists 
in very low concentration in the plasma membrane, but stimulation of cells by 
growth factors, induces the enzyme phosphatidylinositol 3-kinase (PI3K), which 
generates PI(3,4,5)P3 from PI(4,5)P2.
Phosphoinositides are anchored in plasma membranes by their lipid tails, but the 
differentially phosphorylated ionsitol heads sit in the cytosol and bind proteins. 
Individual proteins show binding specificity towards individual phosphoinositides 
species, but individual interactions tend to be of low affinity. Protein sequences 
which bind phosphoinositides tend to be either unstructured clusters of basic 
residues (using electrostatic attraction for association), or folded phosphoinositide 
binding modules such as the pleckstrin homology domain (Lemmon, 2003; Yin 
and Janmey, 2003). Affinity is increased by the cooperative binding of multiple 
phosphoinositides or by protein co-receptors. This dual recognition is a powerful 
mechanism for defining organelle identity and provides the functional basis for 
protein and vesicle trafficking between cell compartments (Wenk and De, 2004).
Cooperation with monomeric GTPases 1.5.2.2 
Phosphatidylinositides work in concert with small GTPases to recruit cytosolic 
proteins to specific membrane compartments. Several GAPs and GEFs, including 
those for Rho-type GTPases, have phosphoinositide binding modules and are 
recruited  to  membranes  by  phosphoinositides  (Cantley,  2002).  Additionally, 
several phosphoinositide kinases and phosphatases are the targets of GTPases, 
resulting in activation, and the subsequent synthesis or elimination of specific 
phosphoinositide species. Finally, GTPases and phosphoinositides act as co-
receptors in many cellular functions, participating in co-operative binding and Chapter 1     
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recruitment.  By  having  a  specificity  for  both  GTPase  and  phosphoinositide, 
proteins have an extensive potential repertoire of localisation signals (Behnia and 
Munro, 2005). These mechanisms inexorably link the activation and localisation 
functions of GTPases and phosphoinositides.
Phosphatidylinositide interaction with the cytoskeleton 1.5.2.3 
PIP2 binds and modulates the activity of most groups of actin binding proteins 
(reviewed in (Yin and Janmey, 2003)). Its role in stimulating the dendritic branching 
of  actin  networks  can  be  summarised  by  four  mechanisms.  As  discussed 
extensively below, it helps activate WASp family proteins to stimulate Arp 2/3 
mediated actin nucleation. Secondly, PIP2 facilitates actin filament elongation 
directly by binding capping proteins (gelsolin and CapZ) and destabilising their 
association with actin filament barbed ends. Thirdly, it promotes the dissociation 
of profilin and g-actin, increasing the concentration of g-actin at the actin filament 
barbed end, and therefore driving filament elongation. Finally, PIP2 inhibits the 
severing action of cofilin / ADF and gelsolin, thereby reducing the number of 
available barbed ends and inhibiting the rate of network expansion (see section 
1.6.2 for further discussion). 
The main mechanism for increasing the local concentration of PIP2, appears to 
be via recruitment of the enzyme phosphatidylinositol-4-phosphate 5-kinase 1 
(PIP5K1). Both Rho and Rac GTPases bind and recruit PIP5K1 to the plasma 
membrane in a GTP independent manner. 
PIP3 has very similar actions to PIP2 although it acts on a more discrete and 
distinct set of effect proteins. Among these, PIP3 is responsible for the recruitment 
and activation of WAVE2 and resultant lamellipodia formation (Oikawa et al., 
2004).  Functionally,  phosphatidylinositol  3-kinase  (PI3K)  and  the  generation 
of PIP3 is pivotal  for the generation  of cell  polarity and promotion  of normal 
chemotaxis (Jones et al., 2003; Haugh and Meyer, 2002; Hannigan et al., 2002; 
Vanhaesebroeck et al., 1999). 
PIP 1.5.2.4  2 binding to WASp
Although it is generally accepted that PIP2 binds to the Basic domain in NWASp 
in vitro (Rohatgi et al., 2000; Prehoda et al., 2000), the site of binding in WASp 
remains  unclear  (Higgs  and  Pollard,  2000).  Experimental  evidence  suggests 
binding sites within the EVH1 domain, the Basic domain and throughout the rest 
of WASp, and some data suggests multiple sites of bind (Yarar et al., 2002). 
The  physiological  relevance  of  these  interactions  also  remains  controversial 
and several groups have argued that upstream activation of Cdc42 (via GAP Chapter 1     
58
activation) is more physiologically important (Ho et al., 2004; Ma et al., 1998a).
The in vitro affinity of PIP2 for the NWASp Basic domain is highly dependant on the 
positive charge of the lysine residues within the domain. Binding is cooperative, 
with affinity for PIP2 increasing as more phospholipids bind. This makes PIP2 
induced activation highly dependent on PIP2 concentration in the local membrane, 
and results in sharp concentration threshold of activation (Papayannopoulos et 
al., 2005). The functional consequence of this is that in vitro NWASp responds to 
activation by PIP2 as an “on - off switch” requiring a relative high concentration 
of membrane bound PIP2 before it is activated. This enhances the specificity of 
NWASp signalling.
WASp activation by Cdc42, PIP 1.5.3  2 and TOCA
Cdc42 activates WASp by destabilising the autoinhibitory pseudo-domain formed 
between the VCA, and the GBD and surrounding residues (Kim et al., 2000). As 
described above (Hemsath et al., 2005), Cdc42 is attracted to WASp by the Basic 
domain, and is therefore able to “dock” adjacent to its target binding residues in 
the CRIB and GBD despite the binding of the VCA domain. Upon Cdc42 binding 
to the GBD, the VCA domain is released, exposing the actin and Arp 2/3 binding 
sites, and activating WASp (Panchal et al., 2003).
Although this basic mechanism is now widely accepted, many of the details and 
co-stimulations required for this process remain controversial, and much of the 
evidence is contradictory. This is partly due to differences in the experimental 
systems used to investigate WASp activation, but also due to the complexity and 
subtlety of WASp regulation.
Experimental systems 1.5.3.1 
The elucidation of the mechanisms of WASp activation has come from several 
experimental modalities;
(1) Determination of binding affinities of WASp (or NWASp) fragments 
and domain deletion constructs, to each other, and to binding partners.
(2) The functional effects of these interactions have been assessed using 
purified  component  pyrene  actin  polymerisation  assays  (PPP  assays) 
(Rohatgi et al., 2000; Prehoda et al., 2000; Higgs et al., 1999; Machesky 
et al., 1999).
(3) Actin polymerisation in a more physiological context has been measured 
using cell lysate pyrene assays (lysate assays) (Suetsugu et al., 2001b; 
Ma et al., 1998a; Ma et al., 1998b).Chapter 1     
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(4) Functional actin filament formation has been assessed by visualisation 
of actin comet formation or bead motility in cell lysates (Yarar et al., 2002; 
Suetsugu et al., 2001b; Higgs and Pollard, 2000; Ma et al., 1998b).
(5) In vivo activity has been determined with the assessment of actin 
structures  in  cells  following  the  microinjection  of  purified  proteins  or 
overexpression of protein constructs in cells (Machesky and Insall, 1998; 
Miki et al., 1998a; Miki et al., 1996; Nobes and Hall, 1995).
Pyrene  based  actin  polymerisation  assays  use  the  fluorescence  emitted  by 
pyrene labelled actin which has been incorporated into actin filaments, to quantify 
the amount of f-actin formed. Pyrene  labelled  actin monomers  are added  to 
the purified protein reaction (containing actin, Arp 2/3 and ATP) or lysate, such 
that the pyrene labelled actin makes up 1-10% of the total actin content in the 
reaction. Fluorescence is measured following the addition of the construct under 
investigation and / or actin polymerisation initiator (e.g. Cdc42). The maximal rate 
of actin polymerisation and the maximal amount of f-actin formed are used as 
output measurements.
Evidence of Cdc42 induced activation 1.5.3.2 
The first evidence for Cdc42 inducing WASp / NWASp activation came from cell 
lysate systems where the addition of GTP bound Cdc42 induced actin filament 
formation (Mullins and Pollard, 1999; Ma et al., 1998a; Zigmond et al., 1997). This 
was abolished with the immunodepletion of NWASp from the lysate (Rohatgi et al., 
1999). Similar evidence came from cellular systems where inhibited or activated 
Cdc42  or  WASp  were  microinjected  or  over  expressed,  and  the  subsequent 
formation of de novo actin structures required both active Cdc42 and WASp (Miki 
et al., 1998a; Symons et al., 1996). NWASp and WASp overexpression resulted 
in different patterns of actin remodelling in cells, with NWASp inducing filopodia 
(Miki et al., 1998a) and WASp producing discrete actin patches (Symons et al., 
1996).
The structure of WASp GBD bound to Cdc42 demonstrated a specific interaction, 
resulting in conformational changes to both proteins (see section 1.5.2.4) (Abdul-
Manan et al., 1999). In immunoprecipitation assays, GTP loaded Cdc42 was found 
to compete with the VCA domain for the binding of extended WASp / NWASp 
protein fragments containing both GBD and basic domains (Kim et al., 2000; 
Rohatgi et al., 2000; Prehoda et al., 2000; Miki et al., 1998a). Once released 
from GBD binding, the VCA domain was capable of binding Arp2/3 and instigating 
actin polymerisation.Chapter 1     
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Further  biochemical  studies  demonstrated  that Arp2/3  and  the  NWASp  GBD 
compete for VCA binding. The presence of Cdc42 and PIP2 in the precipitation 
reaction, however, reduces the VCA affinity for the GBD, and encourages VCA – 
Arp2/3 binding (Rohatgi et al., 2000). In all these experiments the binding of VCA 
to Arp2/3 correlated with the actin polymerisation induced in PPP assays.
Crystal structure of Cdc42 bound to WASp GBD 1.5.3.3 
The NMR crystal structure of WASp GBD bound to Cdc42 was solved in 1999 
(Abdul-Manan et al., 1999). It demonstrates that residues within the WASp CRIB 
domain form an extended binding sequence starting at the carboxyl end of the 
Cdc42 switch 1 motif (Cdc42 has two switch motifs - see section 1.5.1.1). An 
amphipathic WASp region downstream from the CRIB forms two anitparallel β 
sheets and an α helix upon binding Cdc42, which pack down into a hydrophobic 
region of Cdc42 adjacent to both switch 1 and switch 2 regions. Hydrogen bonds 
are formed by WASp residues Val250, Val247 / Ser248, Lys245 and His246 / 
His249 with their respective Cdc42 counterparts, and these are essential for 
stabilisation of the interaction. The NWASp equivalent of His246 (His208) has 
been mutated to Asp with resultant loss of Cdc42 affinity (Miki et al., 1998a), and 
a similar mutation of His246 has been used in this project to inhibit Cdc42 binding 
(see section 1.8).
This structure demonstrates that there is an extensive contact surface between 
Cdc42 and WASp, and that much of this contact is buried within a deep hydrophobic 
core.  The  involvement  of  both  switch  sequences  in  this  interaction  provides 
structural evidence of the necessity for Cdc42 to be GTP bound (and therefore 
activated) to facilitate WASp binding. The affinity of GDP – Cdc42 for WASp is 
500 fold less than that of GTP – Cdc42 (Kolluri et al., 1996). Binding results in a 
conformational change in the GBD, destabilising the cooperative autoinhibitory 
domain formed with the VCA, and releasing the Arp2/3 binding site on the CA 
domain (Leung and Rosen, 2005; Buck et al., 2001; Kim et al., 2000).
Although this model is attractive, Cdc42 alone cannot fully explain the in vivo 
regulation of WASp activity. As described in section 1.4.6.2, other WASp domains, 
independent of the GBD, contribute to WASp’s autoinhibition, and many other 
mediators activate WASp, many synergistically with Cdc42.
Activation of full length WASp 1.5.3.4 
Assessment of the activity of full length WASp or NWASp in the absence of Cdc42 
stimulation  has  resulted  in  heterogeneous  results,  ranging  from  constitutive 
maximal activity to no activity at all (Yarar et al., 2002; Suetsugu et al., 2001a; Chapter 1     
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Suetsugu et al., 2001b; Higgs and Pollard, 2000; Prehoda et al., 2000; Yarar et 
al., 1999; Rohatgi et al., 1999; Egile et al., 1999). The most accepted view is that 
WASp is fully autoinhibited in the absence of activators, and this is consistent 
with the findings of the only published study which assessed WASp purified 
from mammalian tissue (Higgs and Pollard, 2000). These findings fit with the 
structural models of WASp autoinhibition, and also with the cellular function of 
WASp, namely to initiate the formation of actin structures in a temporally and 
spatially controlled manner. Due to the relatively high concentration (10 µM) of 
WASp in haematopoietic cells (Higgs and Pollard, 2000), any constitutive WASp 
activity would lead to significant unregulated actin polymerisation. Generally, in 
the absence of activators, NWASp shows low grade actin polymerisation activity 
in PPP assays, suggesting predominant, but not absolute autoinhibition.
In  contrast  to  full  length  WASp,  the  isolated  VCA  domain  shows  maximal 
constitutive activity in in vitro actin polymerisation assays. The full VCA domain is 
sufficient for initiating actin polymerisation, and its activity is unaffected by known 
regulators of WASp (Pantaloni et al., 2000; Blanchoin et al., 2000a; Rohatgi et al., 
1999; Higgs et al., 1999). When over expressed in cells, it disrupts the formation of 
actin structures (Machesky and Insall, 1998), further emphasising the importance 
of regulated WASp activity for functionality.
Synergistic activation by Cdc42 and PIP 1.5.3.5  2 
Addition of GTP loaded Cdc42 to WASp in PPP assays results in a small increase 
in actin polymerisation. The addition of PIP2 instead of Cdc42 resulted in a much 
larger increase in activity, but maximal activity was only achieved by the addition 
of both Cdc42 and PIP2 (Yarar et al., 2002; Higgs and Pollard, 2000). When these 
nucleation reactions were visualised, WASp supplemented with PIP2 induced 
branching of actin filaments whereas WASp alone or supplemented with Cdc42 
induced  shorter  unbranched  filaments.  Supplementation  with  both  PIP2  and 
Cdc42 resulted in the formation of actin rich halos around PIP2 micelles (Higgs 
and Pollard, 2000).
Interestingly,  NWASp  appeared  to  be  more  sensitive  to  GTP-Cdc42  in  PPP 
assays, with PIP2 alone having a minimal effect on activity. A similar synergism 
between Cdc42 and PIP2 exists (Papayannopoulos et al., 2005; Rohatgi et al., 
2000; Prehoda et al., 2000; Rohatgi et al., 1999). Further work has demonstrated 
that the binding of Cdc42 and PIP2 to NWASp is cooperative and that both are 
able to bind NWASp simultaneously (Prehoda et al., 2000). NWASp activity in 
cell lysate systems is more tightly inhibited than in purified protein systems, but 
activation appears to be induced with GTP loaded Cdc42 only. PIP2 micelles were Chapter 1     
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absent from these assays as the lysate had been ultracentrifuged to remove all 
lipid vesicless (and f-actin) (Ho et al., 2004; Rohatgi et al., 1999).
TOCA1 1.5.3.6 
The differences in activity and sensitivity to activators seen between purified 
protein  and  lysate  systems  suggested  an  additional  activator  is  essential  for 
NWASp activation in vivo. TOCA1 (transducer of Cdc42 activation) was identified 
and characterised in 2004 (Ho et al., 2004). It is required for both Cdc42 and 
PIP2 induced NWASp meditated actin polymerisation in Xenopus lysate, and its 
presence negates the need for both other activators to be present simultaneously 
(Lim et al., 2007; Ho et al., 2004). It binds directly to NWASp via an SH3 domain 
and to Cdc42 via a novel GTPase bind motif, and binding to both of these is 
required for NWASp activation.
In cells, the majority of NWASp exists bound to WIP or CR16, which has an 
inhibitory  effect  on Arp  2/3  activation  (Martinez-Quiles  et  al.,  2001).  NWASp 
complexed to WIP is resistant to activation by Cdc42, and requires the additional 
binding of TOCA1, to facilitate Arp 2/3 activation. This mechanism explains some 
of the differences in experimental systems described above.
The  equivalent  experiments  on  WASp  have  not  been  performed,  although 
significant differences in results between PPP assays and more physiological 
systems have been detected (Yarar et al., 2002). TOCA1 is a member of the Pombe 
Cdc-15 homology (PCH) family, and WASp is known to bind two other proteins 
in this group, CIP4 (Tian et al., 2000) and formin binding protein 17 (FBP17) 
(Tsuboi et al., 2009). Both have been implicated in localising WASp to specialised 
actin structures. Interestingly TOCA1 has recently been implicated in localising 
NWASp to endocytic vesicles and filopodia (Bu et al., 2009), suggesting all these 
proteins may play a role in targeting as well as activating WASp proteins.
Prenylation of Cdc42 1.5.3.7 
Several studies have demonstrated the need for Cdc42 to be prenylated to induce 
actin polymerisation in cell lysate systems (Ma et al., 1998b; Zigmond et al., 
1997). Although several groups have reported GTP loaded Cdc42 purified from 
E.coli (not prenylated) activating both NWASp (Suetsugu et al., 2001b; Egile et 
al., 1999; Miki et al., 1998a) and WASp (Yarar et al., 2002), activation of purified 
bovine thymic WASp required Cdc42 to be prenylated for activation (Higgs and 
Pollard, 2000). Interestingly, the same group found, however, that un-prenylated 
Cdc42 was able to disrupt the autoinhibitory binding between recombinant WASp 
VCA and WAS p Basic – GBD fragment.Chapter 1     
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These conflicting data certainly suggest a role for Cdc42 prenylation in some 
aspect of WASp activation. Whether this is specific to WASp (and not NWASp), 
to the method of WASp synthesis and resultant post-translational modification, 
to the specialisation of cell (or lysate) WASp is functioning in, or to the specific 
species, remains unknown. One possibility is that prenylation of Cdc42 will bring 
it into much closer proximity to PIP2 thereby facilitating the synergistic activation 
of WASp.
Cdc42 independent WASp activation 1.5.4 
There is now excellent evidence for Cdc42 activating WASp and NWASp both in 
vitro and in vivo, however there is increasing evidence that Cdc42 is not essential 
for these processes. Depending on the specific cell or experimental system, 
and the subcellular actin structure being generated, the role of Cdc42 can be 
bypassed. The evidence for this is summarised below.
The use of dominant negative Cdc42 17N, and a specific Rho type GTPase inhibitor 
(clostridium dificile toxin) have revealed that Cdc42 is not required for vaccinia 
motility (Moreau et al., 2000), EGF induced actin polymerisation (Kempiak et al., 
2003) or the Hck mediated tyrosine phosphorylation of WASp (Cory et al., 2002). 
In these systems and in in vitro systems other mediators (Nck, WISH, Hck, Grb2) 
have provided the necessary activation signals rendering Cdc42 redundant (Cory 
et al., 2002; Fukuoka et al., 2001; Rohatgi et al., 2001; Moreau et al., 2000) (see 
sections 1.5.5 and 1.5.6).
As  described  above  (section  1.4.3.1)  deletion  of  the  GBD  seems  to  have 
minimal impact on in vivo WASp or NWASp functioning. Localisation to APC – 
T cell contacts, T cell development, TCR induced T cell proliferation and actin 
polymerisation, and vesicle movement were all normally induced by GBD deleted 
WASp or NWASp constructs (Badour et al., 2004; Benesch et al., 2002; Cannon 
et al., 2001). Furthermore, similar results were found using a point mutation 
substituting a histidine residue for an aspartate residue at WASp 246 (NWASp 
208) which abolishes Cdc42 binding (Kato et al., 1999; Miki et al., 1998a), but 
retains  an  autoinhibited  conformation  (Kato  et  al.,  1999).  Experiments  using 
this mutant WASp / NWASp have demonstrated normal actin polymerisation in 
vitro (Fukuoka et al., 2001), normal vesicular motility (Benesch et al., 2002) and 
normal actin patch (WASp) or microspike (NWASp) formation in vivo (Fukuoka et 
al., 2001; Kato et al., 1999).
These  results  demonstrate  that,  although  Cdc42  plays  a  central  role  in  the 
translation  of  cell  surfacing  signalling  to  the  cytoskeleton,  there  is  sufficient Chapter 1     
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redundancy within these signalling networks that Cdc42 is not essential for WASp 
induced actin polymerisation.
Protein kinase binding and WASp phosphorylation 1.5.5 
Tyrosine kinases 1.5.5.1 
Non-receptor tyrosine kinases play a critical role in downstream signalling following 
ligation of several cell surface receptors. They can act at several functional levels 
of signalling cascades, as illustrated by their interaction with Rho type GTPases. 
They phosphorylate and activate GEFs initiating the activation of GTPases, but 
also directly phosphorylate GTPase targets (such as WASp) and can cooperatively 
modulate the activity of these targets with GTPases. 
Two families of non-receptor tyrosine kinases have been identified to bind and 
phosphorylate WASp and NWASp. The structure of Src family kinases is described 
in section 1.4.1.4, and of these Fyn, cFgr, cSrc, Hck, Lck, Lyn have all been shown 
to bind WASp. Tec family kinases are related to Src kinases, but in addition to 
SH2, SH3 and kinase domains, they have an amino terminal pleckstrin homology 
domain, a Zn2+ binding Btk motif and a short polyproline sequence. Btk, Itk and 
Tec have all been linked to WASp function.
The SH2 domains from these proteins are able to bind phosphorylated tyrosine 
residues within specific short motifs, such as the immunoreceptor tyrosine-based 
activation motif (ITAM) found in the cytoplasmic tails of cell surface receptors 
(Cambier, 1995; Reth, 1989). Their activity is mediated by their interaction with 
other proteins and phospholidids, but also by phosphorylation, and many are 
capable of autophosphorylation. These kinases play an important role in amplifying 
the signalling response and in recruiting new proteins to cell surface signalling 
complexes. It is likely that each kinase family is important in recruiting a specific 
subset of downstream effectors, at a specific time point within the signalling 
cascade.
Phosphorylation of WASp 1.5.5.2 
WASp is tyrosine phosphorylated in vivo in response to a range of cell stimuli 
including collagen stimulation of platelets (Oda et al., 1998), IgE activation of 
mast cells (Guinamard et al., 1998) and pre-B cell receptor cross linking (Baba et 
al., 1999). There are seven tyrosine residues in WASp, six in the EVH1 domain 
or the sequence between EVH1 and basic domains, and one in the GBD. By 
point mutation of each of these sites and by mass spectroscopy, Tyr291 was 
identified as the critical site of WASp tyrosine phosphorylation, both in vitro and in 
vivo. (Badour et al., 2004; Cory et al., 2002; Baba et al., 1999). Subsequently an Chapter 1     
65
equivalent tyrosine phosphorylation site (Tyr256) has been identified in NWASp 
(Suetsugu et al., 2002).
The activity of tyrosine phosphorylated WASp / NWASp has been investigated 
by  phosphorylating  recombinant  NWASp  in  vitro  using  recombinant  kinases 
(Torres  and  Rosen,  2006;  Torres  and  Rosen,  2003),  and  by  generating  the 
phosphomimicking  WASp  point  mutation  Y291E  (Cory  et  al.,  2002).  In  this 
construct the tyrosine residue is replaced by the negatively charged glutamate 
residue which mimics the charge produced by a phosphorylated tyrosine residue. 
Both approaches have demonstrated a modest increase in activity for the tyrosine 
phosphorylated protein over WT. Y291 sits deep in the centre of the GBD / VCA 
autoinhibitory fold. The increase in WASp activity upon phosphorylation is thought 
to be due to the destabilising effect of the highly charged phosphorylated tyrosine 
on the autoinhibitory conformation (Kim et al., 2000). Despite this destabilisation, 
the  tyrosine  phosphorylated  NWASp  is  still  able  to  adopt  the  autoinhibited 
conformation (Torres and Rosen, 2006), and without phosphorylation NWASp is 
still able to induce actin polymerisation (Suetsugu et al., 2002; Miki et al., 1996).
The functional significance of Y291 phosphorylation has been demonstrated in 
a number of systems. An increase in WASp induced macrophage filopodia was 
observed following cellular treatment with phosphatase inhibitors, which correlated 
with an increase in WASp tyrosine phosphorylation (Cory et al., 2002). WASp null 
mice, bone marrow reconstituted with Y291F “phosphodead” (unphosphorylatable) 
WASp, were used to demonstrate that Y291 phosphorylation was essential for 
immune synapse formation, actin polymerisation adjacent to the TCR following 
ligation and coupling of TCR engagement to NF-AT activation (Badour et al., 
2004).
The relationship between tyrosine phosphorylation and Cdc42 induced WASp / 
NWASp activation has been extensively explored by Torres and Rosen (2003, 
2006). They used an in vitro purified protein system, testing amino terminally 
truncated and / or polyproline domain deleted NWASp constructs, generated in 
E.coli. They demonstrated that NWASp was 40x more easily phosphorylated 
following Cdc42 binding (and therefore disinhibited), and once phosphorylated, 
NWASp  was  30x  more  sensitive  to  dephosphorylation  in  the  presence  of 
Cdc42,  compared  to  when  autoinhibited.  They  proposed  that  this  difference 
related to changes in the surface accessibility of NWASp Y256 between the two 
conformations of NWASp, and that this mechanism accounts for the cooperativity 
they found between phosphorylation and Cdc42 binding. They also postulated 
that  in  the  presence  of  transiently  bound  Cdc42,  phosphorylation  acts  as  a Chapter 1     
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molecular marker of previous NWASp activation (Torres and Rosen, 2006; Torres 
and Rosen, 2003).
There  is  some  in  vivo  data  to  support  these  findings.  Overexpression  of 
constitutively  active  Cdc42,  enhanced  the  WASp  tyrosine  phosphorylation 
produced by Lck and Btk protein kinases in mast cells (Guinamard et al., 1998). 
Data from other studies, however, does not support cooperation between Cdc42 
and kinase activity. Cdc42 had no effect on the efficacy of Hck phosphorylation 
of WASp, when all three proteins were over-expressed in Cos7 cells (Cory et 
al., 2002), and similar results were found for NWASp phosphorylation with Fyn 
in PC12 (rat phaeochromocytoma) cells (Suetsugu et al., 2002). In vitro NWASp 
tyrosine phosphorylation by Fyn was significantly enhanced by PIP2 but not by 
Grb2 or by Cdc42 (Suetsugu et al., 2002).
Tyrosine phosphorylation increases susceptibility of NWASp to degradation by 
the proteasome (Suetsugu et al., 2002), but there is no equivalent published data 
for WASp. Tyrosine phosphorylation has also been shown to reduce the affinity of 
WASp for the adaptor protein Grb2 following collagen stimulation of platelets (Oda 
et al., 1998). These examples suggest that WASp tyrosine phosphorylation may 
well have a more widespread regulatory role than simply reducing the threshold 
for WASp activation.
In addition to tyrosine phosphorylation, two sites of serine phosphorylation have 
been identified within the VCA domain of WASp. These have also resulted in 
increasing  WASp  actin  polymerisation  activity  in  vitro  and  the  mechanism  of 
this is enhanced Arp 2/3 binding. Unlike phosphorylation of Y291, S483 / S484 
phosphorylation appears to be constitutive, and mediated by casein kinase 2 
(Cory et al., 2003).
For phosphorylation to act as a regulatory signal there must be physiological 
antagonists to WASp kinases. LAR-PTP (in vitro) and PTP-PEST (in vivo) have 
been identified as WASp specific phosphatases (Torres and Rosen, 2003; Cote 
et al., 2002). The later cannot bind directly to WASp, but does so via the adapter 
protein PSPPIP as described in section 1.5.6.2.
Role in WASp activation 1.5.5.3 
Although tyrosine kinases partially activate WASp through phosphorylation of 
Y291, there is in vitro evidence that they destabilise the WASp autoinhibitory 
conformation in addition to the effects of phosphorylation. This effect has been 
proposed to be through induced GBD conformational change following interaction Chapter 1     
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between the kinase SH2 domain and the WASp Y291 residue (Torres and Rosen, 
2003). Src and Tec kinases have both SH3 and SH2 domains and are therefore 
capable of binding to both the polyproline domain and the GBD, and the presence 
of both domains is required for maximal activation of WASp by kinases (Torres 
and Rosen, 2003). Interestingly the affinity of WASp for Btk and Hck is unaffected 
by the phosphorylation status of Y291 suggesting that the primary binding site 
of tyrosine kinases is via SH3 domains to the WASp polyproline domain (Cory 
et al., 2002; Baba et al., 1999). WASp activation by protein tyrosine kinases, like 
the effects of other WASP activators, is cooperative with Cdc42 and with PIP2 
(Suetsugu et al., 2002).
SH3 domain containing proteins 1.5.6 
SH3 – SH2 adaptor proteins 1.5.6.1 
Src homology domain 3 (SH3) - SH2 adapter proteins are a small group of proteins 
with no intrinsic catalytic activity, which function by binding and co-localising at 
least two different effector proteins, facilitating their interaction. These proteins 
are able to bind both proline rich motifs (via SH3), which are generally found 
in regulators of the cytoskeleton, and phosphorylated tyrosine residues (SH2), 
usually associated with intermediates downstream of receptor tyrosine kinase 
signalling cascades. Structurally they have a single SH2 domain but multiple SH3 
domains (Chen et al., 1998).
Nck and Grb2 are SH3 – SH2 adapter proteins and were among the first proteins 
identified to bind the WASp polyproline domain (She et al., 1997; Rivero-Lezcano 
et  al.,  1995).  Both  bind  a  diverse  range  of  effector  proteins  and  are  involve 
in a variety of cellular functions. A well characterised example of this, is Grb2 
recruitment to the cell surface by Epidermal Growth Factor Receptor (EGFR). 
Following activation, EGFR is tyrosine phosphorylated facilitating Grb2 binding 
via its SH2 domain. Grb2 constitutively binds SOS, a promiscuous GAP for Ras 
family GTPases, and through activation of Ras GTPases co-localised to EGFR, 
Grb2 links receptor tyrosine kinase signalling to activation of the MAK kinase / 
ERK pathway (Schlessinger, 1994; Pawson, 1994). Protein co-localisation, and 
coordinating the formation of multiprotein signalling complexes are central to SH3 
– SH2 adapter protein function.
The binding of these adaptors to NWASp contributes to activation and release of 
autoinhibition. It was originally demonstrated that Grb2 and Cdc42 synergistically 
activated NWASp in a PPP assay, negating the need for PIP2 for maximal activation 
(Carlier et al., 2000). By contrast Nck and PIP2 synergistically activated NWASp, 
with Cdc42 activation redundant in the presence of Nck. Nck alone produced Chapter 1     
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a similar degree of activation as Cdc42, and was a more potent activator than 
Grb2. Maximal Nck activation of NWASp was achieved if all three SH3 domains 
bound the NWASp polyproline domain (Rohatgi et al., 2001).
No synergism was detected between Grb2 and Nck in the in vitro PPP assay, 
however more recently an in vivo EGF induced membrane protrusion model 
demonstrated a need for both Grb2 and Nck to activate NWASp. The resultant 
actin polymerisation and membrane protrusion was independent of both Cdc42 
and phosphatidyl ionositol-3-kinase (and therefore PIP2) (Kempiak et al., 2005; 
Kempiak et al., 2003). Further evidence of a concerted role for Nck and Grb2 in 
NWASp activation comes from the recruitment of both adaptors to lipid vesicles 
during NWASp mediated vesicle rocketing (Benesch et al., 2002). Nck is important 
in targeting WASp to the immune synapse following T cell receptor ligation, and 
this is more fully discussed below. In addition to WASp and NWASp, Nck also 
binds WIP and p21 activated kinase 1 (PAK1), illustrating its pivotal role in actin 
dynamics (Anton et al., 1998; Bokoch et al., 1996).
Two other SH3 – SH2 adaptor proteins have been identified, as playing a role in 
WASp / NWASp signalling although details of their physiological significance are 
limited. The p85 subunit of phosphatidylinositol 3-kinase (p85) has been shown 
to bind WASp in vitro (Banin et al., 1996), and recently has been identified as part 
of a complex with WASp, SNX9 and CD28, which mediates the endocytosis (and 
therefore internalisation) of CD28 following TCR activation (Badour et al., 2007). 
CrkL has been found to bind WIP when complexed to WASp, and may play a 
role in recruiting WASp – WIP complexes to ZAP-70 in lipid rafts adjacent to the 
immune synapse (Sasahara et al., 2002).
Other SH3 adaptor proteins 1.5.6.2 
As  shown  in  figures  1.4  and  1.6  there  are  a  large  number  of  SH3  domain 
containing protein which interact with WASp / NWASp. Several of these have 
demonstrated roles in localising WASp to specific cytoskeletal structures such as 
microtubules (CIP4) and endosomes (intersectin 2, SNX9), without having any 
additional catalytic activity.
Proline-Serine-Threonine  phosphatase  interacting  protein  1  (PSTPIP1)  is  a 
member  of  the  Pombe  Cdc-15  homology  (PCH)  family,  (like  TOCA),  whose 
interaction with the WASp polyproline domain results in impaired WASp activity. 
Following overexpression of WASp and PSTPIP1 in various cell lines, the two 
proteins  immunoprecipitated  together  and  WASp  induced  actin  bundling  was 
disrupted (Wu et al., 1998). PSTPIP1 also binds a PEST family protein tyrosine Chapter 1     
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phosphatase, PTP-PEST, and in vivo these two proteins are bound together in 
haematopoietic cell lines. PSTPIP1 act as a scaffold protein, simultaneously binding 
WASp and PTP-PEST, mediating the dephosphorylation of WASp at Tyr291, and 
reducing its actin polymerisation activity (Badour et al., 2004; Cote et al., 2002; 
Wu et al., 1998). This physiological antagonism to Tec family kinases has been 
best characterised for WASp activation in T cells. Following TCR engagement, 
Fyn binds to WASp and phosphorylates it at Tyr291, inducing the activation of Arp 
2/3 mediated actin nucleation. Within minutes, WASp is recruited by PSTPIP1 to 
PTP-PEST and is dephosphorylated (Badour et al., 2004). As discussed below 
this interaction is also important in recruiting WASp to the immune synapse.
WASp localisation to the immune synapse 1.5.6.3 
WASp is essential for the formation of the T cell synapse, as demonstrated by WASp 
null T cells having impaired synapse formation and impaired actin polymerisation 
adjacent to the synapse following TCR stimulation (Badour et al., 2003; Snapper 
et al., 1998; Gallego et al., 1997; Molina et al., 1993; Molina et al., 1992). Exactly 
how  signal  transduction,  actin  remodelling,  protein  compartmentalisation  and 
endocytosis of surface receptors are coordinated, and what role WASp plays in 
these processes, is an active area of ongoing research.
At least two pathways for WASp recruitment to the T cell synapse have been 
described.  Nck  is  rapidly  recruited  to  the  CD3ε  chain  following  CD3-TCR 
engagement, and this appears to be critical for T cell synapse formation (Gil et al., 
2002). Nck also binds the adapter protein SLP-76 via its SH2 domain, following 
SLP-76 phosphorylation (Wunderlich et al., 1999). SLP-76 is localised, and recruits 
WASp, to the synapse by an inducible interaction with the membrane bound 
adapter protein LAT, via the Grb2 related protein, GRAP2 (Liu et al., 1999). SLP-
76 simultaneously binds Vav-1 (a Cdc42 GEF) and Cdc42, facilitating temporally 
and spatially appropriate WASp activation (Zeng et al., 2003). SLP-76 associated 
protein (SLAP) completes the multimeric complex (Krause et al., 2000). Thus Nck 
can recruit WASp to the synapse both directly via its SH3 domain, and indirectly 
via its association with SLP-76.
In the second described pathway, PSTPIP1 binds to both CD2 and CD2 adapter 
protein  (CD2AP)  following  CD2  engagement.  WASp  is  then  recruited  to  this 
complex by PSTPIP2 (via polyproline - SH3 domain binding), and this recruitment 
is essential for synapse formation (Badour et al., 2003).
Whether these different recruitment mechanisms represent different time points 
after T  cell  stimulation,  relate  to  different  co-stimulatory  signals  or  represent Chapter 1     
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differences in the antigen presenting cell or TCR stimulation conditions remains 
to be determined.
Profilin and VASP 1.5.7 
The actin monomer binding protein profilin, plays a central role in the dynamics of 
actin polymerisation and depolymerisation as described below (section 1.6.2). It 
also has a significant effect upstream on the activation of WASp. 
Profilin  depletion  from  neutrophil  lysate  abolishes  Cdc42  induced  actin 
polymerisation,  and  its  role  in  this  process  is  dependent  on  binding  the 
polyproline domain of WASp (Yang et al., 2000). This role in activation appears 
to be dependent on the presence of VASP (Yarar et al., 2002). It is likely that 
profilin catalyses nucleation by delivering actin monomers to Arp 2/3 at the point 
of nucleation, helping to overcoming the thermodynamic instability of initiating 
filament branching. However profilin’s role in actin nucleation is complex as it 
also sequesters g-actin and enhances barbed end polymerisation. These actions 
reduce free g-actin concentration, which in turn limits the rate of Arp 2/3 nucleation. 
Additionally, there is evidence for profilin having an effect on activating WASp, by 
partially relieving WASp autoinhibition, in a manner similar to Grb2 (Yang et al., 
2000).
Vasodilator-stimulated phosphoprotein (VASP) is an actin regulatory protein which 
plays a role in localising proteins to the actin cytoskeleton and regulating actin 
remodelling. It contains an EVH1 domain, and an f- and g-actin binding domain 
which facilitates VASP oligomerization (EVH2 domain) (Bachmann et al., 1999). 
Like  profilin,  VASP  promotes  actin  polymerisation  at  several  different  levels. 
It binds WASp directly via the interaction of the VASP EVH1 domain with the 
WASP polyproline domain (Castellano et al., 2001). VASP and WASp cooperate 
in regulating actin polymerisation via multimeric signalling complexes formed in 
response to Fcγ receptor evoked phagocytosis (Coppolino et al., 2001) and TCR 
engagement (Krause et al., 2000).
In summary, profilin and VASP are important factors which act together to stimulate 
WASp induced Arp2/3 nucleation and function at several level in this process.
Model of WASp as signal transducer 1.5.8 
The functional analysis of individual WASp domains and their interaction with 
multiple binding partners gives an insight into how WASp functions in vivo. It 
integrates inputs from several signalling cascades; balancing the activating signals 
(GTP bound Cdc42, PIP2, TOCA, Nck, Grb2 binding and tyrosine phosphorylation) Chapter 1     
71
against the inhibitory factors (intrinsic stability of autoinhibitory conformation, WIP 
binding). If the activating signals overcome the inhibitory factors, the autoinhibitory 
conformation of WASp is disrupted and the protein opens. Other binding partners 
act by localising WASp and Arp2/3 to specific sites of actin polymerisation, and 
by recruiting other regulatory proteins.
Several models have been proposed to explain these increasingly complex finding, 
and integrate them into a mechanisms of WASp regulation (Dong et al., 2007; 
Torres and Rosen, 2006; Leung and Rosen, 2005; Hemsath et al., 2005; Kempiak 
et al., 2005; Insall and Machesky, 2004; Ho et al., 2004; Martinez-Quiles et al., 
2001; Higgs and Pollard, 2000; Prehoda et al., 2000). How relevant these models 
are to the in vivo situation remains largely unknown. It does appear, however, 
that WASp induced actin polymerisation is tightly controlled both temporally, by 
molecular release of autoinhibition, and spatially, by the targeting of WASp to 
specific locations and by the colocalisation of synergistic WASp activators.
Actin Polymerisation and Arp 2/3 1.6 
Actin dynamics 1.6.1 
Monomeric actin (g-actin) is a 43 kDa protein made up of 4 similar subdomains 
(numbered 1-4) which form a central cleft containing binding sites for an adenosine 
nucleotide (either ATP or ADP) and a magnesium ion. When bound, the central 
cleft closes around the nucleotide resulting in a structurally globular shape, but the 
protein remains functionally polarised. Purified actin will polymerise spontaneously 
when heated or exposed to high salt concentration (Straub, 1989). Polymerised 
actin forms a double stranded, right handed helix with a width of 5-9 nm and 
a complete helix turn length of 37nm, and is called filamentous actin (f actin) 
(Holmes et al., 1990). Actin filaments will spontaneously depolymerise on cooling 
or dilution of the solution. There is a time lag between increase in temperature 
/ salt and instigation of polymerisation, which is avoided if small amounts of 
filamentous actin are added to the reaction. This is because the formation of 
a de novo filament from individual monomers, a process called nucleation, is 
inherently thermodynamically unfavourable (due to the instability of actin dimers 
and trimers). The longer a filament is, the more favourable actin monomer addition 
becomes (Pantaloni et al., 2001; Oosawa, 1975; Kasai et al., 1962).
Once a filament is established, ATP loaded actin monomers bind with different 
affinity to each end of the filament. As a result in the presence of an excess of 
actin one end will elongate faster (the barbed or positive end) than the other (the 
pointed or negative end). As the reaction continues and the concentration of free Chapter 1     
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actin monomers reduces, the filament stability at the pointed end changes to favour 
depolymerisation. Eventually equilibrium forms where the rate of polymerisation 
at the barbed end equals the rate of depolymerisation at the pointed end, and the 
filament “treadmills”, generating a propulsive force in the direction of the barbed 
end. Treadmilling occurs when the actin concentration within the reaction lies 
between the critical concentrations (the concentration at which actin is added to 
a filament) of each end (Hill and Kirschner, 1982; Kirschner, 1980; Wegner, 1976; 
Wegner, 1982).
The actin subunit, once bound to the filament will hydrolyse ATP to ADP (Carlier 
et al., 1994; Korn et al., 1987; Wegner, 1977). This “slow hydrolysis” occurs at 
some time point after binding to the filament (and therefore usually when the 
actin unit is in the middle of a filament). Hydrolysis and phosphate release induce 
a  conformational  change  around  the ATP  binding  cleft,  which  influences  the 
stability of protein interactions with the actin unit (Otterbein et al., 2001; Maciver 
et al., 1991; Korn et al., 1987). Actin-ADP is less stable in the filamentous form, 
particularly  at  the  pointed  end  of  the  filament,  and  therefore ATP  hydrolysis 
encourages depolymerisation. This provides a temporal element to the stability 
of filamentous actin.
In biological systems, actin monomers and the filamentous actin network of the 
cell cytoskeleton exist in equilibrium together. In eukaryotic cells, actin is the most 
abundant protein and has a cytoplasmic concentration of the order of 100µM, 
although the vast majority of this filamentous actin. The critical concentration for 
actin at the ATP bound barbed end of a filament is approximately 10x that of the 
ADP bound pointed end. Monomeric actin concentration, although highly locally 
variable, is usually approximately the same as the critical concentration at the 
barbed end. This means a steady state of treadmilling is just maintained, but 
the rate limiting step for filament elongation is actin concentration, and therefore 
pointed end depolymerisation (Kirschner, 1980).
Actin cytoskeleton 1.6.2 
The actin cytoskeleton is highly specialised to meet the functionality of specific 
cells. In this discussion I will be considering the generalised properties of cells 
with the capacity to migrate.
Upon detecting a signal to move, the cytoskeleton rapidly rearranges and polarises 
the cell. The cell develops a broad leading edge with an elongated trailing tail 
at the opposite pole. To sense the environment and as an initial step towards 
movement, the cell forms finger like projections, called filopodia, from the leading Chapter 1     
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edge. If appropriate attractant signals are received the filopodia stabilise, and then 
evolve into broader projections called lamellipodia or ruffles. These advance the 
cell membrane, and the concerted advancement of several lamellipodia results 
in movement of the leading edge of the cell. To counteract this fluidity, cells have 
focal adhesions which consist of bundles of actin filaments bound to membrane 
anchoring proteins, which in turn anchor the filament bundles (and therefore the 
cell) to the extracellular matrix. When the cell does move, these structures are 
simultaneous deconstructed, facilitating cell remodelling (Pantaloni et al., 2001).
To be able to rapidly remodel the actin cytoskeleton, the cell must be able harness, 
enhance and regulate (both spatially and temporally) the treadmilling of actin 
filaments. It does this through a series of actin binding proteins with differential 
functions. To aid the investigation of the regulation of actin networks a series of 
in vitro models of actin based motility have been developed. These include the 
visualisation of motility and actin comets formed by bacteria (Listeria or Shigella) 
or beads coated with proteins of interest (Wiesner et al., 2003; Suetsugu et al., 
2001b; Yarar et al., 1999).
The rate of expansion of a branched actin network is determined by the number 
of free barbed ends and the elongation rate of these filaments. There are three 
main mechanisms the cell uses for regulating the number of free barbed ends. 
Capping proteins, such as gelsolin, capping protein (CapZ) and CapG bind to 
the barbed ends of filaments with high affinity, blocking elongation and therefore 
inhibiting network protrusion (Rogers et al., 2003; Schafer et al., 1996). Barbed 
end capping also encourages nucleation and filament branching, as a reduction in 
available barbed ends leads to an accumulation of ATP loaded actin monomers. 
Capping proteins and profilin (see below) act synergistically in increasing Arp 2/3 
nucleation rates (Blanchoin et al., 2000a). They have been shown to be essential 
for efficient cell motility (Hug et al., 1995).
There  are  also  capping  proteins  specific  for  filament  pointed  ends  (such  as 
Spectrin and Arp 2/3) (Mullins et al., 1998; Pinder et al., 1984), which providing 
the filament is in equilibrium, will block depolymerisation, resulting in longer (and 
older) filaments. Pointed end capping will also block the replenishment of free actin 
monomers and therefore reduce the rate of elongation at free barbed ends.
Severing of actin filaments generates new barbed and pointed ends, resulting 
in  shorter  filaments,  and  additional  focuses  of  filament  protrusion  and 
depolymerisation.  The  Actin  Depolymerising  Factor  (ADF)  /  cofilin  family  of 
proteins bind to the sides of ADP-actin subunits within filaments. Once bound they Chapter 1     
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induce depolymerisation from the pointed end (Carlier et al., 1997), encourage 
debranching of filaments (Blanchoin et al., 2000b) and destabilise the helical 
structure of the filament resulting in filament severing (Blanchoin and Pollard, 
1999; Maciver et al., 1991). The net effect of ADF / cofilin is an enhancement of 
actin based motility (Carlier et al., 1997).
Finally, nucleation of actin monomers generates new filaments, and therefore new 
barbed ends. The most important nucleating protein complex is Arp 2/3, which in 
addition to initiating a new filament, also anchors it to an existing filament, resulting 
in 70° branch (Mullins et al., 1998; Svitkina et al., 1997). Arp 2/3 activation results 
in the generation of an orthogonal matrix with short actin filaments and a high 
density of free barbed ends, optimal for exerting a 2 dimensional distributed force 
on the cell membrane.
A second major group of actin nucleating proteins are the formins. These proteins 
are a large family of ubiquitously expressed and highly conserved proteins. Unlike 
Arp 2/3 (see sections 1.6.5 and 1.6.6) these protein nucleate filaments from the 
barbed end and remain bound as the filament elongates. They antagonise the 
binding of capping proteins and as a result, formin filament nucleation results 
in elongated actin filaments. Although formins play little role in generating an 
orthogonal actin network, they are essential for structures requiring discrete actin 
bundles, such as filopodia, stress fibres and the contractile ring formed during 
cytokinesis (Faix and Grosse, 2006). 
The rate of filament elongation is largely determined by the concentration of 
capping  proteins  and  the  concentration  of  free ATP  loaded  actin  monomers. 
As discussed above, free actin concentration is determined by local rates of 
depolymerisation,  but  various  monomer  binding  proteins  also  influence  the 
availability of actin to the barbed ends. Thymosin β4 is actin sequesting protein 
which reduces the available pool of actin monomers for polymerisation (Pantaloni 
and Carlier, 1993). A related protein, profilin plays an important role in enhancing 
actin network branching and extension, by catalysing the exchange of ADP for 
ATP in actin monomers, and then delivering the recycled actin to the barbed 
end of filaments (Loisel et al., 1999; Pantaloni and Carlier, 1993). This delivery 
stimulates barbed end polymerisation of actin filaments. The nucleotide exchange 
in monomeric actin, however, results in the release of cofilin (which preferentially 
binds to ADP – actin). Free cofilin is then able to bind to F-actin, stimulating 
pointed end filament depolymerisation. Although profilin is inhibitory towards actin 
nucleation, it is a more potent inhibitor of spontaneous nucleation than Arp 2/3 
mediated nucleation, and as such promotes filament branching (Blanchoin et al., Chapter 1     
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2000a; Machesky et al., 1999).
Other actin binding proteins are involved in packaging filaments into bundles, cross 
linking filaments, anchoring filaments to the plasma membrane and organising 
higher actin structures.
Filopodia and focal adhesions have long unbranched bundles of actin filaments 
in their cores, but lamellipodia, by contrast, consist of a high density dendritic 
array of branched actin filaments. The actin cytoskeleton is far more branched 
at the leading edge of cells, than within the main cell body, where actin filaments 
are less branched and are longer (Svitkina and Borisy, 1999; Small et al., 1995). 
Recently some groups have suggested two distinct actin networks underlying 
the leading edge, a lamellipod network and a “deeper” lamellum network (Le 
Clainche and Carlier, 2008; Iwasa and Mullins, 2007; Ponti et al., 2004). Although 
both  appear  capable  of  instigating  cell  membrane  protrusion,  they  showed 
distinct architecture and a different composition of actin binding proteins. Arp 2/3 
localises to lamellipodia and the leading edge (Svitkina and Borisy, 1999; Welch 
et al., 1997; Machesky et al., 1994), but is not found in the lamella (Iwasa and 
Mullins, 2007). Similarly there are much higher concentations of capping protein, 
APF / cofilin and free actin within the lamellipodia. These results demonstrate that 
the cell maintains the greatest dynamic potential adjacent to the cell membrane, 
particularly at the leading edge.
Arp 2/3 structure 1.6.3 
The Arp  (actin  related  protein)  2/3  complex  was  first  isolated  in  1994,  from 
Acanthamoeba (Machesky et al., 1994) and its ability to initiate actin polymerisation 
in vitro was first demonstrated on the surface of Listeria monocytogenes in 1997 
(Welch et al., 1997). Subsequently Arp 2/3 was shown to localise to areas of 
active actin polymerisation (Svitkina and Borisy, 1999; Machesky et al., 1994) and 
it is essential for actin based cellular functions such as phagocytosis, pinocytosis 
and establishment of cell polarity (Magdalena et al., 2003; Insall et al., 2001; May 
et al., 1999). Electron microscopy and kinetic studies of purified protein have 
suggest a role for Arp 2/3 as an actin nucleator, a branching agent and pointed 
end capping protein (Mullins et al., 1998).
Arp 2/3 is a stable complex of 240 kDa, made up of 7 different proteins each 
represented once within each complex. Arp 2 and Arp 3 are structurally homologous 
to actin, differing mainly at the pointed end. The other 5 proteins are structurally 
unique (Mullins et al., 1997) and are named ARPC (actin related protein complex 
component) 1-5, with molecular sizes of 42, 34, 21, 20 and 16 kDa respectively Chapter 1     
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(in humans). 
Once the homology between Arp 2, Arp 3 and actin was recognised, it was 
hypothesised that Arp 2 and Arp 3 would form a pseudotrimer “nucleus” with 
an actin monomer bound to a nucleator activator (such as WASp/SCAR). This 
trimer would then initiate the formation of a new filament (Robinson et al., 2001; 
Kelleher et al., 1995). The WASp – Arp 2/3 complex would therefore stabilise 
the trimer formation, overcoming the thermodynamic opposition to nucleation. 
Extensive and ongoing work, particularly using structural biological and electron 
microscopy techniques, have explored this hypothesis.
The crystal structure of bovine Arp 2/3 with no nucleotide bound was solved in 
2001 (Robinson et al., 2001). ARPC2 and ARPC4 form the backbone horseshoe of 
the complex, with Arp2 and Arp3 bound between the open jaws of the horseshoe. 
ARPC1 is structurally distinct from the other units being a seven-bladed WD40 
β-propeller protein, and it interacts with Arp2, ARPC4 and ARPC5. By contrast 
the  globular ARPC3  binds  only Arp3. Arp2  and Arp  3  have  minimal  contact 
and are separated from each other by a cleft, which would require a significant 
conformational change in the complex to mimic the configuration of adjacent 
actin units within a filament (Lorenz et al., 1993). This structure is presumed to 
be an inactive form of Arp2/3, and the crystal structure of a fully activated Arp2/3 
complex remains elusive. 
Subsequent structural studies have assessed the impact of ATP binding to both 
Arp2 and Arp3, and have shown that although both subunits themselves change 
conformation (closing around the nucleotide), there was insufficient change in 
their juxtapositions to mimic an actin dimer, and further conformational change 
would be necessary to initiate nucleation (Kiselar et al., 2007; Nolen et al., 2004; 
Goley et al., 2004).
WASp activation of Arp 2/3 1.6.4 
In isolation,  Arp 2/3 alone is relatively ineffective at initiating actin nucleation (Mullins 
et al., 1998). In addition to monomeric actin and ATP, it requires activation (Higgs 
et al., 1999), and the minimal activating unit is the VCA domain from a WASp/
SCAR family protein (Machesky et al., 1999). The presence of pre-existing actin 
filaments increases the speed and efficiency of actin polymerisation (Marchand 
et al., 2001; Machesky et al., 1999).
The binding of WASp to the Arp2/3 complex involves the interaction of Arp2, 
Arp3, ARPC1 and ARPC3 with the CA domains of WASp (Kreishman-Deitrick et Chapter 1     
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al., 2005; Beltzner and Pollard, 2004; Panchal et al., 2003). This binding can only 
occur following WASp activation as the Arp2/3 binding sites within the CA domain 
are hidden in the autoinhibited conformation (Panchal et al., 2003). Two critical 
anchor points within WASp appear to be the carboxyl terminal of both the C region 
(M474) and the A region (Trp500) (Kiselar et al., 2007; Kreishman-Deitrick et al., 
2005). The exact interaction sites within Arp2/3 remain unclear. Truncation of the 
carboxyl terminal of NWASp to amino acid 484 severely impaired Arp 2/3 induced 
actin polymerisation in vitro (Suetsugu et al., 2001a). The V domain provides no 
additional affinity for Arp2/3 binding (Rohatgi et al., 2000).
Phosphorylation  regulates  the  interaction  between  WASp  and  Arp  2/3.  As 
described in section 1.5.5.2, two serine residues within the C domain of WASp 
(Ser283  and  Ser484)  are  constitutively  phosphorylated  by  casein  kinase  II, 
resulting in a higher affinity of WASp for Arp2/3, and an increase in resultant actin 
nucleation activity (Cory et al., 2003). Interestingly, recent data has demonstrated 
that phosphorylation of Arp2 is also essential for Arp2/3 mediated actin nucleation 
(at residues Thr237 and Thr238), but this effect is independent of WASp binding 
(LeClaire, III et al., 2008).
Interaction between Arp2/3 and WASp is more complex than just the binding 
of the VCA domain. Arp2/3 binding to the EVH1 and Basic domains has been 
demonstrated (Suetsugu et al., 2001a; Prehoda et al., 2000), and these interactions 
also effect the autoinhibition of WASp and the activity of Arp2/3 (see sections 
1.4.1.5, 1.4.2.1, 1.4.6.2 and 1.5.8)
ATP bound monomeric actin binds to the V domain of WASp, although interaction 
with residues in the C domain further stabilise this binding (Marchand et al., 2001; 
Machesky and Insall, 1998). Actin binding to the V domain is essential for Arp 
2/3 activity, and deletion of the V domain eliminates the actin polymerisation 
(Marchand et al., 2001; Miki and Takenawa, 1998). It is likely that profilin plays a 
role in delivering ATP loaded actin monomers to the V domain, via its interaction 
with the WASp polyproline domain.
Although  there  remains  controversy  over  the  exact  nature  of  the  interaction 
with the mother filament during Arp2/3 nucleation, it is certain that Arp2/3 binds 
“side on” to filamentous actin (Egile et al., 2005; Beltzner and Pollard, 2004; 
Volkmann et al., 2001; Gournier et al., 2001). As Arp2/3 shows much greater 
actin polymerization activity in the presence of existing f-actin, it is likely that the 
binding of Arp2/3 to the mother filament changes the alignment of the Arp2 and 
Arp3 subunits, resulting in complex activation.Chapter 1     
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The role Arp2/3 ATP hydrolysis during nucleation and branching is important, but 
the exact details remain controversial. The affinity of ATP for Arp2 and Arp3 is 
significantly lower than that for monomeric actin, and Arp2/3 is structurally stable 
with no ATP bound. WASp binding to Arp2/3 increases the affinity of the complex 
for ATP by 3-fold (Dayel et al., 2001; Le et al., 2001). Dayel et al suggest that 
ATP hydrolysis is necessary for actin nucleation, as Arp2/3 loaded with ADP or 
a non-hydrolysable ATP analogue were unable to nucleate actin (Dayel et al., 
2001). Mutations in the ATP binding cleft of either Arp severely impairs actin 
polymerization (Martin et al., 2006; Goley et al., 2004). An alternative model has 
been proposed by Le Clainche et al. They demonstrated that the binding of ATP 
to Arp2 (following WASp binding) is the critical step to initiate actin nucleation. 
They suggested ATP hydrolysis occured after nucleation and led to instability 
between the daughter and mother filaments, encouraging debranching (Le et al., 
2003; Le et al., 2001)
Several lines of evidence suggest that binding of WASp and initiation of actin 
nucleation are distinct steps. Marchand et al identified two point mutations in 
the NWASp V domain which decrease the ability of bound Arp 2/3 to instigate 
actin polymerisation by 10 fold, without influencing the affinity of NWASp for 
either monomeric actin or the Arp 2/3 complex (Marchand et al., 2001). Different 
WASp/SCAR family proteins have different capacities to activate Arp2/3, but this 
capacity does not correlate to their affinities for either Arp 2/3 or monomeric actin 
(Panchal et al., 2003; Zalevsky et al., 2001). Finally, demonstration that Arp2/3 
with a WASp V domain fused to it in an appropriate position was unable to initiate 
actin polymerisation, suggests that the CA domain plays a distinct and active role 
in Arp 2/3 activation. (Goley et al., 2004).
Conformational  change  of Arp  2/3  upon  binding  of  WASp  CA  domains  was 
demonstrated by an increase in fluorescent resonance energy transfer (FRET) 
between  fluorophore  labelled ARPC3  and ARPC1,  upon  WASp  VCA  domain 
binding (Goley et al., 2004). Electron microscopy findings have corroborated 
this and suggest that ARPC2 instigates the closure of Arp2 / Arp3 cleft, with this 
conformational change stabilised by the WASp CA domain (Rodal et al., 2005). 
These  results  combined  with  the  structural  data  on  WASp  - Arp2/3  binding 
suggest a model whereby the WASp V domain binds an actin monomer and the A 
domain anchors WASp to Arp2/3. The C domain interaction with Arp2/3 instigates 
a change in the relative positions of several Arp 2/3 components (either by a 
rotational or a sliding Arp2 model) and provides a platform for pulling together 
Arp2, Arp3 and the actin monomer (Goley and Welch, 2006; Aguda et al., 2005) Chapter 1     
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Actin nucleation 1.6.5 
Although  much  of  the  mechanism  and  structural  biology  of Arp2/3  activation 
and actin filament branching has been worked out, the exact site of branching 
remains controversial. Two main models exist. In the dendritic nucleation model, 
Arp2/3 binds entirely on the side of the mother filament and Arp2, Arp3 and the 
WASp bound actin monomer form the first 3 actin units of the daughter filament. 
Nucleation is initiated on the side of the pre-existing filament (Amann and Pollard, 
2001; Blanchoin et al., 2000a; Mullins et al., 1998). Evidence for this model 
came initially from real time observation of fluorescently labelled actin filament 
branching, and subsequently from cyro-electron microscopy.
Real time imaging of actin filaments revealed that mother and daughter filaments 
following branching were generally the same length, and it was unusual to find 
a capped actin filament nucleating downstream from the cap. These findings 
and kinetic modelling studies lead to the proposition of an alternative nucleation 
mechanism. In the barbed-end branching model, Arp2/3 binds to the barbed 
end of the filament and one of Arp2, Arp3 or the WASp bound actin monomer is 
incorporated into the mother filament, whereas the other two units form the initial 
units of the daughter filament. Filament elongation occurs synchronously from 
mother and daughter filaments (Falet et al., 2002; Pantaloni et al., 2000).
Although this debate has not resolved, it does not affect the principles of the 
regulation of the actin cytoskeleton.
Filament debranching 1.6.6 
Following  branch  formation,  WASp  and  other  activators  of  Arp  2/3  (except 
cortactin) immediately dissociate from the actin filament (Martin et al., 2006; Egile 
et al., 2005; Uruno et al., 2003). Although not universally accepted, Dayal et al 
suggested that this dissociation is mediated by the hydrolysis of ATP to ADP by 
Arp2/3, which destabilises the Arp2/3-WASp binding, releasing Arp2/3 and the 
actin filament from WASp and the cell membrane (Dayel et al., 2001). By contrast 
the Arp2/3 complex remains at the junction point of the filaments (Svitkina and 
Borisy, 1999).
Branched filaments are inherently unstable and have a half life of only 500-800s, 
before dissociating from the mother filament (Le et al., 2003; Blanchoin et al., 
2000b). The stability of branched filaments is determined by the hydrolysis of ATP 
bound to the individual subunits (Otterbein et al., 2001; Blanchoin et al., 2000b; 
Blanchoin and Pollard, 1999). The hydrolysis of ATP bound to Arp2/3 (see above) Chapter 1     
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may also encourage debranching of the daughter from the mother filaments (Le 
et al., 2003). Once the daughter filament has debranched, affinity between Arp2/3 
and the filament pointed end is reduced by hydrolysis of ATP in either (or both) 
elements. This leads to Arp2/3 decapping from the filament pointed end, inducing 
depolymerisation (Blanchoin et al., 2000a). This process is enhanced by the ADF 
/ cofilin.
WASp Interacting Protein (WIP) 1.7 
WIP was first identified as a WASp binding protein by yeast 2-hybrid assays, 
and subsequent co-immunoprecipitation from cells lines lysates following over-
expression  both  proteins  (Ramesh  et  al.,  1997).  Subsequently  constitutively 
formed complexes have been immunoprecipitated from cells (Martinez-Quiles 
et  al.,  2001),  and  in  resting  lymphocytes  between  80  and  95%  of  WASp  is 
constitutively complexed with WIP (de la Fuente et al., 2007; Sasahara et al., 
2002). Although ubiquitously expressed, it is found in much higher concentrations 
in  haematopoietic  cells,  mirroring  the  expression  of  WASp,  but  not  NWASp 
(Ramesh et al., 1997). It also shows tissue specific alternative splicing, although 
the functional significance of this is not known (Vetterkind et al., 2002).
WIP Structure and binding partners 1.7.1 
WIP is very rich in proline residues, which make up 28% of the protein’s amino 
acids. Runs of consecutive proline residue motifs are prominent in each of the 
recognised functional domains of WIP, and this high proline content has been 
blamed for the difficulties experienced in generating recombinant WIP.
The domain structure of WIP is shown in figure 1.9. Two regions are conserved 
among  all  three  family  members  (see  section  1.4.1.2),  a  double  Verprolin 
homology domain at the amino terminus, and a WASp / NWASp binding domain 
at the carboxyl terminus. WIP also contains three potential profilin binding sites 
(containing the motif XPPPPP), which are also capable of binding both monomeric 
and filamentous actin (Martinez-Quiles et al., 2001). WIP has also been shown to 
bind cortactin via a proline rich region at the carboxyl end of the double Verprolin 
domain (110 -170) (Kinley et al., 2003), and the SH3 – SH2 adaptor proteins Nck 
and CrkL via a polyproline domain (Sasahara et al., 2002; Anton et al., 1998). 
WIP also binds Hck, although the site of binding has not yet been identified (Scott 
et al., 2002). Chapter 1     
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V V WBS CBS Poly P
WIP domain structure
V - Verprolin homology domain
CBS - Cortactin binding site
PolyP - Polyproline domain
WBS - WASp binding site
Profilin binding site
(Actin based motilitiy motif 2)
Fig 1.9 WIP domain structure
WIP function 1.7.2 
WIP molecular function 1.7.2.1 
The functions of WIP at a molecular level can divided into those mediated by its 
interaction with actin and profilin, cortactin and WASp. 
WIP stabilises F-actin from depolymerisation and stabilises actin bundling in vitro 
(Anton and Jones, 2006; Martinez-Quiles et al., 2001). When over-expressed in 
cells WIP induces increased F-actin content, and conversely WIP null cells show 
a reduction in F-actin content (Anton et al., 2002; Ramesh et al., 1997).
Cortactin is an actin binding protein (both f- and g- actin), which localises to 
lamellipodia at cell leading edges in a Rac-dependent manner, following growth 
factor receptor activation (Weed and Parsons, 2001; Kaksonen et al., 2000; Weed 
et al., 1998). It appears to play an important role in initiating cell motility, via actin 
remodelling (Bryce et al., 2005). Cortactin binds and activates Arp 2/3, initiating 
actin  filament  branching,  and  also  has  a  function  in  inhibiting  actin  filament 
debranching (Weaver et al., 2001; Weed et al., 2000). WIP stimulates cortactin 
induced Arp 2/3 activation and actin polymerisation in a concentration dependent 
manner, and co-expression of WIP and cortactin resulted in membrane protrusion 
(Kinley et al., 2003). The interaction of WIP with WASp / NWASp is discussed in 
section 1.7.3.
Cellular function of WIP 1.7.2.2 
In resting fibroblasts, WIP is asymmetrically distributed in the perinuclear areas, 
with a pattern suggestive of a Golgi distribution (Vetterkind et al., 2002; Martinez-
Quiles et al., 2001). WIP also localises to stress fibres in resting fibroblasts, 
perhaps reflecting its role in filament stabilisation (Vetterkind et al., 2002). Upon 
cell stimulation, WIP is recruited to sites of polarisation, such as the T cell synapse 
and the leading edge (Myers et al., 2006).
Fig 1.9Chapter 1     
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The role of WIP in actin dynamics and remodelling has been investigated by 
microinjection  and  over-expression  experiments  assessing  cellular  function. 
Over-expression of WIP in fibroblasts leads to the Cdc42 dependent induction of 
filopodia (Martinez-Quiles et al., 2001) and enhanced ruffle formation following 
PDGF stimulation (Anton et al., 2003). WIP over-expression slowed fibroblast 
spreading and adhesion, whereas WIP deficiency accelerated the rate of adhesion 
and the size of focal contacts (Lanzardo et al., 2007). In Dictyostelium, both WIPa 
(WIP homolog) over-expression and deletion impaired chemotaxis. When WIPa 
was in excess, migrating cells showed frequent changes of direction in response 
to a chemoattactant gradient, whereas deficiency resulted in delayed directional 
pseudopod extension (Myers et al., 2006). WIP is recruited to and is necessary 
for the intracellular motility of Vaccinia virus and PIP2 induced vesicular rocketing 
(Benesch et al., 2002; Vetterkind et al., 2002; Moreau et al., 2000).
WIP knockout mouse model 1.7.2.3 
WIP knockout mice survive to adulthood, but die prematurely of a multisystem auto-
inflammatory disease, involving ulcerative colitis, hypersensitivity pneumonitis 
and glomerulonephritis. They have a granulocytosis and lymphopenia involving 
all lymphoid lineages, but have normal lymphopoeisis. T cells show abnormal 
proliferative  responses  and  impaired  IL-2  production  in  response  to  CD3 
ligation. There is no increase in f-actin following TCR ligation, and T cells show 
poor spreading and filopodia formation. Interestingly T cell activation by PMA 
and  ionomycin,  protein  tyrosine  phosphorylation,  NF-κB  and  NF-AT  nuclear 
translocation and T cell capping following activation are all normal. By contrast, B 
cells have enhanced antigen induced proliferative responses, and make normal 
T independent antibody responses. T dependent antigen responses are absent 
(Curcio et al., 2007; Anton et al., 2002). T cells from WIP deficient mice showed 
impaired chemotaxis to SDF1α (a T cell chemokine), which was exacerbated in 
the double, WASp / WIP knockout mouse. T cell homing to lymphoid tissue was 
impaired as a result of this (Gallego et al., 2006). One caveat with analysis of the 
WIP mouse is that WASp is also deficient in haematopoietic cells (see section 
1.7.3.4) and studies comparing WASp knockout with the double, WASp / WIP 
knockout mouse to delineate the specific role of WIP are awaited. WIP deficiency 
has not been recognised in humans as a disease entity. 
The WASp – WIP complex 1.7.3 
Effect on WASp activation 1.7.3.1 
Unlike  its  effect  on  cortactin,  WIP  has  been  demonstrated  to  inhibit  NWASp 
activation of Arp 2/3 in response to Cdc42 in vitro. WIP, however, had no effect on Chapter 1     
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VCA induced Arp 2/3 activation, and minimal effect on Cdc42 – PIP2 costimulation. 
These results indicate that WIP’s mode of suppression is by desensitising the 
autoinhibitory destabilising effect of Cdc42 on NWASp (Martinez-Quiles et al., 
2001). Evidence of a similar role in stabilising the WASp autoinhibitory conformation 
in vivo has come from overexpression of a split YFP WASp construct in yeast 
cells. Co-expression of WIP led to an increase in YFP fluorescence, indicating an 
increase in the concentration of autoinhibited WASp (Lim et al., 2007).
Interestingly, WIP, WASp and Cdc42 have are capable of forming a stable trimeric 
complex in vitro, demonstrating that WIP and Cdc42 interactions with WASp are 
not mutually exclusive (Martinez-Quiles et al., 2001). This also suggests that 
Cdc42 binding does not destabilise the NWASp – WIP interaction, although there 
is no direct proof of this. Whether or not this trimeric complex exists in vivo, 
how activated it is and whether TOCA is able to bind this complex are important 
unanswered mechanistic questions. The inhibitory activity of WIP has not been 
demonstrated for WASp, or for NWASp in vivo.
The WASp – WIP complex and actin assembly 1.7.3.2 
The NWASp and WIP complex is an important functional unit for the formation of 
filopodia in response to Cdc42 (in 3T3 cells) (Martinez-Quiles et al., 2001).
WASp – WIP complexes are required for establishing cellular polarity and migration 
in  response  to  chemotactic  gradient  in  haematopoietic  cell  lines  and  human 
monocytes, whereas WASp alone was sufficient for in vivo actin polymerisation 
(Tsuboi, 2006).
NWASp  –  WIP  complex  formation  has  been  shown  to  be  essential  for  the 
recruitment  of  NWASp  to  the  surface  of  Vaccinia  in  infected  cells,  and  the 
subsequent  formation  of  actin  tails  (Moreau  et  al.,  2000).  This  recruitment 
appears to be mediated through the interaction between WIP and Nck (Anton et 
al., 1998).
Co-transfection of NWASp and WIP in cell lines resulted in a change in the 
localisation of NWASp from the nucleus to the perinuclear area and membrane 
protrusions. This also provoked and the disassembly of stress fibres and the 
preferential formation of filopodia (Vetterkind et al., 2002).
Effect on WASp stability 1.7.3.3 
The recognition that although most WAS / XLT patients with missense mutations 
express WASp, the cytosolic level of this protein is severely impaired, was critical 
to understanding the phenotype – genotype (proteotype) relationship in WASp Chapter 1     
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mutations (Lutskiy et al., 2005; Jin et al., 2004; Imai et al., 2004; Lemahieu 
et al., 1999; Zhu et al., 1997; Remold-O’Donnell et al., 1997). Several recent 
publications have demonstrated that WIP plays a crucial role in inhibiting the 
constitutive degradation of WASp, and as a consequence the cytosolic level of 
WIP determines the level of WASp (de la Fuente et al., 2007; Konno et al., 2007; 
Chou et al., 2006). A similar stabilising role for WIP has been demonstrated for 
the tyrosine kinase Syk in mast cells (Kettner et al., 2004).
It had been previously been shown that WASp but not NWASp is cleaved by the 
protease calpain both in intact platelets (following stimulation resulting in calcium 
influx) and in cell lysates (Shcherbina et al., 2001; Oda et al., 1998). Degradation 
of NWASp, by contrast, has been demonstrated via the ubiquitinsation pathway, 
following tyrosine phosphorylation by Src family kinases (Suetsugu et al., 2002). 
As yet there are no studies assessing the ubiquitination of WASp.
Calpains are a family of 14 mammalian intracellular cysteine proteases. Many 
are ubiquitously expressed and they play central roles in a wide range of cellular 
processes including the regulation of migration and chemotaxis. Initially they 
were described as being regulated by calcium concentration (Guroff 1964) and all 
contain EF hand calcium binding domains. It is now clear that activation is complex 
and multifactorial, but includes phospholipid binding, tyrosine phosphorylation and 
autolysis. Additional regulation of calpain activity is achieved by its endogenous 
antagonist,  calpastain.  Generally  calpains  cleave  by  limited  proteolysis,  and 
frequently their products are biologically active. They do not, however, cleave 
at  predictable  amino  acid  sequences,  and  although  significant  amino  acid 
preferences exist around cleavage sites, calpain cleavage partly appears to be 
determined by protein secondary structure (Tompa et al., 2004).
Haematopoeitic  cells  from  WIP  knockout  mice  were  found  to  have  very  low 
levels of WASp in addition to WIP, and the levels of WASp were restored with the 
transfection of WIP genes (de la Fuente et al., 2007; Chou et al., 2006). Similar 
results were seen using RNA interference in WIP expressing cell lines (Konno 
et al., 2007). Treatment of WIP null cells with protease inhibitors has revealed 
that in the absence of WIP, WASp is degraded by both calpain proteases and 
the proteasome (de la Fuente et al., 2007; Chou et al., 2006).The minimal WIP 
sequence  required  to  inhibit  this  degradation  was  the  carboxyl  terminal  100 
amino acid residues (410 – 503) (de la Fuente et al., 2007; Konno et al., 2007). 
Interestingly, in a purified protein system the minimal WASp binding sequence 
of WIP (461 – 485) did not prevent calpain cleavage, whereas the longer WIP 
fragment did. This suggests the effect of WIP is to hide the calpain recognition Chapter 1     
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site or inhibit calpain binding, rather than changing the sensitivity of WASp to 
calpain  degradation  through  conformational  change.  Similarly,  WIP  does  not 
inhibit calpain, as calpain was able to cleave CrkL in the presence of WIP (de la 
Fuente et al., 2007).
Increasing the cellular WASp level in the absence of WIP (either with protease 
inhibitors or overexpression of WIP carboxyl terminus) did not return cells to full 
functionality. Podosome formation in dendritic cells, and normal NF-AT signalling 
and  IL2  production  following  T  cell  activation  required  expression  of  a  WIP 
construct containing at least the polyproline and cortactin binding domains (de la 
Fuente et al., 2007; Konno et al., 2007; Chou et al., 2006).
The relative contribution of calpain and the proteasome to WASp degradation 
seems  to  vary  according  to  cell  type,  experimental  system  and  stage  of 
differentiation of the cell. In adhesive WIP null dendritic cells, calpain inhibitors 
were able to rescue WASp levels to approximately 50% of normal cells, whereas 
proteasome inhibitors had no effect (Chou et al., 2006). By contrast, primary T 
cells from a patient with XLT had no response to calpain inhibitors, but increased 
WASp levels from 9% to 22% of normal control T cells with proteasome inhibitors 
(de la Fuente et al., 2007). In activated T cells and EBV transformed B cells 
calpain inhibitors and proteasome inhibitors both increased WASp levels to 25-
30% control levels (de la Fuente et al., 2007).
An attractive hypothesis suggested by these results is that the proteosome is 
responsible  for  background  turnover  of  WASp  degradation,  and  that  calpain 
is induced in response to activation and cell surface signalling. Although this 
hypothesis needs mechanistic investigation, some anecdotal evidence supports 
it. T cells activation results in calpain activation (Sato and Kawashima, 2001; 
Penna et al., 1999; Noguchi et al., 1997; Selliah et al., 1996; Sarin et al., 1993), 
and dendritic cell podosomes, which form following activating adhesive signals 
from  the  extracellular  matrix,  have  reduced  turnover  in  response  to  calpain 
inhibitors (Calle et al., 2006b). 
EVH1 missense mutations and WIP 1.7.4 
The impaired interaction between WIP and WASp containing clinical missense 
mutations was first demonstrated using yeast two hybrid assays (Luthi et al., 2003; 
Stewart et al., 1999). Both groups found a range in the degree of WIP binding 
demonstrated by clinical WASp mutants, and of the four missense mutations 
tested the order from highest to lowest WIP affinity appears to be Y107C > R86H 
= R138P > A134T.Chapter 1     
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As discussed in section 1.4.1.6 the crystal structure of NWASp EVH1 and WIP 
suggested that missense mutations over a wide range of residues may interfere 
with WIP binding (Peterson et al., 2007; Volkman et al., 2002). Based on this 
structure, the effect of specific WAS / XLT missense mutations on WIP interaction 
have been modelled, and 28 out of 35 disease causing mutations in the EVH1 
domain were predicted to disrupt WASp-WIP interactions (Volkman et al., 2002; 
Rong and Vihinen, 2000). Residues on the EVH1 domain surface have been 
predicted to disrupt WIP interaction either directly, or by displacement of adjacent 
residues which form direct contacts with WIP (Kim et al., 2004; Volkman et al., 
2002). Buried residues have been predicted to disrupt the conformation of the 
EVH1 domain and therefore impair WIP binding. It has been hypothesised that 
disruption of EVH1 conformation is more disruptive of WASp function than inhibiting 
WIP binding alone, and that these buried point mutations may result in more 
severe disease (Volkman et al., 2002). Larger analyses of genotype - phenotype 
correlation, however, have not corroborated this hypothesis. Interestingly neither 
of the EVH1 domain mutation hotspots (T45 or R86) are predicted to form direct 
nuclear Overhauser effect (NOE) contacts with WIP (Volkman et al., 2002).
There is some limited data on the functionality of WASp with clinical missense 
mutations. The cellular levels of WASp in lymphocytes from XLT patients with 
R86H and T45M point mutations can be modestly increased by incubation with 
both protease and calpain inhibitors (de la Fuente et al., 2007). Macrophages 
from patients with XLT have an impaired ability to form podosomes (Linder et 
al., 2003). Missense mutations made in NWASp equivalent to the WASp clinical 
mutations C43W, R86C and E133K, abolished the recruitment of NWASp to the 
surface of Vaccinia and thereby inhibited actin tail formation (Moreau et al., 2000). 
Prior to this study, however, no data on the in vitro activity of WASp containing 
disease causing missense mutations had been published.
Aims of project 1.8 
Much of the experimentation on WASp has been done in vitro, often at a biochemical 
level, using recombinant proteins or protein fragments in cell free systems. There 
has been less work addressing the function of WASp or domain deficient WASp 
mutants in living systems, or haematopoietic cellular systems. In addition most 
studies of the role of WASp in cell biology have focused on WASp-deficiency or 
domain deletions and very little is known about the molecular or cellular function 
of disease causing mutants which preserve some (mutant) WASp expression. As 
this group of mutations accounts for the majority of patients affected by WAS, a 
better understanding of their effects on cellular function is clinically important.Chapter 1     
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The aims of my project were to;
Design and make a panel of WASp mutants covering domain deletions,  1. 
and mutations found in patients with WAS, XLT or XLN.
Test  their  actin  polymerising  ability  within  a  haematological  cell  lysate  2. 
system, and to assess biological reagents which influence this activity.
Transfect these constructs into haematopoietic cell lines and WASp deficient  3. 
primary dendritic cells and analyse protein expression and stability, WASp 
localisation and reconstitution of normal cell function.
The structures of the mutants created, and the abbreviations used for them in this 
thesis are shown in figure 3.1.
Four point mutations associated with WAS / XLT were chosen and two point 
mutation causing XLN. T45M and R86H were chosen because they were the two 
most commonly found “hotspot” mutation. Both generally give mild disease, and 
R86H has previously been shown to have impaired WIP binding (Stewart et al., 
1999). A134T and R138P are both missense mutations contained within exon 4 
and appear to have a more severe clinical phenotype than the hotspot missense 
mutations (Lutskiy et al., 2005; Zhu et al., 1997). Impaired WIP binding has also 
been demonstrated with both these mutations (Luthi et al., 2003; Stewart et al., 
1999).
The sequence deleted for the dVCA bind mutant (VCA binding site deletion) was 
determined by the minimal sequence required for VCA-GBD binding as described 
by the NMR structure of the bound complex (242-310) (Kim et al., 2000), minus the 
minimum sequence required for high affinity binding of Cdc42 (230-288) (Abdul-
Manan et al., 1999; Rudolph et al., 1998). The resulting construct has residues 
289-310 deleted, which were predicted to disrupt VCA binding to the GBD, but 
still allow high affinity binding of Cdc42. The H208D point mutation in the CRIB of 
N-WASp has been demonstrated to disrupt Cdc42 binding to the GBD (Miki et al., 
1998a). The equivalent residue in the WASp CRIB is H246, therefore a H246D point 
substitution was created to mimic a functional CRIB deletion, without impairing 
VCA autoinhibitory binding. Finally the Y291E phosphomimicking construct was 
investigated. This missense mutation replaces the critical phosphorylation site, 
tyrosine 291, with a glutamic acid residue which mimics the negative charge of 
phosphorylation. This substitution is thought to induce a similar conformational 
change in WASp as phosphorylation of tyrosine 291.Chapter 2     
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Materials and Methods 2 
Materials 2.1 
All chemicals and reagents were purchased from Sigma unless otherwise stated. 
Standard buffers used are shown in table 2.2, commercial kits used in table 2.4 
and antibodies used in table 2.5. Unless otherwise stated all centrifugation steps 
were performed with a Heraeus Biofuge Fresco microcentrifuge.
Molecular cloning 2.2 
Starting vectors 2.2.1 
The vectors used as the sources of genetic material for further manipulation are 
shown in table 2.1 and figure 2.1.
Restriction digests 2.2.2 
Restriction endonucleases were purchased from New England Biolabs or Promega 
and reactions were performed according to manufacturers’ recommendations. 0.5-
5 µg of plasmid DNA was incubated with an excess of one or two endonucleases, 
a compatible buffer and distilled, RNAase free water (Sigma) to make a total 
reaction volume of 20-60ul. Where two enzymes with incompatible buffers or 
incubation temperatures were used, reactions were carried out serially, with either 
correction of buffer conditions or removal of buffer salts using a DNA PCR clean 
up kit (Qiagen). Total amount of enzyme within any reaction never exceeded 10% 
(v/v) of the final reaction volume.
Where a blunt end was required following a restriction digest resulting in a 5’ 
overhang, DNA Polymerase I Large (Klenow) fragment (New England Biolabs) 
was used to fill in the 5’ overhang. 5 units of Klenow and 33µM of each dNTP was 
added to each 20µl of digest reaction, and the blunting reaction was incubated 
for 20 minutes at room temperature, before inactivation by heating to 75˚C for 20 
minutes.
For reactions used to generate the backbone for a ligation reaction, following 
restriction digests and blunting reactions each was dephosphorylated with calf 
intestinal alkaline phosphatase (CIAP, Promega). 1 unit of CIAP was added to 
each reaction and incubated at 37˚C for 30 minutes.
Agarose Gel Electrophoresis 2.2.3 
Following restriction and subsequent manipulation, DNA fragments were resolved Chapter 2     
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Table 2.1 Starting Vectors 
Name Abbreviation Expression Promoter Tag Source
FL3 WASp   
Mammalian 
expression 
vector 
T3  VSV 
epitope 
Jonathan Derry, 
Howard Hughes 
Medical Institute 
C1-EGFP  C1 
Mammalian 
expression 
vector 
CMV  EGFP  Clonotech 
EF-Bos-GST   
Mammalian 
expression 
vector 
hEF1α  GST  Giles Cory 
SIN-LNT-
cPPT-SFFV-
WPRE 
Lenti 
(SIN lenti SW) 
Mammalian 
expression 
vector 
SFFV  EGFP  Molecular 
Immunology Unit
SIN-LNT-
cPPT-SFFV-
EGFP-WASp-
WPRE 
pHRsinc-
SEWW 
Mammalian 
expression 
vector 
SFFV  EGFP  Molecular 
Immunology Unit
pcDNA3 
EGFP-WIP  EGFP-WIP 
Mammalian 
expression 
vector 
CMV  EGFP 
Narayanaswamy 
Ramesh, 
Harvard Medical 
School 
pOS135 
zzWIP-V5/HIS  zzWIP 
Mammalian 
expression 
vector 
SP6 
zz 
domain of 
protein A 
HIS x6 
V5 
Narayanaswamy 
Ramesh, 
Harvard Medical 
School 
pcDNA6 WIP-
HIS/V5  WIP-HIS 
Mammalian 
expression 
vector 
CMV  HIS x6 
V5 
Narayanaswamy 
Ramesh, 
Harvard Medical 
School 
pCS2+ TOCA  TOCA 
Mammalian 
expression 
vector 
CMV / Sp6 Myc 
Marc Krischner, 
Harvard Medical 
School 
pMDG.2 
(VSV-G) 
Envelope 
plasmid 
Mammalian 
expression 
vector 
CMV     
pCMVΔ8.74 
(gag-pol) 
Packaging 
plasmid 
Mammalian 
expression 
vector 
CMV     
pGEX-2T Cdc-
42  Cdc-42 
Bacterial 
expression 
vector 
E.coli tac  GST 
Anne Ridley, 
University 
College. 
by electrophoresis through 0.8% agarose gels dissolved in TAE buffer. To prepare 
these gels, agarose (Invitrogen) was dissolved in 1 x TAE buffer with the assistance 
of microwave warming. After cooling, ethidium bromide (0.5 µg/ml) was added to 
the gel immediately prior to setting, to facilitate the visualisation of DNA with UV 
light. DNA samples were mixed with Orange G loading buffer (10 mM Tris pH 
7.5, 50 mM EDTA, 10% Ficol 400, 0.4% Orange G) before loading onto agarose 
gels. A 1 kb DNA ladder (New England Biolabs) was loaded onto each gel to 
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C1-
pEGFP
4.7 kb
EF-Bos-
GST
6.5 kb
pcDNA3
EGFP-WIP
7.7 kb
pcDNA6
WIP-HIS
6.6 kb
pHRsinc-
SEWW
10.6 kb
pOS135
zzWIP-HIS
6.0 kb
SIN-LNT-SFFV-
cPPT-WPRE
9.1 kb
EGFP
WASp
SFFVP
MCS LTR-HIV
del U3
AmpR
LTR-HIV
CMVP
EGFP
MCS
SV40
PolyA
BacterialP
SV40 ori
& earlyP
KanoR /
NeoR
HSV TK
polyA
pUC ori
EGFP
AmpR
HEF1αP
GST
MCS
3’UTR
SV40 ori
& earlyP
Origin
AmpR
WPRE
SFFVP
LTR-HIV
del U3
LTR-HIV
cPPT
RRE
MCS
T7P
AmpR
MCS
CMVP
SV40 ori
& earlyP
NeoR
SP6P
WIP
BGH
PolyA AmpR
MCS
WIP T7P
CMVP
SV40 ori
& earlyP
BGH
PolyA
pUC ori BlastR EM7P
HIS
Tag
AmpR
SV40
PolyA CMVP
SP6P
WIP
HIS
Tag
TEV
site ZZ
domain
Figure 2.1 Structure of Starting Vectors
Abbreviations  used;  AmpR  –  ampicillin  resistance, 
BGH polyA – Bovine growth hormone polyadenyla-
tion signal sequence, BlastR – Blastomycin resistance 
gene, CMVP – Cytomegalovirus early promoter, cPPT 
–  central  polyproline  tract,  EM7P  –  EM7  prokayotic 
promoter, HEF1αP – Human elongation factor α pro-
moter, HSV TK polyA – Human Simplex Virus thymi-
dine kinase polyadenylation signal sequence, KanoR 
/  NeoR  –  Kanomycin  /  Neomycin  resistance  gene, 
LTR – Long terminal repeats, MCS – multiple cloning 
site, pUC ori – pUC origin of replication, RRE – REV 
responsive element,  SFFVP – Splenic focus forming 
virus promoter, SP6P – SP6 promoter, SV40 ori & ear-
lyP - simian vacuolating virus 40 origin of replication 
and early promoter, TEV site – Tobacco  etch virus 
protease cleavage site, T7p – T7 promoter, WPRE – 
Woodchuck hepatitis virus post-transcriptional regula-
tory element
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Table 2.2  Buffers 
Name Abbrev-
iation Composition Storage
Cellular 
lysis buffer  LB 
1% IGPAL CA-630, 130mM 
NaCl, 20mM Tris-HCl pH 
8.0, 1mM EDTA, 10mM NaF, 
2mM Na orthovanadate, 1% 
aprotinin, 10µg/ml leupeptin, 
1µM pepstatin, 1mM PMSF 
Base buffer stored at 4C for 
maximum of 2 months. Na 
orthovanadate, aprotinin, 
leupeptin and pepstatin were 
added within 2 hours of use. 
PMSF added immediately prior 
to use. 
Tris-
actetate 
EDTA 
buffer 
TAE  40 mM Tris-acetate and 5 
mM EDTA  10x solution stock (autoclaved). 
Bead 
storage 
buffer 
  75% glycerol, 10mM Tris-Hcl 
pH 8.0, 1mM EDTA  Autoclaved and stored at RT 
Actin 
polymerisat
ion buffer 
APB 
1% IGPAL CA-630, 130mM 
NaCl, 20mM Tris-HCl pH 
7.4, 2mM EDTA, 1% 
aprotinin, 10µg/ml leupeptin, 
1µM pepstatin, 1mM PMSF 
Base buffer stored at 4C for 
maximum of 2 months. Na 
orthovanadate, aprotinin, 
leupeptin and pepstatin were 
added within 2 hours of use. 
PMSF added immediately prior 
to use. 
Purified 
protein 
pulldown 
buffer 
XB 
20mM HEPES, 150mM 
NaCl, 1mM DDT, 10% 
glycerol, 10mM MgCl2, 1mM 
EDTA, 0.5mg/ml ovalbumin. 
Base buffer stored at 4C for 
maximum of 2 months. 
Ovalbumin added prior to use. 
Tris EDTA  TE  10 mM Tris·Cl, pH 8.0; 1 mM 
EDTA 
RT 
Purchased from Qiagen. 
Luria-
Bertani 
broth 
LB broth  10 g/L tryptone, 5 g/L of 
yeast extract, 10 g/L of NaCl  Made up fresh 
Agar  Agar 
10 g/L tryptone, 5 g/L of 
yeast extract, 10 g/L of NaCl, 
15g/L Agar 
Petri dishes stored at 4C 
Bacterial 
lysis buffer 
Bacterial 
LB 
50mM Tris-HCl pH 7.5, 
50mM NaCl, 5mM MgCl2, 
2mM PMSF, 1µM GTP 
Made up fresh. PMSF and GDP 
added immediately prior to use. 
Special 
electropora
tion buffer 
SEB 
120 mM KCl, 10 mM 
K2PO4/KH2PO4 pH 7.6, 2mM 
MgCl2, 25 mM Hepes pH 
7.6, 0.5% Ficoll 400 
50ml aliquots stored at -20°C. 
Filtered before use. 
Phosphate 
buffered 
solution 
PBS  11.9mM Phosphates, 
137mM NaCl, 2.7mM KCl. 
10x stock purchased from 
Fischer Bioreagents. For tissue 
culture Gibco PBS was used. 
Cellular 
fixing buffer 
Fix 
buffer 
4% Paraformaldehyde, 3% 
glucose in PBS  Made up fresh 
NuPage® 
Lithium 
Dodecyl 
Sulphate 
sample 
buffer (x4) 
SB 
40% glycerol, 564mM Tris 
Base, 424mM Tris HCl, 8% 
Lithium Dodecyl Sulphate, 
2mM EDTA, 0.88mM 
SERVA blue, 0.7mM phenol 
red 
Purchased from Invitrogen. 
NuPage® antioxidant added 
immediately prior to use. 
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Table 2.2  Buffers cont.
Name Abbrev-
iation Composition Storage
NuPage® 
MOPS 
SDS 
running 
buffer 
Running 
buffer 
MOPS 50mM, Tris base 
50mM, SDS 0.1%, EDTA 
1mM 
20x buffer purchased from 
Invitrogen 
NuPage® 
Transfer 
buffer 
Transfer 
buffer 
Bicine 50mM, Bis-Tris 
50mM, EDTA 2mM, 
Chlorobutanol 0.1mM, 10% 
Methanol. 
10x buffer purchased from 
Invitrogen. Methonol added 
immediately prior to use. 
BSA 
blocking 
buffer 
Blocking 
buffer 
PBS with 1-5% BSA (w/v), 
0.1% Tween, 0.1% sodium 
azide 
4°C for 2 months 
Phosphate 
buffered 
saline -
Tween 
PBS-T  PBS with 0.1% Tween  10x stored at RT 
GST 
elution 
buffer 
GST EB 
130mM NaCl, 50mM Tris pH 
8.0,20mM reduced 
glutathione 
Made up fresh 
Thrombin 
buffer   
50mM Tris-HCl pH 7.5, 
2.5mM CaCl2, 100mM 
NaCl,5mM MgCl2, 1mM 
DDT, 1µM GDP. 
Made up fresh. DDT added 
immediately prior to use. 
Coupling 
Buffer    0.1M sodium phosphate 
buffer pH 7.4  Store at RT for 3 months. 
Tris 
buffered 
saline - 
tween 
TBS-T  150mM NaCl, 25mM Tris-
HCl pH 7.6, 0.1% Tween  10x stored at RT 
Fix Buffer    4% Paraformaldehyde, 3% 
glucose in PBS  Made up fresh. 
FACS 
buffer    PBS with 0.5% BSA, 0.1% 
sodium azide.  Made up fresh 
DNA lysis 
buffer   
10mM Tris pH 8.0, 1mM 
EDTA, 0.5% NP40, 0.5% 
Tween 20, 1.25 mg/ml 
Proteinase K (Roche) 
Made up fresh 
Quenching 
buffer    1M Tris HCl, pH 7.4  Autoclaved and stored at RT. 
enable size determination of DNA fragments. DNA fragments were visualized and 
images recorded using a UVIdoc gel documentation system (UVItec).
Where gel fragments were generated for ligation, DNA was excised from agarose 
gels using a scalpel blade under ultra-violet light (screening UV source to minimize 
DNA exposure to UV). The DNA was then extracted from the agarose using a 
QIAquick gel extraction kit (Qiagen) as per the manufacturer’s instructions and 
DNA was quantified using a NanoDrop ND-1000 spectrophotometer.
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Polymerase chain reaction 2.2.4 
Primers for PCR (see appendix figure A.1) were generated with the assistance of 
the software package Bioedit, and were synthesized by the MWG, using HPSF 
(high purity salt free) liquid chromatography. PCR reactions were performed in 
50µl using 25ng template DNA, forward and reverse primers at 340nM, dNTPs 
(Promega) at 250µM each, 2.5U of Pfu DNA polymerase (Stratagene) in the 
accompanying buffer (containing 2mM MgCl2). A PCR cycle of 95˚C (denaturation) 
for 30s, 60.0˚C (annealing) for 60s, and 75.0˚C (elongation) for 6.5 minutes was 
used, and reactions were performed in an Eppendorf Mastercycler. 25 cycles 
were used, with the first being a “hot start” (95.0˚C for 30s only). Following PCR, 
DNA fragments were separated by agarose gel electrophoresis and visualised 
and purified as above.
DNA ligation 2.2.5 
DNA ligations were set up with 3:1 molar ratios of purified insert and backbone 
DNA fragments, with 25ng of backbone DNA used in each reaction. Reactions 
were carried out in 20µl using 3 units of T4 ligase (Promega) and an appropriate 
volume of T4 ligase buffer diluted in RNAase free water. Ligation mixtures were 
incubated overnight at 14˚C, followed by 3 hours at room temperature, prior to 
transformation  of  supercompetent  XL1-Blue  E.coli.  Negative  control  ligations 
containing  all  reagents  except  the  insert  DNA  fragment  were  performed  in 
parallel.
Growth and transformation of bacterial cells 2.2.6 
Agar  plates  were  made  from  20g/L  LB  base  and  15g/L  bacto  agar  (Merck) 
dissolved in water prior to autoclaving, and appropriate antibiotic was added once 
the agar had cooled to below 60ºC, but was still liquid. The agar was then poured 
into sterile petri dishes and allowed to set. 250µl aliquots of supercompetent XL1-
Blue E.coli cells (Stratagene) were thawed and kept on ice. 3.4µl of 1.42M β 
mercaptoethanol was added to each aliquot and was kept on ice for a further 10 
minutes. 40µl of chemically sensitised cells were then added to 10ul of each DNA 
ligation reaction and the samples were mixed regularly throughout 30 minutes 
of incubation on ice. The DNA bacteria mix was then incubated at 42oC for 45 
seconds before returning to ice for 2 minutes. 360µl of pre-warmed antibiotic 
free Luria-Bertani broth (LB broth) (made up from LB base, Invitrogen) was then 
added to each sample and they were agitated in an orbital shaker at 37˚C for 30 
minutes. Following this, cultures were centrifuged for 5 minutes at 1200g and 
bacterial pellets were resuspended in 100µl of fresh warmed LB, and then plated Chapter 2     
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out on agar plates. Plates were incubated overnight at 37˚C.
The following morning isolated single bacterial colonies were selected using a 
sterile P20 tip and used to inoculate 5ml of warmed LB containing the appropriate 
antibiotic (mini prep culture). Cultures were grown overnight at 37˚C in an orbital 
shaker (250 rpm), before 1.4ml of culture broth was harvested for DNA extraction 
and purification.
For generation of DNA stocks, 5µl of a miniprep culture was diluted with 100µl of 
warmed LB and then plated out on agar plates containing an appropriate antibiotic. 
After overnight culture a single bacterial colony was picked and a starter culture 
was initiated as above. After 4-8 hours of agitation 100µl of the starter culture was 
used to inoculate 100ml of warmed LB containing an appropriate antibiotic, and 
this maxiprep culture was incubated overnight at 37˚C in an orbital shaker (225 
rpm). The following morning 700µl of this culture was mixed with 300 µl of 75% 
glycerol and frozen at -80˚C as a glycerol stock, and the remaining culture was 
used for DNA extraction.
DNA extraction from bacterial cultures 2.2.7 
DNA extraction was performed using a modified alkaline lysis (Bimboim and Doly, 
1979), using miniprep or maxiprep kits (Qiagen) according to manufacturer’s 
protocols. For minipreps 1.4ml of bacterial culture broth was centrifuged at 15000g 
for 5 minutes in a microcentrifuge, and the pellet was used as the substrate for 
extraction. Purified DNA was eluted using TE buffer.
For maxipreps, 100ml of culture broth was centrifuged at 5000g for 30 minutes 
to  generate  a  bacterial  pellet.  Eluted  DNA  was  purified  by  isopropanol  and 
then ethanol precipitation. The precipitate was then air dried and dissolved in 
1ml of TE buffer. To remove any insoluble impurities, dissolved DNA samples 
were centrifuged at 15000g for 5 minutes and the supernatant was kept. The 
concentration of all DNA samples was determined using a NanoDrop ND-1000 
spectrophotometer (absorbance at 260nm). Absorbance of light at a wavelength 
of 260nm (A260) has a linear relationship to the concentration of double stranded 
DNA.  Centrifugation  steps  during  maxi  preps  were  performed  using  either  a 
Sorvall legend RT or a Sorvall Evolution RC.
Samples were stored at -20ºC, and concentration was rechecked before every 
use.Chapter 2     
95
Checking of ligated plasmids 2.2.8 
Following transformation of ligation reactions, at least 3 colonies from each agar 
plate were selected and miniprep DNA samples were generated. These minipreps 
were  then  restricted  using  two  restriction  enzymes,  which  would  generate  a 
restriction  patterns  upon  electrophoresis  which  would  allow  identification  of 
plasmids containing the correct insert in the correct orientation. Each DNA sample 
was tested with two different restriction enzyme combinations and the restriction 
pattern was compared to DNA containing positive and negative control DNA 
restricted in parallel. If none of the minipreps appeared to contain the correctly 
ligated insert, further colonies were selected and tested (upto a maximum of 20 
minipreps).
For any plasmid subsequently used in experiments the sequence of the gene of 
interest was verified. Sequencing was performed by MWG using standard primers 
or specifically designed primers as shown in appendix 1.
Site directed mutagenesis 2.2.9 
For  the  generation  of  point  substitution  in  WASp,  the  Quikchange  protocol 
(Stratagene)  was  used  (see  figure  2.2).  Briefly,  primers  of  approximately  20 
nucleotides were designed with the altered nucleotide(s) required to generate 
the appropriate amino acid substitution in the middle. The reverse primer was 
the  reverse  complement  of  the  forward  primer  sequence. The  sequences  of 
primers used for site directed mutagenesis are shown in the appendix (figure 
A.1). Primers were synthesized by MWG and were purified using HPLC (high 
pressure liquid chromatography, a higher level of purity than HPSF). C1-EGFP 
containing WT WASp was used as the template for site directed mutagenesis 
PCR reactions, unless otherwise stated. A PCR cycle with a “hot start” of 95°C 
for 30s, followed by 95°C for 30s (denaturation), 60°C for 60s (annealing) and 
72°C for 390s (elongation) repeated 14x, under the same reaction conditions as 
described for PCR above, was used. The PCR products were then digested with 
Dpn1, a restriction enzyme which only cuts when its recognition site is methylated, 
and therefore “nicked” any residual template DNA (this is of bacterial origin, as 
stock DNA samples were purified from bacterial cultures). The complete reaction 
sample was used for transformation of supercompetent bacteria, and selected 
colonies were screened by check restriction as above.
To reduce the risk of accidental mutagenesis as a consequence of the long length 
of the PCR product (6.2 kB), clones which restricted correctly were subcloned back 
into the C1-EGFP WT WASp vector using the 800 bp Bgl II restriction fragment Chapter 2     
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PCR
Dpn 1
Transfection
then restriction
Clone 
into 
template
Template 
vector
Mutation 
primers
Sequencing
Figure 2.2 Site directed mutagenesis protocol
Schematic representation of the protocol used for site directed mutagenesis. Red strands repre-
sent DNA generated by PCR, black strands represent original (bacterial origin) DNA, and the blue 
box represents a point mutation.
(see figure 3.4e) which contains each individual point mutation. Following check 
restriction to ensure the correct orientation of the subcloned fragment, the C1 
EGFP mutant WASp constructs were sequenced as above (MWG).
The Y291E WASp point mutation within the EF-Bos GST vector was a gift from 
Giles Cory at Bristol University.
Cell culture 2.3 
All media and media supplements were supplied by Gibco (Invitrogen), except 
foetal bovine serum (FBS) which was supplied by Sigma. FBS was heat inactivated 
by heating to 60ºC for 2 hours prior to use. Details of the cell lines and primary 
cells used and their culture conditions are contained in table 2.3. All tissue culture 
centrifugation was performed with a Hettich Zentrifuge Rotofix 32 centrifuge.
Cell lines 2.3.1 
Cos 7 cells were purchased from the European Collection of Cell Cultures (ECCC). 
The other cell lines were donated by other members of the Molecular Immunology 
Unit (Institute of Child Health), as frozen cell aliquots which were known to be of 
Fig 2.2Chapter 2     
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Table 2.3  Cell lines 
Name ECACC 
number Species Description Medium grown in 
U937  85011440  Human  Histiocytic lymphoma 
cell line 
RPMI 1640, 10% FBS, 
1% PS 
Cos 7  87021302 
African 
Green 
Monkey 
SV-40 transformed 
kidney fibroblast  DMEM, 10% FBS, 1% PS 
THP 1  88081201  Human  Acute myeloid 
leaukaemia cells 
RPMI 1640, 10% FBS, 
1% PS, 10mM HEPES, 
1.0 mM sodium pyruvate, 
1.5g/L sodium 
bicarbonate 
293T  04072121  Human  Embryonic kidney 
epithelial cells  DMEM, 10% FBS, 1% PS 
Raw 
264.7  85062803  Mouse 
Abelson murine 
leukaemia virus 
transformed 
monocyte-
macrophage 
DMEM, 10% FBS, 1% PS 
Primary 
dendritic 
cells 
NA  Mouse  Bone marrow derived  RPMI 1640, 10% FBS, 
1% PS, GM-CSF 
RPMI – Roswell Park Memorial Institute media 
DMEM - Dulbecco’s modified eagle medium 
FBS – Foetal bovine serum 
PS – penicillin and streptomycin. 1% PS represents 100IU/ml penicillin and 
100ug/ml streptomycin 
GM-CSF – Recombinant murine granulocyte/macrophage colony stimulating 
factor at 20ng/ml  
Table 2.4  Kits 
Name Company Cat. number  Use
jet PEI  Polyplus 
transfection  101-10 Small scale Cos-7 transfection 
Silver stain  Sigma  PROT-SIL1  Silver staining of polyacylamide gels 
Qiagen mini 
prep  Qiagen  12125  Rapid DNA extraction from bacterial 
cultures for colony screening 
Qiagen maxi 
prep  Qiagen  12163 
Generation of stock DNA samples 
errom bacterial cultures (medium 
scale) 
Qiagen Gel 
extraction  Qiagen  28706  Extraction of DNA bands from agarose 
gels 
BCA protein 
estimation kit  Pierce  23225  Estimation of protein concentration 
AminoLink plus 
immobilisation 
kit 
Pierce  44894  Covalently linking antibodies to a 
sepharose resin 
Table 2.3 and 2.4
passage 15 or less. To change media, cells were centrifuged at 1500 rpm for 5 
minutes and old media was aspirated off. The cell pellet was then resuspended 
in pre warmed fresh medium. Cell density and viability was estimated by diluting 
20µl of cell culture with 20µl of 0.4% trypan blue (Sigma) and counting at least Chapter 2     
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100 cells using a haemocytometer.
All the cultures were maintained at 37oC with 5% CO2. Cos 7 and 293T cells were 
detached, by initially washing adherent layers with phosphate buffered solution 
(PBS) and then incubating with trypsin-EDTA for 5-10 min prior to splitting. Cells 
were subcultured upon reaching 80-90% confluence (between every 3 and 5 
days) and were split with a ratio of 1:4 to 1:8 (seeding at approximately 3000 
cells/cm2). RAW cells were detached by scraping and were split with a similar 
ratio.
U937 cells were subcultured every 2-4 days and were split to a confluence of 
1-2x105 cells per ml. THP1 cells were subcultured every 3-5 days and were split to 
a confluence of 2-3x105 cells per ml. it was ensured that neither cell line reached 
a cell concentration of greater than 1x106 per ml.
For long term storage of cell lines, the equivalent of a 50% confluent 80 cm2 
tissue  culture  flask  (adherent  cells)  or  5x106  cells  (non  adherent  cells)  were 
pelleted, washed, resuspended in 0.5ml of fresh medium and transferred to a 
1.5ml cryovial. Pre-cooled (on ice) freezing mix (60% FBS, 20% DMSO, 20% 
medium) was then added to the cells, one drop at a time. Cells were frozen slowly 
overnight to -70°C in an isopropanol freezing bath and then transferred to liquid 
nitrogen.
For revival of frozen cell lines, cells were rapidly defrosted by incubation in a 37ºC 
water bath. The cell aliquot was then transferred to 10ml of warmed medium in 
a falcon tube to wash off the DMSO. The cells were then pelleted, resuspended 
in fresh medium and transferred to an 80 cm2 tissue culture flask for ongoing 
culture.
All cell lines in stable culture were regularly screened for mycoplasma infection.
Primary Dendritic cells 2.3.2 
Mice were culled using a Schedule 1 technique. Femurs and tibias were dissected 
out and were cleaned. Bone marrow was flushed out of the long bones with media 
using a syringe and 26G needle, and boney debris was excluded by passing 
the bone marrow through a cell strainer. Bone marrow from one limb was then 
transferred to a 80cm2 flask and cultured in 10ml of RPMI supplemented with 
20ng/ml recombinant murine GM-CSF (see table 2.3).
On days 3 and 5 of culture, 5ml of fresh GM-CSF supplemented media was 
added to the culture, without washing or removal of existing media. Cells were Chapter 2     
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harvested on day 6, by scraping, and therefore removing both adherent and non 
adherent cells from the culture. Cells were washed and counted prior to use.
Cell transfection 2.4 
Electroporation of Cos7 cells 2.4.1 
Electroporation of Cos 7 cells was based on a previously published protocol (Cory 
et al., 2002). Fully confluent 15cm tissue culture plate of Cos-7 cells were split (1 in 
2) 24 hours prior to electroporation. The cells were washed with PBS and removed 
from the culture plates. 1.2 x 107 cells (for each construct) were then washed 
once with 5ml of special electroporation buffer (SEB), before being resuspended 
in 400μl of SEB and transferred to a pre-cooled 4mm electroporation cuvette 
containing 20μg of plasmid DNA. The cells and DNA were incubated together 
for 5 minutes on ice and then were electroporated using a Biorad Genepulser II 
at 250V and 975μF. Post electroporation the cuvette was incubated for a further 
5-10 minutes on ice before the whole cuvette contents were seeded to a 15cm 
plate. Medium was changed once at 8-12 hours and cells were harvested at 24 
to 36 hours.
Lipofectamine transfection 2.4.2 
Cos  7  cell  transfection  using  lipofectamine  (Invitrogen)  and  “Peptide  6”  had 
previously been optimised by Dr Michelle Writer within the Molecular Immunology 
Unit. 1x107 Cos 7 cells were seeded into 15cm plates 24 hours prior to transfection. 
80µl of lipofectamine and 0.14mg of peptide 6 were mixed with 2.4ml of OptiMEM. 
40 µg of DNA was diluted in 1ml of OptiMEM and added slowly to the lipid peptide 
mixture and then mixed thoroughly. The mixture was left at 4ºC for 30 minutes, 
before being diluted to 20 ml with OptiMEM, and then being added to 1 washed 
plate of Cos7 cells. The medium was changed for fresh DMEM 4 hours later and 
the cells were harvested at 48 hours.
Polyethylenimine (PEI) transfection  2.4.3 
For generation of lentivirus, 293T cells were transfected using PEI, as described 
below. Cos 7 cells growing in 6 well plates were transfected using jetPEI (Polyplus 
transfection) for use in co-immunoprecipitation experiments. 2x105 cells per well 
were plated out the day before transfection. For each well 3µg of DNA was mixed 
with 100µl of 150mM sodium chloride, and 6µl of jetPEI was mixed with 100µl of 
150mM sodium chloride. Both samples were vortexed before the jetPEI solution 
was added to the DNA. This mixture was also vortexed and left to stand for 30 
minutes at room temperature. This mixture was then added drop by drop on one Chapter 2     
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well of a 6 well plate (without removing medium). The cells were harvested at 48 
hours.
Lentivirus preparation 2.4.4 
1.2 x 107 293T cells were seeded into 15cm tissue culture plates the day before 
transfection. For each plate lentiviral vector DNA (40 μg), packaging plasmid 
pCMVΔ8.74 (gag-pol) (30 μg) and envelope plasmid pMDG.2 (VSV-G) (10 μg) 
were added to 5ml of OptiMEM and filtered through a 0.2µm filter. 1µl of 10mM 
PEI stock was added to 5ml of OptiMEM (for each plate) and was similarly filtered, 
before mixing with the filtered DNA (1:1 v/v). The mixture was left to stand at room 
temperature for at least 20 minutes.
The resultant PEI / DNA complexes were added to plates of 293T cells (10ml per 
plate) previously washed with OptiMEM, and incubated for 4 hours at 37°C/5%CO2. 
The media was then replaced with 14 ml DMEM, from which viral supernatant 
was harvested at 48, 72 and sometimes 96 hours post-transfection. Supernatant 
was centrifuged at 2000g for 10 minutes and filtered through a 0.22 μm filter (to 
remove cellular debris) prior to viral concentration by ultracentrifugation at 50,000 
g for 2 hours at 4ºC, using a Sorvall Discovery SE ultracentrifuge. Lentiviral pellets 
were resuspended in 150µl of RPMI and stored at -80ºC in aliquots of 10-50µl.
Titration of lentivirus 2.4.5 
Lentivirus concentration was titrated using an infectious method on 293T cells. 
5x104 293T cells in 500µl of DMEM were plated into 24 well plates. 500µl of virus 
stocks diluted in DMEM at dilutions of 1/100 to 1/106 were then added the 24 well 
plates. A negative control using medium only was included for each construct. At 
48 hours, cells in each well were scraped off, pelleted and washed with PBS, prior 
to fixing for FACS as described below. % EGFP positive cells were determined by 
FACS with a negative control gate of EGFP positivity set at 1%.
To calculate the infectious titre, % EGFP positivity for each dilution was corrected 
by subtracting the % of positive cells in the negative control, and the dilution with 
a % positivity of between 2.5% and 10% was identified. The formula below was 
used to calculate the titre of the viral stock, where the titre represents the number 
of infectious viral particles per ml.Chapter 2     
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Where no dilution gave a % positivity of between 2.5% and 10%, titres were 
calculated for the two dilutions adjacent to this range and an arithmetical mean 
was used as the titre.
Lentivirus transfection of dendritic cell 2.4.6 
8 well chamber slides (Lab-Tek II, Nunc) were coated with fibronectin by washing 
each well with 75µl of PBS, aspirating, and then pipetting 75µl of 10µg/µl fibronectin 
(Sigma) into the centre of each well. The slides were then incubated at 37º for 2 
hours, before aspiration and washing with 200µl of PBS.
Primary murine dendritic cells were generated as above. On day 6 of culture 
2x104 dendritic cells in 50µl of medium (50% fresh DMEM and 50% conditioned 
medium) were added to each fibronectin coated well of a chamber slide. The 
medium formed a discrete drop in the centre of the well. The appropriate volume 
of virus was calculated using the formula below and was then added directly to 
the drop of cells. After 2-4 hours of incubation at 37ºC, the wells were flooded with 
a further 200µl of media.
Infected dendritic cells were cultured for a further 48-72 hours determined by cell 
morphology and expression of EGFP by fluorescence microscopy. They were 
then washed in PBS before incubation in fix buffer for 20 minutes, followed by 
3 further PBS washes and storage in PBS with 0.1% sodium azide, awaiting 
staining.
Infection of dendritic cells for FACS analysis, was performed in fibronectin coated 
48 well plates with 1x105 dendritic cells per well. Cells were harvested by scraping, 
and were fixed and stained as for other cells (see below).
Lentivirus transfection of cell lines 2.4.7 
1x105 U937s or THP1 cells were plated into 96 well plates at a cell density of 1x106 
cells/ml. Lentivirus was added directly to the cell culture at a volume calculated 
for MOIs of 1 and 5. 100µl of fresh medium was added at 4 hours post infection. 
Cultures were rapidly scaled up to larger volumes following infection.Chapter 2     
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Protein electrophoresis and Western blotting 2.5 
Cell lysis and estimation of protein concentration 2.5.1 
Non adherent cells were washed in PBS and then centrifuged to form a pellet. 
Upon aspiration of the supernatant, pellets were place on ice and pre-cooled 
cellular lysis buffer (LB), unless otherwise stated, was added. Cells were mixed by 
pipetting and then left on ice for 10 minutes. The lysate mix was then centrifuged 
at 15000g, at 4ºC for 10 minutes using a microcentrifuge, or a Sorvall Evolution 
RC for larger lysate volumes. Supernatants were immediately transferred to ice 
and pellets were discarded.
Estimation of protein concentration was done using a bicinchoninic acid (BCA) 
assay (Pierce), according to manufacture’s instructions. Cu+1 ion concentration 
was quantified using a FLUOstar Optima plate-reader (BMG) reading absorbance 
at a wavelength of 560nm. Excel was used to generate a standard curve and linear 
regression was used to estimate protein concentration of unknown lysates.
Cytoskeletal and cytosolic fractionation of cell lysates 2.5.2 
Stably growing U937 cells were split to a confluence of 5x105 and reincubated in 
fresh medium 24 hours prior to harvest. 106 cells were washed with PBS, pelleted 
and then resuspended in 50µl of either standard LB, or LB with the 1% IGPAL 
replaced with 0.5% Triton X. Lysates were incubated on ice for 15 minutes before 
centrifugation at 13000 rpm at 4ºC on a bench top centrifuge. Supernatants were 
extracted and reduced in SB as below, in preparation for SDS-PAGE. The pellet 
from the Triton X lysed sample was then resuspended in 50µl of standard LB, 
incubated on ice for 15 minutes and then recentrifuged. The supernatant was then 
reduced as above. All three samples were separated by SDS-PAGE in adjacent 
lanes for comparison of WASp band intensity.
SDS-PAGE electrophoresis 2.5.3 
One dimensional electrophoresis of protein samples was performed using the 
Invitrogen Novex NuPage® electrophoresis system. Cell lysate samples were 
denatured and reduced, by the addition of an appropriate volume of 4x NuPage® 
LDS sample buffer (SB) and 10x reducing agent (500 mM dithiothreitol (DTT)), 
and by heating to 70°C for 10 minutes. Samples were then centrifuged at 15000g 
for 5 minutes and stored at -20°C until electrophoresis was performed.
Following  thawing,  incubation  at  70°C  and  centrifugation  was  repeated,  and 
samples were then kept on ice prior to loading onto a gel. 4-12% Bis-Tris Novex 
pre-cast mini gels (10, 12 or 15 well) or midi gels (12, 20 or 26 well) were used in Chapter 2     
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XCell SureLock Mini-Cell (upto 2 gels) or XCell4 SureLock Midi-Cell (upto 4 gels) 
gel tanks. 10 µl of SeeBlue Plus2 pre-stained standard (Invitrogen) was loaded 
at one or both outer wells of the gel. NuPage® MOPS SDS running buffer (pre-
chilled on ice) with NuPage® antioxidant (proprietary agent) was used as running 
buffer and the gels were run for 60-90 minutes at 200V, with the gel tank enclosed 
by ice.
Western blotting 2.5.4 
Following  electrophoresis,  gels  were  removed  from  precast  cassettes  and 
were washed in NuPage® transfer buffer for 15 minutes on an orbital shaker. 
Resolved proteins were then Western blotted onto PVDF membranes (Millipore) 
using a Biorad semi dry blotter (with NuPage® transfer buffer) set at 18V for 20-
50 minutes, depending on the surface area of gels to be transferred. Adequate 
transfer was assessed by observation of the pre stained markers.
Immunoblotting 2.5.5 
Following transfer, membranes were incubated in 5% BSA blocking buffer for 
between 2 hours and overnight (at 4°C). For immunoblots known to have high 
background signals a commercial blocking agent was used (Starting block T20, 
Pierce). Where appropriate membranes were wrapped in Saran wrap and cut into 
strips for different antibody staining using a scapel blade.
Membranes (or strips) were incubated in primary antibody in 2% BSA blocking 
buffer for between 2 hours (on an orbital shaker at room temperature) and overnight 
(4°C). They were then washed 5 times with PBS-T, before incubation with an 
appropriate horseradish peroxidase (HRP) conjugated secondary antibody in 1% 
BSA blocking buffer for 45 minutes on an orbital shaker. Following 5 further PBS-T 
washes, membranes were developed with enhanced chemiluminescence (ECL) 
substrate (SuperSignal West Pico (Pierce)) for 5 minutes, before the ECL was 
drained off and the protein bands were visualised using a supercooled camera, 
the UVIchemi chemiluminescence gel documentation system (UVItec). Details of 
antibodies used and their concentration are shown in table 2.5.
For membranes due to be blotted with anti phospho antibodies, all washes and 
blocking steps were performed using TBS-T instead of PBS-T.
Membranes which required re-probing were stripped using Re-Blot plus Western 
re-cycling reagent (Chemicon), used according to manufacturer’s instructions, 
and then re-blocked prior to primary antibody staining.Chapter 2     
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Silver staining and gel drying 2.5.6 
Gels to be silver stained were removed from their cassettes as above, and were 
then incubated in 50% ethanol, 10% acetic acid overnight. Staining was performed 
using a ProteoSilverTM silver staining kit (Sigma), according to manufacturer’s 
instructions. Where increased sensitivity was required, gels were stained with 
Coomassie Brilliant blue, prior to silver staining.
Stained gels were washed three times in deionised water and were then incubated 
in Gel-Dry solution (Invitrogen) for 20 minutes. Gels were then mounted on gel 
dying frames between cellophane sheets saturated in Gel-Dry solution, and left 
to dry over 24-48 hours.
Calpain inhibition 2.6 
Storage and stock solutions of specific protease inhibitor 2.6.1 
Calpain inhibitors, ALLM and calpeptin, proteosome inhibitor MG132 and cysteine 
protease inhibitor, cathepsin, were all purchased from Calbiochem. All were made 
up as 500x stock solutions in ethanol (ALLM, MG132 and cathepsin inhibitor) or 
DMSO (Calpeptin), and stored at -20ºC. Starting functional concentrations were 
20µM (Calpeptin and MG132) or 50µM (ALLM and Cathepsin), as suggested 
by published data (Nicola et al., 2005; Coers et al., 2004; Steinhilb et al., 2001; 
Ravid et al., 2000).
Effect  of  protease  inhibitors  on  U937  cells  transfected  with  2.6.2 
EGFP WASp
U937 cells stably transfected with EGFP WT WASp and EGFP A134T WASp 
were seeded in 24 well plates at 1x106 cell in 2ml. After 2 hours incubation at 
37ºC, protease inhibitors (at specified concentrations) were added directly to the 
wells and cells were incubated for three hours. Cells were washed with PBS and 
10% of cells were stained with Trypan Blue and viability was assessed using a 
haemocytometer as above. The remainder were lysed in ice cold LB (pH 7.4 with 
no protease inhibitors or phosphatase inhibitors) and lysates were clarified as 
above. An aliquot of lysate inhibited by ALLM was used to assess residual calpain 
activity. All samples were resolved by reducing PAGE and Western blotted for 
WASp.
Calpain activity assay 2.6.3 
Residual calpain activity was measured using a Calpain-Glo Protease Assay 
(Promega). Breifly, 50µl of lysate was mixed with 50µl of Calpain-Glo reagent, Chapter 2     
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containing the synthetic calpain substrate succinyl-LLVY-aminolyciferin, luciferase 
and 2mM CaCl2. Reactions were performed in 96 well plates. Upon cleavage by 
calpain, succinyl-LLVY-aminolyciferin is cleaved to release aminoluciferin which 
produces a luminescent signal in the presence of luciferase, Mg2+, and ATP. The 
strength of the luminescence is proportional to the activity of the calpain in the 
sample. Luminescence was measured using a FLUOstar Optima plate-reader, 
20 minutes into the reaction. Control reactions performed with lysis buffer only 
were used as negative controls, and the average background luminescence was 
subtracted from each sample reading.
Densitometry and analysis of quantification 2.7 
Band quantification from western blots 2.7.1 
Quantification of protein bands from Western blots was performed using the 
software package UviBand (UVItec) in conjunction with images taken with the 
UviChemi supercooled camera.
Images  used  for  quantification,  were  obtained  after  first  performing  a  test 
exposure, to ensure the final exposure time would utilise the full range of the 
camera’s sensitivity without saturating the highest intensity band. This ensured a 
linear relationship between protein concentration and densitometry reading.
Densitometry bands were created according to the manufacturer’s instructions, and 
background subtractions were performed manually for each band. Comparisons 
were only be made between protein bands run in the same gel, immunoblotted 
with the same antibodies, developed with the same ECL and imaged for the same 
exposure.
Analysis of densitometry for actin polymerisation assays 2.7.2 
Densitometry readings were obtained for WASp bands (anti GST), actin bands 
and ARPC2 bands. Absolute quantities of WASp and Actin were calculated by 
standardising raw densitometry readings to those of known standards of WASp 
and actin run in an independent gel lane in each experiment. Data from all assays 
performed under the same experimental condition and were analysed together as 
a single dataset (three dataset – constitutively active constructs, standard panel 
and NWASp constructs). Raw densitometry data (relative values) and calculated 
absolute data (absolute values) were analysed in parallel to monitor the validity 
of the techniques used. As a result each dataset contained several constructs 
tested from several experiments, but each individual experiment contained a 
variable subset of constructs (see chapter 4.42 for further discussion).Chapter 2     
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Statistical support in the analysis of data from the actin polymerisation assays 
was provided by Prof Tim Cole (Professor of Medical Statistics at the Institute 
of Child Health). Guidance as to which approach to use and assistance with the 
setting up of the regression models used in the analysis was provided by Prof 
Cole, but the analysis itself and interpretation of the results was performed by the 
author.
Densitometry readings for actin and WASp were transformed to percent units 
by taking natural logs and multiplying by 100 (T.J.Cole, 2000). %Actin levels for 
each construct across experiments were then adjusted for %WASp using two-
way analysis of covariance (i.e. two-way analysis of variance plus the covariate 
%WASp), and including adjustments for differences between experiments and 
between  constructs.  This  allowed  the  significance  of  differences  in  %Actin 
between constructs to be tested for.
Further analysis showed that the %Actin-%WASp relationship varied from one 
experiment to another, and therefore the adjustment ought to include a %WASp 
by experiment interaction. Adding this to the model provided a different set of 
construct effects, which could be compared with those obtained from the simpler 
main effects analysis. The analyses of the basic model (main effects) and the 
model containing a WASp by experiment interaction compensation (interaction 
model) are shown for all analyses.
N-WASp input samples were found to have high levels of actin bound to purified 
protein, before assay incubation. For these experiments, the amount of actin 
bound to beads prior to incubation in U937 lysate was determined and this value 
was subtracted from the actin readings determined during the assay (see chapter 
4.8).
For some experiments performed with the constitutively active constructs, high 
levels of background actin polymerisation were detected (as defined by high actin 
signals in the GST only lanes). For this series of experiments, actin readings 
were corrected for this background by subtracting the GST only readings from 
actin readings obtained in experimental lanes.
Analysis of densitometry for U937 lysates 2.7.3 
Densitometry  reading  were  obtained  for  EGFP-WASp,  endogenous  WASp, 
GAPDH, and where stated for WIP and WASp phosphoserine. Reading were 
standardised for loading by dividing the densitometry reading by the densitometry 
reading  for  GAPDH  for  the  same  construct.  For  EGFP-WASP,  the  corrected Chapter 2     
110
densitometry reading was divided by the EGFP-WASp reading for WT-EGFP 
WASp transfected lysates to give an EGFP-WASp reading relative to WT. For 
each  experiment  these  relative  values  were  then  averaged  between  values 
derived from anti WASp immunoblotting and anti EGFP immunoblotting.
In summary
For  endogenous  WASp,  loading  corrected  readings  were  divided  by  the 
endogenous WASp reading for untransfected cells, to give quantify endogenous 
WASp relative to untransfected U937 cells.
Analysis of densitometry for estimation of phosphorylation 2.7.4 
To determine the relative proportion of WASp phosphorylated at serine 483/484, 
loading corrected phosphoserine readings for mutant constructs were divided by 
their loading corrected WASp readings, and these values were then divided by 
the equivalent value for WT EGFP-WASp. As before the values derived from anti 
WASp blots were averaged with values derived from anti EGFP blots. This final 
figure gives a level of phosphorylation for each construct relative to WT, where 
the proportion of WT-WASp phosphorylated is 1.
For each of these values the final reading for each mutant construct is compared 
to a standard value of 1, and as a result a paired one sample test was used to 
analyse the significance of any differences from these standards.
For determination of EGFP-WASp / endogenous WASp ratios for each cell line, Chapter 2     
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the raw densitometry data from the anti WASp immunoblot could be used, as
reading for both proteins were derived from the same blot. As result there was no 
need to compare these ratios to a standard. Paired 2 sample t tests were used to 
compare these values to WT-WASp transfected lysate.
Analysis of densitometry for pulldown and immunoprecipitation  2.7.5 
assays 
For the analysis of the relative strength of WASp – WIP affinity between constructs, 
a  similar ANCOVA  analysis  to  that  used  to  analyse  the  actin  polymerisation 
assays was used. Natural logarithms of WASp and WIP densitometry readings 
were used as these were normally distributed, and a regression model including 
an interaction term between experiment and Ln WASp concentration was used.
Recombinant protein purification 2.8 
GST-WASp purification 2.8.1 
Cos 7 cells were cultured and electroporated as described above. GST tagged 
WASp constructs were generated in batches such that proteins to be tested against 
each other in subsequent experiments (actin polymerisation assays, pulldown 
experiments), were all synthesised at the same time (thus further standardising 
results).
Each 15cm plate of Cos 7 cells was washed in PBB and then placed on ice. 
800µl of pre-cooled cellular lysis buffer (LB) supplemented with 2µM latrunculin 
B (Sigma) and 2 µM cytochalasin D (Sigma) was then added. After 10 minutes of 
incubation in LB on ice, cells were detached with a cell scraper, and transferred to 
microtubes for centrifugation at 15000g for 15 minutes at 4°C. Supernatants were 
then added to 125 – 250µl glutathione Sepharose 4B beads (GE biosciences) (pre-Chapter 2     
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washed 2x with LB), either as neat supernatant or diluted with LB to a specified 
dilution. Lysates and beads were incubated for between 2 hours and overnight 
at 4°C on a rotator. Beads were then pelleted and washed 3x with lysis buffer, 
2x with 0.5M lithium chloride, 20mM Tris pH 8.0, and once with 20mM Tris pH 
8.0. Pelleted beads were then resuspended in 5 bead volumes of 75% glycerol, 
10mM Tris pH 8.0, 1mM EDTA and stored at -80°C.
50µl of each bead sample (8.3µl of beads) was washed and pelleted, and then 
separated by reducing PAGE. Gels were Western blotted and immunoblotted 
for GST and densitometry was performed. These measurements were used to 
standardise the amount of WASp used in subsequent experiments (by volume 
adjustment).
For purification of WT WASp eluted from Sepharose beads, lysate was generated 
from the equivalent of six 15cm plates of electroporated Cos 7 cells, and 1ml of 
washed glutathione Sepharose beads were used. Protein was eluted from the 
beads, after washing, by the addition of GST elution buffer and incubation for 
10 minutes with rotation. Beads were then pelleted and the supernatant was 
removed. Elution was repeated 3 further times, elutants were pooled and were then 
dialysed three times against 5mM Tris pH 8.0, 1mM EDTA with protease inhibitors 
at 4°C for 30 minutes, using a Slide-a-Lyzer 0.5-3ml cassette (10kDa molecular 
weight cut off (MWCO), Pierce). GST-WASp protein was then concentrated using 
Microcon spin concentrators (Millipore) with a MWCO of 10KDa. Aliquots were 
frozen at -80°C.
Cdc42 purification 2.8.2 
E.coli stably transfected with Cdc42 under transcriptional control of the lac operon 
(WT, constitutively active mutant 12V, and dominant negative mutant 17N) were 
gifts from Prof Anne Ridley (University College, London).
100ml of LB broth with 100µg/ml ampicillin was inoculated with Cdc42 transformed 
E.coli,  and  incubated  on  an  orbital  shaker  overnight  at  37ºC.  The  following 
morning the culture was diluted into 1L of pre-warmed LB broth containing 50µg/
ml ampicillin, and cultured with shaking for one further hour. Protein production 
was then induced by the addition of 0.1mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG, Sigma) and further cultured for 4 hours. Bacteria were then pelleted by 
centrifugation (5000g for 30 minutes, Sorvall Evolution RC) prior to resuspension 
in 10ml bacterial ice cold lysis buffer (bacterial LB). Bacterial suspensions were 
then lysed by sonication (6x 10s cycles at 70% power and 30% cycle time) 
using a Bandalin Sonoplus HD2070 sonicator, with cooling on ice between each Chapter 2     
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burst. Lysate was then re-centrifuged, supernatant was removed and DTT to a 
concentration of 15mM was added.
Lysate was then dialysed against bacterial LB (with 0.1mM DTT added), three 
times over 2 hours, at 4ºC (using Slide-a-Lyzer 3-12ml, 10kDa MWCO). The 
lysate was then added to 1ml of washed glutathione Sepharose 4B beads and 
rotated for 2 hours at 4ºC. Following this the beads were pelleted and washed 3 
times with bacterial LB, twice with with 0.5M lithium chloride, 50mM Tris pH 7.5, 
and once with 50mM Tris pH 7.5, each wash solution containing 0.1mM of DTT, 
but no PMSF.
GST tags were cleaved from the Cdc42, using a variety of protocols as described 
in Chapter 3.6.2 (figure 3.14). Where elution from the beads was performed, 
four elutions with 5ml of GST EB were performed as described for GST-WASp. 
Cleavage was performed in thrombin buffer, and bovine thrombin was purchased 
from  Sigma,  and  human  thrombin  from  GE  healthcare.  Following  cleavage, 
GST  was  removed  by  a  30  minute  incubation  with  1ml  of  fresh  glutathione 
Sepharose beads, and the thrombin was removed by a 30 minute incubation 
with p-aminobenzamidine-agarose gel, for 30 minutes (both at 4ºC). Beads or 
resin were removed by centrifugation (twice) and supernatants were carefully 
extracted.
The resultant solution was dialysed three times against 20mM K-HEPES pH7.5, 
100mM KCl, 5 mM MgCl2, 1mM DTT, 1µM GDP, and post dialysis samples were 
concentrated  using  Centriplus  spin  columns  (Millipore).  Samples  were  then 
aliquotted and snap frozen in liquid nitrogen, prior to storage at -80ºC.
Cdc42 loading with GTP 2.8.3 
Recombinant Cdc42 was loaded with GTPγS (a non hydrolysable GTP analogue 
which imparts constitutive activity to Cdc42), based upon previously published 
protocols (Suetsugu et al., 1998; Ma et al., 1998a). 10µl of Cdc42 (WT or 12V) 
at a concentration of 50-75µM was added to GTP loading buffer to give final 
concentration of 50mM Tris pH 7.4, 10mM EDTA and 100µM GTPγS, in 50µl. 
This sample was incubated at 30ºC for 30 minutes and then the reaction was 
quenched and the EDTA chelation overcome, by the addition of MgCl2 to a final 
concentration of 50mM. Loaded Cdc42 was then used immediately.
Assessment of purity and quantification of purified protein 2.8.4 
Protein concentration of purified protein samples was quantified using the BCA 
assay as described in 2.5.1.Chapter 2     
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Concentration estimates were checked by running an aliquot of the protein sample 
on a NuPAGE gel with a series of protein standards of known concentration 
(typically actin and bovine serum albumin). The gel was then silver stained (as 
above) and concentration was estimated by comparing the size of protein bands 
to those of the standards. Purity of protein samples was also assessed using 
silver staining gels and compared to immunoblots for the protein and its tag.
Actin polymerisation assay 2.9 
Assay 2.9.1 
U937 cells were split to 5x105 cells per ml and incubated over night in fresh 
medium. The following day, cells were counted and then washed once in PBS, 
prior  to  pelleting  (1500  rpm  for  5  minutes).  PBS  was  aspirated  off  and  cell 
pellets  were  resuspended  in  ice-cold  actin  polymerisation  buffer  (APB)  at  a 
concentration of 1-6x107 cells/ml. Lysates were incubated on ice for 10 minutes. 
After centrifugation (15000g for 10 minutes at 4ºC), the lysate was supplemented 
with 5mM MgCl2 (and if stated 1mM ATP), then incubated with a standardised 
volume of GST-WASp coated Sepharose beads. GST only coated beads and 
beads incubated with actin polymerisation inhibitor cytochalsin D were used as 
negative controls.
Beads and lysate were incubated for 1 hour at room temperature on a rotator, 
after which the beads were pelleted and washed twice with APB. Where stated 
1/10th of the beads were fixed (4% paraformaldehyde in PBS for 10 minutes) 
and then fluorescently stained for f-actin (1 in 100 Rhodamine phalloidin in PBS 
for 25 minutes in the dark, followed by washing in PBS) before mounting for 
fluorescence microscopy. The remaining sample was reduced in SB and resolved 
by PAGE and western blotting. PVDF membranes were divided transversely at 
approximately 52 and 38 kDa, with the top third being stained for GST (to detect 
GST-WASp), the middle third being stained for actin and the bottom third being 
stained for ARPC2 (and subsequently GST). The concentration of substrate lysate 
was determined using a BCA assay to ensure the lysate concentration was within 
the range of 1.5 – 2.5mg/ml.
This basic protocol was extensively manipulated as described in various results 
chapters.
Fluorescence imaging of beads 2.9.2 
Beads were imaged using a Zeiss Axiovert 135 fluorescent microscope (10x/0.25 
NA lens) and analysed using Volocity 4.0 software (Improvision). Phase and Chapter 2     
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fluorescence images were taken. For fluorescence images exposure time was 
determined by analysing positive and negative control beads, and then using a 
fixed exposure time for all subsequent samples.
Images were manipulated in Photoshop®, with identical manipulations performed 
to each equivalent image taken.
Immunoprecipitation  and  radioisotope  labelling  2.10 
experiments
Pulldown experiments 2.10.1 
Lysates were generated (as above) using cell type, concentration and lysis buffer 
as specified. Protease inhibitors and phosphatase inhibitors were added to the 
lysis buffers, and lysates were modified as specified. 250µl of lysate was added 
to GST-WASp coated Sepharose beads and incubated at room temperature for 
2 hours with rotation. Beads were then pelleted and were washed twice with the 
lysis buffer used, before being resolved by reducing PAGE and immunoblotted 
as specified.
For pulldown of zzWIP constructs, IgG Sepharose Fast Flow (GE healthcare) 
was used. The zz tag contains the IgG binding domain of protein A and therefore 
binds Sepharose beads coated with IgG with high affinity. IgG Sepharose was 
activated by incubating in 0.5M acetic acid (pH 3.4), twice, with TBS-T washes 
between and after. Lysates were then added to the beads and samples were 
processed as for glutathione Sepharose beads.
Generation of resin immobilised antibody 2.10.2 
Immobilisation of antibodies to resin to facilitate immunoprecipitations was done 
using the AminoLink Plus immobilisation kit (Pierce). The beaded resin is activated 
to contain aldehyde groups which can then react with primary amines present in 
proteins to form Schiff Bases. These are then stabilised by reductive amination 
(using sodium cyanoborohydride) to form stable secondary amine bonds.
Briefly, 1.25ml of resin (2.5ml of resin slurry) was washed three times with coupling 
buffer (centrifuging at 3000g for 1 minute and aspirating washes). 200µg of αEGFP 
antibody was diluted to 1.25ml with coupling buffer and added to the washed 
resin. 0.5M sodium cyanoborohydride was added to the mixture and the sample 
was rotated for 4 hours at room temperature. The beads were then pelleted and 
supernatant was carefully removed, before the beads were re-washed with first 
coupling buffer and then quenching buffer. The beads were then resuspended in Chapter 2     
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1.25ml of quenching buffer and 2M sodium cyanoborohydride, for further rotation 
for 30 minutes. Following this, beads were washed twice with coupling buffer and 
twice with PBS, prior to storage in 1.25ml PBS with 0.1% sodium azide (stored 
at 4ºC).
Control resin was made by either performing the same reaction with no antibody 
added (quenched resin), or by using an isotype control antibody (isotype control 
resin).
Immunoprecipitation 2.10.3 
Immunoprecipitation  reactions  were  performed  based  on  the  protocol  for  the 
ProFound Mammalian Co-Immunoprecipitation kit (Pierce) using Handee screw 
cap spin columns. Resin is maintained in the column by a bottom frit which allows 
buffer to flow through upon centrifugation, whilst trapping the resin on the frit.
50µl of antibody bound resin slurry (25µl of resin containing 4µg antibody) was 
pipetted into a Handee column and washed with the specified lysis buffer. Lysate 
was added to the columns and the columns were sealed prior to rotation for the 
specified time. Resin was washed 3 times with lysate buffer prior to elution with 
50µl of ImmunoPure IgG elution buffer (proprietary, Pierce). 2-4 elutions were 
performed.
Beads were regenerated following a further prolonged incubation with an excess 
of elution buffer (400µl for 30 minutes), and washing 2 times with coupling buffer, 
prior to re-storage in PBS with azide.
Radioisotope labelling of cells 2.10.4 
Methods for radiolabelling cellular proteins with 35S were adapted from various 
on line protocols (sources included Invitrogen, Springer lab – Harvard Medical 
School, Tansey lab – Cold Spring Harbour, Department of Biological Sciences 
Warwick University, Hu and Heikka (Hu and Heikka, 2000)).
Stably transfected U937 cells were split to 5x105 cells per ml and incubated 
overnight in fresh medium. Cells were counted and then washed twice in pre-
warmed PBS. Cells were then incubated at 1x106 cells/ml in starvation medium 
(RPMI lacking cysteine and methionine, with 1% PS, 10% dialysed FBS) for 30 
minutes at 37ºC. Cells were then pelleted and resuspended in labelling medium 
(starvation medium with a stated amount of Redivue Promix 35S (GE Healthcare) 
added) and incubated for a stated period of time at 37oC with 5% CO2. After 
the  labelling  period,  cells  were  pelleted  and  washed  with  warm  PBS  before Chapter 2     
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resuspending in chase medium (RPMI 1640, 10% FBS, 1% PS, 2mM methionine, 
2mM cysteine) at 5x105 cells per ml for the stated chase period.
At harvest cells were pelleted and then washed twice in ice cold PBS, before 
being resuspended in ice cold APB. Immunoprecipitation using αEGFP resin was 
performed as above.
Following PAGE of reduced samples, gels were dried as above and then exposed 
to Imaging Screen K (Kodak) storage phosphor screens in a light tight cassette 
for upto 6 weeks. Radio-emission was detected by analysing phosphor screens 
on a Molecular Imager FX (Biorad), and images were analysed using Quantity 
One (Biorad) software.
Analysis of protein stability experiments 2.10.5 
Images  of  radio-emissions  were  exported  to  and  optimised  in  Photoshop. 
Densitometry  was  performed  in  Quantity  One.  Boxes  were  manually  drawn 
around bands, and local background radiation levels were subtracted (average 
signal from the boundary each box was proportionally subtracted from the counts 
within each box). % WASp degradation at each chase time point was calculated 
by dividing radio-emission reading form the value obtained at the end of the pulse 
period, and multiplying by 100. A one way repeated measures ANOVA test was 
performed  and  mean  percentage  degradations  were  compared  to  WT-WASp 
using the Dunnett multiple comparisons test.
Fluorescence activated cell sorting 2.11 
FACS of transfected cell lines 2.11.1 
Cell lines were analysed by flow cytometry to assess the proportion of positively 
transfected cells in culture and the level of EGFP-WASP expression within the 
cells.
Cells were washed with PBS, transferred to FACS tubes and then resuspended 
in Fix buffer for 20 minutes at 4ºC in darkness. Following this cells were pelleted, 
supernatants discarded and cells were resuspended in 0.5ml of PBS with 1% 
paraformaldehyde and stored at 4ºC until they were analysed by FACS. Cells were 
analysed using a Beckman Coulter XL flow cytometer and Expo2 software.
FACS of transfected primary dendritic cells 2.11.2 
Murine dendritic cells were analysed by flow cytometry to assess the degree of 
maturation induced following lentivirus infections.Chapter 2     
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Cells were washed and fixed as for cell lines. For immunostaining, cells were 
pelleted and washed with FACS buffer, before resuspending in 100µl of FACS 
buffer  containing  primary  antibodies  (αCD11c  and  α  MHC  class  II)  at  the 
appropriate concentrations (see table 2.5), and 2% (10µg/ml) murine Fc block. 
Tubes were wrapped in foil, and incubated on ice for 30 minutes. Cells were 
subsequently washed twice with FACS buffer and then resuspended in 100µl of 
FACS buffer containing secondary antibodies at appropriate concentrations, and 
murine Fc block. Tubes were incubated as for primary staining, and then washed 
before resuspending in 0.5ml of FACS buffer. Cells were analysed within 24 
hours on a CyAn ADP flow cytometry analyser and Summit version 4.1 software 
(DakoCytomation). CD11c was analysed via the APC channel, EGFP via the FITC 
channel and MHC class II via the PE channel. Control samples with no primary 
antibodies, and with each individual primary antibody left out were used to set 
positivity threshold and to compensate for bleed through between fluorophores. 
LPS treated dendritic cells were used as a positive control for activation.
Cell sorting 2.11.3 
Transfected U937 cells and THP1 cells were sorted into EGFP high and low 
populations using a Beckman Coulter EPICS Altra Cell Sorter. Cell sorts were 
performed by Joao Metelo from the Molecular Immunology Unit at ICH. Post 
sorting cells were returned to tissue culture incubators for normal culturing. 2 
weeks after sorting aliquots of cells were frozen down.
Real time PCR 2.12 
Genomic DNA extraction 2.12.1 
2.5 x 105 stably transfected U937 cells were washed in PBS and then pelleted 
by centrifugation at 15000g for 10 minutes. Cells were resuspended in 40µl DNA 
lysis buffer and incubated at 56ºC for 2 hours. Lysed cell pellets were pulsed at 
15000g, incubated at 95ºC for 15 minutes and then pulsed again at 15000g. 180µl 
of distilled DNase-free water was added, followed by centrifugation at 13,000 rpm 
for 5 minutes. The supernatant containing the genomic DNA was then transferred 
to sterile microtubes and stored at -20ºC. 
Determination of viral copy number per cell 2.12.2 
Quantitative PCR was used to determine the number of integrated viral copies per 
cell in stably transfected U937 culture as has been described previously (Greg, 
1999).Chapter 2     
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Two separate PCR reactions were run for each sample (in triplicate) using a 
fluorescently labelled probe (FAM) against the lentiviral vector (WPRE) primer 
binding site and against β actin. Primers and probes were purchased from Applied 
Biosystems (see appendix 1). 5µl of extracted genomic DNA (from above) was 
used as the template, and primers (0.9µM) and probes (0.2µM) were added to 
Platinum qPCR SuperMix-UDG with ROX (Invitrogen) as the additional reagents. 
The probes are fluorescently labelled on the 5’ end and have a quencher on the 3’ 
terminus. The endonuclease activity of taq releases the 5’ fluorescent label from 
the FRET activity of the quencher thus increasing the fluorescence in the well with 
each cycle of the PCR. This fluorescence is detected, quantified and monitored 
throughout the reaction. Real time PCR reactions were performed using an ABI 
Prism 7000 Sequence Detection System, using the default cycling parameters (1 
cycle of 50°C for 2 minutes, 1 cycle of 95°C for 10 minutes followed by 40 cycles 
of 95°C for 15 seconds and 60°C for 1 minute).
In parallel, PCR reactions for a dilution series of lentivirus and actin standards of 
known copy number (gift from Dr Mike Blundell, Molecular Immunology Unit, ICH) 
were run in triplicate. By determining the cycle threshold values, (an arbitrary 
value assigned at a point where all the samples are in log phase expansion and 
graphs of fluorescence emitted are parallel), for both standards and samples, 
standard curves could be plotted and the number of viral copies present and 
the number of cell genomes in the reaction could be determined. From this the 
number of copies of integrated virus per cell was calculated.
mRNA extraction 2.12.3 
1 x 106 stably transfected U937 cells were washed in PBS and then pelleted by 
centrifugation at 15000g for 10 minutes in a micro-centrifuge. Cell pellets were 
frozen at -80ºC until RNA extraction could be performed.
Cell pellets were thawed and resuspended in Tri-reagent BD (Sigma) and 1/5th 
total volume of chloroform (stabilised with amylenes) was added. This mixture was 
centrifuged at 15000g to separate the RNA (top clear aqueous layer), DNA (cloudy 
interphase) and protein (red organic layer). RNA layer was removed and an equal 
volume of isopropanol added. The samples were mixed and then incubated at 
-20oC overnight before centrifugation at 13,000rpm to pellet the precipitated RNA. 
The RNA pellet was washed in 70% ethanol, spun at 13,000rpm for 5 minutes 
and air dried. The dry pellet was resuspended in 10-20ul of water and stored at 
-20oC until needed.Chapter 2     
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Making cDNA from RNA 2.12.4 
5ul of RNA was incubated with 0.5ul RNAse inhibitor, 1ul of an oligo dT and 1ul 
of 2.5mM each dNTPs (all Applied Biosystems), at 70oC for 10 minutes. The 
reaction was then placed on ice for 5 minutes, before 1ul of 25mM MgCl2, 1ul 
of PCR buffer 2 (Applied Biosystems) and 0.5ul MMLV reverse transcriptase 
(Applied Biosystems) was added and the mixture incubated at 42oC for 1 hour. 
The resulting cDNA/mRNA hybrid samples were stored at -20ºC in preparation 
for quantitative PCR.
Quantification of EGFP-WASp and endogenous WASp mRNA 2.12.5 
Expression of EGFP WASp and endogenous WASp in stably transfected U937 
cell lines was determined by performing quantitive PCR on the cDNA/mRNA 
hybrid generated as above.
Three separate PCR reactions were performed in triplicate, with primers against 
WPRE (to detect EGFP-WASp introduced by lentivirus), against the untranslated 
region  adjacent  to  endogenous  Human  WASp  (to  detect  endogenous  WASp 
expression) and against phosphoglycerate kinase (PGK – a housekeeping gene). 
Primers and probes were purchased from Applied Biosystems (Assays by design) 
(see appendix 1), and probes were labelled with the FAM reporter. PCR reactions 
were performed as for determination of copy number, using the 5µl of the cDNA/
mRNA hybrid solution as the reaction template.
Cycle thresholds were determined as above. By directly comparing the cycle 
threshold (CT) values obtained from the WPRE and endogenous WASp PCRs 
relative to the PGK gene, the expression levels of EGFP WASp and endogenous 
WASp can be compared between samples, using one sample as the reference 
(WT for EGFP-WASp, untransfected cells for endogenous WASp) to which all 
others can be compared. The fold increase or decrease in expression levels are 
calculated using the formulae below;
Confocal microscopy 2.13 
Dendritic cell preparation and immunostaining 2.13.1 
Dendritic cells were permeabilised and stained in the 8 well chamber slides in Chapter 2     
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which they were grown. Following fixation, dendritic cells were washed three 
times and then permeabilised by incubation in 0.1% Triton X in PBS for 3 minutes. 
This was aspirated off and replaced with 1% BSA in PBS for 30 minutes to block 
non-specific binding sites.
Cells were then incubated in 100µl of PBS with 1% BSA containing anti vinculin 
and anti EGFP antibodies at appropriate concentrations (see table 2.5) for 45 
minutes at room temperature in darkness. Cells were then washed three times 
in PBS, 1% BSA, prior to incubation with secondary antibodies and agents (goat 
anti mouse Cy5, goat anti rabbit Alexa 488, Rhodamine phalloidin and DAPI) 
at appropriate concentrations (Table 2.5) for 45 minutes. The cells were then 
washed 3 further times with PBS, 1% BSA, and once with deionised water, before 
mounting with ProLong Gold antifade mountant (Invitrogen), covering with a cover 
slip and sealing with nail varnish.
Microscopy 2.13.2 
Images  were  recorded  digitally  using  a  Leica TCS-SP2  confocal  microscope 
and Leica software. Images were taken in four channels (Cy5 – vinculin, FITC – 
EGFP WASp, TRITC – actin, and UV DAPI of WIP) and z stacks of 8-12 sections 
were taken to allow composite and overlay images to be generated. Images were 
subsequently analysed using Leica Lite and Photoshop software packages.
Image analysis 2.13.3 
To determine podosome restoration random fields of view were captured using 
a 40X magnification lens, until at least 50 EGFP positive cells were captured. 
Images were labelled using a random number code and were analysed later, with 
blinding as to the nature of the sample. During image analysis, individual cells 
were scored as EGFP positive or negative, and whether or not they expressed any 
podosomes. Scoring was performed by two independent investigators and results 
for the percentage of transduced cells expressing podosomes were averaged. 
Differences between constructs were analysed using the chi squared test. 
Although all the confocal images presented in this thesis are entirely my own 
work, one dendritic cell preparation used for the enumeration of podosomes, and 
the quantification of podosomes expressing cells (figure 9.1e) was performed 
other members of my laboratory (Siobhan Burns and Joao Metelo).Chapter 3     
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Molecular  Cloning,  Protein  3 
Expression and Purification
Introduction 3.1 
In this chapter I describe the experiments performed to generate the raw materials 
and biological reagents used in the rest of this project. This work includes the 
molecular  cloning  of  the  WASp  constructs,  their  expression  and  purification 
from mammalian cell lines, medium scale purification of GST-WASp for use as 
a protein standard, expression and detection of WIP constructs in transfected 
mammalian cell lines, expression of endogenous WASp and WIP in cell lines 
used as experimental substrates and the medium scale purification of Cdc42. 
Details of the experimental procedures followed are contained in chapter 2.2-2.5 
and 2.8.
Molecular cloning 3.2 
Starting materials 3.2.1 
The structure and position of the WASp constructs investigated in this project are 
shown in figure 3.1. The reasons for choosing these constructs for investigation 
are discussed in chapter 1.10. All WASp constructs were generated from WT 
WASp, with the exception of Y291E point mutation, which was a gift from Giles 
Cory  (University  of  Bristol). This  was  provided  as  GST  tagged  WASp  within 
the EF-Bos vector. The starting vectors and their sources are shown in table 
2.1 and figure 2.1. The primary source of the WASp gene was the FL3-WASp 
plasmid from Jonathan Derry (Howard Hughes Medical Institute) (see table 2.1). 
WASp had been previously cloned into a lentivirus vector by members of my host 
laboratory, and it was this vector (pHRsinc-SEWW) which I used as the initial 
source of WASp for further molecular cloning (see figure 2.1 and table 2.1 for 
further details).
The WIP and Cdc42 containing vectors were used as they were received as gifts 
(see table 2.1) and no further cloning was performed on them.
Generation of C1 EGFP-WT-WASp 3.2.2 
All the mutant WASp constructs were generated using WT WASp in the cloning 
vector pEGFP-C1 (Clonotech) as a template. The strategy used for cloning WASp 
into pEGFP-C1 from pHRsincSEWW is demonstrated in figure 3.2. Figure 3.4a 
shows gels of the isolation of WT WASp from pHRsincSEWW and the linearization 
of pEGFP-C1. These fragments were excised and ligated to generate C1 EGFP-Chapter 3     
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Abbreviations:  EVH1  =  Ena Vasp homology  domain,  B  =  Basic  domain,  GBD  =  GTP-ase binding 
domain, P = polyproline domain, V = verprolin homology domain, C = cofilin homology domain, A = 
acidic domain 
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Fig 3.1
WT-WASp (C1-WT). Check restriction of six (correct) clones from this ligation are 
shown in figure 3.4b. The positions within the EGFP-WASP cassette of restriction 
sites used for check restrictions are shown in figure 3.4e.
Generation of deletion and truncation in C1-EGFP 3.2.3 
The truncation and deletion constructs were generated using polymerase chain 
reaction (PCR) of WT WASp in C1-WT, as summarised in figure 3.2. Briefly, primers 
WT
dEVH1
dBasic
dVCA
bind
dPolyP
dVCA
dCA
dA
A134T
R138P R86H
T45M
H246D
S272P
Y291E
I294T
a
b
Fig 3.1 Structure of WASp constructs generated
(a) Sites of point mutations generated by site directed mutagenesis. (b) Domain structure of trun-
cation and deletion constructs.
EVH1 B PolyP V C A
CRIB
GBD
VCA binding site
39 145 225 235 257 288 312 417 430 446 469 487
502
242 310
NH2 COOHChapter 3     
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Fig 3.2
Fig 3.2 Cloning strategy for creating WASp mutant constructs in C1-EGFP
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EVH1 B PolyP V C A GBD
Hind III
Kpn I
dEVH1
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Fig 3.3
Fig 3.3 Primer sites used for generation of deletion and truncation WASp constructs
Deletion and truncation constructs were made by generating WASp fragments by PCR which ex-
cluded specific protein domains. These fragements were generated from primers which included 
a unique restriction site upstream from their DNA binding sequence (Hind III for forward primers, 
Kpn I for reverse primers), facilitating the insertion of these fragments into the C1-EGFP cloning 
vector. For constructs where the deleted domain is in the middle of the protein, two WASp frag-
ments were generated, each with a BamH I site at the “internal” end of each fragment. These two 
fragments ligated to each other as well as to the C1-EGFP backbone during ligation.
The primer binding sites and conjugated restriction sites are shown in the above diagram. The 
sequences and labels given to each primer are shown in the appendix (fig A.1)Chapter 3     
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were designed to generate one or two WASp fragments resulting in the deletion 
of a functional protein domain. The primers contained a unique restriction site 
(HindIII at the amino terminus of the protein, BamHI in the middle of the protein 
and KpnI at the carboxyl terminus of the protein) to allow subcloning of the WASp 
fragment back into the C1-WT backbone. Figure 3.3 shows the binding sites, and 
incorporated restriction sites of the primers used to generate each construct. The 
sequence of the primers is shown in the appendix (figure A.1).
Following  PCR  the  reactions  were  incubated  with  the  appropriate  restriction 
enzyme and the reactions were then run on agarose gels, as shown in figure 3.4c. 
This allowed visualisation of the WASp DNA fragments and purification by gel 
excision. The DNA fragments were then ligated into the HindIII and KpnI restricted 
C1-WT backbone. Constructs with deletions in the middle of WASp required a 
ligation reaction containing two WASp fragments and the vector backbone, and 
three “sticky-sticky end” ligation reactions. The exact position of the WASp insert 
is shown in the restriction map in figure 3.4e. Of note the constructs generated 
by PCR cloning are lacking the multiple cloning site (MCS) at the carboxyl end 
of WASp, which is retained in the C1 EGFP-WT-WASp construct (and therefore 
the  site  directed  mutagenesis  constructs  –  see  below).  Check  restriction  of 
clones selected following ligation of deletion and truncation WASp fragments is 
shown in figure 3.4d. Correctly and incorrectly inserted fragments are marked as 
appropriate. All deletion and truncation constructs were sequenced in C1-EGFP-
WASp to determine the whether or not the predicted cloning had been successful 
and to check secondary mutations had not occurred during the PCR.
Generation of point mutations in C1-EGFP 3.2.4 
Missense mutations in WASp were generated using the Stratagene Quikchange 
protocol  as described  in chapter 2.29 and figure 2.2. Following  site directed 
mutagenesis the Bgl II WASp restriction fragment from each construct (see figure 
3.4e) was sub-cloned back into C1-EGFP-WT-WASp (figure 3.2) to reduce the 
possibility of additional PCR induced mutations. Isolation of this fragment and 
the agarose gels from check restriction digests to determine the orientation of 
the Bgl II fragment are shown in figure 3.5a and b respectively. Because the 
point mutation constructs were all sub-cloned back into the C1-EGFP-WT-WASp 
vector each of these constructs retains the MCS at the carboxyl terminus of the 
WASp gene (see figure 3.4e).
Following this, all constructs were sequenced (by MWG), and the sequencing 
plots for all point mutation samples demonstrating the intended substitution is Chapter 3     
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Fig 3.4
 MCS derived from pHRsincSEWW
 MCS derived from C1-EGFP
EcoR1  Restriction sites in red only present in
WT and SDM constructs 
BamH I also cut t the PCR fragment join site 
for dBasic, dPolyP and dVCA bind
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e
Fig 3.4 Generation of C1-EGFP-WT-WASp and deletion and truncation mutants
(a) Excision of WASp from pHRsincSEWW and linearisation of empty C1-EGFP. (b) Check re-
striction of 6 clones selected following ligation of WASp into C1-EGFP. All six show correct inser-
tion of WASp. (c) Gel of WASp fragments generated by PCR and Hind III / Kpn I linearised empty 
C1-EGFP plasmid.  Bottom panel is an overexposure of the top panel. (d) Check restriction of 
selected clones following ligation of WASp deletion fragments into C1-EGFP. Tick and crosses 
show correct and incorrect insertions. (e) Restrictions sites within EGFP-WASp (in C1) used for 
cloning and check ligation of WASp constructs.
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Fig 3.5
shown in figure 3.6.
Sub-cloning to EF-BOS plasmid 3.2.5 
To allow generation of GST tagged WASp protein, the WASp constructs were 
cloned from C1-EGFP (without the EGFP tag) and inserted into the EF-BOS vector 
(figure 2.1). This resulted in WASp tagged with the GST at the amino terminus. 
The strategy for this cloning step is shown in figure 3.7. Briefly, this required a 
blunt ligation at the carboxyl terminus of WASp, and a partial Bgl II digestion at 
a
Fig 3.5 Subcloning of Bgl II restriction fragment back into C1-EGFP WT WASp following 
successful site directed mutagenesis
(a) Following site directed mutagenesis, selected clones were check restricted using Hind III and 
Bgl II (separate reactions). The fragment produced by the Bgl II restriction was cut out and sub-
cloned back into C1-EGFP WT WASp (linearised using Bgl II). This gel shows the excised Bgl 
II fragments and cut C1 backbone prior to ligation. (b) Following ligation selected clones were 
restricted by Hind III and EcoR I to determine which clones had the Bgl II fragment inserted in the 
correct orientation. Correctly orientated clones produce a 1.6 and 1.3 kb WASp containing frag-
ment respectively.  All constructs contain the 0.3 kb EcoR1 frament from the carboxyl terminus of 
WASp (see figure 3.4e).
b
A134T R138P R86H T45M H246D
B
a
c
k
b
o
n
e
3
6
2
A134T R138P R86H
W
T
C
1
 
e
m
p
t
y
3
3
10
10
1.5
1.5
0.5
√ √ √ √ √ X X X X √ X X X X X X ?
Selected SDM mutant clones following 
subcloning of Bgl II fragment
Hind III
EcoR1
EcoR1Chapter 3     
129
Fig 3.6
F
i
g
 
3
.
6
 
S
e
q
u
e
n
c
i
n
g
 
p
l
o
t
s
 
o
f
 
p
o
i
n
t
 
m
u
t
a
t
i
o
n
 
c
o
n
s
t
r
u
c
t
s
A
B
I
 
p
l
o
t
s
 
o
f
 
s
e
q
u
e
n
c
i
n
g
 
r
e
a
c
t
i
o
n
s
 
f
o
r
 
C
1
-
E
G
F
P
-
W
A
S
p
 
c
o
n
s
t
r
u
c
t
s
.
 
F
o
r
 
f
o
r
w
a
r
d
 
s
e
q
u
e
n
c
i
n
g
,
 
a
 
s
t
a
n
d
a
r
d
 
C
1
-
E
G
F
P
 
p
r
i
m
e
r
 
o
r
 
Δ
B
a
s
i
c
1
_
F
 
w
a
s
 
u
s
e
d
 
a
s
 
t
h
e
 
p
r
i
m
e
r
.
 
F
o
r
 
r
e
v
e
r
s
e
 
s
e
q
u
e
n
c
i
n
g
 
Δ
P
o
l
y
P
1
_
R
 
w
a
s
 
u
s
e
d
 
a
s
 
t
h
e
 
p
r
i
m
e
r
.
 
E
a
c
h
 
c
o
n
s
t
r
u
c
t
 
w
a
s
 
s
e
q
u
e
n
c
e
d
 
t
w
i
c
e
 
(
o
n
c
e
 
i
n
 
e
a
c
h
 
d
i
r
e
c
t
i
o
n
)
 
i
n
 
C
I
-
E
G
F
p
.
 
R
e
v
e
r
s
e
 
s
e
q
u
e
n
c
e
s
 
a
r
e
 
s
h
o
w
n
 
f
o
r
 
t
h
e
 
G
B
D
 
/
 
C
R
I
B
 
p
o
i
n
t
 
m
u
t
a
t
i
o
n
s
 
a
n
d
 
t
h
e
r
e
f
o
r
e
 
t
h
e
 
s
e
q
u
e
n
c
e
s
 
a
r
e
 
t
h
e
 
r
e
v
e
r
s
e
 
c
o
m
p
l
e
m
e
n
t
 
o
f
 
c
o
d
i
n
g
 
s
e
q
u
e
n
c
e
.
 
P
r
i
m
e
r
 
s
e
q
u
e
n
c
e
s
 
a
r
e
 
s
h
o
w
n
 
i
n
 
t
h
e
 
a
p
p
e
n
d
i
x
 
(
f
i
g
u
r
e
 
A
.
1
)
.
W
T
A
1
3
4
T
R
1
3
8
P
R
8
6
H
T
4
5
M
1
3
0
1
3
9
2
5
2
2
6
1
3
9
9
4
1
7
S
e
n
s
e
 
s
t
r
a
n
d
 
s
e
q
u
e
n
c
i
n
g
W
T
H
2
4
6
D
S
2
7
2
P
Y
2
9
1
E
A
n
t
i
-
s
e
n
s
e
 
s
t
r
a
n
d
 
s
e
q
u
e
n
c
i
n
g
8
0
9
8
1
9
7
4
0
7
3
0
8
7
7
8
6
8Chapter 3     
130
Fig 3.7
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Fig 3.7 Cloning strategy for subcloning WASp constructs in to EF-GST-Bos 
Cloning of WASp constructs generated in the C1-EGFP vector into EF-GST-BOS. Strategy shown 
for a WASp construct containing a missense mutation, although the same strategy was used for 
deletion and truncation mutations.  The final EF-BOS vector map shows restriction enzyme sites 
used for check restrictions.
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the amino terminus. Once full length WASp was separated and purified from the 
partial digestion reaction, it was ligated to the BamH I “sticky end” produced by 
linearising the EF-BOS empty vector. This took advantage of the homologous 
“sticky ends” generated by Bgl II and BamH I restriction. The Bgl II and Acc65 I 
sites used to excise WASp from the C1-EGFP vector are shown in figure 3.4e.
Figure 3.9a and b show examples of partial digestion reactions with complete 
digestion  of  C1-EGFP-WT-WASp  and  EF-BOS  for  comparison.  3.9a  clearly 
shows two backbone bands and two WASp digestion bands for each construct 
subjected to a partial digestion. For WT-WASp (and each of the point mutations) 
the 0.8 kb band is made up by two fragments of approximately the same size 
(WASp base pairs -38 to 795 and 795 to 1641). 3.9b more clearly demonstrates 
the separation of these bands with the dEVH1 and dPolyP constructs (for these 
constructs one of the WASp fragments and is smaller than the other).
Figure 3.9c shows the purified WT-WASp fragments following gel extraction, and 
prior to ligation into the EF-BOS backbone. The dEVH1 and dPolyP fragments 
are only faintly seen. Figure 3.9d shows an example of check restrictions used to 
demonstrate correct insertion of the WASp constructs into EF-BOS. The positions 
of the restriction sites are shown in figure 3.7. 
Sub-cloning to lentivector 3.2.6 
For  generation  of  lentivirus  to  allow  stable  transduction  of  primary  cells  and 
haematological  cell  lines,  EGFP-WASp  was  cloned  from  C1-EGFP  into  the 
lentivector LNT-SIN-SFFV-cPPT-WPRE. The strategy for this cloning is shown 
in figure 3.8. Briefly, this step involved a “sticky end” ligation at the EGFP-WASp 
carboxyl terminus and a “blunt ligation” at the amino terminus. Figure 3.9e shows 
the check restriction digests for a selection of correctly inserted constructs. For the 
EcoR I digest, the deletion and truncation constructs have only two restriction sites 
and therefore produce a fragment of approximately 3 kb. By contrast, EcoR I sites 
are retained at the MCSs upstream and downstream of WASp for the constructs 
generated by site directed mutagenesis (see figure 3.4e), and therefore three 
fragments are generated. The dVCA construct has the only EcoR I site within the 
WASp sequence deleted, and therefore only linearises with EcoR I.
Protein expression in Cos 7 cells 3.3 
Expression of constructs 3.3.1 
To ensure that the generated WASp constructs expressed as GST tagged proteins, 
Cos 7 cells were electroporated with EF-BOS GST WASp and cell lysate was Chapter 3     
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Fig 3.8
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Fig 3.9
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Fig 3.9 Subcloning of WASp con-
structs from C1-EGFP to EF-Bos 
and SIN-LNT
(a)  WASp  was  excised  from  C1-
EGFP  by  Acc65  I  (blunt)  followed 
by partial Bgl II restriction. The 1.5 
kb (full lengh WASp) band was ex-
cised  and  purified. This  gel  shows 
the separation of these reactions for 
a range of constructs. C1-EGFP WT 
WASp individually and fully restrict-
ed by Bgl II and Acc65 I, is shown for 
comparison. Band (i) complete 1.5 
kb WASp fragment (excised and pu-
rified). Band (ii) 0.8 kb fragment gen-
erated by partial restriction at Bgl II 
795. (b) Further example of reaction 
described in (a) better demonstrat-
ing  partial  restriction  degradation 
products. Linearisation of EF-Bos backbone with Sma I and BamH I also shown. (c) Gel of puri-
fied WASp fragments prior to ligation into EF-Bos backbone. (d) Check restrictions of clones 
selected post ligation. Correct insertions marked with a tick. As Xcm I site is within the EVH1 
domain, the correctly inserted dEVH1 construct is only cut by Bgl II. (e) Restriction digests of se-
lected clones following ligation of EGFP-WASp insert into the SIN-LNT lentivector backbone. The 
second EcoR I panel shows the cathode end of the same gel at higher exposure, demonstrating 
the 0.3 kb fragment generated by EcoR I digestion of point mutations. The dVCA construct is only 
linearised by EcoR I because the second site is found within the V domain. Some incomplete 
restriction is seen with Nhe I. All constructs show are correctly inserted.
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formed from harvested cells at 48 hours (see chapter 2.4.1 and 2.5.1).
Figures 3.10a and b show examples of western blots of such transfected lysate, 
immunoblotted  with  anti-WASp  or  anti-GST  antibodies.  Firstly,  these  figures 
demonstrate that the molecular cloning of each of these constructs has resulted 
in expression of protein of the anticipated molecular weight, which is recognised 
by WASp specific antibody. Secondly, they demonstrate that the level of WASp 
expression for each mutant construct is approximately equal. Thirdly, they suggest 
the  presence  of  WASp  degradation  products  or  alternatively  spliced  protein 
products within the transfected cell lysate, and that the pattern of these products 
is specific to individual mutant constructs. Specifically, several constructs showed 
a WASp protein 3-5 kDa smaller than full length WASp. The expression of the 
dPolyP construct results in the presence of several smaller proteins detected by 
anti-WASp antibody, some at equivalent levels of expression as the full length 
dPolyP construct.
Expression of EGFP-WASp from the C1 plasmid was tested in a similar manner 
with similar results (data not shown). EGFP-WASp expression from lentivector 
was assessed following generation of lentivirus and subsequent viral transduction 
of U937 cells. Results from such experiments are discussed in chapter 8.
Generation of WASp coated Sepharose beads 3.3.2 
GST-WASp protein was purified from transfected Cos 7 cell lysate by generating 
GST-WASp coated Sepharose beads as described in chapter 2.8.1. Figure 3.10c 
shows transfected Cos 7 cell lysate before and after incubation with Sepharose 
beads. The continued detection of GST-WASp in lysate after Sepharose bead 
incubation suggests that within this purification process the Sepharose beads are 
saturated with GST-WASp. From this it can be assumed that the concentration of 
GST-WASp on the surface of Sepharose beads will be approximately the same 
between constructs, which is important for the standardisation of experiments 
using these beads.
Figures  3.10d  and  e  show  electrophoresis  gels  of  equal  volumes  of  purified 
sepharose beads for each WASp constructs. Figure 3.10d shows these beads 
immunoblotted with anti-GST, anti-actin and anti-ARPC2, and demonstrates that 
each set of beads is coated with a GST-WASp construct of an appropriate size. 
Although degradation products (or alternatively spliced protein) are detectible for 
some constructs, the full length protein is by far the predominant species for each 
construct. The lower two panels in figure 3.10d demonstrate that no or negligible 
actin or Arp2/3 is bound to the beads of any construct.Chapter 3     
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Fig 3.10
Fig 3.10
Expression  of  WASp 
constructs  in  Cos  7 
lysates and on washed 
Sepharose beads
(a), (b) Cos 7 cell lysates 
48 hours after electropo-
ration  with  GST-WASp 
constructs were reduced 
and resolved by NuPAGE 
and  western  blotting. 
Membranes  were  im-
munoblotted  for  WASp 
or GST as stated. Equal 
volumes  of  lysate  used 
for each sample. (c) The 
amount of WASp present 
in transfected cell lysate 
before  and  after  incu-
bation  with  sepharose 
beads was assessed by 
NuPAGE  and  western 
blotting.  Equal  volumes 
of  lysate  loaded.  Dem-
onstrates  saturation  of 
WASp  on  beads  during 
purification process. (d), 
(e)  Purified  GST-WASp 
coated Sepharose beads 
for  each  construct  were 
reduced and resolved by 
NuPAGE and protein was 
detected by western blot-
ting and immunostaining 
(d)  or  by  silver  staining 
NuPAGE gels (e). West-
ern  blots  were  immu-
nostained  for actin and 
ARPC2 to determine any 
residual  bound  protein 
following purification.
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Figure  3.10e  shows  a  silver  stain  of  the  separated  Sepharose  bead  bound 
proteins. The GST-WASp band is seen as the most prominent band on the gel, 
running at between 65 and 85 kDa according to the construct. Other significant 
bands are seen at 51, 20 and a double band at 30 kDa, for most constructs. 
These bands are also seen in the GST only lanes, suggesting these are either 
Sepharose associated proteins or non-specific binding protein. These bands are 
highly unlikely to account for any differences in the biological activity of the WASp 
coated beads between constructs.
Purification of GST-WASp 3.3.3 
To  standardise  the  amount  of  GST-WASp  used  between  individual  actin 
polymerisation  assays,  a  quantification  standard  was  required. This  was  run 
in a separate lane on the gel electrophoresis and western blot, adjacent to the 
experimental lanes in each assay. To generate this standard WT GST-WASp was 
generated from transfected Cos 7 cells as described in chapter 2.8.1.
The individual purification steps of this process are demonstrated by anti-WASp 
western blot and by silver stained gels in figure 3.11. From this it can be seen 
that the final product contains a single discrete band (85 kDa) on anti-WASp 
immunoblotting, making it suitable as a quantification standard. On the silver 
stained gel the same Sepharose associated proteins at 20, 30 and 50 kDa can 
be detected. Figure A.2 (in the appendix) shows gels used to quantify the purified 
GST-WASp standard.
Expression and detection of WIP constructs 3.4 
The  three  WIP  containing  vectors  used  in  this  project  were  gifts  from  Narayanaswamy 
Ramesh (Harvard Medical School) (see table 2.1). WIP, and WIP with the WASp 
binding domain deleted (WdW) were cloned into EGFP tagged and HIS tagged 
mammalian expression vectors. Additionally WIP alone was tagged with both HIS 
and the zz domain of protein A in a mammalian expression vector (pOS135).
The expression of each of these constructs was tested prior to use in experimental 
assays, as shown in figure 3.12a. Immunoblotting with the anti-WIP antibody 
revealed that deletion of the WASp binding domain also eliminated the anti-
WIP antibody binding site. Use of an anti-EGFP antibody clearly labelled the full 
length and truncated WIP constructs, but was associated with a number of non-
specific bands (figure 3.12a right hand panel). The use of this antibody had been 
previously optimised in EGFP-WASP transfected U937 lines (data not shown). 
Immunoblotting with the laboratory standard anti-HIS antibody resulted in poor Chapter 3     
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Fig 3.11
a
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d
Fig  3.11  Sequential  purification  of 
GST-WT WASp from transfected Cos7 
lysate
See Chapter 2.8.1 for details of meth-
odolgy.  (a)  and  (b)  show  anti-WASp 
immunoblots (same blot at different ex-
posures) and (c) and (d) show a silver 
stained gel following reduction and reso-
lution by NuPAGE of samples from the 
purification intermediate steps (different 
exposures). mcl - microlitre
1 2 3 4 5 6 7 8 9 10 11 12 13
1 2 3 4 5 6 7 8 9 10 11
Key for (a) and (b)
1   Lysate
2   Lysate post incubation
3   GST-WASp beads
4   Elutant 1
5   Elutant 2
6   Elutant 3
7   Elutant 4
8   Beads post elution
9   Elutants post dialysis
10 Spin through from col-
umn concentrator
11   Concentrated product
Key for (c) and (d)
α WASp blot
Silver stain
1. Lysate 10mcl/3ml
2. Lysate post dialysis 10mcl/3ml
3. Lysate post bead incubation 10mcl/3ml
4. Beads post bead incubation 5mcl/1ml
5. Elution 1 3.3mcl/1ml
6. Elution 2 3.3mcl/1ml
7. Elution 3 3.3mcl/1ml
8. Elution 4 3.3mcl/1ml
9. Beads post elutions 5mcl/1ml
10. Spin through following spin purification 13mcl/4ml
11. Concentrated product 1mcl/60mcl
12. Actin 20ng
13. Actin 100ng
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and variable detection of the HIS tagged WIP construct, with many additional 
non-specific bands (an example of this is shown in figure 3.12a middle panel). 
As a result a panel of anti-HIS antibodies were tested and optimised against 
HIS-WIP transfected cell lines. The result of this experiment is shown in figure 
3.12b and as a result of this the anti-Penta HIS antibody at a dilution of 1:1000 
was selected for use in further experiments. Details of all antibodies used in this 
project are shown in table 2.5.
WASP and WIP expression in cell lines 3.5 
The WASp and WIP expression of cell lines used in experiments throughout this 
project was assessed. Figure 3.12c demonstrates that U937 cell and THP1 cells 
both express significant levels of WASp and WIP. Cos 7 cells by contrast express 
significantly less WASp and very little WIP, and neither protein was detectible in 
RAW cells. By contrast ARPC2 and Cdc42 levels are equivalent in all four cells 
lines. These results are of importance in the interpretation of several experiments 
throughout this project, and are discussed more extensively in later chapters.
Purification of Cdc42 3.6 
Generation in E.coli 3.6.1 
Recombinant Cdc42 has been used in several experiments in this project. As this 
protein is not commercially available and is unstable in storage, it was synthesised 
and purified as part of the project. The methodology of this process is described in 
chapter 2.8.2. Briefly, E.coli stably transfected with GST-Cdc42 under the control 
of the lac operon were induced to produce protein by IPTG. The bacteria were 
then lysed, and GST-Cdc42 was affinity purified using glutathione sepharose 
resin. The GST tag was then cleaved using thrombin, and the reaction purified.
Figure 3.13 shows anti-Cdc42 and silver stained gels for each intermediate step 
of the purification process. In this purification, a glutathione Sepharose column 
was used for affinity purification and thrombin cleavage was performed “on the 
column”. GST-Cdc42 is seen running at approximately 48 kDa, and Cdc42 is 
seen at 26 kDa. These blots demonstrate that the vast majority of Cdc42 was 
eluted from the column in the first wash following thrombin cleavage. They also 
demonstrate that approximately 50% of the purified Cdc42 was lost during the 
removal  of  thrombin  using  aminobenzamidine  resin,  and  that  the  remaining 
Cdc42 was eluted from a desalting column in a single discrete elution. The yield 
of Cdc42 from “on column cleavage” was found to be very low, therefore an 
separate optimisation of the GST- tag cleavage was performed.Chapter 3     
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Fig 3.12
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Fig 3.12 Expression of WIP constructs in 
Cos 7 lysates and WIP, WASp, Cdc42 and 
ARPC2  expression  in  untransfected  cell 
line lysates
(a) Cos7 cells were transfected with the pOS-
WIP  (His  tagged  WIP  bound  to  a  protein A 
zz  domain)  EGFP-WIP  and  EGFP-WIPdW 
(WIP with the WASp binding domain deleted). 
Lysates  from  these  cells  were  standardised 
by concentration, were reduced and resolved 
by NuPAGE and western blotting. The immu-
nostaining of these lysates using an anti-WIP, 
anti-HIS and anti-EGFP antibodies is shown. 
(b) Optimisation of anti-HIS antibodies using 
pOS-WIP transfected Cos7 cell lysate. (c) Un-
transfected U937, THP1, RAW and Cos7 cell 
lysates  were  standardised  by  concentration 
and then reduced, resolved and immunoblot-
ted for WASp, WIP, Cdc42 and ARPC2.
GAPDH was used as a loading control.
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Fig 3.13
Fig 3.13 Sequential purification of Cdc42
2L of broth containing exponentially growing E.coli, expressing Cdc42 WT, 12V and 17N mutants 
were harvested. The bacteria were lysed in PBS, 5mM  PMSF, 15mM DTT and 1μM GDP, with 
sonification. Lysates were filtered and then loaded on 1ml glutathione Sepharose columns. The 
flow through was then reloaded onto the column. Columns were washed 4 x with PBS and then 
incubated with thrombin overnight. The columns were then eluted 3x with 1ml of PBS (each elu-
tion was processed separately), and the column was then washed with a high salt wash, a Low 
and high glutathione wash. Eluted samples were incubated with aminobenzamidine agarose to 
remove thrombin. 1/5000 of samples are loaded. Immunoblots (a) and (b), and silver stained gels 
(c) are shown from the reduced and resolved samples from intermediate stages of this purifica-
tion.
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Optimisation of GST tag cleavage 3.6.2 
Two protocols for cleaving GST tags from recombinant protein were compared. 
The first (AR) used a low concentration of thrombin over a prolonged incubation 
period (22 hours), whereas the other (GE) used a high concentration of thrombin 
over a much shorter period (2-4 hours). The results of a time course optimisation 
for these two protocols are shown in figure 3.14. This demonstrates that protocol 
GE with a short incubation period (2 hours), resulted in efficient GST cleavage 
without extensive degradation. Longer incubation periods resulted greater non-
specific degradation and reduced Cdc42 yields. This protocol was adopted for 
further generation of Cdc42.
Silver stained gels demonstrating the purity and quantification of Cdc42 are shown 
in the appendix (figure A.2).
Conclusions 3.7 
The results presented in this chapter demonstrate the successful expression and 
purification of all the mutant WASp constructs under investigation.
Cos7 cells transfected with WASp constructs showed similar levels of expression 
between WT WASp and all other constructs. Specifically, the missense mutations 
which give rise to XLT and WT WASp have equivalent levels of expression. These 
results contrast with the findings in human lymphocytes from patients with XLT 
/ WAS, and from the results seen in U937 cells (see chapter 8), where WASp 
containing EVH1 missense mutations has lower cellular concentrations than WT 
(Lutskiy et al., 2005; Jin et al., 2004; Imai et al., 2004; Zhu et al., 1997). The 
accepted model for this instability in patient’s lymphocytes is the impaired ability 
of mutant WASp to bind WIP (de la Fuente et al., 2007; Konno et al., 2007; Chou 
et al., 2006). As demonstrated in figure 3.12c, Cos7 cells express very low levels 
of WIP and therefore this mechanism of WASp protection may not be important 
in Cos7 cells. Taken together, these results suggest that the control mechanisms 
of WASp degradation are cell type specific.
Another observation from these experiments is that individual WASp constructs 
have different patterns of degradation products. Although the clinical missense 
mutations  and  WT  WASp  have  similar  patterns,  the  dPolyP  construct  has  a 
markedly different pattern. Experiments presented in chapters 5, 6 and 7 all 
demonstrate that the dPolyP construct is able to bind WASp regulatory proteins, 
suggesting this construct forms a correctly folded protein, and that the degradation 
products seen are not a consequence of the instability of abnormally folded protein. Chapter 3     
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Fig 3.14
Fig 3.14 Optimisation of the cleavage of the GST tag from Cdc42
3L of E.coli broth expressing WT Cdc42 or 12V Cdc42 were used. Lysates were prepared as for 
figure 3.13 and two 1ml glutathione Sepharose columns were used (end on end) for affinity pu-
rification. GST-Cdc42 samples were then eluted from the columns using 3ml of GST EB buffer. 
Eluted samples were subjected to thrombin cleavage acocording to the following conditions;  AR 
cleavage: 200μl of elutant was incubated with 0.66U of bovine thrombin and 0.16U of Human 
thrombin for 22 hours then a further 0.33U of bovine thrombin and 0.08U of Human thrombin 
for a further 1 hour. GE cleavage : 200μl of elutant was incubated with 5.3U of bovine thrombin 
alone. Samples were analysed at the time points stated, by NuPAGE and western blotting. (i) 
GST-Cdc42 band  (ii) Cdc42 and / or GST band.
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Alternatively, these results suggest that the Polyproline domain itself, or proteins 
which bind to it, have an important role in the regulation of WASp degradation. 
This is more fully discussed in chapter 8.Chapter 4
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Optimisation  of  Actin  Polymerisation  4 
Assay
Introduction 4.1 
Assays of actin polymerisation 4.1.1 
Several techniques have been described to investigate regulation of the initiation 
of actin polymerisation. Functional assays measuring the propulsion of plastic 
beads (Suetsugu et al., 2001b) (Yarar et al., 2002), visualising the formation of 
“actin comets” (Higgs and Pollard, 2000) or the recruitment of Vaccinia or Shigella 
to actin tails (Moreau et al., 2000), all have the advantage of using cellular actin 
functions as an output. These experimental systems however are less suited to 
dissecting out the molecular interactions and signalling which lead to the initiation 
of these outcomes.
Pyrene based actin polymerisations assays (Ho et al., 2004; Yarar et al., 2002; 
Martinez-Quiles et al., 2001; Higgs and Pollard, 2000; Prehoda et al., 2000; 
Rohatgi  et  al.,  1999;  Ma  et  al.,  1998a;  Zigmond  et  al.,  1997)  measure  the 
maximal rate of de novo actin filament formation by determining the fluorescence 
emitted by prenylated actin upon polymerisation. In purified component systems, 
recombinant proteins are mixed with prenylated actin and actin polymerisation 
is initiated with the addition of Cdc42, PIP2 or equivalent (Yarar et al., 2002; 
Rohatgi et al., 2000; Higgs et al., 1999). In High Speed Supernatant systems, 
cell lysates (traditionally xenopus egg extract or bovine brain extract) (Suetsugu 
et al., 2001a; Ma et al., 1998a) have filamentous actin removed by centrifugation 
and then new actin filament formation is assessed following addition of Cdc42 or 
PIP2. The effects of selective deletion of lysate components or addition of excess 
recombinant components can then be assessed.
For  this  project  I  decided  to  use  a  bead  based  pulldown  assay  of  actin 
polymerisation (Cory et al., 2002; Fradelizi et al., 2001). Recombinant protein is 
coated on sepharose beads which are then incubated in lysate from a myeloid 
cell line. The amount of filamentous actin produced is then quantified by SDS-
PAGE and western blotting of washed beads and by immunofluorescence of 
phalloidin stained beads. There are several advantages of this assay. Firstly it 
allows assessment of actin polymerisation within a myeloid cell lysate, which is a 
more relevant substrate for the investigation of dendritic cell cell biology. Unlike 
the High Speed Supernatant pyrene assay, the bead based assay only measures 
filamentous actin induced directly by the bead bound protein of interest. Unlike Chapter 4
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the purified components system, it uses cell lysate as a substrate which is more 
physiological, and does not rely on the artificial initiation of polymerisation by 
addition of an excess of Cdc42. An additional advantage of the bead based assay 
is that it facilitates the detection and quantification of other bound components 
involved in the initiation of actin polymerisation.
The bead based assay does not, however, have the same temporal sensitivity 
as pyrene based assays and is more dependent on measuring the amount of 
filamentous actin associated with the beads at the equilibrium point between 
polymerisation and depolymerisation. As a result the outputs of these two assays 
are measuring subtly different activities.
In this chapter I present results demonstrating optimisation and characterisation 
of the bead based actin polymerisation assay. This background information allows 
for a more insightful interpretation of the subsequent results of the panel of WASp 
constructs used in this project.
Detection of constitutively active but not wild type activity 4.1.2 
Initially the bead based actin polymerisation assay was performed as most recently 
published (Cory et al., 2002) using U937 cell lysate generated with 107 cell per 
ml of lysis buffer. Following centrifugation at 20,000g for 10 minutes, the lysate 
was supplemented with 5mM MgCl2 before incubation with GST-WASp coated 
sepharose beads for 1 hour. As WT WASp exists in an autoinhibited conformation 
at rest (Kim et al., 2000; Rohatgi et al., 1999; Miki et al., 1998b), WT protein was 
compared to the constitutively active WASp mutant I294T (Ancliff et al., 2006). 
As predicted the I294T mutant shows strongly active actin polymerisation. There 
is a dose response between the WASp input (concentration of WASp on a fixed 
volume of beads) and actin pulled down, demonstrating a sustained excess of 
actin in the lysate, and no saturation of activity (figure 4.1a and b). By contrast 
the WT WASp shows low levels of activity and a weak relationship between actin 
pulled down and WASP input. This suggests the filamentous actin bound to WT 
WASp is due to low grade non-specific polymerisation and little is caused by the 
activation of the WT WASp.
Two controls are shown with this experiment. Three concentrations of beads 
coated with GST alone show very low levels of actin pulldown and no correlation 
between dose and response. This demonstrates that the GST tag does not initiate 
actin polymerisation. The second control shows the I294T construct tested in the 
presence of cytochalasin D, a fungal toxin which binds to the barbed end of actin 
filaments, inhibiting elongation of the filament and encouraging depolymerisation Chapter 4
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Fig  4.1
Fig 4.1 Unsupplemented actin polymerisation assay with wild type and I294T mutant
U937 cell lysate was generated at 107 cells/ml. After centrifugation the lysate was supplemented 
with 5mM MgCl and then incubated with 50μl of GST-WASp coated Sepharose beads (3 WASp 
concentrations for each construct). One I294T sample was incubated with lysate containing 5μM 
cytochalasin D. After 1 hour of rotation, the beads were washed and a 1/10 of each sample was 
stained with rhodamine phalloidin and mounted for flourescent microscopy. The remaining sam-
ple was reduced in sample buffer and resolved by SDS-PAGE and western blotting. (a) Western 
blot of resolved beads. Top and bottom thirds of membrane immunoblotted simultaneously with 
anti GST antibody, middle thirds blotted with anti actin antibody. (b) Densitometry of bands from 
blot in (a). Units are arbitary densitometry units. (c) Phase and flourescent microscopy of rhod-
amine phalloidin labelled beads.
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Fig 4.1 Unsupplemented actin polymerisation assay with wild type and I294T mutant
U937 cell lysate was generated at 107 cells/ml. After centrifugation the lysate was supplemented 
with 5mM MgCl and then incubated with 50μl of GST-WASp coated Sepharose beads (3 WASp 
concentrations for each construct). One I294T sample was incubated with lysate containing 5μM 
cytochalasin D. After 1 hour of rotation, the beads were washed and a 1/10 of each sample was 
stained with rhodamine phalloidin and mounted for flourescent microscopy. The remaining sam-
ple was reduced in sample buffer and resolved by SDS-PAGE and western blotting. (a) Western 
blot of resolved beads. Top and bottom thirds of membrane immunoblotted simultaneously with 
anti GST antibody, middle thirds blotted with anti actin antibody. (b) Densitometry of bands from 
blot in (a). Units are arbitary densitometry units. (c) Phase and flourescent microscopy of rhod-
amine phalloidin labelled beads.
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(Krucker et al., 2000; Dubinsky et al., 1999; Cooper, 1987). The fact that the 
activity of the I294T mutant is inhibited by cytochalasin D suggests that the actin 
detected by western blot in the assay is polymerised f-actin rather than sequested 
g-actin. The complete abolition of actin polymerisation with cytochalasin D with 
the WASp I294T mutant, suggests that the inhibitor may act by competitively 
inhibiting the binding of g-actin to WASp, in addition to inhibiting polymerisation 
downstream.
Although a WASp construct with the functional VCA domain deleted was not used 
as a negative control in these optimisation experiments, it was used as part of the 
panel of constructs which was fully tested (see chapter 5).
Detection of beads associated actin by immunoflourescence 4.1.3 
Beads from the above experiment were stained with rhodamine phalloidin (a red 
fluorescent dye which binds to filamentous actin) and were imaged by fluorescence 
microscopy (see chapter 2.9.2). The images were optimised using Photoshop@ 
with identical processing used for each image. Figure 4.1 demonstrates strong 
fluorescence  associated  with  the  I294T  beads,  much  weaker  fluorescence 
associated with the WT and cytochalasin inhibited beads and no fluorescence 
above background on the GST beads. This confirms the findings on SDS-PAGE 
and western blotting and further demonstrates that the actin associated with the 
beads is f-actin.
This protocol appears robust in detecting constitutively active WASp constructs. 
However, because of the low level of WT activity, it is of limited use in assessing 
constructs whose activity is reduced compared to WT. The remainder of this 
chapter describes the optimisation of this assay, resulting in increased sensitivity 
of the assay and a shift in its dynamic range to span the activities of GST alone 
to activities just greater than WT WASp.
Optimising WT activity 4.2 
WASp concentration on beads and bead volume 4.2.1 
One possible explanation for the relative insensitivity of the assay to WT WASp 
was insufficient recombinant WASp in each experiment. To investigate this, the 
concentration of WASp bound to each sepharose bead and the total number of 
beads used in each individual assay was varied.
I have previously demonstrated that WASp coated beads made under standard 
procedures are saturated with recombinant protein, as GST-WASp transfected Chapter 4
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lysate after incubation with sepharose beads still contains significant amounts 
of GST-WASp (see 3.2.3 and figure 3.10c). To try to generate beads with a 
higher concentration of WASp 15cm plates of transfected Cos7 cells were lysed 
in smaller volumes of lysis buffer (500µl compared to the standard 800µl) and 
incubated with smaller volumes of sepharose beads (50µl and 75µl compared 
to 100µl). Figure 4.2a shows that beads generated in this manner had similar 
concentrations of WASp on their surface and actin polymerisation assays gave 
very similar results.
Increasing the volume of beads used did increase the actin signal, and in several 
experiments a larger volume of beads with a lower WASp protein concentration 
produced  greater  activity  per  unit  WASp  than  a  smaller  volume  of  more 
concentrated beads (figure 4.2b and data not shown). These findings suggest that 
as the proportion of final reaction volume made up by sepharose beads increases, 
the rate of new actin filament formation increases. A hypothetical explanation for 
this phenomenon is that increased breakage of elongating actin filament as a 
result of greater numbers of bead collisions, resulting in larger numbers of barbed 
ends being available for actin polymerisation. This increased WT WASp actin 
signal was still not as large as that seen with the constitutively active mutant 
S272P, which remained highly active even at low concentration. This strategy for 
sensitising the assay was abandoned for three reasons. Firstly this concentration 
affect appeared to be inconsistent between mutant constructs (figure 4.2 S272P 
columns and data not shown) and therefore may have given rise to misleading 
results. Secondly in some optimisation experiments large bead volumes gave 
rise to unacceptably high levels of background activity (GST samples in figure 
4.4e). 
Thirdly the volume of beads and transfected lysate required to make enough 
beads of sufficient sensitivity, made this strategy impractical. Nonetheless these 
experiments emphasised the importance of using equal WASp concentrations 
and equal numbers of beads between constructs in experiments when comparing 
WASp activities.
Magnesium concentration 4.2.2 
Magnesium ions are required for the hydrolysis of ATP bound to monomeric actin 
to ADP, providing the energy required for the monomeric actin to bind to the barbed 
end of an actin filament. Magnesium chloride is added to U937 lysate in the actin 
polymerisation assay to overcome the chelating effect of EDTA in the lysis buffer. 
To asses whether the assay could be sensitised by adding additional magnesium Chapter 4
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Fig  4.2
a
b
Fig 4.2 Effect of bead volume, beads WASp concentration and magnesium on actin polym-
erisation assay
(a) Actin polymerisation assay performed on WT GST-WASp coated beads generated by incu-
bating transfected Cos7 lysate of 3 dilutions (lysate dilution) with 3 different volumes of beads 
(bead volume). (b) Actin polymerisation on WT, GST and S272P WASp beads comparing beads 
generated with full strength transfected lysate to 3 times the volume of beads generated with 1/3 
strength lysate. Blots (a) and (b) were blotted simultaneously and therefore band intensities are 
comparable between both blots. U937 lysate concentration for both experiments was 2.4 mg/ml. 
(c) Actin polymerisation assay on WT, GST and S272P constructs with varying Mg2+ concentra-
tions. Lysate concentration 1.7 mg/ml.
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chloride, the assay was performed over a range of magnesium concentrations. 
Figure 4.2c demonstrates magnesium ion concentration had no effect on either 
WT activity within the assay or on background actin polymerisation.
ATP supplementation 4.2.3 
As ATP is required for binding of monomeric actin to filamentous actin and for 
optimal Arp2/3 activity, I hypothesised that ATP may increase the amplitude of the 
actin signal in the assay, by acting down stream of WASp activation. Theoretically, 
ATP could amplify the signal from low levels of WASp mediated actin filament 
nucleation and therefore facilitate the differentiation of more subtle differences in 
WASp activity.
Figure 4.3a and b show the effect of increasing ATP supplementation of U937 
lysate for WT and S272P constructs and for WT with cytochalasin D. Addition 
of 1mM ATP to the reaction brings the actin signal of the WT WASp to a similar 
level of the S272P mutant with no ATP supplementation. By contrast the S272P 
mutant even with no ATP is approaching saturation activity and therefore addition 
of ATP to the assay results in only minimal increase in actin pulldown. By contrast, 
increasing ATP has no effect on the activity of the WT construct in the presence 
of cytochalasin D. This strongly suggests the ATP is acting at the actin filament 
elongation stage of the reaction. ATP concentrations higher than 1mM were also 
tried, but they resulted in protein precipitation during the reaction making SDS-
PAGE impossible (data not shown).
1mM ATP supplemented U937 lysate was then used to assess the WASp activity 
over a titration of WASP bead concentrations. Figure 4.3d demonstrates that 
addition of 1mM ATP to the assay gives WT WASp a dynamic dose – response 
relationship, allowing for more sensitive assessment of activity over a range of 
WASp concentrations. This experiment also demonstrates the lack of such a 
response for GST alone, and a widening in the activity gap between GST and WT 
with the addition of ATP. Other experiments have demonstrated no increase in 
actin polymerisation with increasing ATP supplementation for GST coated beads 
(data not shown).
Lysate concentration 4.2.4 
Within  cells,  the  equilibrium  between  polymerisation  and  depolymerisation  is 
largely controlled by the relative concentrations of monomeric actin and filamentous 
barbed ends. A simple way of increasing the concentration of monomeric actin 
in an in vitro polymerisation assay is to increase the concentration of cell lysate Chapter 4
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Fig 4.3 Effect of ATP on actin polymerisation assay
(a) Actin polymerisation assay on WT, S272P and WT with cytochalasin D added, with a range of 
ATP concentrations added to the U937 lysate immediately prior to bead incubation.
(b) & (c) Graphs of densitometry performed on blots from experiment in Fig 4.3a. Densitometry 
was performed on WASp, actin and Arp 2/3 bands and then expressed as actin / WASp and 
Arp2/3 / WASp ratios. (d) Actin polymerisation using the optimised ATP concentration of 1mM on 
beads coated with a titration of WT WASp and GST concentration.
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used. This will also have the effect of increasing the interaction rate between the 
bead bound WASp protein and other regulatory proteins which may mediate its 
activation (such as Cdc42).
An initial experiment was performed comparing assay activity using U937 cell 
lysate at 1x107 cells/ml with 2x107 cells/ml (without supplementation of ATP). 
Figure 4.4a demonstrates that WT WASp activity is significantly increased by 
the more concentrated lysate, but the activity associated with GST alone and 
WT with cytochalasin D is also increased. A more comprehensive assessment of 
this effect is shown in figure 4.4b. In this experiment all lysate was supplemented 
with 1mM of ATP, and lysates were generated using between 1x107 cells/ml and 
6x107 cells/ml, which yielded protein concentration of between 1.6 mg/ml and 4.9 
mg/ml (as determined by BCA assay). WT WASp activity increases linearly with 
increasing lysate concentration (figure 4.4c). S272P WASp also shows increased 
activity with increasing lysate concentration, but the gap in activity between WT 
and S272P narrows as the concentration g-actin and WASp activators in the 
lysate increases (figure 4.4c and d).
Beads  coated  with  both  GST  and  dEVH1  WASp  show  an  increase  in  actin 
polymerisation from 4x107 cell/ml lysate. As suggested by figures 4.4a and 4.4b, 
increased lysate concentration increases non specific actin polymerisation as 
well as potentiating the activity of WT WASp. This experiment is representative 
of three similar experiments investigating the effect of lysate concentration. As 
a result of these experiments 2x107 U937 cells/ml was felt to be the best lysate 
concentration for comparing the activity of WASp constructs to WT WASp.
Figure  4.4e  shows  the  effect  of  freezing  U937  lysate  prior  to  using  it  in  the 
actin polymerisation assay. Even the activity of the constitutively active WASp 
is  impaired  with  the  previously  frozen  lysate,  (although  this  experiment  was 
performed without ATP supplementation), and therefore fresh lysate only was 
used for further experiments.
Time course 4.2.5 
The kinetics of the bead based actin polymerisation assay were investigated, 
both to provide information about the kinetics of WASp activity and to determine 
the optimal time point to use for assessing relative activity of WASp mutants.
Figure 4.5a shows an actin polymerisation assay without ATP supplementation, 
where WASp coated beads were rotated with lysate for up to 24 hours (at 4˚C), 
to determine whether WT WASp activity required a longer incubation period to Chapter 4
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Fig  4.4
Fig 4.4 Effect of U937 lysate concen-
tration  on  actin  polymerisation  as-
say
(a) Actin polymerisation assay with WT 
WASp and GST coated beads incubat-
ed with U937 lysate generated from 107 
and 207 cells per ml of lysis buffer. (b) 
Actin  polymerisation  assay  with  U937 
lysate generated from 107 ,2x107 ,4x107   
and 6x107 cells per ml. Resolved beads 
blotted for GST, Actin and p34 of ARP 
2/3 complex. Protein concentrations of 
lysates were 1.6, 2.4, 4.3 and 4.9 mg/
ml respectively. (c) & (d) Actin / WASp 
and Arp2/3 / WASp ratios were generated from densitometry on the bands from fig 4.4b and were 
plotted against lysate concnetration. (e) Actin polymerisation assay comparing previously frozen 
lysate with freshly prepared lysate. Also demonstrates higher levels of background actin pulldown 
with high volumes of GST only beads.
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be detected. The results show that both WT and GST samples showed a small 
increase in actin binding over longer incubation periods, which is likely to be non 
specific polymerisation. Interestingly S272P shows maximal activity at 1 hour and 
the actin polymerised on the surface of the beads appears to depolymerise over 
time (figure 4.5b).
Figures 4.5c-e compare the activity of S272P, GST and WT WASp with and 
without ATP supplementation, over the first hour of bead incubation. The S272P 
WASp shows a maximal rate of actin polymerisation within the first 15 minutes of 
incubation, and its activity appears to have plateaued by 30 minutes. As shown 
before, WT WASp without ATP shows very little detectible activity. WT WASp with 
ATP supplementation by contrast shows its greatest rate of polymerisation after 
30 minutes and continues to generate more polymerised actin beyond 1 hour.
Standard conditions 4.2.6 
On the basis of these experiments I decided to use a 1 hour incubation period, 
with U937 lysate of 2x107 cell/ml and 1mM ATP supplementation as the standard 
for comparing activity of mutant WASp construct to WT. Although the WT WASp 
in many such experiments may not yet have reached the equilibrium point where 
polymerisation equal depolymerisation rates, the one hour “snapshot” gives the 
opportunity for detecting constructs which are both more active (approaching 
or at equilibrium) or less active than WT. These conditions result in WT WASp 
activity being within the dynamic range of the assay. For experiments assessing 
the activity of constitutively active WASp constructs and NWASp constructs I 
have used the same conditions without ATP supplementation as the standard 
protocol.
Arp 2/3 complex binding during the assay 4.3 
In addition to measuring the amount of actin bound to WASp coated beads after 
incubation with lysate, I also analysed the association of WASp binding proteins 
known to be involved in WASp activation. Although I have never consistently 
detected Cdc42 bound to beads, the presence of the p34 (ARPC2) subunit of 
the Arp2/3 complex correlates well with the quantity of actin polymerised (figure 
4.3a, 4.3c, 4.4b, 4.4d and 4.5c). There is some inconsistency of p34 detection 
(compare the p34 detected in figure 4.5c, with the equivalent band detected in 
figure 4.4b (WT20) and figure 4.3a), however this is likely to represent a technical 
problem with the p34 detection figure 4.5c.
In fact, the quantity of Arp 2/3 bound appears to be a more specific marker of Chapter 4
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Fig 4.5 Kinetics of actin polymerisation assay and optimisation of incubation time
(a) Actin polymerisation assay using 107 U937s/ml (lysate concentration 2.4 mg/ml) and no ATP 
supplementation. Bead incubation time varied between 1 hour and 24 hours. (b) Densitometry 
was performed on Fig 4.5a and used to generate actin / WASp ratios for each sample. These 
were plotted against incubation time. (c) Actin polymerisation assay using 2x107 U937s/ml (lysate 
concentration 3.41mg/ml) comparing kinetics of WT, S272P and GST without ATP with WT with 
1mM ATP. Incubation time varied from 5 minutes to 4 hours. (d) and (e) Densitometry was per-
formed on Fig 4.5c, and used to generate Actin / WASp and Arp2/3 / WASp ratios which were plot-
ted against incubation  time. These results are representative of four independent experiments.
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WASp activation than actin, as the negative control experiments show no p34 
binding  even  if  low  grade  actin  polymerisation  is  present  (figure  4.3a,  4.4b, 
4.5c). Interestingly WT WASp actin polymerisation assays without ATP lysate 
supplementation  also  have  absent  p34  binding  (figure  4.3a,  4.5c,  4.12b  and 
4.13b). This raises the possibility that some low grade actin polymerisation is 
occurring via an Arp2/3 independent mechanism. Further evidence of two distinct 
pathways to actin polymerisation is suggested by the lysate concentration titration 
experiment (figure 4.4b). Both GST and dEVH1 constructs polymerised actin 
at the highest lysate concentrations, but whereas the dEVH1 domain mutant 
simultaneously bound p34 Arp2/3, the GST coated beads did not.
It is unknown whether in this assay the Arp 2/3 complex detected remains bound 
to an active GST-WASp, or whether it has dissociated from WASp and is bound 
to the branch points within the actin network. Each p34 subunit detected could 
represent one active WASp protein or it could represent a historical record of 
WASp mediated nucleation events, and therefore be proportional to the rate with 
which WASp cycles between an active and inactive state. Alternatively the p34 
binding could be independent of bead bound WASp and be as a result the action 
of other mediators in the lysate acting on the dense actin network generated 
by the WASp on the surface of the bead. These hypotheses could be further 
explored using imaging techniques such as electron microscopy with gold labelled 
antibodies, but have been beyond the scope of this project.
Quantification and variability of the assay 4.4 
Densitometry 4.4.1 
In order to quantify the results of actin polymerisation assays, I have performed 
densitometry on immunoblots generated during the assay. As described in chapter 
2.5, Western blots were developed using chemoilluminescence of HRP conjugated 
secondary antibodies, detected by a supercooled camera (Uvichemi). A strict 
protocol (chapter 2.7.1) was used for determining exposure time, background 
subtraction and band definition, which yielded reproducible results. Nonetheless, 
it was important to check the relationship between densitometry readings and 
protein concentration for the reagents and actin concentrations used in the actin 
polymerisation assay, to validate the assumption of a linear relationship.
Commercially purchased actin was reduced and resolved by SDS-PAGE, and 
the Western blot was immunoblotted for actin, using identical antibodies and 
techniques as used for the actin polymerisation assay. The results of two of 
four similar experiments are shown in figure 4.6. Figure 4.6a assesses low actin Chapter 4
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concentrations and figure 4.6b assesses densitometry for very high actin levels 
(comparable to positive signals in the actin polymerisation assay). For each, the 
blots were developed on three occasions (two optimised for exposure of the largest 
band and one optimised until the weakest band was just visible on the image prior 
to manipulation). Three definitions of “the actin band” were used (figure 4.6b) and 
densitometry readings were compared for all three at each of the exposures.
Both blots show a primary actin band and a series of degradation products below. 
In the actin polymerisation assay only full length actin will be bound to the beads 
and therefore these degradation products are not seen in these experiments. It 
was important to quantify the degradation products with the primary actin band in 
a b
c d e
Fig 4.6 Assessment of linearity of densitometry of actin band resolved by SDS-PAGE and 
western blotting
(a) & (b) Known amounts of commercially purchased actin were reduced in sample buffer and 
resolved by SDS-PAGE and western blotting. The blots were developed on three separate occa-
sions using different exposures (Exp1, 2 and 3). Densitometry was performed on the blots using 
3 different band widths to define the actin band - narrow band (most selective), top cluster and full 
signal (most broad). (c), (d) and (e) Absolute densitometry readings were plotted against actual 
actin quantities and analysed by linear regression. Fig 4.6c and 4.6d relate to Fig 4.6a, and Fig 
4.6e relates to Fig 4.6b. Regression lines plotted exclude the values for 20ng actin in Fig 4.6e. 
Data is representative of four independent experiments.
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order to accurately measure the total protein loaded.
Figures 4.6 c-e show examples of densitometry readings generated from these 
experiments. It can be seen that the densitometry signal varies linearly with actin 
concentration for a wide range of actin concentrations. In figure 4.6a there is 
linearity between 1µg and 15µg and in figure 4.6b between 100ng and 2000ng 
(or greater). Within each experiment there is linearity over a 20 fold increase in 
actin concentration, and with the correct exposure this linearity can be generated 
at any of the absolute actin concentrations tested.
Linearity of densitometry signals were also tested less formally for other proteins 
including WASp and similar correlations were found (data not shown). These 
results  validate  the  use  of  densitometry  for  quantifying  actin  polymerisation 
assays.
Variability of individual experiments 4.4.2 
From the results already presented in this chapter it is obvious that the bead based 
assay  generates  very  significant  variability  in  actin  polymerisation  responses 
between individual experiments. Similarly, there is inconsistency in the amount 
of WASp input both between constructs and between the same construct used 
for different reactions within a single experiment. As a result, presentation of the 
results from this assay using standard deviation or standard error to visualise 
variability would be misleading.
This  variability  is  illustrated  by  figure  4.7  which  shows  scatterplots  of  the 
standardised  densitometry  values  for  actin  and  WASp  for  all  experiments, 
grouped into each construct. Despite each construct being tested at three discrete 
WASp concentrations, WASp values appear as a continuum for every construct. 
Additionally, the actin responses for similar WASp concentrations of the same 
construct are markedly different between experiments. This is further illustrated 
by same dataset separated into individual experiments (appendix figure A.3).
The  exact  condition  of  the  U937  lysate  used  for  these  experiments  cannot 
be  standardised.  Although  lysate  was  generated  at  a  standard  cellular 
concentration, this did not accurately correlate with a subsequently determined 
protein concentration. It was possible to quantify the lysate protein concentration 
before adding it to the beads, however this would have resulted in lysate being 
incubated on ice for at least 1 hour prior to be used in the assay. This would have 
introduced further variability (such as rate of endogenous ATP decay, changes in 
lysate actin dynamics), and there are limitations of the accuracy of rapid protein Chapter 4
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estimation assays. I therefore elected to use the lysate fresh. Even if total protein 
concentration could be standardised the “quality” of the lysate will vary between 
experiments. This will be affected by the rate of division of the cells at the point of 
harvest and how healthy the cells are, among other factors.
Similarly, the exact delay between cell lysis and addition to WASp coated beads 
is likely to affect the potency of the actin response. Although, this delay was 
minimised and lysate was always kept on ice, there was inevitable variation 
between experiments and because of the short half life of mediators such as 
endogenous ATP and GTP, any variability may have a profound effect on the 
sensitivity of the assay. The bead incubation occurred at room temperature, which 
Fig  4.7
Fig 4.7 Actin - WASp scatterplots for individual constructs
Scatterplots of absolute densitometry values for actin and WASp, combined from all experments. 
Data sub-divided by construct.
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will also have varied between individual experiments.
Sepharose beads are known to form clumps on storage, and as a result even 
when thoroughly mixed there will be significant heterogeneity in the number of 
beads present in equal volumes of reagent. This effect was minimised by storing 
the beads in a diluted buffer (1 in 5 v/v) and by ensuring the beads were well 
mixed (by flicking and pipetting) before being dispensed. During bead production 
(see chapter 3.3.2 and figure 3.10), there is variability in the amount of WASp 
generated  for  each  construct  and  each  bead  batch,  and  this  will  inevitably 
result in differences in WASp concentration between sets of beads. WASp bead 
concentrations were determined, as described in chapter 3, and volumes loaded 
for each batch were adjusted to try to standardise the amount of WASp used in 
each experimental sample.
The detection of protein bands by Western blotting is also a source of variation 
between  experiments.  Efficiency  of  antibody  binding,  efficiency  of  blocking 
buffers, activity of ECL, evenness of ECL distribution of blot membranes and 
smudging or flare of high intensity signals all lead to inaccuracies in determining 
protein  concentration  within  reactions.  To  minimise  these  effects  each  actin 
polymerisation gel was run with one well containing a standard of known actin 
and WASp amount. Densitometry readings were only compared within a single 
gel with a single exposure.
Despite  the  above  variations  between  experiments,  comparisons  between 
constructs within experiments will remain valid. By using a multiple linear regression 
model to assess the relationship between actin and WASp, with experiment and 
construct as categorical factors, this variability can be compensated for. To further 
increase the accuracy of the results, most experiments were performed with a 
range of WASp concentration (at least 3) for each construct. This maximised the 
likelihood of detecting an actin response within the dynamic range of the assay 
for all construct, and could be used in a linear regression model.
Statistical analysis 4.5 
Grouping of experiments for analysis 4.5.1 
For analysis, data from experiments have been grouped into three datasets ; 
those assessing constitutively active constructs (S272P, I294T, Y291E and dVCA 
bind - without ATP supplementation), the standard panel (dEVH1, dBasic, dPolyP, 
dVCA, H246D, A134T, R138P, R86H and T45M - with ATP supplementation) and 
the NWASp constructs (S229P, S232P, murine WT WASp and murine WASp Chapter 4
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S272P – without ATP supplementation). Data from every experiment performed 
under  standard  conditions  (see  chapter  4.26)  was  pooled  into  these  groups 
and analysed together. Some of these experiments contained several WASp 
concentrations for each construct, others contained a single concentration. As 
described in chapter 2.72, raw densitometry readings (referred to as relative 
data) and standardised, quantitative readings (referred to as absolute data) were 
analysed in parallel.
In this chapter I explore and validate the statistical approach to analysing the actin 
polymerisation assays. To illustrate this I have used the largest data set available 
(the standard panel of constructs), and included all constructs tested in parallel 
including all negative controls. Similar results were obtained for the constitutively 
active and NWASp data sets and the descriptive statistics, frequency distributions 
and detailed statistical analyses of these data sets are shown in the appendix 
(figure A.4 - A.8 and A.10).
A  summary  of  the  statistical  terminology  used  in  the  analysis  of  the  actin 
polymerisation is shown in figure 4.8.
Statistical approach and terminology used 4.5.2 
Details of the processing of densitometry data and further details of the statistical 
approach to analysis of this data are found in chapter 2.7.2. When analysing the actin 
polymerisation experiments, I was interested in differences between constructs 
in the amount of actin polymerised per unit WASp. Two null hypotheses were 
assessed for each construct – (i) the actin polymerisation activity of the construct 
is the same as WT WASp (or NWASp) activity, and (ii) the actin polymerisation 
activity of the construct is the same as a cytochalsin D inhibited assay activity.
An ANCOVA (two way analysis of covariance of actin with WASp) was performed, 
using  linear  regression  corrections  for  differences  between  “experiment”  and 
“construct”. This  technique  allowed  a  parametric  analysis  of  the  data,  and  a 
quantitative assessment of differences in actin values (standardised to WASp 
amount) between constructs. As described in chapter 2.7.2, two models were 
analysed – a main effects model analysis and an interaction model analysis. To 
be able to use this technique, actin and WASp values must be approximately 
normally distributed, and to compare differences between constructs the variances 
of the actin data should be approximately equal between constructs.
Data distribution and assessment of normality 4.5.3 
To normalise the data, % natural logs were calculated for both actin and WASp Chapter 4
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Fig / Table  4.8
Table 4.8  Definitions of statistical terms 
Term Meaning
% Ln actin / WASp  Natural logarithm of actin (WASp) reading multiplied by 
100
Absolute data  Densitometry readings standardised to absolute mass of 
protein using reading of known standards 
ANCOVA  Analysis of Covariance. In this thesis this refers to the 
two analysis of the variance of % Ln Actin with the 
covariance of % Ln WASp 
Corrected model of 
squares (SSM)
Measure of total variation of % Ln actin values with % Ln 
WASp values 
Corrected total sum 
of squares (SST)
Measure of variation of % Ln actin with % Ln WASp 
accounted for by the regression model 
df Degrees of freedom 
Error (residual) sum 
of squares (SSR)
Measure of variation of % Ln actin with % Ln WASp not 
accounted for by the model (unsystematic or random 
variation)
F ratio  Proportion of variation of % Ln actin values with % Ln 
WASp values accounted for by the model (or factor 
within the model) compared to unsystematic (random) 
variation
Interaction model  Regression model including an adjustment for the 
interaction between % Ln WASp and experiment 
Kurtosis Measure of the degree of clusters within the tails of a 
frequency distribution 
Main effects model  Regression model of % Ln Actin with % Ln WASp 
including adjustments for differences between individual 
constructs and experiments 
Marginal Mean  Estimate of the mean % Ln Actin value for an individual 
construct for fixed value of % Ln WASp (covariant) 
R squared value 
(R2)
Proportion of variability of % Ln Actin accounted for by % 
Ln WASp. A perfect correlation would give a value of 1.0 
Relative data  Raw unstandardised densitometry readings 
Skewness Measure of the degree of asymmetry of a frequency 
distribution
z score  Number of standard deviations an individual value differs 
from the mean of the population 
Fig 4.8 Summary of statistical terms used in this thesisChapter 4
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values (chapter 2.7.2). Scattergraphs, histograms and descriptive statistics for 
transformed and untransformed data is shown in Figure 4.9 for the absolute 
data and in 4.10 for the relative data. Untransformed data for actin and WASp 
have disparate mean and median values for both relative and absolute readings, 
demonstrating a lack of normality. Natural log transformation however produces a 
data set with very similar means and medians (figure 4.9h and 4.10h). Scatterplots 
show a positive correlation between WASp and actin with no obvious non-linear 
relationship.
Histograms  of  actin  and  WASp  distributions  (figure  4.9c-f  and  4.10c-f)  show 
that  the  log  transformed  distributions  are  approximately  normally  distributed. 
Statistics for skewness and kurtosis (for % Ln Actin / WASp) are between 2 and 
3 standard deviations (z scores) from the normal mean (zero) (figures 4.9h and 
4.10h), suggesting that, for the complete dataset both % Ln WASp and % Ln 
Actin show significant deviation from normality. Similarly more formal tests of 
normality, such as the Kolomogorov-Smirnov statistic, performed on the entire 
dataset demonstrate significant deviation form normality for both absolute and 
relative data of % Ln WASp and % Ln actin (analysis not shown). However, if each 
individual construct is tested as a sub population (as they will be subsequently 
analysed) almost every individual construct has a normal distribution for both % 
Ln actin and % Ln WASp. Figure 4.11a shows the Kolomogorov-Smirnov statistics 
for each individual construct’s data subset. A p value of greater than 0.05 predicts 
a 95% chance that the distribution is normal, and these subsets are marked with 
an asterix.
Although these tests state whether or not a distribution is statistically normal, they 
do not describe whether deviation from normality within a data set is important 
enough  to  invalidate  future  analysis.  The  ANCOVA  is  a  robust  technique, 
particularly with a large dataset (267 data points in the standard panel), and can 
tolerate significant deviations from normality. Because of how these experiments 
were performed (with several different WASp input concentrations), actin and 
WASp  distributions  should  not  be  normally  distributed.  The  above  analysis, 
however, demonstrates that they do show enough normality to allow the valid 
use of an ANCOVA analysis.
Assessment of equality or variances 4.5.4 
Levene’s  test  was  used  to  assess  the  equality  of  actin  variances  between 
constructs within the whole dataset. This test assesses the null hypothesis that 
the variance of the dependant variable (% Ln actin) is equal for each construct. Chapter 4
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Absolute Densitometry Readings
Descriptive Statistics - Absolute Values
WASp Actin % Ln WASp % Ln Actin
N 267 267 267 267
Mean 417.0 3601.9 519.9 608.1
Median 223.2 715.0 540.8 657.2
Std. Deviation 862.8 6799.6 141.6 269.3
Skewness 7.386 3.210 -0.668 -0.441
SE of Skewness 0.149 0.149 0.149 0.149
Kurtosis 65.399 12.078 0.749 -0.816
SE of Kurtosis 0.297 0.297 0.297 0.297
Descriptive Statistics - Relative Values
WASp Actin % Ln WASp % Ln Actin
N 267 267 267 267
Mean 624393 1151125 1252 1265
Median 395627 480664 1308 1289
Std. Deviation 630857 1464507 224 140
Skewness 1.222 1.725 -0.574 -0.666
SE of Skewness 0.149 0.149 0.149 0.149
Kurtosis 0.652 3.328 -0.864 -0.204
SE of Kurtosis 0.297 0.297 0.297 0.297
a b
c d
e f
h
Fig 4.9 Distribution and descriptive statistics of absolute densitometry readings
Absolute readings were generated by standardising densitometry readings to those of known 
WASp and actin standards. (a) & (b) Scatterplots of  raw or transformed WASp and actin densit-
ometry readings. Transformation was performed by taking natural logs and multiplying by 100 (to 
produce % Ln readings). (c) - (f) Frequency distributions of raw and transformed data.
(h) Descriptive statistics of raw and transformed data. Ln - Natural log, SE - Standard errorChapter 4
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Descriptive Statistics - Absolute Values
WASp Actin % Ln WASp % Ln Actin
N 267 267 267 267
Mean 417.0 3601.9 519.9 608.1
Median 223.2 715.0 540.8 657.2
Std. Deviation 862.8 6799.6 141.6 269.3
Skewness 7.386 3.210 -0.668 -0.441
SE of Skewness 0.149 0.149 0.149 0.149
Kurtosis 65.399 12.078 0.749 -0.816
SE of Kurtosis 0.297 0.297 0.297 0.297
Descriptive Statistics - Relative Values
WASp Actin % Ln WASp % Ln Actin
N 267 267 267 267
Mean 624393 1151125 1252 1265
Median 395627 480664 1308 1289
Std. Deviation 630857 1464507 224 140
Skewness 1.222 1.725 -0.574 -0.666
SE of Skewness 0.149 0.149 0.149 0.149
Kurtosis 0.652 3.328 -0.864 -0.204
SE of Kurtosis 0.297 0.297 0.297 0.297
a b
c d
e f
h
Fig 4.10 Distribution and descriptive statistics of relative densitometry readings
Relative readings are the unstandardised densitometry readings generated from the UviChemi 
supercooled camera. (a) & (b) Scatterplots of  raw or transformed WASp and actin densitometry 
readings. Transformation was performed by taking natural logs and multiplying by 100 (to pro-
duce % Ln readings). (c) - (f) Frequency distributions of raw and transformed data. (h) Descriptive 
statistics of raw and transformed data. Ln - Natural log, SE - Standard error
Relative Densitometry ReadingsChapter 4
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Fig  4.11
Absolute values Relative values
KS Statistic df Sig. P>0.05 KS Statistic df Sig. P>0.05
% Ln WASp WT 0.110 46 0.200 * 0.138 46 0.028
A134T 0.233 20 0.006 0.155 20 0.200 *
R138P 0.138 20 0.200 * 0.120 20 0.200 *
R86H 0.206 20 0.025 0.155 20 0.200 *
T45M 0.149 20 0.200 * 0.103 20 0.200 *
dEVH1 0.128 24 0.200 * 0.168 24 0.078 *
dBasic 0.093 23 0.200 * 0.117 23 0.200 *
dPolyP 0.141 18 0.200 * 0.131 18 0.200 *
dVCA 0.137 27 0.200 * 0.082 27 0.200 *
dVCA bind 0.297 6 0.106 * 0.190 6 0.200 *
H246D 0.151 20 0.200 * 0.124 20 0.200 *
S272P 0.106 18 0.200 * 0.166 18 0.200 *
Y291E 0.243 5 0.200 * 0.257 5 0.200 *
% Ln Actin WT 0.107 46 0.200 * 0.123 46 0.077 *
A134T 0.116 20 0.200 * 0.208 20 0.024
R138P 0.144 20 0.200 * 0.213 20 0.018
R86H 0.145 20 0.200 * 0.159 20 0.200 *
T45M 0.157 20 0.200 * 0.176 20 0.105 *
dEVH1 0.123 24 0.200 * 0.122 24 0.200 *
dBasic 0.150 23 0.196 * 0.181 23 0.048
dPolyP 0.133 18 0.200 * 0.169 18 0.188 *
dVCA 0.126 27 0.200 * 0.172 27 0.040
dVCA bind 0.264 6 0.200 * 0.222 6 0.200 *
H246D 0.140 20 0.200 * 0.206 20 0.026
S272P 0.124 18 0.200 * 0.115 18 0.200 *
Y291E 0.270 5 0.200 * 0.207 5 0.200 *
Levene's Test of Equality of Error Variances(a)
Dependent Variable: % Ln Actin
F df1 df2 Sig.
0.959 134 132 0.5961
Tests the null hypothesis that the error variance of the dependent variable is equal across groups.
Kolomogorov-Smirnov tests of Normality for individual constructs
Analysis of Covariance (ANCOVA)
Dependent Variable % Ln Actin, Co-variable % Ln WASp, Fixed factors Experiment and 
Construct, Interaction term of Experiment with % Ln WASp (Experiment * %Ln WASp)
Absolute values Relative Values
Main Effects Model Interaction Model Main Effects Model Interaction Model
df F Sig. df F Sig. df F Sig. df F Sig.
Corrected Model 33 31.89 .000 53 26.25 .000 33 19.93 .000 53 16.95 .000
Intercept 1 17.89 .000 1 1.12 .292 1 4.15 .043 1 .36 .548
Experiment 20 27.38 .000 20 6.85 .000 20 11.74 .000 12 4.54 .000
Construct 12 15.99 .000 12 17.30 .000 12 15.99 .000 20 17.31 .000
% Ln WASp 1 127.51 .000 1 4.71 .031 1 127.51 .000 1 4.71 .031
Experiment * 
% LN WASp 20 3.89 .000 20 3.89 .000
Adjusted R 
Squared .793 .834 .701 .761
Levene’s Test of Equality of Error Variances
Dependent Variable % Ln Actin
Tests the Null hypothesis that the error variance 
of the dependent variable is equal across groups
LS
a
b
c
Fig 4.11 Statistical analyses of normality, homogeneity of variance and comparison of dif-
ferent regression models used to perform ANCOVAs
(a) Assessment of normality. An insignificant KS statistic (p>0.05) suggests normally distributed 
data. (b) Assessment of homogeneity of variance (c) Comparison of ANCOVAs performed on ab-
solute and relative densitometry data, and using main effects only and interaction multiple regres-
sion models. df - degrees of freedom, LS - Levene’s statistic,  Ln - natural log, F - F ratioChapter 4
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Figure 4.11b demonstrates that there is no significant difference in the variances 
between constructs.
Analysis  of  Covariance  of  %  Ln  actin  with  %  Ln  WASp  4.5.5 
(ANCOVA) 
The ANCOVA assesses the regression model of Ln % actin with Ln % WASp, 
quantifies any variation from this model seen in the data, and categorises the 
source of this variation as due to differences between constructs, experiments or 
variation which cannot be accounted for by the model (unsystematic variation or 
error).
The total amount of variation in the data is represented by the corrected total Sum 
of Squares (SST), and the amount accounted for by the model is the corrected 
model sum of squares (SSM). The residual (unsystematic) variation, unexplained 
by the model is the error sum of squares (SSR). The sum of squares values are 
then adjusted by their degrees of freedom to give mean squares. The F ratio is 
the mean square value for the model (or any factor within the model) divided 
by the mean square of the error term. This represents the amount of variation 
attributable to the model (or a factor within the model), divided by the amount 
of residual variation. Therefore for the analysis above, it can be seen that the 
regression  model  accounts  for  31.9x  the  amount  of  variation  of  %  Ln  actin, 
compared to unexplained variation. Unsurprisingly, the model is a significantly 
accurate representation of the data, with a p value of < 0.0005.
The construct F ratio represents the ratio of variation attributable to differences 
ANCOVA of Standard panel, absolute data, main effects model
Table 4.1 Full ANCOVA table following analysis of actin polymerisation assays performed 
on the standard panel of constructs, using absolute densitometry readings and a main 
effects only modelChapter 4
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between constructs, compared to the residual variation. This value is 15.99 and 
is highly statistically significant, suggesting that there are significant differences 
between the constructs in their ability to polymerise actin. The R squared value 
represents the regression coefficient of the correlation between % actin and % 
WASp. The higher this value, the stronger the linear relationship between % Ln 
actin and % Ln WASp.
By comparing F ratios and R2 coefficient between absolute and relative data, 
and between the main effect analyses and the interaction analyses, it can be 
determined which data set is most strongly represented by which model, and 
proportionately how much variation is due to differences between constructs. 
Figure 4.11c compares the F ratios between these various combinations. The F 
ratios for all four analyses are very high and are all highly statistically significant. 
This suggests that compensations for experiment and construct explain the vast 
majority of the variation between % Ln Actin and % Ln WASp. Both the F ratios 
and the R2 coefficients for the models using the absolute data are higher than 
those using the relative data. This validates the use of a densitometry standard in 
these experiments, and this technique has been accurate enough to significantly 
reduce the variation between experiments.
Comparisons  between  the  main  effects  analysis  and  the  interaction  analysis 
(figure 4.11c), show that the interaction model has a slightly reduced F ratio, but 
the interaction term itself is significant (F ratio 4.71, p<0.05). Additionally the F 
ratio for the construct factor is increased in the interaction model (17.3 compared 
to 15.99, figure 4.11c), and the strength of the correlation between % Ln Actin 
and % Ln WASp (R2) is higher. These results suggest that, as predicted from the 
experimental practicality (chapter 4.42), there is a significant interaction between 
% WASp and experiment, and therefore this should be included in the analysis. 
Although the proportion of variation accounted for by the interaction model is 
less, the relative contribution of differences between the constructs is greater.
To conclude, the absolute data is a more accurate representation of the actin 
polymerisation assay results. In subsequent chapters results and analysis of 
absolute data only will be shown. The ANCOVA model compensating for an 
interaction between % WASp and experiment is a more true representation of 
the data, but the main effects only model accounts for a greater proportion of the 
variability seen. As a result, both sets of analysis will be presented in subsequent 
chapters.
Although all experimental data (under the same experimental conditions) has Chapter 4
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been included to assess the ANCOVA process, datasets analysed in chapter 
5  have  tailored  to  the  more  accurately  answer  the  specific  questions  being 
addressed. For example, when addressing the differences between constructs 
within the standard panel and WT activity, experiments involving cytochalasin D 
inhibition and those using constitutively active constructs have been omitted from 
the analysis, as they are not relevant to this question.
Estimated means and pairwise comparisons 4.5.6 
The ANCOVA analysis, assesses whether or not there are significant differences 
between the constructs within a dataset, but does give information about which 
individual constructs are responsible for these differences. “Marginal means” can 
be estimated for each construct, which act as a quantification of the average 
amount of actin polymerised per unit WASp. These values are estimates of % Ln 
actin at a fixed covariant (% Ln WASp) value, and are calculated using regression 
analysis. The significance of differences between these marginal means can be 
assessed using a t test.
In assessing the actin polymerisation activity of WASp constructs, I am only 
interested in comparing activity to WT (or cytochalasin D inhibited) activity. As 
the absolute marginal means of % actin are meaningless, I have expressed the 
activity of individual constructs in terms of their differences to WT (or cytochalasin 
D inhibited) activity, measured as multiples of the standard deviation of the WT 
marginal mean (a z score). In such representation, WT (or cytochalasin D inhibited) 
activity is expressed as 0, and individual constructs and their 95% confidence 
intervals have positive values if their activity is greater than WT and negative 
values if their activity is less than WT. An example of the graphical representation 
of such results is shown for NWASp constructs in figure 4.13d-f.
The expression of 95% confidence intervals and z scores is particularly helpful 
as they are identical for the log transformed and untransformed data, and give 
a realistic quantification for “relative ability to polymerise actin”, for which any 
absolute measure would be meaningless. Because I am assessing the difference 
between each construct and a predefined control (WT or cytochalasin D inhibited) 
only, I have used the least significant difference (LSD) pairwise comparison of 
marginal  means  to  assess  differences.  Results  of  this  analysis  for  individual 
constructs are shown in chapter 5.Chapter 4
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Use  of  other  haematopoeitic  cell  lines  as  assay  4.6 
substrates
U937  cells  were  chosen  as  a  substrate  for  the  actin  polymerisation  assay 
because they are of myeloid lineage and because they had been used in the 
previously published method for this assay. It was possible that other cell lysates 
may make the assay more sensitive, and it was important to validate the assay 
in other myeloid lysates. THP-1 cells (a human acute monocytic leukaemia cell 
line which can be differentiated into dendritic cell like cells in culture) and RAW 
132 cells (a murine macrophage cell line) were compared to U937s as lysate 
substrate. The  concentration  of  lysate  produced  by  2x107  cells/ml  had  been 
previously determined and was used to calculate the number of cells of each 
cell line required to generate lysate of the same concentration as 2x107 cells/ml 
U937s. These lysates were supplemented with 1mM ATP and tested with a range 
of WASp constructs.
Figure 4.12a demonstrates that although the assay does work using all three cell 
lines, it is most sensitive with U937 cells and least sensitive with RAW cells.
Optimisation of Cos 7 lysate as assay substrate 4.7 
The actin polymerisation assay can be modified to investigate the effect of WASp 
binding partners on in vitro WASp activation. The most direct way of doing this 
is to add purified recombinant protein to the lysate prior to bead incubation. This 
strategy was suitable for investigating the effects of Cdc42, which can be generated 
and purified from bacterial cell lysates, but for larger more complex proteins such 
as WIP which need to be generated in mammalian cells, the quantity of WIP 
required made this approach impractical. 
An alternative strategy of using lysate of cells overexpressing the protein of interest 
was investigated. U937 cells are difficult to transfect with high efficiency, but I have 
optimised transfection of Cos7 cells by electroporation, which results in greater 
than 90% transfection efficiency of viable cells at 48 hours post electroporation. 
To demonstrate an effect of a second protein on actin polymerisation it is essential 
to have the control experiment (WT-WASp without addition of second protein) 
reliably producing an actin response within the dynamic range of the assay. This 
will allow detection of both suppression and enhancement of activity.
Figure 4.12b shows an actin polymerisation assay using Cos7 lysates testing WT, 
S272P and dEVH1 WASp constructs with a range of lysate and ATP concentrations. 
This and other experiments have demonstrated that Cos7 lysate is very effective Chapter 4
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as  a  substrate  for  actin  polymerisation.  With  no ATP  supplementation  there 
appears to be less low grade actin polymerisation than with U937 lysate, but 
saturation of actin signal is achieved with lower concentration of ATP.
Testing of murine N-WASp in assay 4.8 
As part of a collaboration with another group (Adamovich et al., 2009), I was asked 
to use this assay to assess the activity of two N-WASp constructs (L229P and 
L232P) with point mutations which are predicted to result in constitutive activity. 
This has provided an opportunity to validate the assay for other initiators of actin 
polymerisation and to compare the relative activities of WASp and N-WASp in 
this assay. In addition I was asked to use murine WASp (WT and constitutively 
active L272P) as control.
Generation  of  N-WASp  coated  beads  (from  transfected  Cos7  cell  lysates), 
using the same protocol used for WASp bead generation, resulted in residual 
actin binding after bead washing (figure 4.13a). The murine WASp and GST 
beads made during the same preparation did not contain actin. This finding was 
Fig  4.12
Fig 4.12  Other cell lines as substrate lysate for the actin polymerisation assay
(a) U937 (U), THP-1 (T) and RAW (R) cell lysates were generated at the equivalent of 2x107 U937 
cells (based on previous data). Lysates were supplemented with ATP and incubated with beads 
coated with WT, S272P and WT WASp with Cytochalasin D. (b) Actin polymerisation assays were 
performed using Cos7 cell lysate. Lysate was prepared exactly as for U937 cells. 3 constructs 
were tested (WT, S272P and dEVH1), at a range of ATP supplementation concentrations and at 
2 lysate concentrations.
a
b
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consistent over three separate bead preparations. The amount of actin bound 
to each batch of beads was quantified and actin readings from the assays were 
corrected accordingly for all samples within these experiments (as described in 
chapter 2.7.2).
An example of an NWASp actin polymerisation assay is shown in figure 4.13b, 
and the corrected densitometry from this experiment is plotted in figure 4.13c. 
This experiment is representative of 4 similar experiments, and the descriptive 
statistics and frequency distributions of the actin and NWASp / mWASp data are 
shown in the appendix (figure A.6 and A.7). An ANCOVA analysis was performed 
as described above and the full results of this analysis can also be found in 
the appendix (figure A.10). The differences in mean activities between L229P 
and L232P NWASP mutants and WT NWASp are shown in figures 4.13d and e 
(for main effects only and interaction models respectively). These demonstrate 
that both constructs are significantly constitutively active, showing an activity 
approximately 3x the standard deviation of WT NWASp activity.
I  also  compared  the  activity  of  NWASp  constructs  to  their  equivalent  WASp 
samples, and found that WT NWASp was significantly more active than WT 
WASp (figure 4.13f). Interestingly the two constitutively active NWASp constructs 
showed slightly less activity than the equivalent murine WASp constitutively active 
point mutation (L272P), although this difference did not reach significance.
Conclusion 4.9 
The  experiments  in  this  chapter  demonstrate  that  the  bead  based  actin 
polymerisation assay is a valid and versatile tool in assessing the activity of 
activators of actin filament nucleators, such as WASp family proteins.
In interpreting the results of this assay it is important to consider exactly what is 
being measured and what mechanisms may be responsible for this. The assay 
measures the total amount of filamentous actin bound to WASp coated sepharose 
beads. To produce f-actin, WASp must first be activated exposing the Arp 2/3 
binding site within in the WASp VCA domain (Panchal et al., 2003). Arp 2/3 and 
ATP loaded monomeric actin (delivered by profilin) must then be recruited to form 
a nucleating complex (Marchand et al., 2001). This complex must then bind an 
existing actin filament from the lysate, activating Arp 2/3 and initiating nucleation. 
Following nucleation a daughter branch actin filament will form resulting in a new 
barbed end, which will spontaneously elongate, polymerising actin monomers 
into f actin. The Arp 2/3 complex will remain anchored to the branch site on the 
filament network (Svitkina and Borisy, 1999), however following nucleation WASp Chapter 4
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Fig  4.13
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Fig 4.13 N-WASp and murine WASp in 
actin polymerisation assay
(a) Sepharose beads coated with GST N-
WASp protein (WT, S229P and S232P) re-
solved by SDS-PAGE and western blotting. 
N-WASp  constructs  were  associated  with 
higher  levels  of  actin  following  purification 
than  mWASp  constructs.  Fractions  above 
the    labels  of  the  NWASp  constructs  rep-
resent the dilution of lysate used to manu-
facture the beads. (b) Actin polymerisation 
assay  with  N-WASp  and  murine  WASp 
(mWASp) constructs. U937 lysate prepared 
from 2x107 cells/ml with no ATP supplemen-
tation was used. (c) Densitometry plots of 
actin against N-WASp/mWASp for fig 4.8b 
(d),(e) Estimated marginal means of activ-
ity for each construct were calculated from 
the ANCOVA analysis and were expressed 
in terms of numbers of standard deviations 
from WT activity (z scores). Means and their 
95% confidence intervals are plotted on the 
graphs and the 95% confidence interval (z 
score 2) for WT  is shaded in grey. (f) Comparison of mean activities of WT mWASp to WT 
NWASp, and between L229P/L232P NWASp and L272P WASp.
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will dissociate from the actin filament (Martin et al., 2006; Egile et al., 2005).
In  the  presence  of  adequate  concentrations  of  Arp2/3,  the  rate  of  actin 
polymerisation will be determined by the number of f-actin barbed ends and the 
concentration of ATP loaded actin monomers. Cell lysate formation results in an 
approximately 10 fold drop in the actin concentration in solution compared to the 
physiological concentration in the cell’s cytosol. As the cellular monomeric actin 
concentration is maintained to allow a steady state of treadmilling of the actin 
cytoskeleton, this drop in actin concentration will encourage depolymerisation 
(in the absence of an activator of nucleation). This will be exacerbated by the 
reduction in ATP levels (due to inherent instability in aqueous solution) upon lysate 
formation. Depolymerisation will increase the concentration of monomeric actin 
in the lysate, but paradoxically will ultimately decrease the number of barbed 
ends present to allow filament elongation. Therefore the actin structures which 
will facilitate maximal actin polymerisation are highly branched networks of short 
filaments, with a high barbed end to total f-actin ratio.
Many other proteins will influence the dynamics of f-actin within the assay, such 
as capping proteins, actin sequestering proteins, severing proteins and profilin 
(Faix and Grosse, 2006; Rogers et al., 2003; Blanchoin et al., 2000a; Loisel et al., 
1999; Carlier et al., 1997; Schafer et al., 1996; Pantaloni and Carlier, 1993). These 
should remain constant within the assay and will be the same for each individual 
sample tested within each experiment. Potentially they form an additional source 
of  variation  between  experiments  performed  on  different  batches  of  lysate. 
Similarly as WASp is known to detach from f-actin following nucleation (Martin et 
al., 2006; Egile et al., 2005; Uruno et al., 2003), and is not thought to influence the 
stability of f-actin, the rate of actin depolymerisation should be constant between 
experiments performed with different WASp constructs.
It is apparent from the above discussion that the simplistic concept of each bead 
bound WASp protein initiating a single actin filament which elongates away from 
the bead, resulting in polymerised actin which is detected in the assay, is incorrect. 
The concerted activation of WASp proteins over the surface of the bead will result 
in the generation of a complex and dynamic orthogonal network of actin filaments. 
Each WASp activation will generate a new barbed end, inducing polymerisation, 
but also releasing the filament from the surface of the bead. As the barbed ends 
of daughter filaments elongate, so the branch sites becomes destabilised and 
pointed end depolymerisation accelerates. This results in the translocation of 
the new filament away from the bead, but also delivers new actin monomers 
and Arp2/3 complexes to the proximity of the bead surface and therefore the Chapter 4
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immobilised WASp proteins.
Following initiation of the reaction there is a net polymerisation of actin. After 
a period of time an equilibrium point will form where all the short filaments and 
smaller actin networks have become incorporated into a single actin network 
surrounding the bead, in which the overall polymerisation rate will equal the 
depolymerisation rate. This network will be highly branched and interlinked (with 
a high concentration of immobilised actin nucleators at the centre), such that the 
decay of individual filaments will not lead to detachment from the main network. 
Attachment of the network to the bead itself may be due to the transient binding 
of activated WASp proteins, or due to the three dimensional shape of the network 
surrounding the bead.
Because the amount of actin polymerised on the surface of the bead will be 
determined by the ratio of barbed ends to total f-actin, the greater the activity of 
the WASp constructs (and therefore the greater the branching within the actin 
network), the larger amount of f-actin bound to a bead at the equilibrium point of 
the assay. The activity of an individual WASp construct determines the complexity, 
and therefore the size, of the actin network.
This  model  explains  the  different  kinetics  seen  with  the  bead  based  assay 
compared to the pyrene actin polymerisation assay. The pyrene based assay 
measures the total polymerisation in the whole reaction, under conditions primed 
for polymerisation (such as excess actin and ATP). It follows the chain reaction of 
actin polymerisation throughout the experimental solution following an initiation 
stimulus. The activity of the nucleation activator is measured by the speed with 
which this chain reaction is instigated. The bead based assay is assessing the 
polymerised actin which remains localised to the surface of beads coated with 
nucleation activators. It provides a snap shot of a series of actin networks in 
a steady state of equilibrium, which is maintained by the ongoing nucleation 
activity of the WASp protein on the beads. The activity of the nucleation activator 
is measured as the amount of f-actin maintained in the network surrounding each 
bead.
The concentration of ARPC2 bound to the beads appears to correlate well with 
the amount of f-actin pulled down (figure 4.3a, 4.4b, 4.5c, 4.13b, 5.4a, 5.5b, 
5.8a). In fact, subjectively it appears to be a more specific measure of true WASp 
activity, and does not appear to be pulled down in association with background 
polymerised actin. Arp 2/3 incorporation into the bead associated actin network 
should be a better indicator of WASp activity as it provides a historical record of Chapter 4
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the nucleation events (within the stability window of the daughter filament).
The above model also explains the ARPC2 results seen with the cytochalasin D 
inhibited reactions. As cytochalasin D inhibits actin polymerisation downstream 
of Arp2/3 activation (Cooper, 1987) it will not affect the binding and activation of 
Arp2/3 by WASp. However, as WASp detaches from the actin filament following 
nucleation, the Arp2/3 bound actin will no longer be fixed to the bead. As it is unable 
to elongate, multiple branch point will not form, and a complex actin network will 
not be generated. The resultant short sections of nucleated actin filaments will 
become dissociated from the bead and Arp2/3 will not be detected by the assay. 
This is demonstrated in figures 4.3a and 4.4b.
The  use  of  ATP  to  sensitise  the  assay  is,  I  believe,  both  appropriate  and 
physiological. ATP is highly unstable in aqueous solution and a combination of lysis 
and centrifugation will cause the lysate to be significantly depleted of ATP. Free 
availability of ATP mimics the intracellular environment, and ATP supplementation 
of Xenopus egg lysate and bovine brain lysate has been used in pyrene based 
actin polymerisation assays (Suetsugu et al., 2001a; Ma et al., 1998a).
ATP appears to have at least two distinct effects on the assay. In figure 4.3a 
and figure 4.12b, ATP causes an increase in Arp 2/3 recruitment as well as 
an increase in actin polymerisation, for WT WASp coated beads. By contrast 
the WASp containing the GBD missense mutation S272P (which has caused 
XLN in a patient), shows a reduction of Arp 2/3 recruitment with increased ATP 
concentration, whilst maintaining an increase in actin pulldown (figure 4.12b). 
These results suggest that ATP acts, either directly or indirectly, to reduce the 
threshold for WASp induced Arp 2/3 activation, in addition to amplifying the rate 
of actin polymerisation post filament nucleation. Although ATP does not directly 
bind WASp, it is known to be essential for several steps in the actin polymerisation 
cycle. Monomeric actin must be ATP bound to allow binding to the WASp V domain. 
ATP binding to Arp2 and probably Arp3 is also essential for Arp2/3 activation and 
increases their affinity for WASp (Martin et al., 2006; Goley and Welch, 2006; 
Dayel and Mullins, 2004; Le et al., 2003; Dayel et al., 2001; Le et al., 2001), 
and therefore increasing ATP concentrations will reduce the threshold at which 
WASp is able to activate Arp 2/3. Finally ATP bound monomeric actin has a much 
greater ability to polymerise at the barbed end of established actin filaments than 
ADP bound actin.
The fact that Arp2/3 recruitment is increased with increasing ATP concentration 
suggests that the rate limiting step for actin polymerisation within this assay is Chapter 4
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likely to be either actin binding to WASp, or ATP binding to Arp2/Arp3. As Arp2 
and Arp3 have significantly lower affinities for ATP than monomeric actin, it is 
logical to assume that the primary site of ATP augmentation in this assay is Arp2 
and / or Arp3 activation. This mechanism could be dissected further by performing 
experiments where the availability of g-actin to WASp is decreased, such as 
immunodepleted profillin from the U937 lysate or overexpression thymosinβ4 (to 
sequest g-actin) in the U937 lysate. This would isolate the effect of ATP directly 
on Arp2 and Arp3.
The decrease in ARPC2 recruitment by S272P coated beads with increasing ATP 
concentration suggests that the S272P WASp is so active that it overcomes the 
rate limitation of ATP binding to Arp2 / Arp3. If this is the case, then the primary 
effect of ATP will be downstream of Arp2/3 (i.e. filament elongation), and so more 
actin will be polymerised for each nucleation event, and the equilibrium point of 
the assay will be reached with less Arp2/3 bound.
From the kinetic data presented in figure 4.5 (and other data not shown) I decided 
to use 1 hour as a pragmatic cut off for the end of reaction. It is clear that different 
WASp constructs and individual experiments will take different amounts of time 
to reach the equilibrium point. From the data presented and also from other 
experiments performed, it still remains unclear whether the equilibrium point of 
the assay has been reached in experiments where there is a low (but significant) 
activity (for example figure 4.3a WT samples with less than 1mM ATP, 4.5c WT 
samples with ATP). It is however clear that less active constructs (or conditions) 
have less f-actin bound at the equilibrium point, as well as having slower kinetic 
and therefore the 1 hour cut-off is a valid surrogate measure of activity.
ATP depletion may be an important factor in determining the equilibrium point of 
the assay. The gradual decrease in actin signal seen with the S272P construct over 
time (figure 4.5b and d) is likely to be caused by the reduction in ATP concentration 
following a sustained period of active actin polymerisation and depolymerisation. 
As ATP levels fall, so the amount of f-actin sustained within the bead associated 
actin networks will fall, reducing the assay actin signal.
I have also demonstrated that this assay can be successfully used to assess the 
activity of NWASp constructs. NWASp construct with point mutations within the 
GBD showed similar levels of constitutive activity to XLN causing WASp missense 
mutations (Adamovich et al., 2009; Ancliff et al., 2006; Devriendt et al., 2001). 
This work also suggested some subtle difference in the activity and regulation 
between WASp and NWASp. Further work is required to determine whether or Chapter 4
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not these differences are significant, and what the mechanism 
In summary, from the experiments described in this chapter I have determined 
two  sets  of  conditions  for  assessing  in  vitro  WASp  activity  and  the  assays 
described in the following chapters, unless stated, have been performed under 
these conditions. The standard conditions (for assessing activity compared to 
WT WASp) use U937 lysate at 2x107 cells/ml, supplemented with 1mM ATP with 
an incubation period of 1 hour. The constitutively active conditions (for detecting 
unregulated actin polymerisation activity) use U937 lysate at 1x107 cells/ml, with 
no ATP and an incubation period of 1 hour. I have demonstrated that this assay 
offers a versatile tool for assessing WASp induced actin polymerisation within 
myeloid cell lysate. This experimental system potentially mimics the role of WASp 
in generating a physiological dendritic branched actin network, mimicking the 
cortical lamellipod network of haematopoietic cells (Iwasa and Mullins, 2007).Chapter 5     
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In  vitro  Actin  Polymerisation  5 
Activity
Introduction 5.1 
In this chapter I present the results of bead based actin polymerisation assays 
performed on all the WASp constructs generated during this project. As described 
in chapter 4.5.1 the constructs were grouped as constitutively active or standard 
panel constructs, and activities were compared within these two groups.
For the statistical analysis of data presented in this chapter I have shown results 
from ANCOVAs using two linear regression models – a main effects only model 
(labelled  “main  effects”)  and  a  model  including  compensation  for  interaction 
between WASp concentration and experiment (“interaction model”) (fully explained 
in chapter 4.5). I have shown both because the similarity of the patterns of the 
results between each approach demonstrates the robustness of the statistical 
analysis. The interaction model offers a more accurate representation of the data, 
as discussed in chapter 4.5.
Constitutively active WASp mutants 5.2 
The activity of a series of WASp constructs predicted to have constitutive actin 
polymerisation activity was tested against WT WASp and constitutively active 
WASp  inhibited  by  cytochalasin  D.  Two  of  these  constructs  contained  point 
mutations found in patients with X-linked neutropenia (I294T and S272P) (Ancliff 
et al., 2006). Y291E WASp mimics the phosphorylation of the 291 tyrosine residue, 
which is predicted to destabilize the autoinhibitory conformation of WASp and 
result in constitutive activity (Torres and Rosen, 2006; Torres and Rosen, 2003; 
Cory et al., 2002; Kim et al., 2000). The VCA bind deletion mutant (∆288-310) has 
the critical autoinhibitory binding site for the VCA domain deleted and is therefore 
predicted to be incapable of forming the WASp autoinhibited conformation. This 
deletion does not impinge on the Cdc42 binding site (see figure 3.1 and chapter 
1.4.6 and 1.5.3).
As demonstrated in chapter 4, the standard actin polymerization assay without 
ATP supplementation is a good discriminator between constitutively active WASp 
constructs and those (such as WT WASp) which need activation to induce actin 
polymerization. This assay has been used to determine the relative activity of 
these constitutively active mutants.Chapter 5     
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Equilibrium activity 5.2.1 
Figure  5.1  shows  the  results  of  an  illustrative  actin  polymerization  assay 
performed without ATP supplementation (chapter 2.7). Figures 5.1a and b show 
the immunoblots and Coomassie stained gels respectively and figure 5.1c shows 
a graph of the densitometry for actin and WASp performed on this experiment. 
They demonstrate that Y291E, S272P and I294T WASp mutants show a dose 
response between WASp input and actin output, and all appear to induce more 
actin polymerization than WT WASp. The VCA bind construct also appears to be 
constitutively active although only one WASp concentration was tested in this 
experiment.
The Coomassie stain detects all proteins bound to the beads at the end of the 
experiment,  and  several  protein  bands,  other  than  WASp  and  actin  can  be 
easily seen. The prominent bands at 50 kDa (iv) and 24 kDa (vi) and the faint 
band at 32 kDa (v) appear to be related to non-specific binding to the beads, 
as their concentration is constant regardless of WASp or actin concentrations. 
The prominent band at 24 kDa may well be endogenous GST from the U937 
lysate, as the GST tag used in the EF-Bos construct is known to run slightly larger 
than endogenous GST (see GST only lane). The band at 51 kDa (vii) appears 
to be either a WASp breakdown product or a WASp binding proteins which is 
independent of WASp activation, as its concentration correlates with that of WASp 
rather than actin protein concentration. It has also been seen on Western blots of 
beads alone (Chapter 3.2). 
From the Coomassie stain it can be seen that in this experiment the amount of 
actin pulled down was significantly less than the total amount of WASp protein 
loaded on the beads. This suggests that a relatively small proportion of individual 
WASp proteins are activating Arp2/3 complexes and initiating actin nucleation. It 
also more clearly illustrates the difference in amount of actin polymerized between 
the constitutively active constructs and WT WASp. There are no obvious protein 
bands which correspond to WIP (migrates at approximately 60 kDa), TOCA (62 
kDa) or Cdc42 (25 kDa, although this may be obscured by the putative endogenous 
GST band). Proteins of the Arp 2/3 complex are also difficult to identify (band viii 
may represent p34), demonstrating that the concentration of the Arp 2/3 complex 
proteins is significantly less than that of either WASp or actin. This supports the 
hypothesis that only a small proportion of the WASp proteins are activating Arp2/3 
complexes.
Figure 5.1d demonstrates rhodamine phalloidin staining of the sepharose beads. 
Beads coated with I294T and S272P WASp show significantly greater fluorescence Chapter 5     
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Fig  5.1 AP14 C: WT / Y291E / S292P / I294T comparison
WT Y291E S272P I294T
G
S
T
S
2
7
2
P
+
C
y
t
D
d
B
I
N
S
t
a
n
d
a
r
d
1 1/2 1/4 1/8 1 1/2 1/4 1/8 1 1/2 1/4 1/8 1 1/2 1/4 1/8
97 —
64
51
39
28
19
AP14 C: WT / Y291E / S292P / I294T comparison
WT Y291E S272P I294T
G
S
T
S
2
7
2
P
+
C
y
t
D
d
B
I
N
S
t
a
n
d
a
r
d
1 1/2 1/4 1/8 1 1/2 1/4 1/8 1 1/2 1/4 1/8 1 1/2 1/4 1/8
97 —
64
51
39
28
19
AP14 C: WT / Y291E / S292P / I294T comparison
WT Y291E S272P I294T
G
S
T
S
2
7
2
P
+
C
y
t
D
d
B
I
N
S
t
a
n
d
a
r
d
1 1/2 1/4 1/8 1 1/2 1/4 1/8 1 1/2 1/4 1/8 1 1/2 1/4 1/8
97 —
64
51
39
28
19
WT
Y291E
S272P
I294T
dVCA bind
S272P cyt
GST
WASp
A
c
t
i
n
c
b
a
P
F
WT S272P I294P GST S272P +CytD
P
F
WT S272P I294P GST S272P +CytD WT I294T S272P GST
S272P
+CytD
Phase
Floures-
cence
d
Fig  5.1  Actin  polymerisa-
tion  activity  of  constitu-
tively  active  WASp  point 
mutation constructs in the 
absence of ATP
A  standardised  volume  of 
GST-WASp  coated  Sepha-
rose beads were incubated 
with  U937  lysate  (2x107 
cells/ml  lysed  in  APB  with 
1%  aprotinin,  1mM  PMSF, 
10µg/ml  leupeptin,  then 
clarified  by  centrifugation) 
supplemented  with 
5mM MgCl2 only for 1 
hour. Beads were then 
pelleted  and  washed 
twice with APB. 10% of 
the  beads  were  fixed 
with 4% paraformalde-
hyde and stained with 
rhodamine  phalloidin. 
The  remainder  were 
reduced in SB and resolved by NuPAGE and western blotting. 4 concentrations of WASp were 
tested for each construct (highest on the left, lowest on the right) with a constant bead volume of 
8.3µl. (a) Immunblot showing bands of GST-WASp (78kDa), actin (42 kDa) and GST alone (25 
kDa). (b) Coumassie stain from same experiment. Band label (i) GST-WASp (ii) Actin (iii) GST 
(iv)-(vi)  Non specific bead associated bands (iv 50kDa, v 32 kDa, vi 24kDa) (vii) 51 kDa (viii) 34 
kDa. (c) Densitometry plots from the above experiment, arbitary densitometry units. (d) Phase 
and flourescence microscopy of beads from the above experiment stained with rhodamine phal-
loidin (to stain f-actin). CytD cytochalsin D inhibited assay, Stan purified protein standard of 
100ng GST-WASp and 50ng actin.
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than WT WASp coated beads, which have show a similar level of fluorescence to 
the negative control beads. This result confirms the findings of the immunoblot, 
and demonstrates that the actin pulled down on the beads is f-actin.
Statistical analysis 5.2.2 
Ten independent actin polymerization experiments involving some or all of these 
constitutively active WASp constructs were performed under similar conditions. 
Densitometry was performed on actin and WASp bands for these experiments 
and this data was processed and analyzed as described in Chapters 2.7.2, 4.4 
and 4.5. The descriptive statistics and frequency distributions of this data are 
shown in the appendix (figures A.4 and A.5). A summary of the statistical terms 
used to describe the data processing and ANCOVA analysis can be found in 
figure 4.8.
Chapter 5 Fig 5.2
Analysis of Covariance (ANCOVA) table
Dependent Variable % Ln Actin
Co-variable % Ln WASp
Experiment and Construct as fixed factors
Excluding Cytochalsin D Controls Including Cytochalsin D Controls
Main Effects Model Interaction Model Main Effects Model Interaction Model
df F Sig. df F Sig. df F Sig. df F Sig.
Corrected Model 14 23.90 .000 23 18.67 .000 15 22.34 .000 24 18.21 .000
Intercept 1 70.96 .000 1 17.72 .000 1 66.33 .000 1 14.15 .000
Experiment 9 24.71 .000 9 5.85 .000 9 24.73 .000 9 6.47 .000
Construct 4 28.28 .000 4 34.09 .000 5 23.79 .000 5 29.70 .000
% Ln WASp 1 38.91 .000 1 58.70 .000 1 40.01 .000 1 62.46 .000
Experiment * 
% Ln WASp
9 3.13 .003 9 3.44 .001
Adjusted R 
Squared
.745 .787 .729 .776
Fig 5.2 Statistical analysis of actin polymerisation assays performed on constitutively 
active mutants using lysate not supplemented with ATP
Data from 10 separate experiments, each with up-to 4 WASp concentrations per experiment 
was analysed. Data was separately analysed excluding cytochalasin controls (to asses differ-
ences between contructs and WT WASp) and including cytochalasin control (to assess differ-
ences between constructs and background signal). Analysis for a main effects only regression 
model and a model including an interaction term between experiment and WASp signal are 
shown. df = degrees of freedom, F = F ratio, sig = significance of contribution to overall vari-
ations (p value), Ln = natural logarithm. R = regresion cooefficient of correlation between Ln 
WASp and Ln Actin.
Figure 5.2 shows a summary of the analysis of covariance of actin concentration 
with WASp concentration, using the two linear regression models described in 
chapter 4. The full analysis can be found in the appendix (figure A.8). Both the 
main effects model and the interaction model account for the vast majority of 
Fig  5.2Chapter 5     
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the variability within the data (F ratios of 23.9 and 18.7 respectively for the data 
excluding the cytochalasin D controls and similar values for the inclusive data). 
The high levels of significance (p<0.001) associated with each entire model and 
every factor within each model, demonstrates the strength of the relationship 
between WASp and actin concentrations, and the validity of the analysis. The high 
F ratios attributed to the construct adjustment (especially within the interaction 
model) indicates that the major deviation from a pure linear relationship between 
the natural logarithm of WASp concentration and the natural logarithm of actin 
concentration within this data set is due to the differences in activity between the 
WASp constructs. These findings are very similar to those seen with the complete 
standard panel dataset, presented in chapter 4.5.
Figure 5.3 graphically represents the differences in construct activity between 
each  construct  and  WT  WASp  (Fig  5.3a  and  b)  and  cytochalsin  D  inhibited 
reactions (Fig 5.3c and d). S272P and I294T show a large and highly significant 
increase in activity compared to both WT WASp and the cytochalasin inhibited 
reaction. Both show an ability to polymerize actin approximately 10 times higher 
than  the  standard  deviation  of  WT  WASp  activity.  The  dVCA  bind  construct 
appears to have even greater activity than either of the XLN point mutations, 
although this construct was only directly tested against both S272P and I294T 
in two independent experiments (hence the larger 95% confidence intervals). 
This finding was corroborated by other experiments assessing the dVCA bind 
construct as part of the standard panel of WASp constructs, which used the S272P 
construct as a positive control (figure 5.5a, data not included in this analysis).
The Y291E mutant is also significantly more active than WT (p<0.1), but the level 
of increased activity is much less than that for the S272P and I294T mutants. In 
fact, the phosphomimicking mutant is significantly less active than the S272P, 
I294T and dVCA bind mutants (p<0.0005 for all three constructs). The Y291E 
construct  showed  no  difference  in  activity  compared  to  the  cytochalasin  D 
inhibited reaction. This is likely to be because the cytochalasin D control was 
always performed with the S272P construct (so that a true inhibition could be 
detected). This construct has such a high level of constitutive activity, that some 
actin polymerization is detected despite the inhibition of actin filament elongation. 
This background activity in the inhibited control is illustrated in Figure 5.1a and 
5.5a. This also explains why the WT WASp construct shows (insignificantly) less 
activity than the cytochalasin D inhibited control.Chapter 5     
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Fig  5.3
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Fig 5.3 Actin polymeri-
sation  activity  of  con-
stitutively active WASp 
constructs  compared 
to WT WASp and Cyto-
chalasin D inhibited re-
actions
Estimated  marginal 
means of activity for each 
construct were calculated 
from the ANCOVA analy-
sis  and  were  expressed 
in  terms  of  numbers  of 
standard deviations from 
WT  (or  Cytochalsin  D 
(CytD)  inhibited)  activity 
(z  scores).  Means  and 
their  95%  confidence 
intervals  are  plotted  on 
the graphs and the 95% 
confidence  interval  (z 
score 2) for WT (or CytD)   
is  shaded  in  grey  for 
comparison.  The  signifi-
cance  of  the  differences 
of these means from WT 
or cytochalsin D inhibited 
activity was analysed us-
ing a least significant dif-
ferences  (LSD)  pairwise 
comparison.
(a)  and  (b)  show  com-
parison of activity to WT 
WASp  and  (c)  and  (d) 
show  comparisons  to 
CytD  activity.  For  both 
comparisons results from 
analyses using the main 
effects  and  interaction 
model are shown.
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Activity in ATP supplemented lysate 5.2.3 
As described in chapter 4 the ATP supplemented actin polymerisation assay was 
optimised to produce a large actin signal with WT-WASp to allow assessment of 
constructs less active than WT WASp. Figure 5.4 shows a series of experiments 
performed  on  the  constitutively  active  WASp  constructs  using  U937  lysate 
supplemented with 1mM ATP. Figure 5.4a illustrates that in the presence of ATP 
the S272P, Y291E and dVCA bind constructs all continue to polymerise more actin 
than WT WASp. Additionally they pull down more ARPC2 (p34) than WT WASp, 
suggesting that ATP potentiates Arp 2/3 activation and that a larger proportion of 
these WASp constructs are activated than WT WASp at the equilibrium point of 
the reaction.
Figure 5.4b shows a silver stained gel of an actin polymerisation assay directly 
comparing  WT  and  constitutively  active  constructs  with  and  without  ATP 
supplementation. The addition of ATP increases the amount of actin pulled down 
by all constructs by several fold, resulting in an actin band much larger than the 
WASp input band. The similar actin band sizes for WT and the constitutively 
active mutants in the presence of ATP, suggests that WT WASp is approaching 
the maximum activity for the assay. Due to this “saturation” of the assay with ATP, 
there is less discrimination in activity between WT and the constitutively active 
WASp constructs.
Figures  5.4c  and  d  show  graphical  representations  of  all  these  experiments 
combined. The results generally show a similar pattern to the experiments with 
the  unsupplemented  assay.  S272P  still  shows  a  highly  significant  and  large 
increase in activity compared to WT WASp, whereas the increase in activity 
seen with dVCA bind does not reach significance. In addition to the effect of 
assay saturation, the larger p values and wider confidence intervals seen in 
these experiments compared to the unsupplemented lysate experiments is partly 
because of relatively small numbers of experiments performed (n = 18 [S272P], 
n= 5 [Y291E], n = 6 [dVCA bind])
Kinetic activity 5.2.4 
Figures 5.4e and f show a time course experiment for WT and S272P WASp 
using ATP supplemented lysate. This clearly demonstrates that although WT and 
S272P WASp coated beads polymerise similar amounts of actin at 60 minutes, 
the S272P construct has faster kinetics. This experiment can be compared to 
similar experiments using unsupplemented lysate in figure 4.5.Chapter 5     
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Fig  5.4
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Fig 5.4 Actin polymerisation activity of constitutively 
active WASp mutants in the presence of ATP
A standardised volume of GST-WASp (WT or constitutive-
ly active mutants as labelled) coated Sepharose beads 
were incubated for 1 hour with U937 lysate (2x107 cells/
ml lysed in APB with protease inhibitors, then clarified by centrifugation) supplemented with 5mM 
MgCl2 +/- 1mM ATP. Beads were then pelleted and washed twice with APB, prior to reduction in 
SB and resolution by NuPAGE and western blotting. A single WASp concentration was tested.   
(a) shows an immunoblot of the experiment, whereas (b) shows a silver stained gel of the same 
experiment. Band i - GST-WASp; band ii - actin; band iii - non specific / WASp degradation band. 
(c) and (d) Estimated marginal mean activity compared to WT for constitutively active mutants, in 
the presence of ATP. These results are from the ANOVA analysis shown in chapter 4.5.5 and fig 
4.11c. Methodology is described in chapter 4.5.5 and 4.5.6 and is identical to that used in figures 
5.3 and 4.13. (e) Time course of actin polymerisation assay in the presence of ATP for WT and 
S272P constructs. 6 identical actin polymerisation assays were performed for each construct 
using the same experimental protocol as described in (a) and (b). Reactions were stopped by 
washing beads at variuous durations of incubation. (f) Densitometry plot from experiment in (e). 
Actin / WASp units are a ratio of arbitary densitometry units.
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Clinical  point  mutations  and  domain  deletion  5.3 
constructs
The “standard panel” of WASp constructs was made up of four point mutations in 
the EVH1 domain which in humans cause either WAS or XLT (clinical mutants), as 
well as deletions of the EVH1 domain, the basic domain, the polyproline domain, 
the VCA domain and a point mutation which inhibits Cdc42 binding (H246D) (see 
figure 3.1). The activity of each of these constructs was compared to that of WT 
WASp, GST coated beads and WT WASp in the presence of cytochalasin D (as 
negative controls) and S272P WASp (as a positive control).
For the description of these results the constructs will be discussed in two groups 
– the clinical mutants and the dEVH1 domain construct, and the remaining domain 
deletion constructs and the H246D mutant.
Activity in the absence of ATP 5.3.1 
Figure 5.5a shows the activity of each of the constructs in U937 lysate without ATP 
supplementation. It clearly shows that all WASp constructs in the standard panel 
and WT WASp show minimal actin polymerisation above background levels. The 
VCA bind construct, by contrast, shows strong actin polymerisation activity and 
even the cytochalasin D inhibited S272P construct shows more activity than any 
of the standard panel constructs.
Equilibrium activity in the presence of ATP 5.3.2 
The above experiment repeated with ATP supplemented lysate is shown in figures 
5.5b (immunoblot) and 5.5c (silver stained gel). A sample experiment showing 
each construct tested over a range of WASp concentrations is shown in figure 
5.5d and the densitometry from this experiment is shown in figure 5.5e. Although 
each experimental sample was performed synchronously with the same lysate, 
the samples had to be split between two gels (due to lack of well space), with the 
standard wells used to compare results between gels.
The clinical mutants show at least as much activity as WT WASp, whereas the 
dEVH1 construct shows impaired (but some) actin polymerisation activity. Of 
the domain deletion constructs the dBasic and H246D mutants show similar or 
slightly increased activity compared to WT WASp, whereas the dPolyP construct 
shows less activity than WT. Like the dEVH1 construct, the dPolyP construct 
does appear to polymerise more actin than the negative control samples. The 
dVCA construct shows the least activity of all WASp constructs tested, and in the 
experiments shown in figures 5.5b and c shows no increase in activity above the Chapter 5     
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Fig  5.5
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Fig 5.5 Western blots of actin polymerisation assays for standard panel of constructs
(a) Assay using U937 lysate without ATP. Top αGST panel shows GST-WASp, bottom panel 
shows GST. (b) Assay using U937 lysate supplemented with ATP. (c) Assay using U937 lysate 
supplemented with ATP (silver stain). Bands (i) - (v) are activation associated bands. (Experi-
ments a, b and c are using single WASp concentration per construct). (d) Sample assay using 
U937 lysate supplemented with ATP, three WASp protein concentrations for each construct.
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negative control.
Figure 5.5c demonstrates that with ATP supplemented U937 lysate, for each active 
constructs the actin band pulled down is significantly larger than the bead bound 
WASp band. Differences in protein bands visible on the silver stained gel between 
the experimental columns and the GST only or standard (purified WASp and 
actin protein) columns, may give clues about other regulatory proteins involved in 
WASp activation or actin polymerisation. Once again there is no prominent band 
around 60kDa in any column which may represent either WIP or TOCA. Bands at 
39kDa (ii), 34kDa (iii), and 17kDa (v) all appear to be pulled down only when there 
is active actin polymerisation. These may well correspond to components of the 
Arp2/3 complex (p41, p34 and p16 respectively). A 30kDa band (iv) and the lower 
of a double band at approximately 46kDa (i) are also associated with active actin 
polymerisation, but do not have the appropriate sizes for Arp2/3 components. 
Each of these activation associated bands is best appreciated by comparing the 
WT column with the GST and cytochalasin inhibited columns.
As with the constitutively active constructs, fluorescence microscopy of rhodamine 
phalloidin stained Sepharose beads confirmed the results seen by western blotting 
and immunoblotting (data not shown).
Statistical analysis 5.3.3 
The activity of the standard panel constructs was assessed over 21 independent 
experiments, and quantification and analysis was performed as above. Figure 
5.7 shows a summary of the results table from the ANCOVA analysis performed 
on this data. The full statistical analysis can be found in the appendix (figure A.9), 
and further details of interpretation of this analysis are discussed in chapter 4.5. 
Once again the high F ratios for the corrected models demonstrate that the vast 
majority of variation seen within the data can be accounted for by the model, 
and the significance of the models show that once correction for experiment 
and construct are accounted for there is a tight correlation between (the natural 
logarithms of) WASp and actin concentrations.
Figure 5.6 shows a graphical representation of the estimated differences in mean 
activity of each construct compared to WT WASp (figures 5.6a and b) and the 
cytochalasin D inhibited reaction (background activity)(figures 5.6c and d).
Three of the four clinical mutants show significantly greater activity than WT WASp 
(p<0.05), whereas the increased activity of R86H does not reach significance. 
All  four  mutants  show  significantly  greater  activity  above  background  actin Chapter 5     
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Fig  5.6
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Fig 5.6 Actin polymerisation activity, with ATP supplementation, of standard panel of WASp 
constructs compared to WT WASp and Cytochalasin D inhibited reactions
Graphs were generated as described in Fig 5.3, and the ANCOVA table is shown in Fig 5.6. (a), 
(b) show comparison of activity to WT WASp. (c),(d) show comparisons to CytD activity. For both 
comparisons results from analyses using the main effects and interaction model are shown.Chapter 5     
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polymerisation. The level of increased activity of these mutants was less than 
that of the two XLN mutants, but similar to that of the phosphomimicing mutant 
(3 standard deviations higher than WT activity). The dEVH1 construct shows 
significantly  less  activity  than  WT  WASp  (p<0.0005),  but  does  show  greater 
activity than background (p<0.05). It appears to have approximately 8 standard 
deviations less activity than WT WASp, but two standard deviation greater activity 
than the cytochalasin D inhibited reaction.
The dBasic construct has a similar activity to the clinical mutants with significantly 
greater activity than WT WASp. The H246D mutant has very similar activity to 
WT WASp with no significant difference between the two. The dPolyP and dVCA 
deletion constructs both have very significantly less activity than WT WASp, and the 
dPolyP construct shows no significant increase in activity above the cytochalasin 
D inhibited assays. The dVCA domain construct shows greater activity than would 
have been expected. An observation from several experiments was that the dVCA 
construct seemed to have disproportionate actin polymerisation activity at low 
concentrations, whilst no activity was detected when the highest concentration 
of dVCA was used. When an ANVOCA analysis is repeated using data only from 
beads coated with the highest WASp concentrations, the dVCA construct has 
Analysis of Covariance (ANCOVA) for the Standard panel of constructs
Dependent Variable % Ln Actin
Co-variable % Ln WASp
Experiment and Construct as fixed factors
Excluding Cytochalsin D Controls Including Cytochalsin D Controls
Main Effects Model Interaction Model Main Effects Model Interaction Model
df F Sig. df F Sig. df F Sig. df F Sig.
Corrected 
Model 30 26.97 .000 49 22.68 .000 34 29.52 .000 54 24.50 .000
Intercept 1 11.83 .001 1 0.29 .591 1 13.23 .000 1 1.89 .171
Experiment 20 24.63 .000 19 6.94 .000 20 25.97 .000 20 6.72 .000
Construct 9 15.55 .000 9 16.75 .000 13 17.65 .000 13 18.89 .000
% Ln WASp 1 115.02 .000 1 25.69 .000 1 120.17 .000 1 39.82 .000
Experiment * 
% LN WASp
19 4.03 .000 20 3.92 .001
Adjusted R 
Squared
.767 .818 .729 .776
Fig 5.7 Statistical analysis of actin polymerisation assays performed on standard con-
struct panel using ATP supplemented lysate
Data from 21 separate experiments. Data was separately analysed excluding cytochalasin con-
trols (to asses differences between contructs and WT WASp) and including cytochalasin control 
(to assess differences between constructs and background signal). Analysis for a main effects 
only regression model and a model including an interaction term between experiment and 
WASp signal are shown. df = degrees of freedom, F = F ratio, sig = significance of contribution 
to overall variations (p value), Ln = natural logarithm. R = regresion cooefficient of correlation 
between Ln WASp and Ln Actin.
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less activity than both the dEVH1 and dPolyP constructs and has no significant 
difference in activity from the inhibited control reactions (data not shown).
Kinetic activity 5.3.4 
Figure 5.8 shows time course data for each standard panel construct, for assays 
performed with ATP supplemented lysate. These results show that the clinical 
mutants  and  WT  WASp  show  a  similar  kinetic  of  actin  polymerisation,  with 
maximal rate of actin polymerisation being achieved between 30 and 60 minutes 
incubation.  This  is  slower  than  the  kinetic  seen  for  the  constitutively  active 
construct S272P (figure 5.8c). The dBasic construct shows an intermediate kinetic 
between WT and S272P, and surprisingly the H246D show a rapid onset of actin 
polymerisation, similar to that of S272P. This data must be treated with caution, 
as it represents only a single experiment. Nonetheless, with the exception of the 
H246D construct, the activity of constructs at one hour correlate to the speed of 
actin polymerisation in the kinetic experiments. All constructs show a markedly 
slower kinetic than that seen with pyrene based actin polymerisation assays, as 
discussed in chapter 4.9.
Conclusion 5.4 
The results presented in this chapter demonstrate that the bead based actin 
polymerisation assay is a robust tool in assessing differences in activity between 
different  WASp  constructs.  Using  unsupplemented  U937  lysate  it  clearly 
differentiates constitutively active and inactive WASp constructs, and with ATP 
lysate  supplementation,  relative  differences  in  susceptibility  to  activation  of 
natively  autoinhibited  constructs  are  detected.  The  addition  of ATP  to  lysate 
appears to lower the threshold for the detection of WT WASp activation in the 
absence of an excess of exogenous WASp activators such as Cdc42 and PIP2.  
The use of an ANCOVA statistical analysis overcomes the problems associated 
with variable activity between assays and differences in amount of WASp input 
for  different  constructs  in  the  same  assay.  The  activity  differences  detected 
between experimental WASp constructs and WT show high levels of statistical 
significance and corroborate the subjective observation of Western blots from 
individual experiment.
Constitutively active constructs 5.4.1 
The first conclusion from these experiments is that the activation of WT WASp is 
significantly regulates in physiological lysate compared to the constitutively active 
WASp constructs. This is presumably because its constitutive conformation is 
autoinhibited. In the unsupplemented assay, WT WASp showed no significant Chapter 5     
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Fig  5.8
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Fig 5.8 Kinetics of ATP supplemented actin polymerisation assay
(a) Immunoblots of time course experiments for the standard panel of WASp constructs (2 sepa-
rate experiments). (b) - (e) Time courses for Actin / WASp and Arp2/3 / WASp ratios derived from 
densitometry performed on experiments shown in (a)
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activity greater than that of a cytochalasin D inhibited reaction (figure 5.3c,d). 
By  contrast,  WASp  constructs  predicted  to  have  an  unstable  autoinhibitory 
conformation show very significant activity under these conditions. Prior to the 
commencement of this project, results from two WASp constructs demonstrating 
constitutive activity had been published. Devriendt et al demonstrated constitutive 
activity and reduced structural stability of the first identified missense mutation 
causing  XLN  (L270P)  (Devriendt  et  al.,  2001).  Predictions  from  the  tertiary 
structure of the WASP GBD bound to the VCA, suggest that L270 would form part 
of the α1 helix of the autoinhibitory pseudodomain, and mutation of this residue to 
a bulky proline residue would disrupt this structure (Kim et al., 2000).
Tyrosine phosphorylation of the Y291 residue has also been demonstrated to 
destabilise  the  WASp  autoinhibitory  conformation  (Torres  and  Rosen,  2006; 
Torres and Rosen, 2003; Cory et al., 2002). This residue is found within the α3 
helix of the autoinhibitory pseudodomain, and phosphorylation of this residue will 
introduce a highly ionic charge into an amphipathic tertiary structure, inducing 
structural  instability.  Substitution  of  the  tyrosine  residue  for  a  glutamic  acid 
residue mimics this ionic change, and the resultant Y291E WASp mutant shows 
constitutive activity both in vitro and in vivo (Cory et al., 2002).
The  results  presented  here  demonstrate  constitutive  activity  of  two  further 
missense mutations (S272P and I294T) which cause XLN in patients. These 
mutations are predicted to disrupt the α1 and α3 helices respectively, and are 
predicted to have an unstable autoinhibitory conformation (Ancliff et al., 2006; Kim 
et al., 2000). The activity of these two mutants was compared to that of the Y291E 
phosphomimicking mutant and a novel construct in which the WASp sequences 
essential for Cdc42 binding are preserved, but those uniquely involved in VCA 
(autoinhibitory)  binding  are  deleted.  Interestingly  the  XLN  missense  mutants 
showed greater activity than the Y291E residue, but less than the dVCA bind 
construct. These constructs therefore form a continuum of constitutive activity, 
suggesting that the autoinhibition of WASp does not function as an “on – off switch”, 
but rather as a “rheostat” grading the susceptibility of WASp to activation.
These  conclusions  provide  functional  evidence  in  a  physiological  system  to 
support kinetic and stability studies performed on purified WASp protein which 
suggested a similar model of activation (Torres and Rosen, 2006; Torres and 
Rosen,  2003).  This  has  important  implications  in  understanding  the  role  of 
tyrosine phosphorylation in regulating WASp activity. Phosphorylation induces a 
partial destabilisation of the autoinhibitory conformation, reducing the threshold 
for WASp activation, but not rendering it uncontrollably active. This suggests that Chapter 5     
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tyrosine phosphorylated WASp can exist in both open and closed conformations, 
and still be potentially activated by Cdc42, SH2-SH3 adapter proteins, PIP2 and 
other WASp regulatory proteins. The interaction of Cdc42, protein kinases and 
WASp phosphorylation is further discussed below and in chapter 7.6.
The H246D construct and the role of Cdc42 5.4.2 
The H246D WASp mutant has indistinguishable activity from WT WASp in these 
experiments. This construct is unable to bind Cdc42 as demonstrated in figure 7.1 
and as has been previously published (Kato et al., 1999). These results suggest 
that the WASp induced actin polymerisation assessed by the bead based actin 
polymerisation  assay  is  Cdc42  independent.  Several  previous  studies  have 
demonstrated similar Cdc42 independent WASp or NWASp activation in a variety 
of experimental systems (Badour et al., 2004; Kempiak et al., 2003; Benesch et 
al., 2002; Cory et al., 2002; Fukuoka et al., 2001; Cannon et al., 2001; Rohatgi 
et al., 2000; Moreau et al., 2000; Kato et al., 1999). As discussed above, WT 
WASp and the majority of experimental WASp constructs do not behave in a 
constitutively active manner and can therefore be assumed to be autoinhibited, 
requiring activation by mediators in the U937 lysate. PIP2, Nck, Grb2, Hck and 
Lck have all been shown to activate or destabilise the autoinhibition of WASp 
or NWASp, independently of Cdc42 (Torres and Rosen, 2006; Kempiak et al., 
2005; Benesch et al., 2002; Cory et al., 2002; Rohatgi et al., 2001; Rohatgi et al., 
2000; Higgs and Pollard, 2000). PIP2 and Nck cooperatively activated NWASp in 
a purified protein system, resulting in maximal activation and rendering Cdc42 
redundant (Rohatgi et al., 2001). Similar cooperativity inducing maximal NWASp 
activation  has  been  demonstrated  for  Nck  and  Grb2  (Kempiak  et  al.,  2005; 
Benesch et al., 2002).
PIP2, SH2 – SH3 adapter proteins and protein kinases are all potential activators 
of WASp in this experimental system. The U937 lysate used was not subjected 
to a prolonged high speed ultracentrifugation step, as Xenopus and bovine brain 
lysates have been in previously described lysate actin polymerisation assays 
(Suetsugu et al., 2001b; Ma et al., 1998a), and therefore is likely to contain some 
endogenous lipid vesicles containing PIP2. The role of PIP2 in this assay could 
be explored in a number of ways. Firstly, the activity of WT, dBasic and H246D 
WASp constructs could be compared in lysate prepared with and without high 
speed ultracentrifugation. Secondly, PIP2 vesicles could be synthesised using 
standard protocols and these could be added at increasing concentrations to 
U937 lysate prior to incubation with WASp coated beads. PIP2 binding could be 
assessed simultaneously using a cosedimentation lipid vesicle binding assays Chapter 5     
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(Prehoda et al., 2000).
The silver stained gels of figure 5.3b and 5.5c may give some clue as to the 
identity of possible WASp activators. Two bands were identified which were only 
pulled down by WASp when actin was polymerised, and were the wrong size for 
components of the Arp 2/3 complex (in figure 5.5c band labelled (iv) and the lower 
of the double band labelled (i)). The sizes of these bands are approximately equal 
to the molecular weights of Nck (44kDa) and Grb2 (28kDa), and are completely 
absent from the dPolyproline construct lane. This hypothesis could be investigated 
by performing the assay using lysate pre-treated by immunoprecipitation with 
anti-Nck, anti-Grb2, both or isotype control antibodies.
Clinical missense mutations and the EVH1 domain 5.4.3 
All four missense mutation which lead to WAS / XLT (clinical mutations) showed a 
small but significant (in three out of four constructs) increase in actin polymerisation 
activity compared to WT WASp. Prior to this study the in vitro activity of clinical 
WASp mutants had not been assessed. There are several possible explanations 
for these findings.
The best established effect of EVH1 missense mutations on WASp function is 
to reduce its affinity for WIP (de la Fuente et al., 2007; Kim et al., 2004; Luthi 
et  al.,  2003;  Volkman  et  al.,  2002;  Rong  and  Vihinen,  2000;  Stewart  et  al., 
1999). WIP stabilises the autoinhibitory conformation of WASP in vitro and in 
vivo (Lim et al., 2007; Martinez-Quiles et al., 2001) and inhibits WASp induced 
actin polymerisation in vitro (Martinez-Quiles et al., 2001). Therefore missense 
mutations which inhibit WIP binding might be expected to show greater activity 
than WT WASp. Against this hypothesis, it has been impossible to detect WIP 
binding to WT WASp within the bead based actin polymerisation assay using 
U937 lysate, despite its abundant presence in the lysate (see chapter 6.1, 6.4 and 
figures 6.1 and 2.12c). Nonetheless, impaired WASp – WIP association in clinical 
mutants could still be responsible for the increased actin polymerisation activity 
they show. It is possible that the association between WASp and WIP in the assay 
is of low affinity and that binding is disrupted during the bead washing steps prior 
to SDS-PAGE resolution. Published experiments demonstrating WASp – WIP 
interaction suggest that the interaction is strong and not disrupted by simple wash 
steps (de la Fuente et al., 2007; Sasahara et al., 2002; Martinez-Quiles et al., 
2001; Ramesh et al., 1997), and experiments I have performed minimising wash 
steps have not elucidated WIP binding (data not shown). 
A second possibility is that transient WIP association with WT WASp could be Chapter 5     
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involved in recruitment of a third (unknown) WASp inhibitory factor. This factor 
could then bind to WASp and stabilise its autoinhibition, without the ongoing 
binding of WIP. In the clinical mutants, impaired WIP binding would result in 
reduced recruitment of this inhibitory factor. This hypothesis is possible, but at 
present there is little or no supporting evidence for it. One group of candidate 
inhibitors are the ERM family of proteins which have been described as binding 
to the WASp EVH1 domain and inhibiting WASp activation (Manchanda et al., 
2005). Testing the relative affinity of ERM proteins for WT and clinical mutant 
WASp would be possible within this experimental system.
An alternative hypothesis is that the missense mutations in the EVH1 domain induce 
a conformational change in WASp which slightly destabilises the autoinhibitory 
conformation and therefore reduces the threshold for WASp activation. I feel this 
possibility is unlikely as the EVH1 domain missense mutations are separated from 
the GBD by at least 100 amino acids, however as we have no data on the tertiary 
structure of a WASp construct containing both an EVH1 domain and a GBD, this 
is impossible to rule out. Several lines of evidence have suggested an intrinsic 
role for the EVH1 domain in WASp activation (Yarar et al., 2002; Benesch et al., 
2002; Suetsugu et al., 2001a; Kato et al., 1999). It has been proposed that the 
mechanism underlying this is that the EVH1 domain acts by correctly aligning the 
Arp 2/3 complex, facilitating its binding and activation by the WASp CA domain 
(Suetsugu et al., 2001a). Perhaps a more plausible explanation for the increased 
activity of EVH1 missense mutations is that they enhance the association of 
WASp with the Arp 2/3 complex, lowering its threshold for activation.
A fourth possible explanation of these results is that the increased activity of 
the clinical mutant WASp relates to dysregulation of WASp phosphorylation. The 
EVH1 domain is known to bind to and inhibit the activity of Src family tyrosine 
kinases (Schulte and Sefton, 2003). EVH1 missense mutations could conceivably 
impair their inhibition, whilst maintaining their recruitment to WASp, resulting in 
increased tyrosine phosphorylation and WASp activation. Interestingly, preliminary 
data suggests that clinical mutant WASp has increased S483/484 phosphorylation 
when expressed in U937 cells (figure 8.7a), suggesting another mechanism of 
enhanced activity. Both these mechanisms are more fully discussed in chapter 
8.7.4.
The results presented in this chapter clearly show that, in contrast to the clinical 
missense mutations, deletion of the entire EVH1 domains significantly decreased 
activity compared to WT. Similar findings have been demonstrated in some (Yarar 
et al., 2002; Benesch et al., 2002; Suetsugu et al., 2001a; Moreau et al., 2000; Kato Chapter 5     
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et al., 1999), but not all (Cannon et al., 2001; Castellano et al., 2001; Rohatgi et al., 
2000; Zhang et al., 1999) studies assessing the functionality of dEVH1 constructs 
(see figure 1.5). As described above, a mechanistic model has proposed a direct 
role for the EVH1 domain in WASp activation (Suetsugu et al., 2001a). Two of 
these studies demonstrate that sensitivity to the cooperative activation of NWASp 
by Cdc42 and PIP2 is normal in dEVH1 constructs, suggesting that these two 
mediators render redundant any intrinsic activation activity of the EVH1 domain 
(Suetsugu et al., 2001a; Rohatgi et al., 2000).
Taken together this data suggests that the EVH1 domain has a significant, but 
not essential role in WASp activation, and that this can be overcome by PIP2 and 
Cdc42. As the bead based actin polymerisation assay appears to be a Cdc42 
independent system (see chapter 5.4.2 and 7.6), defects in activity with dEVH1 
constructs are detected. The variability in activity seen with dEVH1 constructs 
both  between  individual  experiments  within  this  study  and  between  different 
experimental systems, may reflect difference in the presence of PIP2, which can 
be practically difficult to exclude and quantify in lysate systems. As WIP appears 
to inhibit NWASp activation (Martinez-Quiles et al., 2001), and enhanced actin 
polymerisation associated with WIP appears to be due to regulated localisation 
(Tsuboi, 2006; Vetterkind et al., 2002; Moreau et al., 2000), I feel it is unlikely that 
the impaired activity of the dEVH1 construct in this assay is due to its abolished 
WIP binding. The difference in activity between the dEVH1 contruct and the 
clinical missense constructs also supports this proposal.
Deletion of Basic, Polyproline and VCA domains 5.4.4 
In contrast to deletion of the EVH1 domain, deletion of the basic domain results 
in a significantly enhanced ability of WASp to polymerise actin. This increased 
activity was approximately equal to that of the most active clinical missense 
mutation constructs. Previously published data on dBasic domain WASp and 
NWASp constructs has yielded mixed results. Some systems have demonstrated 
increased activity in purified protein actin polymerisation assays but impaired 
activity in whole lysates systems (Suetsugu et al., 2001b; Rohatgi et al., 2000). 
Other experiments have demonstrated no effect on activity with basic domain 
deletion (Benesch et al., 2002; Kato et al., 1999).
Three discrete roles for the basic domain in WASp activation have been proposed. 
Firstly it binds PIP2 (demonstrated in NWASp, but not in WASp) resulting in 
activation (Papayannopoulos et al., 2005; Otsuki et al., 2003; Rohatgi et al., 
2000; Prehoda et al., 2000). Secondly it intrinsically inhibits WASp activation by Chapter 5     
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stabilising the GBD – VCA autoinhibitory fold (Leung and Rosen, 2005; Suetsugu 
et al., 2001b; Prehoda et al., 1999). Finally it has a critical role in recruiting Cdc42 
to WASp to allow Cdc42 binding to the GBD, resulting in activation (Hemsath 
et al., 2005). The impaired activity of basic domain deleted NWASp constructs 
has always been demonstrated following PIP2 initiated polymerisation in lysate 
systems. Enhanced activity has only been seen in purified protein systems with 
spontaneously initiated actin polymerisation, without the addition of Cdc42 or PIP2. 
Taken together, this suggests that in isolation the dBasic constructs have reduced 
autoinhibition, but in lysate systems inhibitory factors (such as WIP binding to 
the EVH1 domain) are present which then require PIP2 and / or Cdc42 to allow 
NWASp activation. Deletion of the basic domain impairs the recruitment of these 
activators, preventing the displacement of the inhibitory factors and therefore 
increasing the threshold for NWASp activation.
If PIP2 were an important activator in the bead based actin polymerisation assay, 
I would have expected the dBasic domain construct to be less active than WT. 
From the discussion above it is clear that the bead based assay is independent 
of Cdc42, and the dBasic domain results suggest that activation is also PIP2 
independent. This also helps to explain the impaired activity of the dEVH1 domain 
construct, as previously published data suggests that PIP2 can overcome the 
inhibitory effects of deleting the EVH1 domain. It is more difficult to explain why 
the U937 lysate does not impart an inhibitory effect on the dBasic construct in 
the assay. Although WIP is present in U937 lysate, it does not appear to bind to 
WASp (figure 6.1), and this may explain why the dBasic construct remains active. 
Alternatively there may be another as yet unidentified inhibitory mediator which 
is present in the Xenopus and bovine brain lysate systems but not U937 lysate, 
whose binding to WASp is disrupted through interaction of PIP2 or Cdc42 with the 
basic domain.
Finally, all of the previously published work on dBasic domain constructs has 
been performed on NWASp, and it is very plausible that the regulation of WASp 
differs from that of NWASp. The proposed mechanistic models for role of the 
basic domain in NWASp regulation may not be directly transferable to WASp, 
and therefore may not be valid for interpreting the results of the bead based actin 
polymerisation assay.
Deletion  of  the  polyproline  and  VCA  domains  led  to  profound  impairment  of 
WASp activation. The polyproline domain is the binding site for a large number 
of mediators known to modulate WASp function (see figures 1.4 and 1.6), and it 
is important in both activation mechanisms and localisation of WASp. Previous Chapter 5     
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studies using polyproline domain deleted construct have demonstrated impaired 
or abolished function (Yarar et al., 2002; Benesch et al., 2002; Cannon et al., 
2001; Castellano et al., 2001; Suetsugu et al., 2001b). The VCA domain is the 
effector  output  of  WASp  family  proteins  and  the  binding  site  for  the Arp  2/3 
complex (Panchal et al., 2003). Several studies have demonstrated its essential 
role in WASp activation (Yarar et al., 2002; Benesch et al., 2002; Suetsugu et al., 
2001b; Machesky and Insall, 1998; Symons et al., 1996).
Summary 5.4.5 
The results in this chapter demonstrate that WT WASp appears autoinhibited 
in unsupplemented U937 lysate and that point mutations that cause XLN are 
more active. WASp containing XLT / WAS missense mutations polymerise actin 
in a regulated manner and have a significantly reduced threshold for activation 
compared to WT WASp. The EVH1 domain, Polyproline domain and VCA domain 
all make an intrinsic contribution to WASp activation, and their deletion significantly 
reduces the ability of WASp to initiate actin polymerisation. The Basic domain 
plays a small but significant role in reducing WASp activity in this experimental 
system, possibly through stabilising the autoinhibition of WASp.
These results also suggest that the WASp induced actin polymerisation assessed 
by the bead based actin polymerisation assay is independent of both Cdc42 and 
PIP2 induced activation. This concept is further explored in the following two 
chapters.Chapter 6     
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Effect of WIP on WASp function  6  in 
vitro
Introduction 6.1 
The NMR structure of the complex formed between the NWASp EVH1 domain 
and WIP has revealed an extended contact sequence, involving up to 34 amino 
acids and three distinct binding motifs (Peterson et al., 2007; Volkman et al., 
2002; Zettl and Way, 2002). The WIP sequence wraps circumferentially around 
the EVH1 domain, interacting with EVH1 amino acid residues throughout the 
entire domain. This structure has provided a mechanistic explanation for why 
missense mutations causing WAS / XLT cluster within the EVH1 domain, but are 
still distributed throughout the domain.
Modelling of XLT / WAS missense mutations based on the above crystal structure, 
suggested  that  approximately  two  thirds  of  clinical  mutations  may  result  in 
disruption of WASp – WIP binding (Kim et al., 2004; Volkmann et al., 2001; Rong 
and Vihinen, 2000). This has been demonstrated with four missense mutations by 
yeast 2 hybrid assays and by purified protein pulldown assays (Luthi et al., 2003; 
Stewart et al., 1999). These studies have also suggested that different mutant 
WASps can bind WIP with different affinities. One study has suggested that WASp 
– WIP interaction may be disrupted by phosphorylation of WIP at residue S488 
following WASp activation, and that this initiates complex dissociation (Sasahara 
et al., 2002), however more recent work has disputed the physiological relevance 
of this (Dong et al., 2007).
The  interaction  of  WIP  with  WASp  almost  certainly  has  several  distinct 
functionalities. It has a role in protecting WASp from degradation (Tsuboi, 2007; 
de la Fuente et al., 2007; Konno et al., 2007; Chou et al., 2006), and this is 
explored further in chapter 8. It appears to be central in localising WASp to sites 
of active actin remodelling within cells, such as the leading edge of migrating 
cells, filopodia, podosomes and the T cells synapse (Myers et al., 2006; Chou et 
al., 2006; Anton et al., 2003; Moreau et al., 2003; Benesch et al., 2002; Sasahara 
et al., 2002; Vetterkind et al., 2002; Martinez-Quiles et al., 2001; Moreau et al., 
2000). WIP also plays a significant role in regulating actin polymerisation, and 
this is the focus of this chapter.
In  vitro  experiments  have  demonstrated  that  WIP  inhibits  the  activation  of 
NWASp, as demonstrated by purified protein pyrene actin polymerisation assay 
(Martinez-Quiles et al., 2001). Ho et al assessed the sensitivity of native NWASp Chapter 6     
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– WIP complexes in the same pyrene assay, and found (as before) that these 
complexes were relatively insensitive to Cdc42 induced activation compared to 
NWASp alone. They also found that with WIP bound, NWASp was activated by 
Cdc42 combined with TOCA1, suggesting that in vivo relief of WIP induced WASp 
inhibition may require the formation of a multimeric complex involving NWASp, 
Cdc42, TOCA1 and WIP (Insall and Machesky, 2004; Ho et al., 2004). There is 
no published data on the effect of WIP on WASp / NWASp activation in a lysate 
(and therefore more physiological) in vitro assay.
In  contradiction  to  these  in  vitro  results,  over  expression  or  microinjection 
experiments of WIP generally promote in vivo actin polymerisation (Anton et al., 
2002; Martinez-Quiles et al., 2001; Ramesh et al., 1997). WIP, however, has 
other functions independent of WASp, including stabilising F-actin (Anton and 
Jones, 2006; Martinez-Quiles et al., 2001) and activating cortactin resulting in 
Arp 2/3 activation (Kinley et al., 2003). Both these roles induce de novo actin 
polymerisation. The integration of these opposing roles of WIP in the in vitro 
setting remains poorly understood.
In addition to binding WIP, purified protein in vitro experiments have suggested 
that the EVH1 domain may have intrinsic effects on inducing WASp activation, 
and may play a cooperative role in the binding and activation of Arp 2/3 (Suetsugu 
et al., 2001a). The role of WIP binding in such a mechanism, and its relevance in 
more physiologically systems remain unknown.
In this chapter I have presented data assessing the affinity for WIP of the WASp 
clinical mutants, domain deletion mutants and constitutively active mutants. I 
have then assessed the effect of WIP on the activity of these constructs using the 
bead based actin polymerisation assay. The aim of these experiments was; (1) 
to assess the differential WIP binding capacities of the four clinical mutants (2) to 
determine the impact of other WASp domains on WIP binding or function, (3) to 
determine whether constitutively active WASp constructs, with their autoinhibitory 
conformation destabilised, have a reduced affinity for WIP and (4) to determine 
the effect on WIP on WASP activation in a lysate actin polymerisation assay.
WASp – WIP affinity 6.2 
In order to assess differences in affinity of WASp for WIP, between WT and 
mutant WASp constructs, it was necessary to establish a robust and reproducible 
experimental system in which good levels of WASp – WIP binding could be 
detected. This proved to be difficult and this chapter describes the strategies 
I employed to try to establish this system and the results these experiments Chapter 6     
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yielded.
I have used a variety of pulldown, immunoprecipitation and co-immunoprecipitation 
techniques. These have been used to either detect binding between immobilised, 
purified WASp and WIP from cell lysates or to detect WASp-WIP complexes 
generated within cells in which one or both of these proteins are overexpressed. 
These two experiments are measuring subtly different outputs. The first strategy 
is a better measure of biochemical affinity of the two proteins, but is likely to be 
influenced by the experimental conditions in which the pulldown is performed. 
The immunoprecipitation of WASp-WIP complexes generated in cells, is more 
representative  of  functional  affinity  of  these  proteins  within  cells,  but  pure 
differences in biochemical affinity may be masked by cellular processes favouring 
or attenuating WASp-WIP complex formation. The former approach measures 
the association of WASp with WIP whereas the later measures (the inverse) the 
dissociation of WASp and WIP complexes. 
WASp WIP binding during actin polymerisation assay 6.2.1 
Initially, the affinity of WASp for WIP during the in vitro actin polymerisation assay 
was assessed. A standard actin polymerisation assay was performed with U937 
lysate supplemented with 1mM ATP. The resultant membrane was immunoblotted 
for WIP in addition to WASp, Actin and ARPC2. Figure 6.1 demonstrates that no 
WIP was bound to beads loaded with GST-WASp at the end of the assay for 
any construct tested. The size of endogenous WIP is shown in the far right hand 
column (U937 lysate), and none of the experimental lanes have a significant band 
present at this size. A silver stain of a similar experiment also demonstrated no 
significant, discrete band at 65 kDa, the molecular weight at which WIP migrates 
during SDS_PAGE (Anton and Jones, 2006; Martinez-Quiles et al., 2001) (figure 
5.5c). Similar results were seen in at least 3 actin polymerisation assays.
WIP pulldown from U937 lysate by immobilised GST-WASp 6.2.2 
Several  hypotheses  were  considered  as  to  why  WIP  is  not  pulled  down  by 
WASp during the actin polymerisation assay. Firstly, the majority of WIP in U937 
lysates is likely to be bound to other proteins (including endogenous WASp) (de 
la Fuente et al., 2007; Sasahara et al., 2002) and therefore the level of free WIP 
may be very low. Secondly, as WIP may inhibit actin polymerisation in this assay 
(Martinez-Quiles et al., 2001) it may have a lower affinity for WASp following its 
activation. Thirdly, the concentration of WIP in the cell lysate of the assay may not 
have been high enough to induce WASp –WIP interaction. Although I was easily 
able to detect WIP within U937 lysates (at considerably greater concentration Chapter 6     
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than was present in either Cos7 or RAW cells, see figure 3.12c), relatively low 
concentration of WIP in U937 cells has previously been reported (Tsuboi, 2006).
Optimisation 6.2.2.1 
A strategy was explored to disrupt the binding of WIP to endogenous WASp in U937 
lysate, prior to incubation with bead bound WASp constructs. Some published 
evidence suggested that WIP binds to autoinhibited WASp, and that on WASp 
activation, WIP and WASp dissociate as a result of WIP tyrosine phosphorylation 
(Sasahara et al., 2002).
Investigating this hypothesis, U937 lysate was treated with magnesium chloride, 
ATP  and  constitutively  active  Cdc42  to  encourage  WASp  activation,  actin 
polymerisation and therefore the proposed dissociation of endogenous WASp from 
endogenous WIP. After 30 minutes of incubation, these conditions were quenched 
with an excess of EDTA, actin polymerisation inhibitors and GDP (to deactivate 
Rho type GTPases such as Cdc42), generating lysate conditions which would be 
inhibitory for actin polymerisation. Upon quenching, the lysate was immediately 
transferred to the bead bound GST-WASp and incubated for 2 hours, to facilitate 
WIP-WASp binding. U937 lysate was generated using 6x107 cell/ml lysis buffer, 
three times the concentration used in the standard actin polymerisation assay, to 
increase WIP concentration.
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Fig 6.1 WIP does not bind to WASp during the actin polymerisation assay
Standard actin polymerisation assay supplemented with 1mM ATP. Reduced samples were di-
vided into two, and two gels were run. The first was blotted for GST, Actin and ARPC2, the sec-
ond was blotted for WIP. An aliquot of U937 lysate was run with the WIP samples as a positive 
control. 
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GTP + +
GDP
5
GDP
2 - + + + -
+ - + + + + + + + -
+ + - + + + + + + -
+ + + + + + + - - -
+ + + + + + + + - -
+ + + + + + + + + -
GTP + +
GDP
5
GDP
2 - + + + -
+ - + + + + + + + -
+ + - + + + + + + -
+ + + + + + + - - -
+ + + + + + + + - -
+ + + + + + + + + - Lysate
Pre-
treatment
Added to 
pulldown
Mg
ATP
Cdc-42
EDTA
Inhibitors
GDP
I
n
p
u
t
L
y
s
a
t
e
Supernatant
Bead bound
α WIP
α WIP
WIP
WASp
WIP
←
←
←
64
51
64
Supernatant
Pulldown
α WIP
α WIP
α WASp
64
64
52
W
T
G
S
T
d
E
V
H
1
d
B
a
s
i
c
d
P
o
l
y
P
d
V
C
A
H
2
4
6
D
A
1
3
4
T
R
1
3
8
P
R
8
6
H
T
4
5
M
Y
2
9
1
E
L
y
s
a
t
e
64
51
WIP
b
←
←
WASp }
} a
Fig 6.2 Pulldown of endogenous WIP from U937 lysate by bead bound GST WASp
(a) Untransfected U937 cells were lysed at a concentration of 6x107 cells/ml in a modified lysis 
buffer (50% glycerol, 1% tritonX, 20mM HEPES pH 7.6, 150mM NaCl, 1mM EDTA, 2mM Na 
orthovanadate, 10mM NaF, 1% aprotinin, 10μg/ml leupeptin, 1mM PMSF). After centrifugation 
lysate was supplemented with all or some of 5mM MgCl, 1mM ATP and 500nM GTPγS loaded 
Cdc42 V12, according to the annotation in the figure, and “preincubated” for 30 minutes on a 
roller at room temperature. After this, a second addition of some or all of 10mM EDTA, 1mM 
GDP (labelled as + ), 2 or 5 mM GDP, 1mM GTP, 5mM latrunculin B and cytochalasin D (given 
together and labelled as inhibitors). The lysate was then added to 75μl of WT GST-WASp coated 
sepharose beads, and incubated at room temperature for 2 hours. The beads (after washing) and 
supernatant were then resolved by SDS-PAGE and immunoblotting. (b) The above experiment 
was repeated with preincubation of lysate with 1mM ATP and 5mM MgCl, followed by a final ad-
dition of 5mM GDP. Lysate was incubated with a range of GST-WASp construct coated beads. 
Supernatants were immunoblotted for WIP and the beads were immunblotted for WASp and WIP. 
(a) WASp bands and WASp degradation products (b) Non specific band
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The  results  of  an  experiment  optimising  the  various  aspects  of  this  protocol 
using WT GST-WASp is shown in figure 6.2a. Assessing the effect of lysate pre-
treatment, it can be seen that most WIP is pulled down when the lysate is incubated 
with magnesium chloride and ATP but not Cdc42. The critical component of the 
quenching conditions appears to GDP, with most WIP pulled down when the 
highest concentration of GDP (5mM) was used. EDTA and polymerisation inhibitors 
appeared to have little additional effect. From this experiment, it was concluded 
that  maximal  WASp-WIP  interaction  could  be  achieved  with  preincubation  of 
lysate with magnesium chloride and ATP, and quenching with 5mM GDP.
Results and reproducibility 6.2.2.2 
WIP pull down from U937 lysate was repeated using the optimised conditions for 
a panel of mutant WASp constructs. A typical experiment is shown in figure 6.2(b). 
Although a WIP band can be discerned (the lower of a double band running at 
approximately 58kDa, most clearly seen in the WT lane), there is much background 
and  non  specific  staining,  making  interpretation  of  results  very  difficult.  This 
experiment was performed a total of three times and no occasion was convincing 
WIP pull down demonstrated. There was no consistency between experiments as 
to which constructs demonstrated even the weakest of WIP binding.
Because of lack of reproducibility of results, this strategy for assessing WASp-WIP 
interactions was abandoned. Although I am unable to demonstrate the reasons for 
this inconsistency, a number of possibilities have been suggested by subsequent 
experiments. Firstly, the antibody used to detect (untagged) WIP (Anton et al., 
2003), showed significant cross reactivity with several proteins (including WASp), 
and it has frequently been difficult to distinguish a WIP band on Western blots 
using this antibody unless there is a high protein concentration in the band. Several 
different blocking buffers and wash strategies were tried to improve the specificity 
of antibody binding, but none were successful. Subsequently a commercial WIP 
antibody has become available (Santa Cruz), which shows greater sensitivity and 
specificity than the Anton WIP antibody. Although not all of the above experiment 
have been repeated with this antibody, WIP binding to WASp coated beads could 
still not be detected following the actin polymerisation assay.
Secondly in all of these experiments a triton X based lysis buffer was used to 
generate the U937 lysate. Later experiments demonstrated problems detecting 
WASp-WIP complexes in triton X based lysis buffer (see figure 6.5(d) and 6.2.5.1 
for further discussion).Chapter 6     
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Overexpressed zzWIP in Cos 7 cell pulldown by immobilised  6.2.3 
GST-WASp
An alternative approach was to incubate GST-WASp coated sepharose beads 
with Cos7 lysate transfected with the zzWIP construct (WIP carboxyl terminally 
tagged with the zz domain of protein A, a 6x His tag and the V5 epitope). This has 
two advantages over using U937 lysate. Firstly Cos7 cells are easily transfected 
and therefore high levels of WIP can be generated in cell lysates. Secondly, 
because Cos7 cells express low levels of WASp, very little if any of the WIP in the 
lysate will be complexed with WASp (see figure 3.12c).
Figure 6.3 shows such a pull down experiment. 5mM GDP and 5mM EDTA were 
added to the lysis buffer to enhance the WASp-WIP interaction. Unfortunately, 
as previously described, the anti WIP antibody shows significant cross reactivity 
with WASp. The WIP band can be distinguished, running at a slightly higher 
relative molecular weight than WASp (the size of the WASP band varies with the 
specific contruct tested). In this experiment there is a high level of background 
WIP pulldown (note GST and dEVH1 lanes), however there does appear to be 
more WIP pulled down by WT-WASp than with any of the four clinical mutants. 
The other domain deletion and the constitutively active point mutations mutants 
appear to bind a similar amount of WIP as WT.
The WASp and WIP bands could have been definitively separated using 2D  gel   
electrophoresis, but in light of the high levels of background WIP binding and 
the cross-reactivity of the anti WIP antibody, this experimental approach was 
not repeated. Subsequent detection of the zzWIP construct used an anti His tag 
antibody, whose use was only optimised later on during the project (see figure 
3.12b).
Co-immunoprecipitation of EGFP-WASp/zzWIP contructs from  6.2.4 
Cos7 cell overexpressing both constructs
To assess the ability of WASp mutants to bind WIP in cells, the GST-WASp 
construct  and  the  zzWIP  construct  were  co  transfected  into  Cos7  cells  and 
complexes were pulled down using glutathione sepharose (GST binding) beads   
and IgG sepharose (zz binding) beads.
Figure 6.4(a) shows zzWIP co-immunoprecipitated using GST WASp as bait and 
figure 6.4(b) shows GST-WASp co-immunoprecipitated using zzWIP as bait. It is 
apparent from these blots that there was little consistency of expression of bait 
protein between experimental samples (top layer in each figure). In particular the 
R138P construct and the constitutively active constructs (S272P, Y291E and VCA Chapter 6     
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Fig 6.3
bind) showed very low levels of expression. I have previously demonstrated that 
GST-WASp expression in Cos7 cells can be comparable between the constructs 
under investigation (Figure 3.10a and b). The differences seen may be as a 
result of transfecting small numbers of cell (6 well plates compared to 15cm 
plates), because of using a different transfection mechanism (PEI compared to 
electroporation), or because of difference in levels of “DNA saturation” caused 
by the two transfection techniques. The low levels of protein detected with the 
constitutively active mutants, may be caused by WASp toxicity inducing cell death 
(this is discussed in detail in chapter 8). This experiment was repeated but similar 
inconsistencies in protein expression made interpretation of the results difficult.
The  WIP  binding  capacity  of  each  WASp  mutant  was  quantified  using  band 
densitometry and the quantity of WIP or WASp bound per unit bait protein was 
determined. These values were expressed as a fraction of the equivalent value 
for WT WASp binding, and are expressed graphically in figure 6.4c and d. Only 
experimental  samples  whose  bait  protein  quantification  was  at  least  10%  of 
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Fig 6.3 zzWIP pulldown by bead bound GST-
WASp from Cos-7 cells transfected with the 
pOS-zzWIP construct
Cos7 cells were electroporated with the pOS-
zzWIP construct. Plates of cells were harvested 
48 hours later, were washed and snap frozen, 
and  stored  at  -80°C.  On  defrosting  the  cells 
were lysed in a modified lysis buffer (10% glyc-
erol, 1% tritonX, 20mM HEPES pH 7.6, 150mM 
NaCl,  5mM  EDTA,  5mM  GDP,  2mM  Na  or-
thovanadate, 10mM NaF, 1% aprotinin, 10μg/ml 
leupeptin,  1mM  PMSF).  Following  centrifuga-
tion lysate was incubated with standardised vol-
umes of a panel GST-WASp coated beads. The 
beads were incubated for 2 hours, then washed 
and resolved by SDS-PAGE and western blotting. Input lysate was run as a control (labelled 
lysate). (a) Shows immunoblots for GST (WASp), WIP and actin and (b) shows a graph of the WIP 
/ WASp ratio of densitometry readings from this blot.
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Fig 6.4 WASp and WIP co-immunoprecipitation from co-transfected Cos7 cells
Cos 7 cells were transfected with an equal amount of GST-WASp and zzWIP DNA, using the 
transfection agent JET-PEITM, according to manufacturer’s instruction. Cells were harvested at 48 
hours, washed and then lysed in a modified RIPA buffer (1% triton X, 0.1% SDS, 1% Na deoxy-
cholate, 150mM NaCl, 20mM HEPES pH 7.6, 1mM EDTA, 5mM GDP, 2mM Na orthovanadate, 
10mM NaF, 1% aprotinin, 10μg/ml leupeptin, 1μM pepstatin, 1mM PMSF), before clarification by 
centrifugation. Lysates were then incubated with 10μl of GST sepharose (figure (a)) or activated 
IgG sepharose beads (figure (b)) on a rotator at 4°C overnight. The beads were then washed 
3x in RIPA buffer, prior to reduction in laemelli buffer and resolution by SDS-PAGE and western 
blotting. Reduced lysate was run on two gels for each experiment - one was blotted for the bait 
protein and the other for the prey protein. (c) and (d) Densitometry was perfomed on the above 
gels and prey / bait ratios were calculated. For each experiment these ratios were divided by the 
ratio for WT, to give a WIP / WASp ratio (c) or WASp / WIP ratio (d) standardised to WT. Only ex-
periments where the bait protein densitometry reading was over 10% of that for WT were included 
in the analysis.Chapter 6     
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WT were analyses. Despite the limitations of these results, these experiments 
show that all WASp constructs except the dEVH1 (which has the WIP binding 
site deleted) are capable of forming WASp - WIP complexes within cells, if both 
proteins are over expressed.
Co-immunoprecipitation  of  EGFP-WASp  /  endogenous  WIP  6.2.5 
complexes from stably transfected U937 lines
Cos7 cells have been a useful experimental tool for investigating WASp - WIP 
interaction, because of their ease of transfection and ability to synthesis large 
amounts of cytosolic protein with minimal toxicity. U937, however, are a more 
biologically relevant tool for investigating WASp molecular cell biology. I have 
therefore also assessed the ability of EGFP-WASp mutants to form WASp - 
WIP complexes (with endogenous WIP) in stably transfected U937 cells. To do 
this I have immunoprecipitated EGFP-WASp using an anti EGFP antibody, as 
described in chapter 2.
Optimisation 6.2.5.1 
Figure 6.5a shows the WASp and WIP immunoprecipitated from U937 lysate 
transfected with EGFP-WT-WASp, under various experimental conditions (lysate 
concentration,  incubation  time  for  immunoprecipitation,  volume  of  antibody 
resin used and transfection MOI of U937 cells used for lysate, were all varied). 
Non-specific  binding  was  assessed  using  resin  immobilised  isotype  control 
antibody and quenched resin with no antibody bound. It was found that a lysate 
concentration of at least 1.0 mg/ml was required to detect immunoprecipitation, 
and that overnight incubation reduced the strength of the immunoprecipitated 
WIP band. Complexes could be immunoprecipitated from cells transfected with 
MOIs of both 1 and 5, but more WIP was detected using lysate from MOI 5 cells. 
25µl of resin was sufficient to immunoprecipitate a strongly detectible WIP band.
Fig 6.5b and c demonstrate that one wash is probably sufficient to eliminate 
non specific binding to the beads, as no WIP was detected in the post wash 
supernatant following the second and third washes. Similarly almost all of the 
WASp-WIP complexes were eluted from the beads on the first three elutions 
(WIP was only detected in the first elution, but EGFP WASp was still detected by 
silver stain in the third elution).
Figure 6.5d shows the effect of using different detergents in the lysis buffer on 
immunoprecipitation. Triton X based lysis buffers and RIPA buffer (containing SDS, 
Triton X and sodium deoxycholate) prevented WIP immunoprecipitation. APB (an 
IGPAL based buffer) resulted in the highest levels of WIP immunoprecipitation. Chapter 6     
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Fig 6.5
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Fig  6.5  Optimisation  of  co-immunoprecipitation  of 
EGFP-WASp - WIP complexes by αEGFP antibody
(a) WT EGFP-WASp stably transfected U937 cell lysates 
(lysed  in  APB  with  full  protease  inhibitors  and  phos-
phatase inhibitors) were incubated with resin linked to 
αEGFP antibody (250ng antibody / μl resin). Lysate concentration, incubation time, resin volume 
and MOI used to transfect U937 cells with EGFP-WASp, were varied to detemine optimal condi-
tions for WIP immunoprecipitation. Resin bound with an unrelated isotype control antibody, and 
quenched resin with no antibody bound were used as controls. (b) Processing steps of the im-
munoprecipitation for the experiment with lysate of MOI 5 cell line, 1mg/ml concentration, 2 hour 
incubation and 25 μl of beads. (c) Silver stain of experiment (b). Band labels (i) EGFP-WASp (ii) 
WIP. (d) Effect of different detergents in the lysis buffer on immunoprecipitation. Immunoprecipi-
tation perfomed as above using 25μl of resin, U937 cells transfected with WT EGFP-WASp and 
lysate generated using 1.2x106 cells/ml in 5 different lysis buffers; RIPA +/- sodium deoxycholate 
(1% Triton X, 0.1% SDS, 150mM NaCl, 50mM TRIS pH 7.4, 1mM EDTA), Triton X lysis buffer 
+/- GDP 5mM (10% glycerol, 1% triton X, 20mM HEPES pH 7.6, 150mM NaCl, 5mM EDTA) and 
APB (1% IGPAL, 130mM NaCl, 50mM TRIS pH 7.6, 1mM EDTA). All lysis buffers contained full 
protease inhibitors and phosphatase inhibitors (2mM Na orthovanadate, 10mM NaF, 1% apro-
tinin, 10μg/ml leupeptin, 1μM pepstatin, 1mM PMSF).Chapter 6     
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Interestingly  the  removal  of  sodium  deoxycholate  from  RIPA  buffer  partially 
restored  immunoprecipitation.  This  experiment  also  confirms  the  finding  that 
2 hours incubation for the immunoprecipitation is more efficient than overnight 
incubation.
Sodium  deoxycholate  (weak)  and  SDS  (strong)  are  both  anionic  detergents, 
which can denature of the tertiary structure of proteins, although antibodies are 
usually resistant to this (Neugebauer, 1990). There is some suggestion from 
the overnight incubation experiment that the addition of sodium deoxycholate 
additionally interferes with WIP – WASp interaction, rather than anti EGFP – 
EGFP-WASp interaction. This is perhaps not surprising as WIP is a highly ionic 
protein with a predicted isoelectric point of pH 11.99 and therefore may be more 
susceptible to denaturing by anionic detergents. Triton X and IGPAL are both 
non ionic detergents. Triton X selectively solublises cytosolic, but not cytoskeletal 
proteins (although this effect is usually seen using a lower concentration of Triton 
X than was used in this experiment). This however may be the explanation for the 
lack of efficacy of immunoprecipitation of EGFP-WASp using Triton X based lysis 
buffer. This effect is further explored in Chapter 8.4.
As these experiments were optimisation experiments they were  only performed 
on a single occasion and were not repeated. On the basis of these experiments 
and those shown in figure 6.2a optimal experimental conditions were finalised 
(as described in legend to figure 6.6a) and these conditions were used in all 
subsequent immunoprecipitation experiments.
Results 6.2.5.2 
Figure 6.6a shows the co-immunoprecipitation of WIP by a selection of EGFP-
WASp constructs. It can be seen that the dEVH1 mutant shows no WIP binding, 
whereas the dBasic construct and the H246D mutant both show normal levels 
of WIP binding. There is less EGFP-WASp immunoprecipitated for the clinical 
mutants than for WT (as would be expected from the results presented in chapter 
8). Despite this there appears to be disproportionately less WIP pulled down for 
the clinical mutants than for WT WASp. Similar results were produced when the 
experiment was repeated using lysate with concentration adjusted to standardise 
the concentration of EGFP-WASp in lysate for each construct.
Figure 6.6b shows a summary of the results of densitometry performed on the above 
experiments. Results are expressed as the amount of WIP immunoprecipitated 
per unit WASp, relative to WT-WASp (WT WASp = 1). This suggests there is a 
reduction in affinity of WIP for clinical mutant WASp compared to WT, but that Chapter 6     
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Fig 6.6
some WIP-WASp complexes do form within cells. This reduction is quite variable 
between constructs. By contrast the dEVH1 construct shows absent WIP binding. 
The constitutively active mutants were not tested with this assay.
Relative affinity of WIP for endogenous and mutant WASp 6.2.5.3 
To  investigate  the  relative  proportion  of  endogenous  WIP  bound  to  EGFP-
WASp and to endogenous WASp within U937s, a multiple immunoprecipitation 
experiment  was  performed.  Lysate  from  each  construct  tested  was  serially 
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Fig 6.6 Co-immunoprecipitation of EGFP-WASp - WIP complexes by αEGFP antibody from 
transfected U937 cells
(a) 2.5x106 U937 cells stably transfected with a range of EGFP-WASp contructs were lysed in 
100μl of APB supplemented with 10% glycerol, 0.1mM DTT and 5mM GDP. Lysates were clarified 
by centrifugation and incubated with 25μl of αEGFP resin (6.25μg antibody) for 2 hours. The resin 
was then washed 3x and eluted with 3 resin volumes of elution buffer. Samples were reduced 
and resolved by SDS-PAGE and immunoblotted for WASp and WIP. Blots shown are representa-
tive of 3 repeat experiments. (b)  Densitometry was performed on the bands from 2 experiments 
as described in (a). Ratios of WIP / WASp were calculated and standardised to WT within each 
experiment. Average ratios are plotted (WIP / WASp for WT = 1). As data from only 2 experiments 
is shown, no statistics were performed. (c) 5x106 U937 cells were lysed in 200μl of supplement-
ed APB and immmunoprecipitations were performd as above. Following immunoprecipitation, 
the lysate was subjected to 3 further αEGFP immunoprecipitations using fresh resin. Finally the 
lysate was incubated with 10μg of anti WASp antibody (B9) for 2 hours, before addition of protein 
G Sepharose and further incubation of 1 hour. The protein G Sepharose was then washed and   
reduced in laemelli buffer and resolved by SDS-PAGE (with the reduced elutants from the primary 
immunoprecipitation).
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immunoprecipitated until all EGFP-WASp had been depleted from the lysates. 
The  resultant  lysates  then  underwent  immunoprecipitation  using  anti  WASp 
antibody to determine the amount of WIP bound to endogenous WASp. For each 
immunoprecipitation bound proteins were eluted off and resolved together by 
electrophoresis and immunoblotted for WIP.
Figure 6.6c demonstrates no WIP immunoprecipitated by anti EGFP from the 
SEW and dEVH1 expressing lysate as would be expected. The WT and R138P 
samples show reducing WIP pulldown with serial anti EGFP immunoprecipitation. 
The anti WASp immunoprecipitations demonstrate that the SEW transfected and 
untransfected cell lines have high levels of WIP bound to endogenous WASp. The 
dEVH1, R138P and R86H construct transfected lysates have lower but detectable 
levels of WIP bound to endogenous WASp. By contrast the WT transfected cells 
have very low levels of WIP bound to endogenous WASp.
This experiment demonstrates that in EGFP WT WASp transfected U937 cells, 
where there is a great excess of EGFP WASp over endogenous WASp, almost 
all of the cellular WIP is bound to the EGFP-WASp. For cells transfected with 
the clinical mutant WASp, there is still an excess EGFP-WASp over endogenous 
WASp, but a significant proportion of the cellular WIP is bound to endogenous 
WASp. Interestingly the majority of cellular WIP still appears to be bound to 
mutant EGFP-WASp, suggesting the affinity of clinical mutant WASp for WIP is 
biologically significant, if less than that for WT WASp.
Summary of WASp-WIP affinity experiments 6.2.6 
Densitometry was performed on all successful experiments used to assess the 
affinity of WASp and WIP by immunoprecipitation or pulldown (as described in 
6.22-6.25). 8 valid experiments were identified and their results were pooled and 
analysed together. Experimental samples were only included in the analysis if the 
amount of input (or bait) protein was at least 10% that of WT within that experiment. 
These results were analysed using an ANOVA with identical methodology to that 
employed for assessing the actin polymerisation assays. Absolute densitometry 
readings for WASp and WIP showed a skewed frequency distribution, but once 
log transformed they showed an approximately normal distribution (see appendix 
figure A.11).
Although pooling results from experiments using different methodologies is not 
ideal, each of the experiments I have used in this analysis is assessing the same 
biochemical interaction. I feel these results do provide a useful summary of the 
WASp-WIP interaction experiments presented in this chapter, although replication Chapter 6     
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Fig 6.7
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0.394
p values
<0.001**
Difference in WIP-WASp affinity
relative to WT (Z Score)
 *  p<0.05
** p<0.01
Sum of 
Squares
df
Mean 
Square
F Sig.
Corrected Model 134.16 27 4.97 15.28 .000
Intercept 0.76 1 0.77 2.36 .133
Experiment 32.12 7 2.68 2.75 .020
Construct 6.25 12 0.89 8.23 .000
Ln WASp 9.61 1 9.61 29.56 .000
Experiment *  Ln WASp 6.43 7 0.92 2.82 .018
Error 12.68 39 0.33
Totals 10602 67
Corrected total 146.8 66
Adjusted R Squared .854
ANCOVA of Ln WIP with Ln WASp - Ln WIP dependant variable 
Fig 6.7 Summary of WASp - WIP affinity experiments
(a) Densitometry readings for WASp and WIP from all WASp - WIP binding affinity experiments 
were combined. The natural logs of these values were normally distributed (see appendix, figure 
A.11) and therefore used for parametric statistical analysis. An analysis of co-variance of Ln WIP 
with Ln WASP was performed using a main effects regression model and including an interaction 
term between experiment and Ln WASp concentration. The results of this model are summarised 
in the table. (b) Estimated marginal means of the affinity of WIP for WASp for each construct were 
calculated from the ANCOVA analysis and were expressed in terms of numbers of standard de-
viations from WT affinity (z scores). Means and their 95% confidence intervals are plotted on the 
graph and the 95% confidence interval (z score 2) for WT WASp is shaded in grey for comparison. 
The significance of the differences of these means from WT was analysed using a least significant 
differences (LSD) pairwise comparison, and p values are stated.
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of specific experiments would increase the statistical certainty of the findings.
Figure  6.7  demonstrates  that  construct  type  is  responsible  for  a  significant 
proportion of the variation seen in these results. Comparing affinity to WT WASp, 
deletion of the Polyproline and Basic domains, and disruption of Cdc42 binding 
have no significant effect on WIP affinity, although each of these samples showed 
on average lower affinity for WIP than WT WASp. Similarly the constitutively active 
mutants have no significant difference in WIP binding capacity from WT, but on 
average show slightly reduced affinity. The clinical point mutations do however 
show a significant reduction in WIP affinity, with the A134T mutant having the 
least affinity for WIP. This data is in line with previously published results (de la 
Fuente et al., 2007; Tsuboi, 2006; Kim et al., 2004; Luthi et al., 2003; Volkman et 
al., 2002; Stewart et al., 1999).
Effect of WIP on actin polymerisation 6.3 
Effect of WIP on WT WASp activity 6.3.1 
To assess the effect of WIP on WASp mediated actin polymerisation in vitro, 
zzWIP transfected Cos7 cells were used as a substrate for the actin polymerisation 
assay. To ensure both an inhibitory or excitatory effect could be detected, the 
assay was performed using a range of WIP concentrations by mixing transfected 
and untransfected Cos7 lysates, and performing the assay with and without ATP 
supplementation. In addition to WT WASp, the S272P construct was also tested 
to determine whether WIP influenced WASp activity upstream of downstream of 
destabilisation of the WASp autoinhibitory conformation.
Figure 6.8b shows the concentration of WIP, actin and ARPC2 in the four lysates 
used in the assay, and compares them to the U937 lysate used in the standard 
actin polymerisation assay. The concentration of WIP in the lysates used varies 
from none to a greater concentration than that in U937 cells. By contrast the 
concentrations  of  actin  and  ARPC2  are  approximately  the  same  in  all  four 
lysates. Figures 6.8a,c and d demonstrate no significant effect of WIP on actin 
polymerisation activity in any of the conditions tested. Despite showing no effect 
on actin polymerisation the bead bound WASp was able to bind WIP, as shown in 
the anti WIP immunoblot of the beads.
Effect of GDP on actin polymerisation 6.3.2 
It was been proposed that WIP binding to WASp may be destabilised by Cdc42 
induced  WASp  activation  (Sasahara  et  al.,  2002).  To  investigate  this,  actin 
polymerisation assays were performed using WIP transfected Cos7 lysate in the Chapter 6     
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Fig 6.8
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Fig 6.8 Effect of WIP on in vitro actin polymerisation
Cos 7 cells were transfected with a pcDNA3 EGFP-WIP 
plasmid by electroporation. 24 hours after electropora-
tion the cells were lysed in APB with protease inhibi-
tors and clarified by centrifugation. An equal number of 
untransfected Cos7 cells were harveested in parallel. 
Protein concetrations of both lysates were determined 
using a BCA assay, and both lysates were standardised 
to a concentration of 2.25mg/ml. Transfected and un-
transfected lysates were then mixed to give 4 different   
EGFP-WIP concentrations (100%, 30%, 10% and 0% transfected lysate). 250µl of lysate was 
then incubated with a standardised volume of WT or S272P WASp coated sepharose beads 
for each reaction condition. Assays were performed with and without ATP supplementation 
(0.25mM) of the lysate, but all lysates were supplemented with 5mM MgCl2 prior to incuba-
tion. After 1 hours incubation, the beads were washed once with APB, prior to reduction in SB 
and resolution by NuPAGE and western blotting. (a) Immunoblots for GST, actin ARPC2 and 
WIP (using anti-WIP antibody) are demonstrated. Stan referes to a standard of 500ng of actin 
and 100ng of GST-WASp. (b) Immunoblots of lysate used in the assay, and U937 lysate used 
as a positive control. (i) EGFP-WIP (ii) Endogenous WIP. (c) and (d) Densitometry of bands 
from immunoblot shown in (a) were used to calculate Arp2/3 / WASp and actin / WASp ratios, 
which were then plotted against WIP concentration. (e) In parallel with experiment (a), an assay 
was performed to assess the effect of GDP (5mM) on actin polymerisation. 100% WIP trans-
fected lysate was used for each sample.  (i) 130kDa band ?EGFP-WiP dimer. (ii) EGFP-WIP.
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presence and absence of an excess of GDP, and figure 6.8e shows the result.
This experiment suggests that an excess of GDP is associated with both increased 
actin polymerisation and increased WIP binding to WASp. Two other interesting 
results are demonstrated in this experiment. GDP also appears to induce the 
pulldown of a second band at approximately 150kDa which reacts to the anti 
WIP antibody. This could be a non specific band, but it is the correct molecular 
weight for a dimerised WIP complex, and the size of the band in each lane is 
proportional to the size of the WIP band. As the gel was run under denatured 
conditions (heated to 70°C for 10 minutes in NuPAGE Lithium Dodecyl Sulphate 
sample buffer with propriatory reducing agent), it would be unlikely that a dimer         
would remain following electrophoresis. This could be resolved by repeating the 
experiment using a range of denaturation conditions, or by identifying the band by 
mass spectropscopy. These experiments were beyond the scope of this project. 
Secondly, the addition of GDP appears to cause a motility shift in the WASp 
construct, and this effect appears to be proportional to the amount of WIP bound 
to the beads. A similar motility shift is seen when WASp is phophorylated at the 
Y291 residue (Cory et al., 2002).
These findings require further work to be validated and to explore the mechanisms 
behind them, but this work is beyond the timeframe of this project. Nonetheless, 
they do potentially challenge the hypothesis that WIP stabilises the autoinhibitory 
conformation of WASp.
Effect of WIP on other WASp constructs 6.3.3 
Actin polymerisation assays were performed using Cos7 cells transfected with 
EGFP,  EGFP-WIP  and  EGFP-WIPdWASp  as  lysate  and  a  range  of  WASp 
constructs as the substrate. Figure 6.9a shows the composition of the lysate 
used in the experiment, and figure 6.9b shows the results. There appears to 
be no consistent difference in the results between any of the lysates for any of 
the constructs tested. Similar experiments have been performed on a total of 
four occasions using a range of different conditions and cell lysates, and on no 
occasion was a difference between lysate with a high or low WIP concentration 
detected in any construct.
These  results  demonstrate  that  WIP  has  no  effect  on  WASp  induced  actin 
polymerisation in this bead based cell lysate in vitro system.Chapter 6     
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Fig 6.9
Conclusion 6.4 
The key findings from the experiments presented in this chapter are;
(1) Missense WASp mutations which give rise to XLT / WAS in patients 
showed significantly reduced WIP affinity compared to WT WASp, whereas 
those giving rise to XLN have equivalent WIP affinity.
(2) WIP did not associate with bead bound WASp during the U937 lysate 
actin polymerisation assay.
(3)  Over-expression  of  WIP  in  lysates  had  no  effect  on  in  vitro  actin 
polymerisation.
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Fig 6.9 Effect of WIP on in vitro actin polymerisation (experimental WASp constructs)
Cos 7 cells transfected with EGFP, WIP-EGFP or WIPdWASp-EGFP (WIP with the WASp binding 
site deleted) were lysed in APB.  Lysates were standardised to a concentration of 1mg/ml (de-
termined by BCA assay) were and supplemented with 0.25mM ATP and 5mM Mg2+. A standard 
actin polymerisation assay was then performed using a selection of WASp constructs purified 
on sepharose beads. (a) Immunoblots of lysates used. (i) EGFP-WIP (ii) non specific band (iii) 
EGFP-WIP degradation band (iv) EGFP. (b) Blots from actin polymerisation assay using all three 
lysates.Chapter 6     
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Affinity determinants for WIP binding 6.4.1 
The  experiments  presented  in  this  chapter  illustrate  some  the  technical 
problems I encountered in reliably eliciting WASp – WIP binding. There is not a 
precedent for this in the literature, and WASp - WIP complexes have been co-
immunoprecipitated from cells over-expressing protein, from native cell lysates 
and from purified protein interaction experiments (Tsuboi, 2007; de la Fuente et 
al., 2007; Dong et al., 2007; Tsuboi and Meerloo, 2007; Tsuboi, 2006; Sasahara 
et al., 2002; Martinez-Quiles et al., 2001; Moreau et al., 2000; Stewart et al., 
1999; Ramesh et al., 1997). The cell lines used in this project (U937 and Cos7) 
have not been published as tools for investigating the formation of WASp – WIP 
complexes, although one study commented on low levels of both WASp and 
WIP in U937 cells compared to THP1 cells (Tsuboi, 2006). In my experience (as 
shown in figure 3.12c) and that demonstrated in other publications (Cory et al., 
2003), U937 cells expressed equivalent levels of WASp and WIP to THP1 cells. 
Following transduction, U937 cells expressed higher levels of EGFP-WASp than 
transduced THP1 cells (data not shown). These differences may represent the 
well documented heterogeneity associated with U937 cell lines.
My difficulties in forming WASp – WIP complexes using bead bound recombinant 
WASp  and  endogenous  WIP  from  U937  cells  may  well  result  from  the  vast 
majority of WIP being bound to endogenous WASp. I tried to address this by 
inducing the dissociation of endogenous WASp and WIP by WASp activation, 
based on published evidence in T cell signalling (Sasahara et al., 2002). Since 
my  experiments  were  performed,  other  data  has  questioned  whether  WASp 
activation does induce WASp – WIP dissociation (Dong et al., 2007). Currently, 
the question as to whether WASp activation destabilises WASp – WIP complex 
stability remains unanswered, and my experiments provide no supportive evidence 
for this hypothesis.
The finding that the affinity of WAS / XLT WASp for WIP is reduced compared to WT 
is in keeping with previously published data from yeast two hybrid and pulldown 
experiments (Luthi et al., 2003; Stewart et al., 1999), as well as predicted binding 
affinities from structural modelling (Kim et al., 2004; Volkmann et al., 2001; Rong 
and Vihinen, 2000). Among the four clinical mutants I tested, I found that the 
order from least to greatest affinity was; A134T < R138P = T45M < R86H, which 
extends but is in keeping with previously published results: T45M had never been 
tested before and the other three constructs had not been tested simultaneously. 
R86H showed significantly greater affinity for WIP than A134T (p=0.071) and 
T45M (p=0.038), whereas there were no other significant differences between the Chapter 6     
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constructs (ANCOVA using a Bonferroni correction for comparing mean affinities 
– analysis not shown).
The finding that the constitutively active mutants bind WIP with similar affinity to WT 
is not previously published. These constructs were not tested in the most robust 
of the four techniques used (co-immunoprecipitation from stably transfected U937 
cells), because these constructs did not allow the formation of stably transfected 
cells (see chapter 8). As a result they were tested in fewer assays and the results 
show wide confidence intervals. Nonetheless, the S272P construct was tested in 
5 independent experiments and no significant difference from WT was detected. 
This is significant because point mutations causing XLN have been demonstrated 
to destabilise the WASp autoinhibitory conformation, based on structural modelling 
(Devriendt et al., 2001). If WASp is able to remain bound to WIP in the disinhibited 
conformation, WASp may exist in vivo simultaneously active (and Arp 2/3 bound) 
and WIP bound. This has implications for the role of WIP in localising WASp and 
for inhibiting its activation (Dong et al., 2007; Benesch et al., 2002; Sasahara et 
al., 2002; Martinez-Quiles et al., 2001), and also for the function of the WASp – 
WIP complex.
Deletion  of  the  Basic  domain  and  Polyproline  domain  appeared  to  have  no 
significant effect on WIP binding. This provides us with useful information about 
the molecular mechanisms underlying WASp - WIP complex formation. Firstly it 
suggests that formation of the WIP-WASp complex does not require interaction 
with mediators which bind either of these two domains (such as kinases, SH3 
– SH2 adaptors, profilin, other SH3 proteins, PIP2 binding to the basic domain). 
Secondly, it suggests that deletion of these domains does not impair the folding 
and conformation of the EVH1 domain, and suggests that functionally the EVH1 
domain is intact in these constructs. Thirdly it suggests that neither of these 
domains make a direct contribution to the WASp – WIP binding affinity. The fact 
that the H246D mutant does not have greater affinity for WIP than WT WASp is 
supportive of the hypothesis that WIP binding is not disrupted by (Cdc42 induced) 
WASp activation. Further support for this comes from the fact that addition of 
GTPγS to the co-immunoprecipitation reaction from transfected Cos7 cells has 
no effect on WASp – WIP affinity (see appendix figure A.12).
The dVCA domain mutant appears to have significantly reduced affinity for WIP. 
This has not been previously described in the literature, but could be compatible 
with one model of WASp-WIP interaction proposed by Dong et al in which the 
NH2-terminus of WIP interacts with the WASp VCA domain in a complex with 
actin and profilin (Dong et al., 2007).Chapter 6     
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WIP effect on actin polymerisation 6.4.2 
It has been previously clearly demonstrated that in vitro, in a purified protein 
system, WIP inhibits the actin polymerisation activity of NWASp (Ho et al., 2004; 
Martinez-Quiles et al., 2001). By contrast, several lines of evidence suggest that 
over-expression of WIP in vivo leads to increased cellular actin polymerisation 
(Lanzardo et al., 2007; Anton et al., 2003; Benesch et al., 2002; Anton et al., 
2002; Vetterkind et al., 2002; Martinez-Quiles et al., 2001; Moreau et al., 2000). 
In this project, I have assessed the role of WIP in an in vitro lysate system, and 
have found no impact on activity
When the assay was performed using U937 lysate, containing endogenous WIP 
and WASp, I was unable to demonstrate WIP binding to bead bound exogenous 
GST WASp. As suggested above, because of the stability of endogenous WASp – 
WIP complexes, the amount of free WIP in these assays may have been very low 
(de la Fuente et al., 2007). As a result, assays performed with U937 lysate, may 
have effectively been a “WIP free” experiment. In support of this, WIP did bind to 
WASp, during actin polymerisation assays performed with lysate from Cos7 cells 
transfected with WIP, which contained physiological levels of tagged WIP, but no 
endogenous WASp (or WIP). This hypothesis could be investigated by serially 
immunoprecipitating U937 lysate with anti-WASp antibody and measuring the 
amount of free WIP in the post precipitation lysate. An alternative hypothesis is 
that there is a mediator in U937 lysate which inhibits WIP binding to GST WASp. 
In support of this, when actin polymerisation assays were performed using U937 
lysate mixed with WIP transfected Cos7 lysate, no WIP binding was detected 
(data not shown). The lack of WASp – WIP interaction detected during the actin 
polymerisation assay, and the activity of the WAS / XLT mutant WASp constructs 
is discussed in greater detail in chapter 5.4.3.
I was unable to detect any effect (either positive or negative) of WIP on in vitro 
lysate  based  actin  polymerisation,  despite  five  well  controlled  experiments. 
These experiments used lysates from different cell lines, combinations of mixed 
transfected and untransfected cell lysates, use of full length and truncated WIP 
and varying concentrations of ATP to try to detect any difference WIP may be 
producing. Assays were performed at both the “active” and the “largely inactive” 
spectrum ends to ensure an effect was not missed due to saturation or lack of 
sensitivity for a signal. This surprising result contradicts previously published 
data, but the effect of WIP in lysate based actin polymerisation assay has not 
been previously assessed.
It is possible that in Cos7 cells the levels of, or affinity for WASp of CR16 or WICH Chapter 6     
223
/ WIRE is much higher than that of WIP. If this were the case, then it is possible 
that the WASp EVH1 domains would all become saturated with CR16 or WICH 
/ WIRE, and therefore the effect of WIP overexpression in these cells would be 
negligible. Although I was unable to assess the levels of these other verprolin 
family proteins, I feel it is unlikely that they would be expressed in high enough 
concentration to completely saturate the effect of WIP. As WIP is the physiological 
binding partner for WASp it is unlikely that the affinity of WASp for CR16 or WICH 
/ WIRE would be significantly stronger than that for WIP.
Alternatively, it is possible that WIP is only bound to a small subset of the bead 
bound WASp, and therefore inhibition of this subset does not result in a detectible 
difference in the measured activity in the assay. Again I feel this is unlikely, as 
although I did not formally quantify the amount of WIP generated in Cos7 cells 
following transfection, EGFP WIP transfected cells were robustly green under 
the fluorescent microscope prior to harvesting, and WIP was detected easily on 
Western blots of lysate used in the assays.
A further possible explanation is that WIP may have several effects on WASp 
which balance each other out. For example it has been postulated that WIP is 
required for TOCA1 binding, and that TOCA1 is essential for NWASp activation 
in vivo (Ho et al., 2004). Therefore any inhibitory effect of WIP, through WASp 
autoinhibitory  stabilisation  would  be  negated  by  the  subsequent  enhanced 
binding of TOCA1. In the absence of WIP, TOCA1 recruitment may be slower 
or alternative activation pathways (involving Nck or Grb2) may be required, and 
the net result would be similar levels of activity in the presence and absence of 
WIP. Although this hypothesis is attractive, I feel it is unlikely to explain the lack of 
WIP activity in the bead based assay, because TOCA acts in concert with Cdc42 
to activate WASp but Cdc42 activation does not appear to be important in this 
assay.
Another alternative explanation for this discrepancy, is that WIP’s role in stabilising 
the  WASp  autoinhibitiory  conformation  is  an  artefact  of  the  purified  protein 
system.  In  more  physiologically  systems,  it  has  been  suggested  that  WASp 
may polymerise actin as part of a multimeric complex (Insall and Machesky, 
2004), where the effects of several mediators are balanced to determine final 
activity. In such a model, WASp would not exist in an autoinhibited conformation, 
but rather its conformation and activity would be governed almost exclusively 
by which mediators were bound to it. WIP may not have the same inhibitory 
activity on WASp as part of a complex containing TOCA1, Grb2, Nck and VASP, 
and in this context its role in localisation may be more critical. In the context Chapter 6     
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of WASp integrating activating signals from many different mediators, WIP may 
play a critical role in inhibiting Cdc42 mediated activation, but this effect may be 
bypassed by other activating signals (eg Grb2, Nck). In light of the other results 
presented in this study and breadth of published literature reviewed, I feel this is 
the most likely explanation for these findings.
A final hypothesis is that the post translational modification of WASp (or WIP) when 
over-expressed and manufactured in Cos7 cells, makes these proteins insensitive 
to one another. For example, it has been suggested that phosphorylation of specific 
tyrosine residues within WIP can lead to a reduced affinity for and dissociation from 
WASp. Non-physiological post-translational modification could lead to continued 
WASp – WIP association, but loss of autoinhibitory stabilisation. Evidence for 
enhanced and atypical tyrosine phosphorylation of WASp synthesised in Cos7 
cells is discussed in chapter 7.5.3.
Unfortunately further investigation of the mechanisms underlying these results 
was beyond the time scale of this project. Experiments such as quantifying the 
amount of WIP, CR16 and WIRE in assay lysates, use of purified protein systems 
involving different proteins, and testing WASp constructs or WIP lysates which 
have been pre-treated with alkaline phosphatase to eliminate phosphorylation, 
would help clarify the mechanisms underlying these findings.Chapter 7     
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Effect of Cdc42 and assessment of  7 
phosphorylation  on  WASp  activation 
in vitro
Introduction 7.1 
The results described in chapter 5 suggest that the bead based actin polymerisation 
assay assesses de novo actin polymerisation independent of Cdc42 induced 
WASp activation (discussed in chapter 5.4). In this chapter I have explored this 
further by assessing the direct effect of Cdc42 on WASp activation and its affinity 
for various WASp constructs. It has been previously demonstrated that in vitro 
Cdc42 induced WASp activation reduces the threshold for WASp phosphorylation 
by 40 fold (Torres and Rosen, 2006), and a functional link between Cdc42 and 
WASp tyrosine phosphorylation has been proposed. To explore this hypothesis 
within the bead based actin polymerisation system, I have assessed the effect of 
the actin polymerisation assay on WASp phosphorylation.
In this chapter I present results of experiments which manipulate the activity of 
Cdc42 either by loading with an excess the non hydrolysable guanine nucleotide 
(GTPγS) or by using constitutively active or dominant negative Cdc42 mutants. 
The activity and the ability of Cdc42 to bind WASp are absolutely dependent 
on it being bound to GTP. As discussed in chapter 1.5.1, Cdc42 has an intrinsic 
GTPase activity which limits its duration of activation, and this is regulated by 
opposing actions of GAP and GEF proteins. As a result, activity of Cdc42 is tightly 
regulated, and the molecular basis of this regulation is the phosphorylation state 
of the guanine nucleotide bound to the Cdc42 switch region.
Guanosine 5′-[γ-thio]triphosphate (GTPγS) is a non hydrolysable analogue of 
GTP which once bound to a small GTPase maintains it in an active state for much 
longer than GTP. As a consequence, once loaded with GTPγS Cdc42 becomes 
constitutively  active  and  loses  its  regulation  by  GAP  and  GEF  proteins. The 
Cdc42 G12V (12V) missense mutant is GTPase deficient, and as a result once 
GTP has bound Cdc42 12V, it remains unhydrolysed, keeping Cdc42 in an active 
conformation. As a consequence, like GTPγS loaded WT Cdc42, Cdc42 12V is 
constitutively active, and resistant to regulation. By contrast, the T17N Cdc42 
mutation (17N) has a much higher affinity for GDP than WT Cdc42. As a result 
the rate of nucleotide exchange from GDP to GTP in 17N Cdc42 is much slower 
than that of WT Cdc42, maintaining the 17N mutant in an inactive conformation. 
Cdc42 17N acts as a dominant negative mutant because it is still able to bind Chapter 7     
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Cdc42 activating proteins, such as GEFs, and therefore reduces the activation 
signals available to WT Cdc42. These mutants are well established tools in the 
investigation of Cdc42 function both in vitro and in vivo (Symons et al., 1996; 
Kozma et al., 1995).
WASp - Cdc42 affinity 7.2 
Pulldown of exogenous Cdc42 by immobilised GST-WASp in  7.2.1 
presence of GTPγS
Purified protein system 7.2.1.1 
The interaction of Cdc42 and WASp was initially investigated in a purified protein 
system based on previously published protocols (Suetsugu et al., 1998; Ma et al., 
1998a). Bead bound GST-WASp was incubated with GTP or GDP loaded Cdc42 
in XB buffer for 1 hour with rotation. Unfortunately no Cdc42 binding was detected 
on the washed beads (Appendix figure A.13) for any samples, and therefore this 
approach was abandoned.
Supplementation of U937 lysate 7.2.1.2 
An alternative approach was explored where excess Cdc42 was incubated with 
bead bound WASp in the presence of physiological cell lysate. GTPγS loaded 
Cdc42 12V was added to U937 lysate and this was then incubated with GST-
WASp coated beads, and the Cdc42 pulled down by WASp was assessed. Excess 
GTPγS was used because Cdc42 12V requires GTP binding to be constitutively 
active,  and  by  preloading  the  Cdc42  with  GTPγS,  the  potential  confounding 
requirement  of  endogenous  GTP  (which  is  unstable  in  aqueous  solution)  is 
removed. This experiment is essentially the same as an actin polymerisation 
assay with Cdc42 supplementation replacing ATP supplementation. The Cdc42 
binding in this experiment is shown in figure 7.1a, and the full actin polymerisation 
assay is shown in figure 7.2c.
Figure 7.1a demonstrates WASp binding to Cdc42, when excess exogenous 
Cdc42 12V is present, but no binding of endogenous Cdc42 from un-supplemented 
lysate. The H246D and dBasic domain WASp constructs show no Cdc42 binding, 
but  the  remaining  domain  deletion  constructs,  the  clinical  mutations  and  the 
constitutively active constructs all show good Cdc42 pulldown. The importance 
of GTP binding to Cdc42 in its interaction with WASp is demonstrated by the 
experiments with the S272P construct, where 12V Cdc42 binds WASp, but 17N 
Cdc42 does not. Unfortunately the equivalent WT WASp experiments were lost 
due to technical problems with the electrophoresis and Western blotting.Chapter 7     
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Fig  7.1
Fig 7.1 Cdc-42 bind-
ing to standard pan-
el of constructs and 
effect  of  GTPγS  on 
actin  polymerisa-
tion.  (a)  GST-WASp 
coated  beads  were 
incubated  with  U937 
lysate  (2x10  7  cell/ml 
lysed in APB with pro-
tease  inhibitors,  clari-
fied  by  centrifugation 
and  supplemented 
by 5mM Mg2Cl but no 
ATP), with or without recombinant 125nM Cdc42 12V (constitutively active) or Cdc42 
17N (constitutively null) added to the lysate (as labelled). Cdc42 was preloaded with 
GTPγS for 1 hour (see 2.8.3 for details). Beads were incubated for 1 hour, then washed once 
with APB prior to being reduced and resolved by NuPAGE and western blotting. Blots were im-
munostained for GST (WASp) and Cdc42. (b) Cos 7 cells were transfected (using JET-PEI) in 6 
well plates with GST-WASp constructs. At 72 hours, 200μM of GTPλS or GDP was added to the 
culture medium for 30 minutes. Cells were then washed and lysed in 250μl of ice cold LB con-
taining protease and phosphatase inhibitors and clarified by centrifugation. Supernatants were 
incubated overnight with 10μl of sepharose beads, and then the following morning they were 
washed 3 times in lysis buffer. The resultant beads were reduced and resolved by SDS-PAGE 
and blotted for GST and Cdc-42. Immunoblots of lysate prior to bead incubation, and beads 
themselves are shown. UT - untransfected lysate. (C) A standardised volume of GST-WASp or 
GST coated Sepharose beads were incubated for 1 hour with U937 lysate (2x107 cells/ml lysed 
in APB with protease inhibitors, then clarified by centrifugation) supplemented with 5mM MgCl2, 
no ATP, but with the stated concentration of GTPγS prior to bead incubation .  Beads were then 
pelleted and washed twice with APB, prior to reduction in SB and resolution by NuPAGE and 
western blotting.
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Co-immunoprecipitation of GST-WASp / Cdc42 complexes from  7.2.2 
transfected Cos 7 cells
The experiment described in 7.2.1.2 assesses the formation of WASp – Cdc42 
complexes in vitro on the surface of sepharose beads. By transfecting Cos7 cells 
(using PEI) with GST WASp, and then treating the cells with GTPγS prior to 
lysis, the formation of in vivo cellular WASp – Cdc42 complexes was assessed. 
After GTPγS treatment Cos7 cells were washed and lysed, and GST-WASp was 
pulled down using glutathione sepharose beads. The beads were then washed, 
resolved by NuPAGE, Western blotted and immunoblotted for Cdc42.
Figure 7.1b again demonstrates good Cdc42 binding for all constructs except for 
H246D and the dBasic deletion constructs. This experiment again illustrates that 
this interaction is dependent on GTP binding to Cdc42, as treating the cells with 
GDP rather than GTPγS inhibited the WT WASp – Cdc42 binding.
These two experimental approaches demonstrate a similar pattern of Cdc42 binding 
among the experimental WASp constructs. Although this data is preliminary and 
requires further confirmatory experiments, it is supportive of previously published 
results (Hemsath et al., 2005; Kato et al., 1999). Other than the dBasic domain 
and H246D constructs the majority of the other WASp constructs tested appear 
to have a similar affinity to WT WASp for Cdc42. Both experiments suggest the 
dVCA domain construct has a higher affinity. In Figure 7.1 the Cdc42 band pulled 
down by the dVCA construct is larger than that for the other constructs, and in 
figure 7.1b the Cdc42 bands appear to be of similar size, but the input WASp band 
for the dVCA construct is significantly reduced. The first experiment suggests that 
the dPolyP construct may have a reduced Cdc42 affinity, but this is not borne out 
in the second experiment. 
Effect of guanosine nucleosides on WASp activity 7.3 
An  initial  approach  I  used  to  explore  the  effect  of  Cdc42  on  the  activity  of 
different WASp constructs was to supplement the U937 lysate used in the actin 
polymerisation assay with GTPγS. Such a strategy should render all endogenous 
Cdc42 in the U937 lysate constitutively active, and therefore increase the level 
of Cdc42 dependent actin polymerisation. This approach has the advantage of 
being simple to implement, and maintains physiological proportions of Cdc42 
and other mediators in the lysate. The major disadvantage to this approach is 
that GTPγS will indiscriminately activate all small GTPases, and therefore the 
actin polymerisation measured may reflect the activity of several small GTPases, 
acting on different aspects of actin dynamics.Chapter 7     
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Figure 7.1c demonstrates no effect of GTPγS on the activity of WT WASp in 
the absence of ATP. The level of actin polymerisation seen with WT in U937 
lysate supplemented with 100µM GTPγS, was equivalent to the activity seen with 
cytochalsin D inhibition and with GST alone. This figure is representative of two 
experiments, with a total of six different constructs tested for GTPγS sensitivity 
(including constitutively active and constructs with reduced actin polymerisation 
activity). None showed any change in activity with addition of GTPγS.
A possible explanation for the lack of response to GTPγS is that the assay was 
not  supplemented  with ATP. I feel  this  is  unlikely  as  the  constitutively  active 
constructs are able to polymerise actin in the absence of ATP, and binding of 
Cdc42 to WASp is thought to render WASp uninhibited and therefore active. A 
second possibility is that any increase in WASp activity is negated by a GTPγS 
induced inhibitory action on actin polymerisation upstream of WASp, mediated 
by other Rho type GTPases. In light of the other data presented in this chapter 
and in chapter 5, I feel it is more likely that these results represent insensitivity to 
Cdc42 in the bead based actin polymerisation assay.
Effect of exogenous Cdc42 on WASp activity 7.4 
Optimisation 7.4.1 
To investigate the direct effect of Cdc42 on the activity of WASp in the bead based 
actin polymerisation assay, it was necessary to supplement actin polymerisation 
reactions with exogenous Cdc42. Cdc42 was purified from transformed E.coli 
and preloaded with guanosine nucleotides prior to addition to U937 lysate, as 
described in chapters 2.8 and 3.6 and figure 3.13.
Figures 7.2a and b show the effect of increasing concentrations of exogenous 
Cdc42 on WASp activity. Fig 7.2a shows an actin polymerisation assay performed 
with lysate supplemented with 0.5mM ATP. GTPγS loaded Cdc42 (WT, dominant 
negative or constitutively active as stated) was then added to the lysate prior to 
incubation with WT WASp coated beads. Despite an increase in Cdc42 binding to 
WASp, increased Cdc42 concentration did not produce a corresponding increase 
in actin polymerised on the bead surface. Additionally there was no difference in 
activity between assays performed in the presence of WT or 12V, and no dominant 
negative effect on activity seen with 17N Cdc42.
One possible explanation for the lack of effect of Cdc42 in this assay, was that 
the addition of 0.5mM ATP had maximally enhanced the WASp activity induced 
by endogenous WASp activators, and therefore the effect of Cdc42 was not Chapter 7     
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Fig  7.2
Fig 7.2 Effect  of  Cdc42  on 
actin polymerisation assay
(a) Standard actin polymerisa-
tion assay performed with WT 
GST-WASp  coated  beads. 
Lysate  supplemented  with 
0.5mM  ATP  and  stated  con-
centration  of  GTPγS  loaded 
Cdc42 (WT or stated mutant). 
(b)  Standard  actin  polymeri-
sation  assay  performed  with 
WT GST-WASp coated beads. 
Lysate  supplemented  with  no 
ATP  and  stated  concentration 
of GTP loaded Cdc42 12V. (c) 
Actin polymerisation assay per-
a
b
C
formed on standard and constitutively active panels of WASp constructs. Lysate was supplement-
ed with 125nM GTPγS loaded Cdc42 12V (or Cdc42 17N) or an equal volume of GTPγS loading 
solution without Cdc42. No ATP added to the lysate. For all three experiments reactions were 
stopped at 1 hour and the beads were washed in APS. Beads were then reduced and resolved by 
NuPAGE and western blotting. Membranes were immunoblotted for WASp, GST, Actin, ARPC2 
and Cdc42 as stated.
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detected due to saturation of the assay. To investigate this, a similar experiment 
was repeated using U937 lysate without ATP supplementation, but with increasing 
concentrations of GTPγS loaded Cdc42 12V. Figure 7.2b suggests that at a 
concentration  of  125nM  Cdc42  12V  does  enhance  actin  polymerisation,  but 
that at higher concentrations this effect is lost. It is important to emphasis that 
the image of the actin blot in figure 7.2b is significant overexposed compared to 
that in figure 7.2a, as demonstrated by the relative sizes of the actin standards. 
Therefore the activity of WASp in the presence of 125nM Cdc42 12V alone is 
still significantly less than that of WT in the presence of 0.5mM ATP. In light of 
the results of the other experiments presented in this chapter it is likely that this 
result is a technical artefact, as it is the only experiment which has demonstrated 
any effect of Cdc42 on the actin polymerisation assay. As it was performed as 
an optimisation experiment to determine the most appropriate concentration of 
Cdc42 to use in subsequent experiments, it was not repeated, and a concentration 
of 125nM Cdc42 was used in subsequent experiments.
Results 7.4.2 
Figure 7.2c shows the effect of 125nM Cdc42 12V on the actin polymerisation 
activity of the full panel of experimental WASp constructs. The conditions used 
were the same as for figure 7.2b, with each construct’s activity compared in Cdc42 
supplemented U937 lysate to sham supplemented lysate. The results from this 
experiment were unable to reproduce the enhanced actin polymerisation with 
Cdc42 by WT WASp seen in figure 7.2b. None of the constructs tested showed any 
appreciable difference in actin polymerisation between the Cdc42 supplemented 
experiment and the un-supplemented experiment. Together, these results suggest 
that Cdc42 at most has a minimal effect on the activity of WASp constructs in the 
bead based actin polymerisation assay.
Tyrosine and serine phosphorylation of WASp during  7.5 
actin polymerisation assay
It has been proposed that phosphorylation of tyrosine 291 in WASp occours 
following destabilisation of the WASp autoinhibitory conformation (Torres and 
Rosen, 2006; Torres and Rosen, 2003; Cory et al, 2002). As this destabilisation 
must also occour for WASp activation, this hypothesis would suggest that tyrosine 
phosphorylation of WASp would increase during the actin polymerisation assay. 
To determine whether changes in WASp phosphorylation occur during the actin 
polymerisation assay, the degree of tyrosine and serine483/484 phosphorylation 
of bead bound WASp was compared before and after incubation with U937 lysate 
in the actin polymerisation assay. Figure 7.3 shows a series of immunoblots from Chapter 7     
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a standard actin polymerisation assay (ATP supplemented) comparing several 
WASp constructs from the standard and constitutively active panels of constructs. 
For each construct the first column shows purified bead bound WASp, and the 
second column shows the same volume of beads following incubation with U937 
lysate as an actin polymerisation assay. The beads were immunoblotted for GST, 
phosphotyrosine and phosphserine483/484, as well as for actin and ARPC2 to 
demonstrate activity.
For all constructs, the purified WASp protein showed some tyrosine and serine 
phosphorylation, and the levels of phosphorylation appeared to be equivalent 
between each construct. There did not appear to be any change in phosphorylation 
status  following  the  actin  polymerisation  assay,  for  any  construct.  Previous 
studies  have  demonstrated  a  subtle  motility  shift  associated  with  tyrosine 
phosphorylation of WASp at Y291 (Cory et al., 2002). No difference in migration, 
Fig 7.3 Serine and Tyrosine phosphorylation during actin polymerisation assay
(a) A standard actin polymerisation assay (with 1mM ATP) was performed and the resultant beads 
were washed, reduced and resolved next to equivalent beads which had not been incubated with 
U937 lysate. Following NuPAGE and Western blotting, membranes were first blotted for phospho-
tyrosine, and subsequently stripped and reblotted for phosphoserine. Finally the membrane was 
stripped and reblotted with anti GST antibody. Blots were developed following stripping to ensure 
no residual signal remained on the membrane. The secton of the membrane containing proteins 
smaller than 50 kDa was blotted for actin and ARPC2.
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suggestive of phosphorylation, between the pre and post assay WASp samples 
is seen in figure 7.3, or in a similar experiment where the gel was run for much 
longer allowing greater separation of WASp bands (data not shown). This data is 
representative of two experiments, and a similar lack of correlation between actin 
polymerisation activity and WASp phosphorylation was seen when immunoblots 
from the ATP titration and time course experiments (figures 4.3a, 4.5c and 5.8a) 
were stripped and reblotted with anti phosphotyrosine antibody (appendix figure 
A.14). The results from these experiments would have been stronger if reliable 
positive and negative control samples had been run along side the experimental 
samples. Such controls could be generated by pretreating WT WASp beads with 
purified phosphatases and kinases, and this experiment will be repeated in future 
work. Nonetheless, these results suggest there is no net change in tyrosine or 
serine483/484 phosphorylation of WASp during the bead based actin polymerisation 
assay.
Conclusions 7.6 
The data in this chapter provides further information to that already published 
on the complex role of Cdc42 in the regulation of WASp activity. The key finding 
from these experiments, and those in chapter 5, is that Cdc42 has no effect on 
WASp activity in the bead based actin polymerisation assay, despite binding to 
WASp appropriately. I will discuss this surprising result in the context of previously 
published data.
WASp – Cdc42 binding 7.6.1 
Binding of Cdc42 to WT WASp was demonstrated under conditions where the 
Cdc42 was constitutively active (either as mutant 12V Cdc42, or bound to GTPγS). 
Interestingly endogenous Cdc42 was not pulled down by WASp in physiological 
lysate (figures 7.1a and A.13). This may be because of the inherent instability 
of GTP in aqueous cell lysate, or it may represent the transient binding of GTP 
bound Cdc42 to WASp.
Both experimental approaches shown in figures 7.1a and b demonstrated that 
substitution of the WASp 246 histidine residue for an aspartate residue abolished 
Cdc42 binding. Both this missense mutation (Kato et al., 1999) and the equivalent 
point mutation in NWASp (H208D) (Miki et al., 1998a) had been previously shown 
to prevent Cdc42 binding. This histidine residue is highly conserved among the 
CRIB domains of Cdc42 binding proteins (Symons et al., 1996), and the large 
ionic change induced by substituting a basic amino acid for an acidic amino acid 
is sufficient to abolish Cdc42 binding.Chapter 7     
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Deletion of the basic domain similarly prevented Cdc42 binding. Although the Basic 
domain does not contain a direct binding site for Cdc42, Hemsath et al proposed 
a model in which the positive charge of the basic domain electrostatically attracts 
Cdc42. Association between the negatively charged Glu49 and Glu175 Cdc42 
residues and the WASp Basic domain facilitate docking of Cdc42, which initiates 
destabilisation of the autoinhibitory conformation, and reveals the Cdc42 binding 
sites in the GBD (Hemsath et al., 2005). They demonstrated that substituting 
the WASp basic amino acids within the Basic domain for neutral amino acids 
reduced the affinity for Cdc42 by 93 fold, and this correlated with an equivalent 
reduction in WASp activity in a purified protein pyrene actin polymerisation assay. 
The results from this study support this hypothesis.
Alternative  explanations  for  the  dBasic  domain  mutant’s  impaired  Cdc42 
association should be considered. It is possible that the basic domain binds a 
third protein which is essential in recruiting Cdc42 to WASp. An obvious candidate 
for such a protein is TOCA1 (Ho et al., 2004), but against this, TOCA1 interacts 
with  NWASp  via  its  SH3  domain,  and  therefore  almost  certainly  binds  the 
polyproline domain. Alternatively the basic domain may play a role in the change 
in tertiary structure brought about in the GBD on transition from the autoinhibitory 
conformation to the Cdc42 bound conformation. As the tertiary structure has only 
been elucidated for Cdc42 bound to an isolated WASp GBD (Abdul-Manan et 
al., 1999), the basic domain may be critical for the stability of the Cdc42 – GBD 
complex, in the context of full length WASp.
Both H246D WASp and the dBasic construct are able to induce actin polymerisation 
at similar or greater levels compared to WT WASp. This functionality strongly 
suggests that the gross tertiary structure and folding of these constructs is similar 
to WT WASp. This cannot therefore account for their inability to bind Cdc42.
Both the missense mutations responsible for WAS / XLT, and the constitutively 
active WASp constructs showed normal affinity for Cdc42. Normal Cdc42 binding 
to  R86H  and  R86C  WASp  has  been  previously  demonstrated  (Kolluri  et  al., 
1996), but there is no published data on the Cdc42 affinity of XLN missense 
mutations or other constitutively active WASp constructs. These results support 
the conclusions from chapter 5, that the key activation mechanisms of WASp 
containing WAS or XLT point mutations is normal, and the clinical phenotype 
seen in these conditions is not due to an inability of the WASp protein to nucleate 
actin effectively and appropriately. The similar affinity of Cdc42 for WT-WASp and 
constitutively active WASp suggests that Cdc42 binds both the autoinhibited and 
open conformations of WASp. Chapter 7     
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WASp binding to Cdc42 was demonstrated in a cellular and a cell lysate system, 
but was not detected in a purified protein system. Cdc42 may require a further 
factor to optimally bind WASp, which is present in U937 lysate, but is not present 
in the purified protein experiments. Again TOCA-1, which is essential for Cdc42 
mediated actin polymerisation in a pyrene based actin polymerisation assay (Ho 
et al., 2004), is a candidate protein. Direct binding of Cdc42 to WASp in purified 
protein  systems  has,  however,  been  previously  published  by  several  groups 
(Hemsath et al., 2005; Torres and Rosen, 2003; Symons et al., 1996; Kolluri 
et al., 1996; Aspenstrom et al., 1996). I feel it is more likely, therefore, that my 
results represent a technical failure and that further optimisation work may have 
elucidated a similar interaction to that detected in the cell lysate system.
Cdc42 activation of WASp in bead based assay 7.6.2 
Several lines of evidence suggest that Cdc42 has no effect on WASp activation 
in the bead based actin polymerisation assay;
WASP H246D and dBasic constructs show normal (or increased) actin  1. 
polymerisation activity despite an inability to bind Cdc42.
The dEVH1 construct shows reduced actin polymerisation activity compared  2. 
to WT, despite previously published data suggesting that in the presence of 
Cdc42 the EVH1 domain contribution to activation is redundant (Suetsugu 
et al., 2001a; Rohatgi et al., 2000).
Supplementation of U937 lysate with increasing concentrations of GTPγS  3. 
has no effect on WASp activity.
Addition of recombinant Cdc42 to U937 lysate has no effect on WASp  4. 
activity, and no difference is detected between WT and H246D WASp in 
the presence of Cdc42.
Supplementation of U937 lysate with constitutively active and dominant  5. 
negative Cdc42 results in identical levels of WASp activity
Tyrosine phosphorylation of WASp is thought to be facilitated following  6. 
Cdc42 binding (Torres and Rosen, 2003), but no change is seen in WASp 
tyrosine phosphorylation during the actin polymerisation assay.
Although some of this data represents experiments which need further repetition, 
taken  together  this  strongly  suggests  Cdc42  insensitivity  in  the  bead  based 
actin polymerisation assay. Two questions arise from this observation; (1) why Chapter 7     
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does Cdc42 have no effect on WASp activity in this assay and (2) how is WASp 
activated when Cdc42 is having no effect?
One  possible  explanation  for  the  lack  of  effect  seen  with  Cdc42  is  the  fact 
that  the  exogenous  Cdc42  was  made  in  E  coli  and  therefore  would  not  be 
prenylated.  Previous  studies  have  found  that  Cdc42  synthesised  using  a 
Baculovirus transduction system (with Cdc42 synthesis in eukaryotic cells), but 
not by a prokaryotic synthesis system, has induced actin polymerisation in in 
vitro experiments (Higgs and Pollard, 2000; Ma et al., 1998b; Zigmond et al., 
1997). Other groups, however, have demonstrated WASp or NWASp activation 
with unprenylated Cdc42 (Yarar et al., 2002; Suetsugu et al., 2001b; Egile et al., 
1999; Miki et al., 1998a), and lack of prenylation cannot explain the similar activity 
of WT and H246D constructs, or the insensitivity of GTPγS supplementation of 
lysate.
As stated above, TOCA1 is also required for Cdc42 mediated WASp activation. 
A more plausible explanation for Cdc42 insensitivity is that U937 lysate is either 
lacking in TOCA1 or contains an excess of a TOCA1 inhibitor. I did obtain (gift 
from Marc Krischner, Harvard Medical School) a small aliquot of an anti TOCA1 
antibody, which I used to try to determine the presence and relative concentration 
of TOCA1 in U937 lysate. Unfortunately I was unable to get clear signals in 
positive and negative control cell lines and therefore the results in U937 cells 
were meaningless. This hypothesis could be tested by performing the bead based 
actin polymerisation assay using xenopus egg lysate (the substrate from which 
TOCA1 was identified and purified) and testing WT and H246D WASp constructs. 
By mixing U937 and xenopus egg lysates it would be possible to differentiate 
between a TOCA1 deficiency and the presence of an inhibitor in U937 cells.
How WASp is activated independently of Cdc42 is discussed in chapter 5.4.2.
WASp phosphorylation in the actin polymerisation assay 7.6.3 
Phosphorylation of WASp at Y291 (Torres and Rosen, 2003; Cory et al., 2002) is 
thought to occur following WASp activation and is associated with an increase in 
WASp activity. Phosphorylation of Y291 is markedly facilitated following Cdc42 
binding in vitro, and it has been proposed that Cdc42 acts synergistically with 
tyrosine kinases to activate WASp via phosphorylation (Torres and Rosen, 2006; 
Torres and Rosen, 2003). In this model the release of WASp autoinhibition makes 
the  Y291  residue  sterically  more  accessible  to  kinases,  which  provides  the 
molecular mechanism of this synergism. The authors demonstrate that tyrosine 
phosphorylated WASp is able to return to the autoinhibited conformation, but that Chapter 7     
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phosphorylation acts as a molecular marker of previous activation. This synergism, 
however, has not always been demonstrated in in vivo systems (Suetsugu et al., 
2002; Cory et al., 2002).
Phosphorylation of WASp at S483 / S484 is thought to be constitutive in cells 
and has also been associated with an increase in WASp activity (Cory et al., 
2003). Although casein kinase 2 has been shown to mediate this phosphorylation, 
the  mechanisms  and  regulatory  importance  of  this  modification  is  less  well 
understood.
Figure  7.3  suggests  there  is  no  change  in  WASp  phosphorylation  at  either 
tyrosine or serine residues during the actin polymerisation assay. This finding 
is surprising, considering the model proposed for f-actin production in the bead 
based actin polymerisation assay, relies on multiple activation events for each 
bead  bound  WASp  protein  (Chapter  4.9).  Each  WASp  construct  appears  to 
shows significant phosphorylation prior to incubation with U937 lysate, raising the 
possibility that the WASp may already be maximally phosphorylated. Although 
phosphorylation at S483 / S484 might be expected following purification from 
Cos7 cells, tyrosine phosphorylation would not be expected. WASp produced at 
physiological concentrations in haematopoietic cells is likely, however, to have 
a different phosphorylation pattern to WASp purified form a malignant monkey 
kidney fibroblast cell line.
Unfortunately no positive control lane for tyrosine phosphorylation was included 
in this experiment. It is possible that the tyrosine phosphorylation detected is 
unrelated to WASp activation and does not involve Y291. Although WASp has 
six other tyrosine residues, it has been published that tyrosine phosphorylation 
only occurs at Y291 (Badour et al., 2004; Baba et al., 1999). These experiments 
were all performed in haematopoietic cells, which may show more specific and 
tighter control of tyrosine phosphorylation than Cos7 cells. Other unpublished 
data suggests WASp is tyrosine phosphorylated at residues other than Y291 
(Giles Cory personal communication).
Two  other  results  are  anecdotally  supportive  of  this  hypothesis.  Firstly,  as 
discussed above (chapters 7.6.2 and 5.4.2) the actin polymerisation assay is 
independent of Cdc42 induced WASp activation. It has been proposed that Y291 
phosphorylation is specifically associated with Cdc42 activation. This is supported 
by the impaired in vivo tyrosine phosphorylation of H246D and dBasic WASp 
constructs expressed in U937 cells (figure 8.7 and chapters 8.3 and 8.7.4). The 
lack of change in tyrosine phosphorylation state during the actin polymerisation Chapter 7     
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assay, therefore, may reflect no Cdc42 induced WASp activation in this assay. 
Secondly, the Y291E WASp construct has an equal tyrosine phosphorylation 
signal to WT WASp, despite having no tyrosine residue at Y291. Furthermore if 
WASp were maximally phosphorylated at Y291 prior incubation with U937 lysate, 
then no difference in activity would be expected between WT WASp and Y291E. 
Figure 5.3, and previously published data (Cory et al., 2002) demonstrate a small 
but definite difference between these constructs. Together this data supports the 
hypothesis that the tyrosine phosphorylation detected on bead bound GST-WASp 
is neither at Y291 or related to WASp activation, and that no Y291 phosphorylation 
occurs during the bead based actin polymerisation assay.Chapter 8     
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EGFP-WASp  expression  in  U937  8 
cells
Introduction 8.1 
Determinant of WASp expression 8.1.1 
Genotype  –  phenotype  studies  in  Wiskott  Aldrich  Syndrome  and  X-linked 
thrombocytopenia  have  demonstrated  a  correlation  between  levels  of  WASp 
expression in lymphocytes and severity of disease (Lutskiy et al., 2005; Jin et al., 
2004; Imai et al., 2004; Lemahieu et al., 1999; Zhu et al., 1997; Remold-O’Donnell 
et al., 1997). Generally children with XLT have missense mutations within the 
EVH1 domain, although some of these children develop the more severe WAS 
phenotype,  frequently  with  autoimmune  complications.  Exon  4  mutations,  in 
particular, have been associated with worse clinical disease (Lutskiy et al., 2005; 
Zhu et al., 1997). Understanding the mechanisms which determine the level of 
mutant WASp protein in lymphocytes, and the effect this mutant protein has on 
cell survival and function, is important for understanding the pathogenesis of 
autoimmunity and immunodeficiency in these conditions.
WIP has been shown to be essential in maintaining cellular WASp levels (de la 
Fuente et al., 2007; Konno et al., 2007; Chou et al., 2006). In resting cells the 
vast majority of WASp is bound to WIP (de la Fuente et al., 2007; Sasahara et 
al., 2002), and in addition to preventing WASp degradation it also inhibits WASp 
activation (Martinez-Quiles et al., 2001) and probably directs WASp to sites of 
active actin remodelling (Myers et al., 2006; Vetterkind et al., 2002; Martinez-
Quiles et al., 2001; Moreau et al., 2000). Both calpain and the proteasome have 
been implicated in WASp degradation (de la Fuente et al., 2007; Chou et al., 
2006; Suetsugu et al., 2002) but the regulation of this degradation and how it 
relates to WASp function remains poorly understood.
Mutations  in  the  WASp  gene  lead  to  cytopenias  in  several  haematopoietic 
lineages, but classically WAS patients develop lymphopenia and patients with 
XLN develop neutropenia. The reasons for this are poorly understood, but toxicity 
of mutant WASp protein in blood cell precursors has been suggested as a possible 
aetiology (Moulding et al., 2007).
In  this  chapter  I  present  experiments  which  assess  the  expression,  stability 
and toxicity of EGFP-WASp when overexpressed in U937 cells following stable 
transduction with lentivirus. I have elected to use U937 cells for this purpose for 
several reasons. Firstly, they are a myeloid cell line and therefore representative Chapter 8     
240
of cells which are effected in WAS / XLT. Secondly, they express high levels of 
both WASp and WIP, which facilitates a comparison of the expression of mutant 
EGFP-WASp  with  endogenous  WASp.  Finally  they  are  a  robust  and  rapidly 
dividing cell line, which allowed a high throughput of experiments in a realistic 
time frame.
Lentivirus as a tool for transduction 8.1.2 
In this research project I have utilised modified (second generation) lentivirus 
as a tool for transducing primary cells and haematopoietic cell lines (U937 and 
THP1 cells), both of which are extremely resistant to transfect using non-viral 
methods (Zhong et al., 1999; Arthur et al., 1997). Lentiviral transduction of cell 
lines reliably yields very high efficiencies of gene transfer (>80%) and the genes 
are subsequently stably expressed for many months. Both of these attributes 
were essential for many of the experiments I have performed in haematopoietic 
cells lines.
For bone marrow derived primary dendritic cells, lentivirus transduction allows 
gene transfer at reasonable efficiency and low toxicity. Other viral vectors have 
been used successfully, but dendritic cells are resistant to transduction by gamma-
retroviruses once terminally differentiated (and therefore not dividing) (Ardeshna 
et al., 2000; Gruber et al., 2000; Gasperi et al., 1999; Lewis and Emerman, 1994), 
and are therefore not suitable for transforming bone marrow derived dendritic 
cells.  Other  viral  vectors  which  have  been  used  to  successfully  transduce 
dendritic cells (Herpes simplex virus, Vaccinia virus and Influenza virus) have 
demonstrated significant dendritic cell cytopathic effects, and reduced viability 
(Jenne et al., 2001). Adenoviral vectors have lower transduction efficiencies than 
lentivirus, with similar low levels of toxicity (Esslinger et al., 2002).
Lentiviruses are members of the retroviridae family of viruses. These are RNA 
viruses  characterised  by  an  ability  to  reverse  transcribe  their  RNA  to  DNA 
following host cell infection, and integrate the resultant proviral DNA into the host 
cell’s genome. Following reverse transcription, a U3, R, U5 unit is generated at 
each end of the proviral genome, which is called the long terminal repeat (LTRs). 
These sequences are essential for the insertion of the proviral DNA into the host 
genome and also act as promoters for transcription of the viral DNA.
Lentiviruses (in particular HIV-1) have been manipulated to create a safe gene 
transfer  system  which  has  minimal  toxicity  to  the  target  cell.  Manipulations 
included in the second generation lentivirus include breaking the “infecting” viral 
genome into three plasmids (Naldini et al., 1996), removal of viral accessory Chapter 8     
241
and regulatory genes which are not absolutely necessary for virus synthesis, 
and selective mutation of the U3 region of the LTR. This makes the virus self 
inactivating (SIN) and replication incompetent (Zufferey et al., 1998).
The three plasmids are a transfer vector, containing the gene of interest with 
an internal promoter contained within the LTRs, a packaging vector, containing 
gag, pol and other essential HIV-1 accessory factors under a CMV promoter, 
and  an  envelope  vector  containing  a  VZV-G  envelope  protein  under  a  CMV 
promoter. These are co-transfected into a packaging cell line, which generates 
replication deficient virus containing only the RNA encoded within the LTRs of 
the transfer vector. The VZV-G envelope protein provides the virus with broader 
trophism than the HIV-1 envelope protein and therefore increases the efficiency 
of transduction of both DCs and U937 cells. The transfer vector also contains a 
Woodchuck hepatitis post translational regulatory element (WPRE) and a central 
polyproline tract (cPPT) both of which act to enhance the nuclear transport of the 
viral genome and increase the efficiency of transduction (Follenzi et al., 2000; 
Schambach et al., 2000; Zufferey et al., 1999).
Expression  of  EGFP  tagged  clinical  and  domain  8.2 
deletion mutants
U937 cells were infected with lentivirus encoding a panel of EGFP-WASP constructs 
(EGFP alone (SEW), WT, 4 EVH1 missense mutations, dEVH1, dBasic, dPolyP, 
dVCA, and the H246D point mutation) at MOIs of 5 and 1. These cells were then 
cultured for one month during which time expression of the EGFP-WASp was 
monitored by FACS, and by SDS-PAGE and western blotting of cell lysates. After 
31 days of culture the MOI 5 stably transfected cell lines were sorted into high 
and low expression populations (with negative cells discarded), and these purer 
populations were then cultured for a further 2 months with monitoring of EGFP-
WASp expression. Data from the “MOI 5” cell lines (figures 8.1) and the “high 
expression” lines (figures 8.2 – 8.4) are shown here, as these results were clearer, 
but the results from cell lines with lower expression of EGFP-WASp constructs 
are described in the text where relevant (data not shown). Examples of the gating 
used for sorting and the EGFP expression in the sorted populations are shown in 
figures 8.1b-i.
A second series of experiments was performed on a panel of constitutively active 
WASp constructs (WT, S272P, I294T, Y291E, dVCA binding domain). Previous 
evidence suggested that these constitutively active constructs are not stable in 
long term culture and lead to cell division defects and apoptosis in EGFP-WASp Chapter 8     
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Fig 8.1 Growth  of  U937  cells  trans-
duced with EGFP-WASp constructs
U937 cells were transduced using lenti-
virus encoding EGFP-WASp constructs 
with an MOI of 5. (a) % EGFP positive 
cells as determined by FACS at 10, 17, 
24 and 31 days post infection. (b-i) 31 
days post infection cells were sorted into 
high and low EGFP expression. Plots for 
WT-EGFP-WASp and untranfected (UT) 
cells are shown. (b) and (e) show forward 
– side scatter plots and the gating used 
for unsorted cells. (c) and (f) shows the 
EGFP expression of gated cells. (d) and 
(g) show the gates used to separate high 
expressor  (gate  I)  and  low  expressors 
(gate H). (h) and (i) show the EGFP ex-
pression  of  sorted  cells.  (j)(k)  Follow-
ing sorting, % EGFP positivity of stably 
transduced  cell  lines  (high  expressers) 
was  determined  regularly  by  FACS.  (j) 
shows clinical mutant constructs and (k) 
shows  domain  deletion  constructs.  For 
all FACS experiments at least 104 cells 
were analysed.
b - i
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positive cells ((Moulding et al., 2007) and personal communication Dale Moulding). 
As a result, these cell lines were established using an MOI of 5, and expression 
was checked using FACS at day 3 and 9. At day 9 cells were completely harvested 
for SDS-PAGE and western blotting (see figure 8.3).
Stability of EGFP-WASp expression 8.2.1 
The percentage of EGFP-WASp positive cells within each transfected culture, gives 
a surrogate marker of the impact of over expression of each WASp construct on 
the cell’s growth, division and survival. Any cell culture containing EGFP positive 
cells will also contain untransfected cells, and therefore any impairment of growth 
induced by transfection will result in a rising percentage of EGFP negative cells.
Figure 8.1a shows the percentage EGFP positivity for each construct during the 
31 days following transfection and figures 8.1j and k show similar data for the 55 
days following cell sorting. All the WASp constructs show a fall in expression by 
31 day post transfection compared to the SEW transfected cells. The greatest 
loss of EGFP expression is seen with the 4 clinical, dEVH1, H246D and dVCA 
domain constructs.
Following sorting, EGFP positivity drops from 100% to between 85 and 95% for 
all constructs within the first 10 days (figure 8.1j and k). After this, however, EGFP 
expression  remains  stable  at  between  80  and  90%  for  all  constructs  except 
dVCA (figure 8.3a). The dBasic and dPolyP constructs retain higher levels of 
EGFP positivity than WT, whereas the H246D and dEVH1 constructs show a 
similar pattern to WT WASp. The clinical mutants have a small but consistent 
impairment of EGFP expression compared to WT WASp, with expression running 
at approximately 5% lower than WT. The dVCA construct showed a much faster 
fall in EGFP expression and once stabilised, this expression was approximately 
20% lower than that of WT WASp.
The fall in EGFP WASp expression seen in lentivirus transduced cells could be 
due to toxicity of the virus itself or due to toxicity of the encoded protein. In the 
experiments shown a high multiplicity of infection was used (5) to transduce the 
U937 cells, with the aim of maximising the detection of any differences between 
the constructs. As a result some viral and / or transgene toxicity is very likely, and 
a high proportion of EGFP positive cells will contain more than one copy of the 
EGFP WASp gene. If it is assumed that cell death due to lentiviral toxicity is equal 
between each WASp construct, then differences in EGFP WASp expression are 
likely to reflect differences in toxicity of mutant WASp protein. The effect of viral 
toxicity was further minimised in these experiments by sorting the cells several Chapter 8     
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weeks after lentiviral infection, and following EGFP expression for a further 2 
months following sorting.
In summary, these results demonstrate that the dVCA construct shows a significant 
fall in expression over time, and this fall continued throughout the 3 months of 
monitoring expression. The clinical mutants showed a small reduction in EGFP 
expression compared to WT, although this difference appeared to stabilise at 
approximately 5% less than WT WASp expression. The rate of decrease in EGFP-
WASp positivity was similar between the clinical mutant and WT. The remaining 
truncation and deletion constructs showed a similar temporal pattern of EGFP-
WASp expression to WT.
Level of EGFP WASp expression by FACS 8.2.2 
Figure 8.2 shows the EGFP fluorescence profile, by FACS, of the stably transfected 
U937 cell lines 55 days following sorting and this information is shown graphically 
in figures 8.3a and 8.3b. These plots illustrate that although each of these cell 
lines may have similar levels of EGFP positivity, the amount of fluorescence within 
each cell varies between different cell lines. The SEW transfected cell lines show 
levels of fluorescence 20x higher than the next “brightest” cell line and the dVCA 
transfected cells showed a significantly lower mean fluorescence intensity (MFI) 
than the other WASp transduced cell lines.
The clinical mutants all show lower levels of fluorescence than WT. Although 
this difference appears quite small in figure 8.3b, it is more convincing when the 
individual FACS plots are assessed (figure 8.2). This difference in MFI between 
WT and the clinical mutants was repeatedly seen on a total of 10 FACS analysis 
taken at time points before and after the cell lines were sorted for expression. 
The MFI recorded is that of EGFP positive cells only, so this difference cannot 
be accounted for by small differences in the % positivity within each culture. The 
dEVH1 transfected cell line consistently showed higher levels of fluorescence 
than WT transfected cell line (figure 8.2 and 8.3b).
FACS data for constitutively active constructs 8.2.3 
Figures 8.3c and 8.3d show the % EGFP positivity and median fluorescence 
intensity of U937 cells, 3 and 9 day following lentivirus transfection with various 
constitutively  active  EGFP-WASp  constructs.  All  the  constitutively  active 
constructs tested dropped both the number of cells expressing EGFP-WASp and 
the intensity of expression much faster than WT WASp. For the constructs I294T, 
Y291E and dVCA binding, this fall in expression was noticeably more rapid than Chapter 8     
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R138P
A134T
dPolyP
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T45M
R86H
H246D
FS
SS
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R1
Fig 8.2 FACS plots of EGFP-WASp transduced U937 cells
U937 cells stably transduced with EGFP-WASp and sorted for high expression.  These plots were 
generated 55 days after sorting. 105 cells were acquired with at least 80% within the viable cell 
gate (R1). (a) Forward - side scatter plot of untransduced cells showing gated cells analysed. (b) 
Frequency histograms showing EGFP fluorescence intensity plots for full panel of constructs. Red 
line illustrates the mean flourescence intensitiy for WT-WASp.
a b
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that seen with all the other constructs tested in the standard panel (compare % 
positivity at 9 days post infection in figure 8.3c, to 10 days in figure 8.1a). A fall in 
MFI of the remaining positive cells also supports this, suggesting cells with lower 
levels of WASp expression have a survival advantage over those with higher 
expression levels. Interestingly the rate of fall in expression (figure 8.3c) appears 
proportional to the level of constitutive activity (figure 5.3).
Transfection with the S272P construct led to very high levels of toxicity within 
the cell culture. In fact, at day 9 post infection only 15% of cell analysed fell into 
the viable cell gate as determined by side and forward scatter, compared to at 
least 55% for all other constructs. It is very likely that this high level of cell death 
will have impacted on the growth of untransfected as well as transfected cells in 
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Fig 8.3 % EGFP positivity and mean fluorescence intensity of U937 cells transduced with 
EGFP-WASp constructs
(a) and (b) show % EGFP positivity and median fluorescence intensity for U937 cells after 55 
days of culture following cell sorting for high expression. (c) and (d) show % EGFP positivity and 
mean fluorescence intensity for the constitutively active mutant panel of constructs, 3 and 9 days 
following lentivirus infection with an MOI of 5.
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culture, resulting in a falsely high % positivity reading. The cell culture growth of 
the S272P transfected cells was insufficient to allow any further experiments on 
this construct in U937 cells.
Expression by Western blotting 8.2.4 
SDS-PAGE and western blots were performed on standardised cell lysates from 
post sorted stably transfected U937 cells lines. Blots were performed to analyse 
the expression of EGFP-WASp constructs within the U937 cells and also to assess 
the impact of over expression of mutant EGFP-WASp constructs on endogenous 
WASp expression. Because these cell lines stably express EGFP-WASp with 
similar levels of positivity (except for the dVCA construct) it is valid to directly 
compare lysates from these stable cell lines. The results from dVCA transduced 
lysate should be treated with more caution, as this cell line showed approximately 
70% of the EGFP positivity of WT cell lines.
Figure 8.4a shows an example series of blots and figures 8.4b – d show the 
combined analysis of densitometry performed on blots from 3 separate batches 
of  transfected  U937  cell  lysates.  The  methodology  used  to  standardise  the 
densitometry readings is described in detail in chapter 2.7.3
These results demonstrate that the clinical mutants have lower levels of EGFP-
WASp expression than WT. Although this difference is small (25-50% protein levels 
of WT WASp), it is reproducible and significant. Of note a similar difference was 
also found in U937 cells lysates following initial transfection, but before sorting, 
and in THP-1 cells transfected with EGFP-WASp constructs (data not shown). 
The dEVH1, dBasic and dPolyP transduced cell lines all show higher levels of 
expression than WT, (although these differences never reached significance), 
and the H246D construct showed similar expression to WT. The dVCA construct 
expressed at significantly lower levels than WT, and this level (approximately 
1/25th that of WT WASp) could not be explained by the differences see in % EGFP 
positive cells. All these results corroborate the MFI data from FACS analysis.
A more striking difference is seen in the effect of EGFP-WASp expression on 
endogenous  WASp  expression.  The  WT,  dBasic  and  Polyproline  constructs 
all  markedly  suppress  endogenous  WASp  expression,  whereas  all  the  other 
constructs (including the dEVH1 construct) do not reduce endogenous WASp 
expression. The H246D construct shows a similar pattern of endogenous WASp 
suppression to WT WASp, but this suppression does not reach significance. Figure 
8.4d demonstrates that the clinical mutants (and dVCA) have more endogenous 
WASp than EGFP-WASp, whereas WT EGFP-WASp and the remaining domain Chapter 8     
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Fig 8.4 Western blots of lysates of U937 cells stably transduced with EGFP-WASp constructs 
(standard panel)
(a) 2x106 U937 cells stably transduced with EGFP-WASp constructs and sorted for high expression 
were lysed in 100μl of lysis buffer. Lysate was clarified by centrifugation and the concentration 
of supernatants was determined by BCA assay. Lysate concentration was standardised between 
constructs and then reduced in sample buffer, before resolution by SDS-PAGE. Each immunoblot 
shown represents a separate electrophoresis gel. Band labels (i) EGFP-WASp (ii) endogenous 
WASp (iii) Non specific band cross reacting with anti EGFP antibody.
(b) to (d) The above experiment was repeated with 3 separate batches of U937 cell lysate, 
from the same stably transfected U937 lines. Densitometry was performed on EGFP-WASp, 
endogenous WASp and GAPDH bands. From these readings, standardised values for EGFP-
WASp (relative to U937 cells tranfected with WT-EGFP-WASp) and endogenous WASp (relative 
to levels in untranfected U937s) were determined for each experiment and the mean and standard 
error for this data are shown in (b) and (c). For ease of viewing the y axis of these graphs has 
been logged to base 2 and as a result the standardised values (WT in (b) and UT in (c)) appear 
as 0. (d) shows the mean and standard error of the EGFP WASp / endogenous WASp ratio for 
each construct. For graphs (b) and (c) paired one sample t tests were used to compare deviation 
of the means from a standard of 1, and for (d) paired two sample t tests were used to assess 
deviation of each sample from the WT mean. See materials and methods for further details of 
data processing and analysis.
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deletion constructs have a great excess of EGFP-WASp compared to endogenous 
WASp. All four clinical mutants show a weakly significant (0.05 < p < 0.1) reduction 
in the EGFP-WASp / endogenous WASp ratio compared to WT. Of importance 
the level of WIP in all these cell lines appears comparable (figure 8.4a). The 
serine phosphorylation results are discussed in chapter 8.3.
Figure  8.5  shows  the  equivalent  results  for  U937  cells  transduced  with  the 
constitutively  active  panel  of  constructs,  with  cells  harvested  9  days  post 
transfection. It can be seen that cells transduced with I294T, Y291E and dVCA bind 
EGFP-WASp show similar levels of EGFP-WASp expression as WT. Similarly all 
three constitutively active constructs induced marked suppression of endogenous 
WASp (figure 8.5c). Figure 8.5d demonstrates that within these transduced cell 
lines the vast majority of WASp is the exogenous EGFP-WASp.
Copy number of exogenous WASp genes 8.2.5 
To assess whether the differences in intracellular protein concentration could be 
accounted for by differences in efficiency of cell transfection by different EGFP-
WASp constructs, I assessed the copy number of exogenous EGFP-WASp genes 
within the cell lines being assessed. As U937 cells were harvested for lysate 
preparation in one of the experiments shown in figure 8.4, cells were simultaneously 
harvested for DNA and RNA preparation. Copy number of transfected genes 
was determined using real time PCR to a sequence within the WPRE, and was 
quantified by standardisation to actin (chapter 2.12). Unfortunately data from the 
A134T construct was uninterpretable and is therefore not shown.
Fig 8.6a shows that all the stable U937 cell lines had an average copy number 
within a factor of 2 of WT, (with the exception of R138P which had a copy number 
approximately 4x greater than WT). Of importance all the constructs with lower 
levels of protein expression showed higher copy numbers than WT. Therefore 
reduced  transfection  efficiency  cannot  account  for  the  differences  in  protein 
expression seen.
mRNA transcription of EGFP-WASp and endogenous WASp 8.2.6 
RNA isolated as above was converted to cDNA by reverse transcriptase and then 
real time PCR was performed on the cDNA to determine the levels of EGFP-
WASP and exogenous WASp mRNA transcripts in each stably transfected cell 
line. The level of expression was standardised to the housekeeping gene PGK1, 
and transcript expression was calculated as a ratio of the expression seen in WT 
EGFP-WASp (for EGFP-WASp) or in untransfected cells (endogenous WASp). Chapter 8     
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Fig 8.5 Western blots of lysates of U937 cells stably transduced with EGFP-WASp constructs 
(constitutively active panel)
(a)  U937  cells  transfected  with  EGFP-WASp  by  lentivirus  were  harvested  on  day  9  after 
infection. Lysate from 2x106  cells lysed in 100μl of lysis buffer, was clarified by centrifugation 
and  the  concentration  of  supernatants  was  determined  by  BCA  assay.  Lysate  concentration 
was standardised between constructs and then reduced in sample buffer, before resolution by 
NuPAGE. For each immunoblot a separate electrophoresis gel was run (using the same lysate). 
Band labels (i) EGFP-WASp (ii) endogenous WASp (iii) Non specific band cross reacting with anti 
EGFP antibody (iv) 35kDa degradation band (v) EGFP. (b) to (d) densitometry and analysis was 
performed as for fig 8.4, except western blots were only performed on a single batch of lysate.
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Fig 8.6 Copy number and expression of transduced EGFP-WASp genes in U937 cells
DNA and RNA was extracted from cell pellets of stably transduced U937 cells as described in 
chapter 2.12.1 and 2.12.3. (a) Copy number was determined by RT-PCR as described in chapter 
2.12.2. The data presented is representative of two experiments, each performed in triplicate. 
(b),(c) mRNA expression was determined by reverse transcriptase RT-PCR as described in chap-
ter 2.12.4 and 2.12.5. Expression of exogenous EGFP-WASp was determined by amplification of 
a sequence within the WPRE (Woodchuck Posttranscriptional Regulatory Element), which was 
contained within the lentivirally encoded transcript. This, and expression of endogenous WASp, 
were standardised to the expression of the housekeeping gene, phosphoglycerate kinase (PGK), 
and standardised expression was calculated relative to either WT-EGFP-WT (WT) trasnduced 
cells or untransduced cells (UT). Results are representative of two experiments each perofmred 
in triplicate. For each experiment the samples on the A134T construct were lost for technical 
reasons. Chapter 8     
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The technique and analysis are described in more detail in Chapter 2.12.
Figures 8.6b shows that the T45M, dBasic and H246D showed similar levels 
of transcription to WT, whereas the remaining constructs showed substantially 
greater levels of transcription. No construct tested had lower levels of mRNA 
detected  than  WT.  Interestingly  the  WT  and  dBasic  constructs  also  show 
suppression of endogenous WASp transcription compared to untransfected cells, 
whereas the majority of the other constructs show increased endogenous WASp 
transcription.
Together  these  results  strongly  suggest  that  the  mechanism  underlying  the 
differential  levels  of  cellular  EGFP-WASp  protein  between  constructs  lies 
downstream of transagene copy number and expression. There is some suggestion 
that over expression of EGFP-WASP constructs with the greatest functionality 
(WT, dBasic, H246D), may lead to suppression of endogenous WASp (and even 
EGFP-WASp) gene transcription. Conversely constructs resulting in the lowest 
levels of functional WASp in cells have upregulation of endogenous WASp gene 
transcription. Unfortunately there were technical problems with repeats of the 
above experiments which would have strengthened this data. Further work could 
clarify this potentially interesting finding, but this was beyond the scope of this 
project.
Phosphorylation of EGFP-WASp 8.3 
Phosphorylation is thought to play an important role in the regulation of WASp 
activity.  Phosphorylation  of  residues  ser242  (Yokoyama  et  al.,  2005),  ser483 
and ser484 (Cory et al., 2003), and tyr291 (Torres and Rosen, 2006; Torres and 
Rosen, 2003; Cory et al., 2002) have been shown to increase actin polymerisation 
activity, and it has been demonstrated that this phosphorylation is required for 
normal WASp activity (Badour et al., 2004; Suetsugu et al., 2002).
To  assess  whether  the  mutant  WASp  constructs  under  investigation  are 
phosphorylated  normally  in  U937  cells,  the  levels  of  tyrosine  and  serine 
phosphorylation were compared between WT and mutant EGFP-WASp in cell 
lysates. An antibody specific to WASp phosphorylated at ser483 or ser484 is 
commercially available, therefore this was used to directly immunoblot cell lysates. 
To assess tyrosine phosphorylation, EGFP-WASp was immunoprecipitated using 
an anti EGFP antibody, and the immunoprecipitated was then immunoblotted 
with an anti phosphotyrosine antibody. For both experiments phosphorylation was 
expressed as a proportion of EGFP-WASp phosphorylated relative the proportion 
of WT EGFP-WASp phosphorylated (see chapter 2.7.4 and figure 8.7 legend). Chapter 8     
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Fig  8.7  Phosphorylation 
of  EGFP-WASP  in  stably 
transduced  U937  cell 
lines
(a)  and  (b)  Densitometry 
was performed on the WASp 
phosphoserine  483/484 
immunoblots  shown  in 
figures 8.4a and 8.5a. This 
data  was  standardised 
for  loading,  and  then 
divided  by  standardised 
densitometry  readings 
for EGFP-WASp. This ratio was then standardised to WT EGFP-WASp to give a proportional 
serine phosphorylation relative to WT (see chapter 2.7.4 for more details and formulae used). 
The fraction of serine phosphorylated WASp in the WT EGFP-WASp cell line is standardised 
to a value of 1. (c) Tyrosine phosphorylation of EGFP-WASp immunoprecipitated from U937 
lysates. 2.5x106 transfected U937 cells were lysed in APB supplemented with 1mM DDT, 10% 
glycerol and 5mM GDP and clarified by centrifugation. Supernatants were incubated with 25µl 
of anti EGFP antibody immobilised on resin containing 6.25µg of antibody, overnight at 4˚C. The 
resin was then washed 3x with APB before elution with IP elution buffer. The elutant was then 
reduced in sample buffer and resolved by SDS-PAGE prior to immunoblotting for WASp and anti 
phosphotyrosine. (d) Densitometry was performed on WASp and phosphpotyrosine bands and 
was analysed as above.
aChapter 8     
255
The phosphoserine immunoblots of whole cell lysates shown as part of figure 
8.4a and 8.5a, and the remaining data are in figure 8.7.
Figure  8.7a  shows  that  the  clinical  mutants  show  proportionally  more  serine 
phosphorylation  than  WT,  whereas  the  other  constructs  show  very  similar 
phosphorylation levels to WT. The low level of phosphorylation seen with the 
dVCA is expected because the ser483 and ser484 residues are deleted in this 
construct.
By  contrast,  the  clinical  mutants  and  the  dEVH1  mutant  showed  reduced 
tyrosine phosphorylation compared to WT. Interestingly the dBasic and H246D 
constructs showed almost absent tyrosine phosphorylation. The two constructs 
were unable to bind Cdc42 (figure 7.1), and therefore emphasise the importance 
of Cdc42 binding to WASp for tyrosine 291 phosphorylation. These results are 
representative of two experiments.
Sensitivity to protease inhibition 8.4 
Results presented earlier in this chapter demonstrated that intracellular levels of 
clinical mutant WASp are lower than WT WASp when over expressed in U937 
cells.  One  explanation  for  this  finding  is  that  clinical  mutant  EGFP-WASp  is 
degraded by cellular proteases faster than WT EGFP-WASp. Previous studies 
have suggested a specific role for calpain in both the degradation of WASp, 
and  also  in  the  normal  turnover  of  WASp  mediated  actin  based  structures 
(Calle et al., 2006b; Shcherbina et al., 2001). Other groups have suggested that 
degradation by the proteosome is more important (de la Fuente et al., 2007). To 
test these hypotheses and to assess the role of specific proteolytic pathways in 
the degradation of mutant WASp, stably transfected U937 cells were treated with 
a range of protease inhibitors. For calpain inhibitition, ALLM and calpeptin were 
used, for proteosome inhibitition, MG132 was used and for cysteine protease 
inhibition, Cathepsin inhibitor 1 was used.
Figure 8.8a shows a western blot of lysates of A134T and WT EGFP-WASp 
transduced U937 cells treated for 3 hours with a range of protease concentrations. 
Selected data only is shown in figure 8.8a; the WT transduced cell line was tested 
with all four inhibitors but as the results were identical, the blots from only two 
inhibitors are shown. There appears to be no significant effect on the levels of 
either EGFP-WASp or endogenous WASp in response to any of these protease 
inhibitors (graphs of densitometry for this experiment are shown in figures 8.8d 
and e). There is a suggestion that treatment of the A134T cell lines with calpain 
inhibitors may cause a rise in both endogenous and EGFP-WASp levels (figure Chapter 8     
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Fig 8.8 Effect of protease inhibitors on EGFP-WASp levels 
in U937 cells
WT  and  A134T  EGFP-WASp  transduced  U937  cells  were 
seeded in 24 well plates at 0.5x106/ml. The following day each 
construct was treated for 3 hours with 3 concentrations of 4 
protease  inhibitors  (ALLM  and  Cathepsin  inhibitor  at  0mM, 
15mM, 50mM and 150mM and Calpeptin and MG132 at 0mM, 
5mM, 20mM and 60mM. Following this 20% of cells in each 
well were stained with tryphan blue and counted for viability, 
and the remaining cells were washed and then lysed in LB, 
reduced in SB and resolved by reducing NuPAGE and western 
blotting. Additional wells were treated with ALLM, and these 
were used to assay the effect of ALLM on calpain activity in 
cell lysates using the Calpain-GloTM protease assay (Promega). Lysates were incubated with a 
proluminescent calpain substrate, which releases luciferase on cleavage by calpain. Luciferase 
activity was measured using a luminometer at 15 minutes. Background subtracted light emission 
is proportional to calpain activity. (a) Immunoblots of lysates of A134T transfected cells treated 
with all 4 inhibitors and WT transfected cells treated with ALLM and MG132. (b) Viability of inhibitor 
treated cells. (c) Effect of ALLM on inhibition of calpain activity as determined by Calpain-GloTM 
assay. (d) and (e) Densitometry plots of EGFP-WASp and endogenous WASp from fig 8.8a
aChapter 8     
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8.8d and e). As this effect is small, is based on a single low protein concentration 
for cells incubated with no inhibitors, and there is no correlation between increase 
in WASp concentration and inhibitor concentration, I think this observation is 
artefactual.
One possible explanation for this insensitivity is that even at the highest calpain 
inhibitor concentration used only 30% of normal calpain activity was blocked 
(figure 8.8c). Despite this the toxicity seen with these inhibitors was significant 
(45% death with 150mM of ALLM and 35% death with calpeptin, compared to 
15% death with no inhibitors) (figure 8.8b). MG132 and cathepsin inhibitor 1 
showed less toxicity, but the inhibition of functional activity in lysates was not 
tested. Although the protease inhibitor concentrations used spanned the published 
range of effective usage (Nicola et al., 2005; Steinhilb et al., 2001; Ravid et al., 
2000; Melloni et al., 1998), it is possible that higher concentrations of inhibitors 
were required to see an effect in U937 cells. Similarly, generally the effects of 
protease inhibitors on protein levels are seen within one hour of treatment (Calle 
et al., 2006b) (and personal communication Y. Calle), but it is possible that U937 
are particularly resistant to protease inhibition (being a malignant cell line) and 
require longer incubation. Repeat experiments using higher concentrations of 
protease inhibitors for longer periods of time would help clarify these issues.
Relative stability of EGFP-WASp constructs 8.5 
Analysis of the levels of EGFP-WASp in U937 cell lysates suggest that WASp 
protein containing EVH1 missense mutations is less stable than WT WASp. These 
experiments, however, only measure the cellular protein levels at a single time 
point, and as such give a “snap shot” of the cellular processes involve in WASp 
metabolism. By radiolabelling WASp using 35S at a set time point and following 
the persistence of this labelled population of WASp proteins over a period of time 
more accurate information can be obtained about the relative dynamics of the 
WASp proteins under investigation.
A  full  description  of  methodology  used  is  given  in  the  chapter  2.10.  Briefly, 
U937 cells, were pulsed with 35S labelled cyteine and methionine (pulse period), 
followed by incubation with RPMI medium supplemented with excess cyteine and 
methionine (chase period). Cell lysates were generated at various time-point into 
the chase period and EGFP-WASp was immunoprecipitated from these lysates 
using  anti-EGFP  antibody  coated  beads  as  previously  described.  Following 
elution form the beads the EGFP-WASp samples were then resolved by SDS-
PAGE and the radioactive emission was measured from the dried gels using Chapter 8     
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amplifying phospholuminescence screens and a phosphoimager.
Optimisation 8.5.1 
Initially two 35S loading protocols were compared and a chase period of up to 48 
hours was assessed (see chapter 2.10.4 and figure 8.9 legend). Figure 8.9a and 
b show the radioactive emission of immunoprecipitant from these experiments, 
and figure 8.9c shows a graph of the specific emission of the WASp band for each 
lane (background subtracted). These figures demonstrate that both strategies 
gave  good  levels  of  WASp  labelling,  and  therefore  the  6  hour  load  protocol 
was adopted as it used less radioisotope. Although there appears to be some 
difference in the WASp levels by 4 hours chase, the difference is much clearer 
by 48 hours. Based on these results a standard chase period of 24 hours was 
subsequently used.
To investigate the relative effects of proteosome mediated and calpain mediated 
degradation  on  WASp  stability,  protease  inhibitors  (ALLM  and  MG132)  were 
added to the chase medium. Figures 8.9d and e, show that rather than decreasing 
degradation  as  had  been  hypothesised,  addition  of  either  protease  inhibitor 
results in a markedly reduced EGFP-WASp signal post chase. The most likely 
explanation for this is that incubation with protease inhibitors for 24 hours has 
caused significant cell toxicity, and as a result fewer cells are viable, and therefore 
less WASp protein survived to be immunoprecipitated.
Results 8.5.2 
Figure 8.10 summarises the results of pulse chase experiments performed on 
cells transfected with the clinical mutants and selected domain deletion mutants. 
Due to technical problems with the immunoprecipitation of the 0 hours chase 
dBasic sample no results are available for this construct. Figure 8.10b clearly 
shows that the amount of EGFP-WASp protein labelled at the end of the chase 
period is less for the clinical mutants than for WT. Additionally it can be seen that 
very little dVCA mutant protein was immunoprecipitated even at the end of the 
pulse period.
All four clinical mutant proteins show less stability than WT and for three of these 
proteins that difference was significant (figure 8.10c). By contrast the dEVH1 
and SEW proteins are more resistant to degradation and appear to accumulate 
within the cell (the labelled dEVH1 protein level actually increases during the 
experiment, suggesting almost absent degradation). A higher proportion of the 
dPolyP and H246D WASp proteins are degraded by 24 hours than WT, but these 
Fig  8.8Chapter 8     
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Fig 8.9 Optimisation of 35S labelling of 
U937 cells and assessment of WASp 
stability
(a) and (b) U937 cells stably transduced 
with  WT,  R138P,  R86H  and  dEVH1 
EGFP-WASp  and  SEW,  were  labelled 
with  35S  cysteine  and  35S  methionine 
(Redivue  PRO-MIX  L-[35S]TM)  using 
two  loading  strategies.  For  the  2  hour 
load,  2x106  cells  were  incubated  with 
80µCi of PRO-MIX in 400µl of loading medium (cysteine/methionine free RPMI medium, 5% 
dialysed FCS, 5mM glutamine, penicillin and streptomycin). For the 6 hour load 2x106 cells were Chapter 8     
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incubated with 50µCi of PRO-MIX in 1ml of loading medium, supplemented with 25mM ALLM and 
10mM MG132. Following the load period, cells were washed and reincubated in chase medium 
(RPMI supplemented with 2mM cyteine and 2mM methionine), and harvested at 0, 0.5, 1.5, 
2, 4 or 48 hours of chase incubation. Harvested cells were lysed in APB (containing protease 
and phosphatase inhibitors), and following centrifugation supernatants were incubated with anti-
EGFP resin for immunoprecipitation as previously described. Immunoprecipitates were reduced 
in SB and resolved by reducing NuPAGE. Gels were dried and then exposed to a phosphor 
storage screen for 1 month before reading using a Biorad Molecular Imager FX. (c) Densitometry 
readings from experiments (a) and (b). (d) U937 cells were loaded as for the 6 hour incubation 
protocol described in (b). The effects of a 24 hour chase period with 25mM ALLM or 10mM MG132 
added to the chase medium was assessed. (e) Densitometry from experiment (d). Degradation 
bands (a) 68kDa, (b) 62kDa, (c) 55kDa, (d) 48kDa, (e) 35kDa.
Fig 8.10 Stability of EGFP-WASp constructs expressed in U937 cells using intracellular 35S 
protein labelling
U937 cells stably transduced with various EGFP-WASp constructs were labelled with 35S using 
the 6 hour load, and EGFP-WASP protein was immunoprecipitated as described in figure 8.10. 
A chase period of 24 hours was used to assess relative stability of constructs. Experiments were 
performed in triplicate for WT, A134T, R138P, R86H, T45M and dEVH1 and singly for remaining 
constructs. (a) Radioactivity counts from the gel of one experiment. Band labels (i) EGFP-WASp 
(ii) Degradation products - (a) 68kDa, (b) 62kDa, (c) 55kDa, (d) 48kDa, (e) 35kDa. (b) Graph of 
mean absolute densitometry readings. (c) Mean and standard error for percentage of labelled 
EGFP-WASp degraded at 24 hours. A one way repeated measures  ANOVA test suggested 
significant differences in the mean values for % degradation (p value of < 0.0001). The Dunnett 
multiple comparisons test was used to assess which constructs were significantly different from 
WT, and significance of these differences are marked by stars.
Fig 8.9 cont.Chapter 8     
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two constructs were only tested in a single experiment and therefore repeats are 
required to confirm these findings.
Figure 8.10a also demonstrates that the clinical mutants appear to give a different 
pattern of degradation compared to WT and H246D protein (no degradation bands 
are visible for the dEVH1 construct). Specifically the clinical mutants appear 
to have unique bands at 68 and 35 kDa, whereas the WT and H246D lanes 
have prominent bands at 62 and 48 kDa which are weaker in the clinical mutant 
transduced cells. All constructs have a band at 55 kDa. The sizes of these bands 
are all very approximate because of difficulty in determining band size from a 
radio-emission image.
These results categorically demonstrate a higher rate of turnover of clinical mutant 
EGFP-WASp protein in stably transfected U937 cell compared to WT WASp. 
They also show that the dEVH1 WASp mutant appears particularly resistant 
to degradation, and yet does not appear to be toxic to the cells. By contrast 
the dVCA construct appears extremely unstable. Importantly these results also 
demonstrate that the half life for WASp in U937 cells is in the region of 12 to 
48 hours, relatively long for a dynamic cytosolic protein. Further experiments to 
assess whether this stability is reduced if U937 cells are induced to make de novo 
actin structure (for example by activation to become adherent), would provide 
interesting information.
Conclusions 8.6 
In this chapter I have investigated the effect of over expressing EGFP-WASp in a 
human leukaemia cell line, on WASp homeostasis and modification, and host cell 
survival. The key findings from this work are the following;
EVH1  missense  mutations  (clinical  mutations)  have  significantly  lower  1. 
levels of cellular expression than WT WASp, despite similar or greater 
levels of transgene transcription. I have demonstrated that this is due to 
an increased susceptibility to degradation, although it is possible that the 
clinical mutants also have a small increase in toxicity compared to WT 
WASp when over expressed.
Deletion of the entire EVH1 domain inhibits degradation, resulting in a  2. 
WASp protein with a long half life and high levels of cellular expression. 
This construct does not show increased cellular toxicity compared to WT 
WASp.Chapter 8     
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The dVCA WASp construct shows greater toxicity and less stability than  3. 
WT WASp and the clinical mutants, whereas the other domain deletion 
constructs show similar levels of toxicity, expression and stability to WT 
WASp.
The constitutively active WASp constructs showed the greatest toxicity of  4. 
all constructs tested, making assessment of protein stability very difficult.
If EGFP-WASp was stably expressed at high levels within the cell, the  5. 
instability of endogenous WASp was increased. The exception for this 
finding  was  dEVH1  WASp  which  had  no  impact  of  cellular  levels  of 
endogenous WASp.
Assessing WASp expression, stability and toxicity 8.6.1 
In this project I have used four parameters to assess the cellular WASp levels in 
stably transduced U937 cells; (a) percentage EGFP positivity in cell line cultures, 
(b) mean fluorescence intensity of EGFP positive cells within these cultures, (c) 
densitometry from western blots of unsorted cell lysates of cultured cells and (d) 
a radio-isotope labelling degradation assay. Each of these parameters measures 
a subtly different output and gives information about a combination of WASp 
synthesis, WASp degradation and toxicity of over expressed WASp. It is important 
when interpreting the results of all of these assays, to try to dissociate which of 
these factors account for the behaviour of each WASp construct.
Interpretation of the EGFP positivity experiments is the most complex (figures 8.1 
and 8.3a and c). Cell toxicity associated with viral transduction and cell sorting 
should be seen in the week immediately following this intervention. Interestingly, 
following cell sorting each transduced cell line (including SEW) has impaired cell 
division compared to untransduced cells. This suggests that even weeks following 
lentiviral transduction, the presence of lentivirally inserted genes increases cell 
toxicity (i.e. cell death or slowed cell division) induced by a stressful event such 
as cell sorting. If an EGFP-WASP construct exhibited toxicity at the sorted level 
of expression, then it would be expected that % EGFP positivity within the culture 
would progressively and rapidly drop to very low levels. This pattern was seen 
with the constitutively active constructs, but this simple explanation does not 
account for the stable but lower levels of EGFP positivity compared to WT, seen 
in the clinical mutants and dVCA transduced cell lines.
One explanatory hypothesis (“toxicity threshold model”) is that these constructs 
lower the toxicity threshold of U937 cells to an expression level with in the sorting Chapter 8     
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window. Therefore with WT WASp transduced cells, sorting by high expression 
will select cells with an evenly distributed range of EGFP-WASp expression within 
the sorting window. U937 cell cultures transduced with clinical mutants will have 
lost the higher expressing transduced cells due to toxicity. Sorting will therefore 
select only cells with the lowest expression within the (same) sorting gate. During 
long term culture, all cells have a slow attenuation of transgene expression, 
and as the clinical mutants have a higher proportion of cells with EGFP-WASp 
expression levels close to the positive / negative threshold, these cell cultures will 
exhibit lower EGFP positivity.
An alternative explanation (“degradation model“) is that the clinical mutants / 
dVCA protein is less stable, and therefore any individual cell will have a lower 
MFI for a given transgene copy number. During sorting on identical MFI gates, 
the unstable WASP constructs will have cells with higher copy numbers selected 
compared to WT WASp. Greater numbers of lentiviral insertion events are likely 
to be more disruptive to the host cell genome, and therefore lead to higher levels 
of toxicity and lower stable levels of EGFP positivity. In support of this model, the 
copy number of transgenes present in the clinical mutant and dVCA transduced 
cell cultures was higher than that of WT WASp, despite exhibiting lower % EGFP 
positive cells in stably transduced culture.
The MFI data (figures 8.2 and 8.3b and d) shows that cell lines with lower stable % 
EGFP positivities have lower levels of EGFP-WASp expression within individual 
cells, and is therefore supportive of both the above hypotheses. Interpretation of 
MFI data assumes that the degradation rate of functional tagged WASp is equal 
to that of functional EGFP, and that EGFP fluorescence doesn’t persist beyond 
the degradation of WASp. This assumption is also central to the “degradation 
model”. Figure 8.10c suggests that EGFP has a similar half life to WT WASp 
(assessed at 24 hours only), but this is significantly longer than that of clinical 
mutant WASp. 
The western blot data avoids this problem in that only full length EGFP-WASp is 
measured, although as discussed above (chapter 8.2.4), differences in % EGFP 
positivities between different cell lines may bias interpretation of results. The 35S 
labelling experiments offer a complete dissociation between toxicity and protein 
stability,  and  are  therefore  the  clearest  to  interpret.  Even  these  experiments 
assume  that  the  rates  of  degradation  of  EGFP-WASp  are  comparable  when 
EGFP-WASp is present at different concentrations within the cell.Chapter 8     
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Toxicity 8.6.2 
Reviewing the results in this chapter in the context of the above discussion, it is 
clear that the constitutively active constructs are markedly toxic to U937 cells. The 
rapid fall in EGFP positivity following transduction suggests a significant growth 
advantage  to  untransduced  cells. This  fall  is  proportionally  greater  than  that 
seen in MFI, suggesting that toxicity rather than protein instability is the primary 
explanation for these findings. This is in keeping with previously published data 
(Moulding et al., 2007), which suggests that constitutively active WASp constructs 
induce cell division defects and apoptosis in U937 cells.
With results for the dVCA construct, it is difficult to definitively dissociate protein 
instability from cytotoxic effects of the protein. The ongoing fall in EGFP expression 
and the fluorescence profile in figure 8.2 suggest that an effect similar to the 
toxicity threshold hypothesis is occurring and that toxicity of the construct is the 
most important effect. Additional, no prominent degradation bands were found 
in western blots of dVCA cell line lysates. In the absence of results from the 35S 
stability assay, however, and the presence of a high copy number and mRNA 
expression (figure 8.6) in the remaining cells it is difficult to exclude a major role for 
protein instability in these findings. Previously published data has demonstrated 
severe functional defects following over expression of dVCA WASp construct in 
cells (Tsuboi and Meerloo, 2007; Yarar et al., 2002; Zhang et al., 2002; Suetsugu 
et al., 2001b; Kato et al., 1999; Machesky and Insall, 1998; Symons et al., 1996), 
and from these findings a cytotoxic effect of this construct would be expected.
Although the clinical mutant cell lines show a reduced EGFP positivity in long term 
cell culture, I feel these results are entirely in keeping with the reduced stability of 
these proteins demonstrated in the 35S stability assay. The reduced positivity can 
be entirely explained by the “degradation model” described above. Furthermore 
these clinical mutations are expressed in patients with XLT, who do not show 
signs of significant cytopenia in any haematopoietic lineage (except platelets).
WASp degradation and suppression of endogenous WASp 8.6.3 
Clinical mutant WASp 8.6.3.1 
Each  of  the  WASp  constructs  containing  an  EVH1  missense  point  mutation 
clearly  shows  less  stability  than  WT  WASp,  as  demonstrated  in  all  of  the 
experimental approaches used to assess this. This is the first direct demonstration 
of reduced stability of WASp clinical mutants in haematopoietic cell lines and 
supports  previously  published  experimental  (de  la  Fuente  et  al.,  2007)  and 
clinical observational data (Lutskiy et al., 2005; Jin et al., 2004; Imai et al., 2004; Chapter 8     
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Lemahieu et al., 1999; Zhu et al., 1997; Remold-O’Donnell et al., 1997). This data 
combined with the demonstration that these constructs have a reduced affinity for 
WIP (chapter 6 and figure 6.7) is supportive of the hypothesis that WIP protects 
WASp from endogenous degradation (de la Fuente et al., 2007; Konno et al., 
2007; Chou et al., 2006).
Figure 8.4 demonstrates that overexpression of WT EGFP-WASp in U937 cells 
leads to suppression of the levels of endogenous WASp, whereas expression 
clinical  mutant  EGFP-WASP  has  little  impact  on  endogenous  WASP  levels. 
Expression of EGFP-WASp constructs in U937 cells in the presence of limited 
WIP, results in competition between endogenous and exogenous WASp for WIP 
binding. As WT EGFP-WASp is expressed in excess of endogenous WASp, but 
these two proteins have the same affinity for WIP, the vast majority of the cellular 
WIP will bind to EGFP-WASp, leaving the endogenous WASp susceptible to 
degradation. With clinical mutant EGFP-WASp transduced cells, the majority of 
the cellular WIP will be bound to endogenous WASp as it has a greater affinity 
for WIP than mutant EGFP-WASp, despite the higher rate of protein synthesis 
for  EGFP-WASp.  As  a  consequence  the  clinical  mutant  EGFP-WASP  is 
degraded preferentially and the endogenous WASp is protected. The sequential 
immunoprecipitation  experiment  in  figure  6.6c  demonstrates  this  mechanism, 
and together this data is strongly supportive of the above hypothesis.
Unfortunately I was unable to detect any rise in WASp concentration following 
incubation of transduced cell lines with a range of protease inhibitors (figure 8.8 
and 8.9d and e). Possible technical explanations for this are discussed above 
(chapter 8.5), and further optimisation of this experiment within the current system 
may yield useful mechanistic data. A further possibility is that the mechanism of 
WASp degradation is dependent on the cell type and / or level of cell activation / 
differentiation. Increases in cellular WASp concentration following incubation with 
protease inhibitors have been detected in cultured splenic derived dendritic cells 
(Chou et al., 2006) and in lymphocytes (de la Fuente et al., 2007). Interestingly, 
subtle differences in protease susceptibility were found between patient derived 
peripheral blood T cells, PHA / IL-2 propagated T cells and EBV-transformed 
B  cells  (de  la  Fuente  et  al.,  2007),  supporting  an  activation  /  differentiation 
dependent WASp degradation pathway. As discussed in chapter 1.7.3.3, there is 
some evidence for a link between WASp activation and degradation, and calpain 
is known to regulate the activity of other proteins by proteolysis (Calle et al., 
2006b; Suetsugu et al., 2002; Sato and Kawashima, 2001; Penna et al., 1999; 
Noguchi et al., 1997; Selliah et al., 1996; Sarin et al., 1993).Chapter 8     
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Such a mechanism could be investigated using transduced U937 cell lines by 
activating  U937  cells  using  PMA  (causing  them  to  adhere  and  spread),  and 
determining the effect on cellular WASp levels and susceptibility to protease 
inhibitors. Unfortunately this experiment was beyond the time frame of this project. 
Some information on the relationship between WASp activation and degradation 
can be gained from the analysis of the results of the domain deletion constructs. 
The constitutively active WASp constructs showed similar levels of cellular WASp 
to WT, suggesting that disruption of autoinhibition during WASp activation does 
not appear to enhance WASp degradation within U937 cells. Because of the 
high levels of toxicity these constructs exhibited, the lysate of constitutively active 
construct transduced U937s was made from transiently transduced cell cultures. 
This data must therefore be treated with some caution. The fact that endogenous 
WASp was suppressed by the expression of constitutively active WASp suggests 
that the protective mechanism of WIP is maintained for WASp constructs in the 
activated conformation.
Other  studies  have  suggested  that  tyrosine  phosphorylation  of  NWASp  is 
important in predisposing NWASp to degradation (Suetsugu et al., 2002). Both 
the dBasic and H246D constructs are unable to bind Cdc42 which is essential 
for in vivo phosphorylation at tyrosine 291 (figures 7.1 and 8.7). Neither construct 
showed any significant increase in cellular EGFP-WASP level compared to WT, 
by either FACS or by western blot. Testing the constitutively active, dBasic and 
H246D constructs in the 35S labelled stability assay will provide useful data on the 
relationship between WASp activation and degradation.
dEVH1 WASp 8.6.3.2 
Unlike the clinical mutant constructs, dEVH1 WASp showed a reduced rate of 
degradation compared to WT WASp (figure 8.10), resulting in accumulation of 
protein in U937 cells (figure 8.2). This result is surprising considering the WASp 
dEVH1 construct shows a significantly lower affinity for WIP than the clinical 
constructs (figure 6.7).
The most logical hypothesis to explain this result is that the critical binding or 
cleavage  site  for  the  protease  responsible  for  initiating  WASp  degradation 
is also found within the EVH1 domain. Studies using WIP fragments to block 
WASp degradation suggested that the critical site for WASp degradation was 
not identical to the WASp binding site, and that WIP inhibited degradation by 
sterically inhibiting the binding of a critical protease (Konno et al., 2007). The 
EVH1 domain does not contain any classical protease recognition sequences, but 
calpain binds and cleaves at sites predicted by three dimensional conformation Chapter 8     
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rather than amino acid sequence, and therefore cleavage sites are difficult to 
predict  (Tompa  et  al.,  2004).  Calpain  most  frequently  cleaves  at  proline  rich 
regions and at the boundaries of structural domains. The carboxyl terminus of the 
EVH1 domain (between the EVH1 and Basic domains) fulfils both of these criteria 
and is therefore the most likely calpain cleavage site. This could be investigated 
by generating missense mutations of the proline residues in this area, combining 
them with clinical missense mutations, and seeing the effect these mutations 
have on WASp stability.
The dPolyP WASp construct produces a unique pattern of degradation fragments, 
most obviously demonstrated in transfected Cos7 cells (figure 3.10), but also 
apparent in U937 cells. FACS and western blot data suggest that the levels of 
dPolyP WASp in U937 cells is equivalent or higher than that of WT WASp, yet 
unlike the dEVH1 construct, there is no impaired degradation and endogenous 
WASp is predictably suppressed. This data suggests the polyproline domain, or 
one of its many binding partners is also important for the regulation of WASp 
degradation.
Phosphorylation 8.6.4 
In figure 8.7 I have presented some preliminary data assessing the phosphorylation 
state of EGFP-WASp constructs when expressed in unstimulated U937 cells. 
As expected, the dVCA construct showed no S483/484 phosphorylation (as the 
residues are contained within the deleted VCA domain), and provides a clean 
negative control for assessing serine phosphorylation. Similarly the H246D and 
the dBasic domain constructs showed low levels of tyrosine phosphorylation. This 
was expected as these constructs are unable to bind Cdc42, a step essential for 
Y291 phosphorylation (figures 7.1 and 8.7).
The  clinical  WASp  mutants  demonstrated  enhanced  levels  of  S483/484  but 
reduced levels of Y291 phosphorylation. As phosphorylation at both sites activates 
WASp,  these  events  would  be  expected  to  have  opposite  effects  on  WASp 
activity. As Y291 phosphorylation is known to be induced by Cdc42 mediated 
WASp activation, and actin polymerisation in the bead based actin polymerisation 
assay  is  Cdc42  independent,  it  is  tempting  to  speculate  that  the  enhanced 
actin polymerisation seen with the clinical mutants is mediated by enhanced 
phosphorylation at S483/484. Against this hypothesis, WT WASp and the clinical 
mutants showed similar levels of S483/484 phosphorylation throughout the actin 
polymerisation assay (figure 7.3). This could be further explored by performing the 
actin polymerisation on beads pre-treated with phosphatases, or in the presence Chapter 8     
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of serine kinase inhibitors.
The relationship between tyrosine phosphorylation and EVH1 domain deletion 
and missense mutations also justifies further investigation. It has been previously 
demonstrated  that  Src  family  kinases  bind  to  the  EVH1  domain  of  WASp, 
resulting in an inhibition of kinase activity (Schulte and Sefton, 2003). }. Clarifying 
whether this interaction is dysregulated in the WASp clinical mutants or whether 
it influences the activity of these constructs would enhance the understanding of 
WASp activation. Finally the observation that the constitutively active constructs 
show less serine phosphorylation than WT raises several interesting mechanistic 
questions. This may reflect a greater activity of casein kinase 2 on WASp in the 
autoinhibited conformation, or it may suggest increased dephosphorylation at this 
site by active WASp proteins. Either mechanism may play an important role in the 
regulation of WASp activity.
Summary 8.6.5 
In this chapter I have presented direct evidence of the increased rate of degradation 
of  EVH1  missense  mutation  WASp. This  data  provides  excellent  support  for 
the hypothesis that WIP protects WASp from degradation, and that this is the 
mechanism underlying the reduced levels of WASp seen in the cells of patients 
with XLT. The resistance to degradation of the dEVH1 WASp mutant provides 
important clues as to the mechanisms of WASp degradation, and this is an area 
which requires further work to elucidate more detailed mechanisms. I have also 
demonstrated cell toxicity with the overexpression of constitutively active and 
VCA domain deleted WASp. This and other data presented is additive to our 
understanding of the importance and the regulation of WASp activation in cells.Chapter 9     
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Discussion 9 
Bead based actin polymerisation assay 9.1 
In this project I have explored, optimised and enhanced the understanding of a 
previously published in vitro actin polymerisation assay (Cory et al., 2002; Fradelizi 
et  al.,  2001).  Several  different  assay  of  WASp  induced  actin  polymerisation 
have been published, ranging from purified component pyrene assays (Rohatgi 
et al., 2000; Prehoda et al., 2000; Higgs et al., 1999; Machesky et al., 1999), 
which measure the biochemical initiation of actin filament nucleation, to assays 
assessing complex actin based cellular functions such as vesicle rocketing or 
bead propulsion (Yarar et al., 2002; Benesch et al., 2002; Suetsugu et al., 2001b). 
The bead based actin polymerisation assay assesses the generation of branched 
actin  networks  within  physiological  lysates,  and  mimics  the  dynamics  of  the 
cortical dendritic branched actin networks within cells. The assay simultaneously 
maintains a (diluted) cytosollic protein composition, with the ability to assess the 
specific protein associations of WASp during activation. A practical advantage 
of this assay is that it only requires small scale WASp protein generation and 
purification. This makes the practicalities of experimentally assessing the details 
of WASp activation more feasible.
I have demonstrated the reliability of this assay and also its versatility in detecting 
differences  in  WASp  activity  under  a  range  of  experimental  conditions.  The 
actin polymerisation initiated in the assay appears to be both Cdc42 and PIP2 
independent,  but  requires  an  excess  of ATP.  Optimisation  of  the  assay  has 
suggested that the primary rate limiting step in WASp mediated actin polymerisation 
is activation of WASp itself. Following this, recruitment of ATP loaded g-actin to 
the V domain of WASp and the ATP loading of Arp2 and Arp3 determine the rate 
of actin polymerisation.
In  this  project  I  have  not  compared  the  results  of  the  bead  based  actin 
polymerisation assay to those derived from other actin polymerisation assays. 
Such a comparison is likely to demonstrate differences in the relative activities of 
specific WASp constructs between assays. These differences may provide useful 
insights into WASp activation mechanisms and the dynamics of actin networks, 
reflecting  the  different  biochemical  activities  being  assessed.  Disagreements 
between different experimental systems do not undermine the results from any 
specific assay, however as the bead based assay utilises a physiological lysate 
it is likely to be representative of the in vivo environment. The reproducibility of 
the bead based assay is impaired by the reliance on band quantification from Chapter 9     
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western blots and the variability of the activity of the cell lysate used as the assay 
substrate. This variability has been compensated for by adequately repeating 
experiments, and by using a statistical approach which allowed comparison to 
an invariable standard activity (WT) and compensation for inter-experimental 
variability.
Further work would provide a greater understanding of the assay and role WASp 
plays within it. Pre-treating U937 lysate by immunoprecipitation using anti-SH3 or 
specific WASp binding adapter proteins (such as Nck and Grb2), and performing 
the assay in the presence of kinase inhibitors would further define the crucial 
WASP activating proteins in this system. Generating WASp in cells treated with 
kinase inhibitors and phosphatase inhibitors will allow assessment of maximally 
phosphorylated and entirely dephosphorylated WASp. Testing these samples in 
the assay and this would enhance our understanding of the role of phosphorylation 
within this assay. The use of other cell lysates would assess how cell specific these 
activation mechanisms are. Finally, examination by electron microscopy, of the 
actin networks formed on the bead surface of various constructs, would confirm 
the branched structure of actin networks surrounding the beads and illustrate the 
position of Arp 2/3 complexes within the network.
Mechanisms of WASp activation 9.2 
Cdc42 independent activation 9.2.1 
Data presented in this study provides further insight into the understanding of the 
mechanisms of WASp activation in cellular systems. Actin polymerisation within 
lysate of resting myeloid leukaemia cells was assessed using an in vitro bead 
based assay. The results demonstrate that within this system, WASp initiated actin 
polymerisation was entirely Cdc42 independent and indirect evidence suggested 
it was also PIP2 independent. A strength of this experimental system, is that unlike 
much of the in vitro work investigating WASp / NWASp activation, it assesses 
WASp (not NWASp) activation in human haematopoietic lysate. This is much 
more relevant for investigating the pathophysiology of WAS / XLT, than xenopus 
or bovine brain lysates. Further work is required to clarify the significance of these 
findings, and to facilitate interpretation of these results in the context of previously 
published data. In particular, it is necessary to assess the sensitivity of actin 
polymerisation to prenylated Cdc42, to compare the Cdc42 sensitivities of WASp 
and NWASp, and to directly determine the effect of PIP2 on actin polymerisation. 
Cdc42 induced WASp / NWASp activation has been extensively investigated 
in a variety of in vitro and cellular experimental systems. An increasing body Chapter 9     
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of evidence, however, has demonstrated Cdc42 independent WASp activation, 
suggesting  redundancy  among  WASp  activation  pathways.  Most  strikingly,  a 
WASp null mouse containing a transgenic WASp construct incapable of binding 
Cdc42, demonstrated normal T cell development, TCR induced T cell proliferation 
and cellular actin polymerisation (Badour et al., 2004).
The presence of parallel WASp activation pathways has several hypothetical 
functional implications. Firstly different WASp activation mechanisms may be 
employed by the same cell at different stages of activation or differentiation. 
For example, resting U937 cells may require Nck / Grb2 WASp activation. Once 
they are activated, however, and U937 cells become adherent and require actin 
cytoskeleton remodelling, Cdc42 induced WASp activation may become more 
important.
A  second  possibility  is  that  the  mechanism  of  activation  is  governed  by  the 
subcellular site of WASp activation. At a crude level, cytosolic WASp may require 
a different activation mechanism to that at both the plasma membrane and on the 
surface of vesicles. Alternatively, WASp activation mechanisms may be specific 
to the actin substructures being remodelled. For example, the proteins essential 
for WASp activation may be different at the immune synapse, at podosomes and 
at the surface of phagosomes. In support of this hypothesis, several proteins have 
been implicated in localising WASp to specific subcellular structures (Badour et 
al., 2007; Banerjee et al., 2007; Badour et al., 2004; Badour et al., 2003; McGavin 
et al., 2001; Tian et al., 2000; Linder et al., 2000b), and the composition of WASp 
containing multimeric complexes at specific structures appears to be different 
(Dong et al., 2007; Badour et al., 2007; Sasahara et al., 2002; Moreau et al., 
2000).  The  synergism  demonstrated  by  several  WASp  activating  proteins  or 
phospholipids,  and  the  co-localisation  of  these  activators  may  represent  the 
molecular mechanism of this specificity of activation. Such a mechanism could 
explain how WASp activation is tightly regulated despite playing an essential role 
in many intracellular processes, spatially dispersed throughout a range of cellular 
compartments.
Constitutively active WASp constructs 9.2.2 
The results presented on the XLN constitutively active WASp constructs support 
and extend previously published findings (Ancliff et al., 2006; Leung and Rosen, 
2005;  Devriendt  et  al.,  2001). This  work  suggests  that  the  change  in  WASp 
conformation from autoinhibited to open does not signal like a binary switch, but 
rather, that there is a continuum of conformations between the two extremes. Chapter 9     
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Phosphorylation  of Y291  (if  the Y291E  is  an  accurate  representation  of  291 
phosphorylation), does induce a less autoinhibited conformation in WASp, but it is 
significantly less active (open) than the XLN point mutations. A novel finding from 
this study is that the XLN missense mutant WASp constructs are able to bind both 
Cdc42 and WIP. This important finding suggests WASp doesn’t dissociate from 
these binding partners in response to activation, which has been a controversial 
debate in recent literature (Dong et al., 2007; Sasahara et al., 2002). Important 
ongoing work includes an assessment of the tyrosine phosphorylation of the 
XLN constructs both in vitro and in cellular systems. This will provide a better 
understanding of the relationship between tyrosine phosphorylation, release of 
autoinhibition and the binding of Cdc42.
Tyrosine phosphorylation and WASp activation 9.2.3 
Torres et al proposed an allosteric model of how Cdc42 and tyrosine kinases 
synergistically bind to, and regulate the activity of WASp by phosphorylation 
(Torres and Rosen, 2006; Leung and Rosen, 2005; Torres and Rosen, 2003). 
They propose that following Cdc42 induced disruption of the WASp autoinhibitory 
conformation, the Y291 residue is more accessible to tyrosine kinases.
Several experiments in this project have demonstrated a direct link between 
Cdc42 binding and Y291 phosphorylation, which is supportive of this model. 
Furthermore, the results presented on the Y291E WASp construct strongly suggest 
this construct (and therefore 291 phosphorylated WT WASp) exist in a partially 
autoinhibited conformation, which also supports this model. The model, however, 
does not address Cdc42 independent WASp activation, which also induces an 
open WASp conformation, and would therefore expose the Y291 residue, leaving it 
susceptible to phosphorylation. The preliminary results presented here, however, 
demonstrate  no  increase  in  Y291  phosphorylation  during  bead  based  actin 
polymerisation, however WASp purified from Cos7 cells demonstrated significant 
levels of tyrosine phopshorylation, prior to incubation with U937 lysate. Further 
experiments using the biological reagents generated in this project could clarify 
this mechanism and establish regulatory differences between Cdc42 dependent 
and independent WASp activation pathways.
WIP and WASp activation 9.2.4 
The lack of an inhibitory effect of WIP in the bead based actin polymerisation assay 
was surprising in light of previously published data (Lim et al., 2007; Martinez-
Quiles et al., 2001). A criticism of these experiments is that within the WIP enhanced 
assay lysate, no WIP mediated biological activity was demonstrated, and no Chapter 9     
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positive control for functional WIP was possible. The reproduction of previously 
published WASp inhibition using the WIP reagents used in this study, would 
confirm a real difference in WIP activity between the experimental systems. The 
purification of WIP and the optimisation of a purified protein actin polymerisation 
assay were beyond the time constraints of this project.
Several  possible  explanations  for  this  result  are  discussed  in  chapter  6.4.2, 
however  the  most  plausible  explanation  is  that  Cdc42  independent  WASp 
activation bypasses the WIP inhibitory mechanism. Understanding the relative 
contribution of WIP to the localisation of WASp – WIP complexes to sites of 
actin remodelling, and to the regulation of WASp activity is a critical area for 
understanding the control of WASp function.
Two step WASp activation model 9.2.5 
Many of the results presented in this thesis are difficult to explain using current 
models of WASp activation. As a result I have proposed a hypothetical activation 
model (figure 9.1) which will provide a useful framework for further investigation 
in this area. I will breifly discuss some of these key results which have suggested 
this model.
Firstly, the deletion mutant which most profoundly effected the ability of WASp to 
polymerise actin is the Polyproline domain deletion, despite have a normal ability 
to bind Cdc42 and WIP, and have similar levels of tyrosine 291 phosphorylation. 
Furthermore this protein is stable in haematopoeitic cell lines suggesting that it 
does not have aberant protein folding. This strong suggests the primacy of the 
polyproline domain in WASp activation.
Secondly, the Y291E construct shows increased activity compared to WT WASp, 
but decreased activity compared to XLN WASp constructs. Interestingly, once 
U937 lysate was supplemented with ATP the difference in activity between WT 
and Y291E WASp becames less significant. This suggests a WASp conformation 
with  intermediate  activity  between  maximal  WASp  activity  and  autoinhibited 
WASp activity. The importance of tyrosine phosphorylation for WASp activity has 
been  demonstrated  by  the Y291F  (“phosphodead”)  transgenic  mouse,  which 
has completely non-functional WASp (Blundell et al., 2009), suggesting that this 
step is non-redundant. Although I have demonstrated a clear link between Cdc42 
binding to WASp and 291 phosphorylation, the fact that the H246D WASp protein 
generated in Cos7 cells is tyrosine phoshorylaterd when purified, strongly suggests 
that tryosine phosphorylation can be mediated independently of Cdc42.Chapter 9     
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Thirdly, the two step model, can account for the essential role for ATP in actin 
polymerisation  in  the  bead  based  assay.  Although  I  have  not  provided  any 
evidence for a mechanism of the role of ATP, the central role of profillin and VASP 
(both actin binding proteins) in WASp activation has been demosntrated by others 
(Yarar et al., 2002). By constrast Cdc42 activity is not influence by ATP.
Finally, this model also provides a possible explanation for why WIP had no 
supressive effect in this assay. WIP may be important in stabilising the autoinhibitory 
conformation of WASp prior to tyrosine phosphorylation, but have no effect once 
WASp conformation has been changed by phosphorylation of 291. In terms of the 
model, WIP in inhibititory for step one of WASP activation, but not for step two. 
Whether or not WIP is inhibitory for both Cdc42 dependent and independent step 
one pathways is an interesting question which should be addressed.
Two  other  concepts  are  important  for  this  model.  The  first  is  that  WASp  is 
continually in a state of conformational flux between autoinhibited and activate 
states.  Secondly  this  model  presumes  that  WASp  activity  is  regulated  by  a 
large complex of several proteins, which is itself in a continual state of flux. This 
regulatory mechanism, draws parallels with our understanding of how WAVE 
proteins are regulated. 
K SH3 domain containing proteins Tyrosine kinase
Act Prof Actin Profillin P Phosphorylation of Y291
SH3
Fig 9.1 Two step WASp activation model
The results of the experiments performed for this thesis suggest a modification of current mod-
els of WASp activation is required. I propose a two step model of WASp activation. For maximal 
WASp activation, the autoinhibitory conformation must first be disrupted, resulting in a partially 
open WASp conformation. This step can be achieved in a Cdc42 dependent pathway, resulting 
in the cooperative binding of Cdc42 and PIP2, and the Cdc42 induced conformational change 
in the WASp GBD. This results in exposure of the tyrosine 291 residue, facilitating phospho-
rylation. This WASp state can also be achieved in a Cdc42 independent manner. Polyproline do-
main binding mediators such as the SH2-SH3 adapter proteins, possibly with cooperative bind-
ing of PIP2, bind to the polyproline domain. These are then able to recruit tyrosine kinases (Src 
and Tec family kinases) which also bind to the polyproline domain and phosphorylate tyrosine 
291. Both pathways result in a tyrsoine phosphorylated WASp with a partially open conforma-
tion, which has some Arp2/3 activating activity, but is not maximally active. A second activation 
step, stabiising a fully open WASp conformation is then mediated by polyproline domain binding 
proteins such as profillin and VASP. This step is ATP dependent and facilitates the recruitment 
of actin to the V domain of WASp and to the Arp2/3 complex. Other SH3 containing adaptor pro-
teins play a role in coordinating this complex and ensuring that full WASp activity is spatially and 
temporally regulated. Following activation, WASp can revert to its less active conformation and 
it exists in an equilibrium between each of its conformations, regulated by its binding partners. 
Similarly, phosphatases such as PSTPIP bind to the polyproline domain and dephosphorylate 
tyrosine 291, stabilising a more autoinhibited conformation. A final level of regulatation of WASp 
activity is achieved through WASp degradation, either by ubiquitination and subsequent degra-
dation via the proteasome, or by calpain. The suseptibility of WASp to degradation is increased 
by phosphorylation of tyrosine 291.Chapter 9     
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Pathogenicity of WASp mutations 9.3 
Although many immunological and cellular characteristics of patients with WASp 
mutations  have  been  described,  very  little  work  has  been  published  on  the 
functional activity of (clinical) mutant WASp protein (Kolluri et al., 1996). The 
impaired binding of WIP to WASp containing specific EVH1 missense mutation 
had been previously demonstrated experimentally, and predicted from structural 
modelling studies (Kim et al., 2004; Luthi et al., 2003; Volkman et al., 2002; Rong 
and Vihinen, 2000; Stewart et al., 1999).
In this study I have demonstrated that four WASp mutants with missense mutations 
in the EVH1 domain bind Cdc42 normally and have a normal ability to polymerise 
actin in vitro. I have also demonstrated that each of these has a reduced but not 
absent affinity for WIP compared to WT WASp. Despite this impaired binding, 
mutant WASp – WIP complexes could be immunoprecipitated from lysate of U937 
cells over-expressing mutant WASp. I have directly demonstrated that EVH1 
missense mutant WASp is degraded more rapidly than WT WASp, but that these 
mutants are minimally more toxic than WT when over-expressed in U937 cells.
These results, and other contemporaneously published data, have suggested a 
model whereby WIP acts as a chaperone for WASp, protecting it from degradation 
(de la Fuente et al., 2007; Konno et al., 2007; Chou et al., 2006). WASp with 
EVH1  missense  mutations  has  a  lower  affinity  for  WIP,  and  therefore  has  a 
higher rate of degradation, resulting in the reduced cytosolic concentration seen 
in the lymphocytes of patients with these mutations (de la Fuente et al., 2007). 
In patients the cellular level of WASp is proportional to the severity of the clinical 
phenotype (Lutskiy et al., 2005; Jin et al., 2004; Imai et al., 2003).
The majority of patients with missense mutations in the EVH1 domain have the 
mild clinical phenotype of XLT, without clinically relevant abnormalities of the cells 
of the myeloid or lymphoid lineages. This is despite having a fraction of a normal 
individual’s cellular WASp concentration in these cells. This observation suggests 
that immune cells can function relatively normally with low levels of WASp, and 
even lower levels of WASp – WIP complexes. This may be due to functional 
redundancy between WASp and NWASp in these cells, as has been proposed 
to explain the normal T cell development of WASp null mice (Zhang et al., 2002). 
Alternatively these cells only require very low levels of WASp, which functions 
transiently prior to degradation, to maintain normal function.
The fact that immune cells are able to function effectively despite an impaired 
ability  to  form  WASp  –  WIP  complexes,  raises  several  questions  about  the Chapter 9     
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functional significance of these complexes. In addition to protecting WASp from 
degradation, it has been proposed that WIP regulates WASp activity and localises 
WASp to sites of actin remodelling. If these latter two functions are important, 
then other WASp binding proteins must compensate for WIP to allow for normal, 
or near-normal functionality. Despite the relatively benign clinical course of XLT, 
functional defects do occur in these patients (e.g. low platelet volume, autoimmune 
disease), and understanding why problems arise in these specific situations will 
provide a better understanding of the function of WIP.
WASp containing point mutations which cause X-linked neutropenia were highly 
toxic when over-expressed in U937 cells. Investigating the mechanism of this 
toxicity would have been a diversion from the primary aims of this project, however 
other published work has suggested that unregulated actin polymerisation disrupts 
the cytokinesis of dividing cells (Moulding et al., 2007). There was no evidence 
of  direct  cellular  toxicity  of  constitutively  active  WASp. As  discussed  below, 
investigation of the degradation of constitutively active WASp constructs would 
enhance the understanding of both the pathogenicity of XLN and the regulation 
of WASp.
Mechanisms of WASp degradation 9.4 
Although increased susceptibility to degradation has now been established as 
the mechanism underlying the low cellular levels of WASp in XLT / WAS patient 
cells, the regulation, mechanism and functional significance of WASp degradation 
remains poorly understood. The results from this study provide some important, 
novel insights into this area.
What limited data exists about the protease pathways responsible for WASp 
degradation  is  largely  contradictory.  Calpain  and  the  proteasome  have  been 
implicated as prime candidates, however the relative importance of these systems 
appears vary according the cell type or experimental system under investigation 
(de la Fuente et al., 2007; Chou et al., 2006; Suetsugu et al., 2002; Shcherbina et 
al., 2001; Oda et al., 1998). Tyrosine phosphorylation has been shown to increase 
the susceptibility of NWASp to degradation via ubiquitination (Suetsugu et al., 
2002), which suggests a hypothesis whereby the more active a WASp protein is, 
the more rapidly it is degraded. 
I was unable to demonstrate any enhanced WASp stability in U937 cells, with a 
range of protease inhibitors (including calpain and proteasome inhibitors). Further 
optimisation of the use of these and other protease inhibitors, and the use of 
alternative cell lines to assess the susceptibility of different WASp constructs to 
Fig  9.2 cont.Chapter 9     
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specific proteases, could provide valuable data in this area.
The  difference  in  susceptibility  to  degradation  between  the  EVH1  missense 
WASp  mutants  and  the  dEVH1  WASp,  emphasises  the  central  role  of  this 
region  in  determining  WASp  stability. As  discussed  in  chapter  8.7.3.2,  these 
results suggest that binding site of the critical WASp protease resides within the 
EVH1 domain. Furthermore, the difference in sizes and lysate concentration of 
WASp degradation fragments between the EVH1 missense mutants and the 
dPolyP construct, and WT WASp, raises the possibility that these constructs are 
degraded by different pathways. The comparable expression levels of the H246D 
construct (which cannot be tyrosine phosphorylated) to WT WASp, suggests 
phosphorylation of WASp does not target WASp for degradation. Unfortunately 
the radio-isotope degradation assay was not performed on the Y291E and other 
constitutively active WASp constructs due to their toxicity, but this experiment 
would more adequately address this question.
The results relating to WASp degradation presented in this project are significant, 
but  preliminary. They  raise  many  important  questions  and  hypotheses  about 
the regulation of WASp activity and cellular control of protein levels. The key 
experiments required to expand and clarify these preliminary findings are outlined 
below;
Definitive  testing  of  the  remaining  domain  deletion  and  constitutively  1. 
active  WASp  constructs  with  the  radio-isotope  protein  stability  assay. 
The constitutively active constructs would have to be tested in cell lines 
transduced using a low MOI and the assay performed rapidly following 
transduction, to avoid the effects of toxicity.
Further  optimisation  of  the  effects  of  protease  inhibitors  on  WASp  2. 
transduced cell lines as outlined above.
Purification of WASp degradation products from WT WASp, EVH1 missense  3. 
mutants and dPolyP WASp transduced cell lines. Characterisation of these 
constructs by mass spectroscopy.
Generation of point mutations within potential calpain and proteasome  4. 
cleavage  or  binding  sites  within  the  WASp  EVH1  domain. Testing  the 
stability of WASp containing these mutations.
Assessment of the ubiquitination of selected WASp constructs, when stably  5. 
expressed in U937 cells, and assessing any differences in ubiquinisation Chapter 9     
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following cell activation.
Functional and WASp localisation experiments 9.5 
In this thesis I have not yet presented any data demonstrating the ability of 
individual WASp constructs to reconstitute cellular functions lost from WASp null 
cells. This next stage of investigation is critical, and will allow the assessment of 
domain function or missense mutation, from molecular characterisation, through 
cellular expression, to cellular function. The WASp null mouse (Zhang et al., 1999; 
Snapper et al., 1998) and cells from WASp null patients have both been used 
successfully for demonstrating the reconstitution of aberrant cellular functions 
following lentiviral transduction of WT WASp (Dewey et al., 2006; Martin et al., 
2005; Dupre et al., 2004; Strom et al., 2003; Jones et al., 2002; Burns et al., 
2001). 
The impaired ability of dendritic cells and macrophages to form podosomes on 
adhesion to fibronectin is a consistent finding in WAS and XLT patient cells and in 
the WAS mouse model (Calle et al., 2004; Linder et al., 2003; Jones et al., 2002; 
Burns et al., 2001; Linder et al., 2000a; Binks et al., 1998). In human WAS dendritic 
cells, podosomes are usually absent, whereas in murine dendritic cells a residual 
5% of cells express podosomes (Calle et al., 2006a). Although controversy exists 
over the function and in vivo relevance of podosomes in haematopoietic cells, it 
is now generally thought that these structures are important for adhesion to and 
focal degradation of the extracellular matrix, and for sensing the microenvironment 
to facilitate cell polarisation in response to external stimuli (Gimona et al., 2008; 
Calle et al., 2006a). Structurally, podosomes consist of a core of actin filaments 
extending  from  the  cell  membrane,  surrounded  by  structural  and  adhesion 
proteins such as paxillin, talin, vinculin and integrins (Linder and Kopp, 2005; 
Marchisio et al., 1988; Marchisio et al., 1987). Actin nucleators (such as Arp2/3 
and formins) and polymerisation activators (WASp, cortactin and WIP) are all 
found in the core of the podosomes, immediately adjacent to the cell membrane 
(Calle et al., 2006a). Visualisation of the reconstitution of podosomes in WASp 
null murine dendritic cells therefore assesses both the formation of a functionally 
important cellular structure and the localisation of WASp to a dynamic site of actin 
polymerisation.
Figures 9.2 and 9.3 show some preliminary data from podosomes reconstitution 
experiments  in  dendritic  cells.  DCs  were  cultured  from  the  bone  marrow  of 
WAS and Black 6 mice (a wild type strain), and were transduced with EGFP-
WASp by lentiviral infection (as described in chapters 2.3.2 and 2.4.6). Cells Chapter 9     
280
P
P
P
P
Black 6 mice (WASp +ve) WAS null mice (WASp -ve)
P  Podosomes
A  Actin stained
V  Vinculin stained
M  Merged image
B
6
W
A
S
S
E
W
W
T
d
E
V
H
1
A
1
3
4
T
R
1
3
8
P
R
8
6
H
T
4
5
M 0
10
20
30
40
50
60
WASp Construct transduced
%
 
C
e
l
l
s
 
w
i
t
h
 
p
o
d
o
s
o
m
e
s e
a b
c d
A A V V
M M
Fig 9.2 Podosome reconstitution of 
WASp null dendritic cells following 
transduction with EGFP-WASp 
(a)(b) Actin staining of Black 6 (WT 
stain) and WAS murine bone marrow 
derived DCs. Clusters of podosomes 
marked  with  P  and  arrows.  (c)(d) 
Actin  (A),  Vinculin  (V)  and  merged 
(M)  confocal  micrographs  of  the 
areas marked with a box in (a) and 
(b).  Black  6  cells  demonstrate  co-
localisation  of  actin  and  vinculin  at 
podosomes, whereas WAS DCs lack 
co-localisation. (e) WAS bone marrow 
derived  DCs  were  infected  with 
EGFP-WASp encoding lentivirus at a 
MOI of 30, on day 6 of culture. Cells 
were fixed and immunostained at 48-
72 hours post infection. % of DCs with 
podosomes for each construct is shown (two experiments). Differences between contructs and 
untransduced (WAS) DCs (red stars) and SEW transduced DCs (black stars) were assessed 
by  Chi squared analysis. * p<0.05, ** p<0.01, *** p<0.001. WAS - WAS DCs, B6 - Black 6 DCs.
***
* *** *
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*** *** *** *
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were then cultured for 48-72 hours on fibronectin coated slides before fixing and 
immunostaining for FACS and for confocal microscopy (chapter 2.11.2 and 2.13). 
The expression of DC activation markers (MHC class II and CD86) by FACS 
revealed that the majority of dendritic cells were of an immature phenotype and 
that expression of activation markers was similar between all WASp (and SEW) 
constructs assessed (data not shown). The podosome reconstitution data is the 
summary from two separate experiments using a lentiviral MOI of 30, whereas 
the  confocal  micrographs  are  representative  images  from  three  independent 
experiments each transducing cells with an MOI of 100.
Figures 9.2a-d illustrate the differences in morphology and podosomes formation 
between murine WAS and Black 6 dendritic cells. Black 6 DCs show clear co-
localisation of actin and vinculin “hotspots”, illustrated by the discrete purple spots 
seen in the merge images (figure 9.2c). By contrast, the WAS cells show the 
typical spindle shaped morphology of WAS dendritic cell, and a lack of discrete 
actin – vinculin co-localisation within actin rich structures (figure 9.2d). Figure 
9.1e demonstrates, as previously published, that transduction of WAS null DCs 
with WT WASp leads to a significant repopulation of podosomes positive cells, 
although the level seen in Black 6 cells was not attained. Transduction of DCs 
with the EGFP only lentivirus (SEW) results in a small and insignificant rise in 
podosomes formation. The dEVH1 WASp construct and one of the clinical mutant 
constructs (T45M) show a significant rise in cells expressing podosomes (p<0.05 
when  compared  to  SEW  transduced  cells).  Although  the  remaining  clinical 
constructs show a greater number of podosomes expressing cells compared to 
untransduced WAS DCs, there is no significant rise compared to SEW transduced 
cells.
Figure 9.3 shows a higher resolution view of the podosomes formed in dendritic 
cells  transduced  by  each  construct.  Interestingly  like  WT  WASp,  the  three 
EVH1 missense mutant WASp constructs localise to the cores of podosomes. 
By contrast the SEW construct shows no localisation to any actin structures. 
The podosomes formed by the dEVH1 WASp transduced dendritic cell are very 
atypical, being larger in size, irregular in shape and forming ring like structures. 
This appearance was typical of the podosomes-like structures formed by dEVH1 
WASp transduced cells. In the illustrated cell there is little colocalisation of WASp 
to these structure, but in other cells more localisation was apparent (data not 
shown), although it was never as pronounced as for WT WASp.
It is unclear from this data whether or not WASp containing EVH1 missense 
mutations  are  able  to  reconstitute  podosomes. There  is  some  evidence  that Chapter 9     
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Fig 9.3 Localisation of EGFP-WASp to podosomes in transduced WASp null DCs
High magnification confocal micrographs of podosomes from WASp null dendritic cells transduced 
with EGFP-WASp constructs (MOI 100). EGFP-WASp panels demonstrate the co-localisation of 
EGFP-WASp constructs to podosomes.
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these constructs do partially reconstitute podosomes, but further experiments 
are required to detect a significant difference from SEW alone transduced cells. 
It is apparent that these constructs do not reconstitute podosomes as efficiently 
as WT WASp, however the fact that these constructs are able to polymerise actin 
normally and localise to podosomes supports a role in podosomes formation.
It is possible that, due to their greater instability, these WASp constructs may 
require higher MOIs than WT WASp, or the presence of protease inhibitors, 
to  allow  sufficient  cytosolic  WASp  concentration  to  reconstitute  podosomes. 
Evaluation of results using a range of MOIs to compare different WASp constructs 
requires caution, because the high MOIs required to induce podosomes in some 
constructs (e.g. clinical mutants) may result in toxicity and reduced podosome 
formation in other constructs (WT). Studies in patient cells bearing these mutations 
would be complimentary and would avoid the problems of toxicity due to vector 
over-expression. Alternatively, DCs transduced with EVH1 missense mutation 
WASp may induce podosome formation, but the stability of these podosomes 
may be significantly reduced, resulting in less podosomes positive cells at any 
one time point. Other studies have suggested a role for WASp-WIP complexes 
in determining the stability, rather than the formation of podosomes (Chou et al., 
2006).
The results in figures 9.2 and 9.3 raise interesting questions about the role of 
WIP in podosomes formation and in localising WASp to podosomes. The fact that 
the dEVH1 construct is able to form significantly more podosome-like structures 
than SEW transduced cells, suggests that WIP is not essential for podosomes 
formation. It is unclear, however, whether the structures demonstrated in figure 
9.3 are true podosomes or aberrant actin based structures, which might be due 
to an excess of the dEVH1 construct or specific functional defects associated 
with this mutation. More detailed imaging, using techniques such as total internal 
reflection  fluorescence  (TIRF)  microscopy,  should  resolve  this  issue.  This 
technique selectively assesses the cell-substratum contacts of adherent cells and 
allows real time imaging, and would therefore also assess the dynamic turnover 
of podosomes in transduced living dendritic cells.
The localisation of EVH1 missense mutant WASp to podosomes does not exclude 
a role for WIP in WASp localisation, as these results may reflect the residual WIP 
binding to these constructs demonstrated in figure 6.7. To definitively answer 
this question we are in the process of generating a WIP construct linked to the 
flourophore mCherry, which when co-expressed with EGFP-WASp would allow 
the assessment of WASp-WIP colocalisation by fluorescence resonance energy Chapter 9     
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transfer (FRET).
Although the in vivo results presented here are only preliminary data, they illustrate 
the some important mechanistic questions about the in vivo function of WASp and 
its role in podosome biology, which can be answered by this experimental system. 
Such reconstitution and localisation experiments can be extended to assess the 
function of WASp in phagocytosis, T cell synapse formation, chemokine induced 
migration and cytotoxic granule release. Assessment of the clinical WASp mutants 
and the dEVH1 construct in these systems will provide important information 
about the pathophysiology of WAS, XLT and XLN, and the biological importance 
of WASp-WIP complexes. The assessment of the domain deletion constructs in 
these experiments will help tease out the in vivo mechanisms of WASp activation 
and localisation at different sites of actin polymerisation. Furthermore, the H246D 
construct provides an invaluable tool in assessing the hypothesis that Cdc42 
dependent and independent activation mechanisms are important in the formation 
of different cellular structures.
Much of the continuation work suggested in this thesis will be addressed as part 
of an ongoing program of research into Wiskott Aldrich Syndrome at the Institute 
of Child Health, London. This work will advance our understanding of the role of 
WASp in the healthy and dysregulated immune system, and help elucidate some 
of the mechanisms of the cell biology which underpins immunology.Appendix     
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Appendices
Appendix 1 
 
Sequence of primers used for PCR reactions are shown below. (F) are forward 
primers and (R) are reverse primers. 
 
ΔEVH1_F    GACAAGCTTCTCAAAAAAGGAATCAGAGGCAAAG 
ΔEVH1_R    GTCGGTACCTCAGTCATCCCATTCATCATC 
ΔBasic1_F    GACAAGCTTCTATGAGTGGGGGCCCAATG 
ΔBasic1_R    CTCGGATCCATCAGCTGGGCTAGGTCC 
ΔBasic2_F    GAGGGATCCGCTGATATTGGTGCACCC 
ΔBasic2_R    GTCGGTACCTCAGTCATCCCATTCATCATC 
ΔPolyP1_F    GACAAGCTTCTATGAGTGGGGGCCCAATG 
ΔPolyP1_R    CTCGGATCCCTCCTGGCGCCTCATCTC 
ΔPolyP2_F    GAGGGATCCGCTCTGGTGCCTGCCG 
ΔPolyP2_R    GTCGGTACCTCAGTCATCCCATTCATCATC 
ΔVCABind1_F   GACAAGCTTCTATGAGTGGGGGCCCAATG 
ΔVCABind1_R  CTCGGATCCTTTAGAGGTCTCGGCGTCG 
ΔVCABind2_F   GAGGGATCCGAGCCACTTCCGCCGC 
ΔVCABind2_R  GTCGGTACCTCAGTCATCCCATTCATCATC 
ΔVCA F    GACAAGCTTCTATGAGTGGGGGCCCAATG 
ΔVCA R    GTCGGTACCTCACCCACCAGGGGCCAGG 
ΔCA F     GACAAGCTTCTATGAGTGGGGGCCCAATG 
ΔCA R     GTCGGTACCTCACTTGTTCAGCTGAATTCCCTG 
ΔA F      GACAAGCTTCTATGAGTGGGGGCCCAATG 
ΔA R      GTCGGTACCTCACCCTTCGTCGGAGGAGTG 
 
A134T_F    CAGACGAGGACGAGACCCAGGCCTTCCG 
A134T_R    CGGAAGGCCTGGGTCTCGTCCTCGTCTG  
R138P_F    GCCCAGGCCTTCCCGGCCCTCGTGCAG 
R138P_R    CTGCACGAGGGCCGGGAAGGCCTGGGC 
R86H_F    GAAGTCCTACTTCATCCACCTTTACGGCCTTCAGG 
R86H_R    CCTGAAGGCCGTAAAGGTGGATGAAGTAGGACTTC 
T45M_F  GCTTGGACGAAAATGCTTGATGCTGGCCACTGCAGTTGTTC 
T45M_R  GAACAACTGCAGTGGCCAGCATCAAGCATTTTCGTCCAAGC 
H246D_F    CCCAGTGGATTCAAGGATGTCAGCCACGTGGGG 
H246D_R    CCCCACGTGGCTGACATCCTTGAATCCACTGGG 
Y291F_F     CTCTAAACTTATCTTCGACTTCATTGAGGACCAGGG 
Y291F_R    CCCTGGTCCTCAATGAAGTCGAAGATAAGTTTAGAG 
Y291E_F   GACCTCTAAACTTATCGAGGACTTCATTGAGGACCAGG 
Y291E_R  CCTGGTCCTCAATGAAGTCCTCGATAAGTTTAGAGGTC 
S272P_F  GCGGAGTCTGTTCCCCAGGGCAGGAATC 
S272P_B  GATTCCTGCCCTGGgGAACAGACTCCGC 
 
 
PCR Primers
Fig A.1 Sequences of the PCR primers used to generate WASp missense mutation and 
domain deletion / truncation constructsAppendix     
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Fig A.2 Assessment of purity and quantification of purified GST-WT-WASp and Cdc42
(a) Purity of GST-WASp standard assessed by anti-WASp immunoblot. Comparison to 20μg of 
U937 lysate (b) Purity of GST-WASp standard as assesed by silver stain (c) Quantification of 
GST-WASp standard by comparison of intensity of silver staining to that of known commercial 
purchased standards (BSA - Bovine serum albumin, and actin). (d) Purity and quantification of 
Cdc42 proteins by silver stain. N - 17N mutant, V - 12V mutant.Appendix     
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Fig A.3 Actin - WASp scatterplots for individual experiments
Scatterplots of absolute values for Actin and Wasp, demonstrating variablity in response between 
individual experiments.Appendix     
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Distribution and Descriptive Statistics of Constitutively 
Active Construct experiments - Absolute readings
Relative Absolute
 
WASp Actin
% LN 
WASp
% LN 
Actin
WASp Actin
% LN 
WASp
% LN 
Actin
N     Valid 120 120 120 120 102 102 102 102
N     Missing 0 0 0 0 18 18 18 18
Mean 163662 508759 1008 1195 2.900 350 477.1 59.63
Median 25697 209964 1015 1225 2.120 144 497.1 75.12
Std. 
Deviation
385446 676038 228 183 2.842 426.1 177.6 113.0
Skewness 4.870 1.901 -.407 -.280 2.498 1.428 -.391 -1.270
Kurtosis 31.292 3.621 .288 -1.117 9.114 1.433 -.910 3.773
Fig  A.4
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Fig A.4 Distribution and descriptive statistics of absolute densitometry readings for con-
stitutively active constructs
Actin polymerisation assays were performed under conditions described in chapters 2.7 and 4.2.6. 
Absolute readings were generated by standardising densitometry readings to those of known 
WASp and actin standards. (a) & (b) Scatterplots of  raw or Ln transformed WASp and Actin den-
sitometry readings. (c)(d) Frequency distributions of transformed data. (e) Descriptive statistics of 
raw and transformed data, for absolute and relative data. Ln - Natural log, SE - Standard errorAppendix     
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Distribution and Descriptive Statistics of Constitutively 
Active Construct experiments - Relative readings
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Fig A.5 Distribution and descriptive statistics of absolute densitometry readings for con-
stitutively active constructs
Actin polymerisation assays were performed under conditions described in chapters 2.7 and 
4.2.6. Relative readings are the unstandardised densitometry readings generated from the Uvi-
Chemi supercooled camera. (a) & (b) Scatterplots of  raw or natural log (Ln) transformed WASp 
and actin densitometry readings. (c)(d) Frequency distributions of transformed data.Appendix     
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Distribution and Descriptive Statistics of NWASp
 experiments - Absolute readings
Relative Absolute
 
WASp Actin
% LN 
WASp
% LN 
Actin
WASp Actin
% LN 
WASp
% LN 
Actin
N     Valid 54 54 54 54 54 54 54 54
N     Missing 0 0 0 0 0 0 0 0
Mean 739152 558781 1263 1255 516 526 347 402
Median 431832 452483 1298 1302 556 567 259 290
Std. 
Deviation
779353 531340 177 157 150 165 333 399
Skewness 1.45 1.52 -1.17 -1.58 -1.23 -1.55 1.36 1.57
Kurtosis 2.09 2.35 1.15 2.95 1.60 2.77 2.03 2.52
Fig  A.6
a b
c d
e
Fig A.6 Distribution and descriptive statistics of absolute densitometry readings for NWASp 
and mWASp experiments
Actin polymerisation assays were performed under conditions described in chapters 2.7 and 
4.2.6. Absolute readings were generated by standardising densitometry readings to those of 
known WASp and actin standards. (a) & (b) Scatterplots of  raw or Ln transformed NWASp/
mWASp and Actin densitometry readings. (c)(d) Frequency distributions of transformed data. (e) 
Descriptive statistics of raw and transformed data, for absolute and relative data. Ln - Natural log, 
SE - Standard errorAppendix     
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Distribution and Descriptive Statistics of NWASp
 experiments - Relative readings
Fig  A.7
a b
c d
Fig A.7 Distribution and descriptive statistics of absolute densitometry readings for NWASp 
and mWASp experiments
Actin polymerisation assays were performed under conditions described in chapters 2.7 and 
4.2.6. Relative readings are the unstandardised densitometry readings generated from the Uvi-
Chemi supercooled camera. (a) & (b) Scatterplots of  raw or natural log (Ln) transformed NWASp/
mWASp and actin densitometry readings. (c)(d) Frequency distributions of transformed data.Appendix     
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Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
3023606.965a 14 215971.926 23.895 .000
641346.914 1 641346.914 70.960 .000
2009607.221 9 223289.691 24.705 .000
1022334.725 4 255583.681 28.278 .000
351667.576 1 351667.576 38.909 .000
867665.741 96 9038.185
163412542.4 111
3891272.706 110
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .777 (Adjusted R Squared = .745) a. 
.
Page 1
Main Effects model excluding Cytochalasin D controls
Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
13951367.958a 49 284721.795 22.679 .000
3635.667 1 3635.667 .290 .591
1655206.318 19 87116.122 6.939 .000
1892997.471 9 210333.052 16.754 .000
322548.172 1 322548.172 25.692 .000
962376.040 19 50651.371 4.035 .000
2360203.105 188 12554.272
94737282.715 238
16311571.063 237
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Experiment *
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .855 (Adjusted R Squared = .818) a. 
.
Page 1
WASp*Experiment interaction model excluding Cytochalasin D controls
Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
16413060.578a 34 482737.076 29.518 .000
216351.047 1 216351.047 13.229 .000
8493473.417 20 424673.671 25.968 .000
3752469.513 13 288651.501 17.650 .000
1965263.222 1 1965263.222 120.172 .000
3973969.374 243 16353.783
120993799.1 278
20387029.952 277
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .805 (Adjusted R Squared = .778) a. 
.
Page 1
Main Effects model including Cytochalasin D controls
Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
17446815.856a 54 323089.183 24.505 .000
24888.570 1 24888.570 1.888 .171
1771584.482 20 88579.224 6.718 .000
3236962.409 13 248997.108 18.885 .000
524993.669 1 524993.669 39.818 .000
1033755.278 20 51687.764 3.920 .000
2940214.096 223 13184.817
120993799.1 278
20387029.952 277
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Experiment *
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .856 (Adjusted R Squared = .821) a. 
.
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WASp*Experiment interaction model including Cytochalasin D controls
Fig  A.8
Fig A.8 Complete ANCOVA statistics for each constitutively active construct analysis
df - degrees of freedom, F - F ratio, Sig. - significanceAppendix     
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Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
12988991.918a 30 432966.397 26.974 .000
189894.398 1 189894.398 11.831 .001
7907065.899 20 395353.295 24.631 .000
2231072.404 9 247896.934 15.444 .000
1846192.437 1 1846192.437 115.020 .000
3322579.146 207 16051.107
94737282.715 238
16311571.063 237
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .796 (Adjusted R Squared = .767) a. 
.
Page 1
Main Effects model excluding Cytochalasin D controls
Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
13951367.958a 49 284721.795 22.679 .000
3635.667 1 3635.667 .290 .591
1655206.318 19 87116.122 6.939 .000
1892997.471 9 210333.052 16.754 .000
322548.172 1 322548.172 25.692 .000
962376.040 19 50651.371 4.035 .000
2360203.105 188 12554.272
94737282.715 238
16311571.063 237
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Experiment *
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .855 (Adjusted R Squared = .818) a. 
.
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WASp*Experiment interaction model excluding Cytochalasin D controls
Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
16413060.578a 34 482737.076 29.518 .000
216351.047 1 216351.047 13.229 .000
8493473.417 20 424673.671 25.968 .000
3752469.513 13 288651.501 17.650 .000
1965263.222 1 1965263.222 120.172 .000
3973969.374 243 16353.783
120993799.1 278
20387029.952 277
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .805 (Adjusted R Squared = .778) a. 
.
Page 1
Main Effects model including Cytochalasin D controls
Tests of Between-Subjects Effects
Dependent Variable: Actin_percent
17446815.856a 54 323089.183 24.505 .000
24888.570 1 24888.570 1.888 .171
1771584.482 20 88579.224 6.718 .000
3236962.409 13 248997.108 18.885 .000
524993.669 1 524993.669 39.818 .000
1033755.278 20 51687.764 3.920 .000
2940214.096 223 13184.817
120993799.1 278
20387029.952 277
Source
Corrected Model
Intercept
Experiment
Construct_Code
WASp_percent
Experiment *
WASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .856 (Adjusted R Squared = .821) a. 
.
Page 1
WASp*Experiment interaction model including Cytochalasin D controls
Fig  A.9
Fig A.9 Complete ANCOVA statistics for each standard panel construct analysis
df - degrees of freedom, F - F ratio, Sig. - significanceAppendix     
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Tests of Between-Subjects Effects
Dependent Variable: abActin_percent
1132180.564a 8 141522.570 20.885 .000
40296.384 1 40296.384 5.947 .019
102592.677 3 34197.559 5.047 .004
215379.212 4 53844.803 7.946 .000
373824.390 1 373824.390 55.166 .000
304937.349 45 6776.386
16368726.453 54
1437117.913 53
Source
Corrected Model
Intercept
Experiment
Construct_Code
abWASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .788 (Adjusted R Squared = .750) a. 
.
Page 1
Main Effects model 
Tests of Between-Subjects Effects
Dependent Variable: abActin_percent
1163605.889a 11 105782.354 16.244 .000
19837.773 1 19837.773 3.046 .088
58649.774 3 19549.925 3.002 .041
218893.217 4 54723.304 8.403 .000
285518.730 1 285518.730 43.844 .000
31425.326 3 10475.109 1.609 .202
273512.024 42 6512.191
16368726.453 54
1437117.913 53
Source
Corrected Model
Intercept
Experiment
Construct_Code
abWASp_percent
Experiment *
abWASp_percent
Error
Total
Corrected Total
Type III Sum
of Squares df Mean Square F Sig.
R Squared = .810 (Adjusted R Squared = .760) a. 
.
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WASp*Experiment interaction model
Fig  A.10
Fig A.10 Complete ANCOVA statistics for each NWASp/mWASp construct analysis
df - degrees of freedom, F - F ratio, Sig. - significanceAppendix     
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Distribution of WASp and WIP densitomtery readings 
from binding affintity experiments
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Fig  A.11
a b
c d
Fig A.11 Distribution and descriptive statistics of densitometry readings for WASp and WIP 
from affinity experiments
Experimental proceedures and methodology for data selection are described in chapter 2.10.1, 
2.10.3 and 6.2.6. (a) & (b) Scatterplots of  raw or natural log (Ln) transformed WASp and WIP 
densitometry readings. (c)(d) Frequency distributions of transformed data, demonstrating ap-
proximate normality.Appendix     
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Fig  A.12 and A.13
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Fig A.13 Cdc42 pulldown by GST-WASp using purified proteins
WT Cdc42 was preloaded with either GDP or GTP as described for GTPγS in chapter 2.8.3. GST-
WASp beads were washed in XB and then resuspended with XB and Cdc42 to a total volume of 
300μL and a Cdc42 concentration of 1μM. Samples were rotated at room temperature for 1 hour. 
These beads were then washed 3x with XB before reduction and resolution by NuPAGE and 
western blotting. Membranes were divided and proteins larger than 50kDa were blotted for WASp 
using anti GST antibody, and proteins smaller than 50kDa were blotted with anti Cdc42.
Fig A.12 No effect of guanine nucleotides 
on WASp - WIP affinity
Cos  7  cells  were  transfected  with  an  equal 
amount of WT GST-WASp and zzWIP DNA, 
using  the  transfection  agent  JET-PEITM,  ac-
cording  to  manufacturer’s  instruction.  At  72 
hours cells were treated with 200μM of GTPλS, 
GDP or water for 30 minutes. Cells were then 
washed and lysed in 250μl of ice cold LB con-
taining protease and phosphatase inhibitors. 
Supernatants  were  incubated  overnight  with 
10μl of activated IgG Sepharose beads, and 
then washed 3 times in lysis buffer. The result-
ant beads were reduced and resolved by SDS-
PAGE and blotted for His (WIP) and WASp. (a) 
WIP  expression  in  lysate  prior  to  incubation 
with IgG Sepharose beads (b) Immunoblot of 
pulldown.
a
bAppendix     
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Fig  A.14
Figure 4.5c
Figure 4.8a
Figure 4.3a
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Fig A.14 Tyrosine phosphorylation of WASp during optimisation actin polymerisation as-
says
Immunoblots from the stated experiments were stripped following probing with anti-GST antibody 
and then re-probed with anti-phosphotyrosine antibody. Membranes were test exposed following 
stripping to ensure no residual signal was left on the membranes. Figure 4.5c and 5.8a were time 
course experiments, whereas figure 4.3a was an ATP cocentration titration experiment.Chapter 9     
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